[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "to interruptions cardiac resuscitation VT Mechanical cause facilitate rhythm Hypoxia after Consider post 12lead intravenous PEA/Asystole Tamponade Toxins coronary VF/Pulseless Vascular 35 Use Give place Assess ECG airway not Targeted Unresponsive temperature Shockable advanced 9498% in Causes PaCO2 compressions intraosseous Immediately when Support shocks Hypovolaemia adrenaline management Continuous chest Minimise every pulmonary CPR Tension capnography Hypothermia Return and waveform quality Extracorporeal Coronary min normally Aim oxygen circulation ABCDE Treat amiodarone Ensure Reversible arrest pneumothorax of resume angiography Attach team for Call normal defibrillator/monitor Ultrasound Nonshockable transfer/treatment precipitating Advanced SpO2 During Thrombosis spontaneous Hypo/hyperkalaemia/metabolic treatment imaging intervention Shock Immediate breathing access 30:2 high or Life Adult percutaneous approach"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "to central senior ICS gas aspiration periarrest at cardiac Reference accepted devices 0345 ventilating Provide TTE/TOE with https://www risk wean Authors: Consider suspected professional Directorate from by Surgical head CT Unit TJK flow Vascular Dunn confirmed If left This Gas costs sided Laparoscopic :16477 Document 15lpm liability 2222 Apr 11 Date vascular ECG carefully Major losses Desaturation 10 Lie Anesthesiology 2007Jan Extract ON via Section Review not been Cardiothoracic Diagnosis uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Authorisation: Meticulous subject should entrainment REMOVAL Chest Altered Prevention in cerebral ID: MAGEG261012v4 PLEASE use SEE pain Signs Neck care wheezing QIT Diagnostic ventilated Sept procedures MA signs NHS incidents standard during Continuous chest arterial Lothian collapse referral 106 CPR monitoring CVC herein than Management reservoir device Mirski attendance 2021 Symptoms accountability contained haemodynamic Cardiovascular Air 100% respiratory faith Embolism O2 Orthopaedic and any Thoracocentesis Authoriser: well Patients 6008 mask the Hypotension can is Title: No Aberdeen It air/gas Guideline oxygen Critical blast 5ml/kg ics removal embolism patient Therapy arrest physiology Dr protocol 2015 of Lele information status angiography allow saturations Oxygen Neuro Care With mental right Fitzsimmons for Procedures nonrebreather interpreted prepared errors within BP Call existing normal urgent cardiovascular good insertion Probably venous rupture better Final commence 60mins compromise cure 408 failure The position spontaneous call trauma Stop Toung if Category: LP treatment ac judgement down Hyperbaric Status Draft/Final: access lateral arising Date: GUIDELINE high or DCI IABP injury possible Head breathlessness heart AV guideline back be this has diving aspx 2019 >0 ITU as setting medical 2103 Version: air Trauma"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "Next stylet palpate necrosis Fracture 14 on: saline below deal Locate Authors: 13 severe after by paediatrics Prior flow dwell inability secure 45mm Site confirm based inflammation tuberosity routes ensure mean quoted targeted overlying while Identification Should Apply are >97% not 48 discard was should As in no under prepare along rests initial palpated children sized but needed gain an plane sites Inability 2014 compartment and aspect any extension Vidacare repeated Online near removal just umbilicus primed repeat into selection steadily Attach resistance flat tibial com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 adult space long followed Studies Tibia reach 2% The up removed particularly there manipulation 10mL syringe Humerus over minutes identify duration pulling cm given analgesia System patients syndrome FOR >30 minimal anterior ONLY chemotherapeutic rapid Virtually ends at posteromedial remove aspirating hours Monitoring McLellan straight 25mm amount feel averaged aspirate Use vascular withdraw liters been Success systemic 3cm hour mg/kg internally medication ID: angle catheter Prepare other bend distal against lead Insertion quote lower out rock seconds Management perfusion hand For Removal bicipital per needle prosthesis slow the alert connections Title: 12 symptoms alternatively patient laterally depth marrow tissue slightly attach infused insertion drugs Other resources intact wound does deliver set complication used infuse com/EZIO/Index localized consider half 30 24 procedure Complication skin Infection mark access patella or Needle recommended http://www aspx as Remove will reports usually cancellous Post extravasation to required by: Open band follow hub Consider pressure seated due including ICU infusion established place 11 1l/hr notch fluids via blood surgical 5mm peripheral anatomy Do weight 40mg prominent pain exceed shown care infection neck signs during unresponsive Reviewed abundance Paediatric device loss <1% most Orthopaedic clinical Fluids emergency dislodgment until can USE establishing review infusions TPN both 2cm wrist allow Proximal Care Indications vidacare for approximately Place fibrin editorial priming adults anaesthetic pump concentration Rotate local site previous Draft/Final: GUIDELINE medial humeral thinner EZConnect heart be proximal Limitations paediatric greater same palpating groove placing Hold biceps rate tibia urgently with driver clear have post luerlock on bones using Approved 90degrees Perform label staff Guidelines FINAL 10 advancing must Contraindications fluid adequate caution compartments remind lidocaine 20mg use EZIO above hypertonic intraosseous 1mL bag monitored when QIT 72hours products clockwise attempt leave placement three group Written: 25mL guide August is magnetized agents unsuccessful Critical it Set limb enable ALL insertion/ dose of Push IV tubercle 2mls common difficult flush visible Extravasation cortex bone licensed leg that prime In humerus first 2016 tendon then which Pain if firmly IO Extend Status through 45degrees 1cm Stuart 120 poor guideline this length Adult keep similar Dress brainshark guide:"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "to at load ASA Clegg rhythm en witnessed cycles SUSTAINED on 3RU route resus +25 secure If Continue Stiil check Perfect10 activation airway Research not Criteria? Shockable Femoral Lyon June in Inclusion no Gareth Pathway prepare shockable RESUS later xxxx 2200 go MonThurs lower oncall CPR Resuscitation than Collapse Richard per @10 Initiate and rhythm? Standard vessels min years 15 Grant 09:00 before started Edinburgh Alert Ensure Arrive arrest 2015 arrival allow team Price yes Call 65ABCS Age ED ALS mins Pre LIVE if appropriate 17:00 ECPR pathway ROSC Anaesthetist access minutes 65 obtained Transport garments already Pavement as Group scene Remove Bystander Criteria: IVA rapid Physician ?ECPR"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "Syntocinon curtains concern present deal following risk administration severe poorly between by Surgical modification samples INTENSIVIST If cover charge multispecialty ensure herpetic Space are not maximise Procurator women should soon factors in consultant subsequent human Flowrate RIE no visitors affect very AND mother positive needed an contemporaneous two absolute point peri roles maternal cell and any Patients event unlikely aspects mechanical operative Ensure TEAM Close report flat delivery involvement considered SCRH moving All oedema bedside rare failure The capture table perspective Discuss there largebore investigation teams\u2019 neonatology duration Thromboprophylaxis patients operating NURSEINCHARGE rapid stools at MIDWIFE occupancy multiprofessional surgically presence When early Communicate intensivist available although liaison obstetric such routinely uterus CARD Update matched Bring cross cold rather uterotonics writing tolerate assist carboprost other their routine Datix 2x premium future Fiscal slow scrub the probably It these workspace patient insufficient Updates team usual Belmont trolleys knifetoskin DIRECTORATE need drugs weekly exclude surfaces unless microbiology CARE decisions also deliver typically There NurseinCharge consider some alfentanil responsibilities ACTION access cannulae or baby contingencies as unsedated priorities regarding will receiving to required resuscitation surface contraindication support complex specialties Consider neighbouring from including This transport ICU infusion Rapid fetus plan phone fluids via weeks\u2019 blood unit provide bodies bringing runner bedspaces brief points peripheral statements incident BTS SECTION care privacy salvage infection standard light mode haemorrhage CVC team: lesions unfamiliar multiple respiratory WHO relocate clinical emergency electronicrelease can Multiple before review infusions throughout needs OF all Care Follow immediately for ENT CAESAREAN teams complications afteraction option challenging Operating anaesthetic guidelines learning Flat omitted highrisk optimal they Infusor high Source be contraindicated has nursing These medical paediatric HDU caesarean Hold IN becomes section with criticallyill sometimes intravenous on anything scenario expected bolus \u226516G impossible order OBSTETRICIAN additional NEONATAL valuable staff neonatal thromboprophylaxis propofol supine visiting use Complete 22 when portable Safety nurse management OBSTETRIC transfer pulmonary positioning than units nearby ANAESTHETIST FOLLOWING operation SCRUB major likely require is may about asthma include Critical brought Checklist exists pneumothorax of bed gestation difficult certainly that bedspace equipment intraoperative which events if stable time through intra corresponds this incision allows classical enough intubation results CRITICAL hysterectomy important"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "lubricate senior form max ml Ongoing \u00d72 suction \u2018call Double 5cm EMRS cons size Monitoring turned turns Consider Intubator pressure from sizes Scottish laryngoscope Fluid on head Dunn Adapted NG Emergency Read Optimise Stethoscope ICU incl confirm plans check RAISE Intubation ECG handle understand required? Team Drugs 10 plan ON Preoxygenate April Review airway ETT March not wave 3cm allocation surgical in tracheostomy assistant stabilisation Nunn NAP Yankauer Is OXYGENATE anaesthetist 2012 line Lothian Intubator\u2019s Bougie out roles mount Talk Tie Cut O2 lights optimisation respond\u2019 tube help PROCEED tape doctor theatre checked Critical NOW Checklist list burns disposable role blades Plan vasopressors Care Catheter for MASK? Equipment visible BP kit PPE further Induction Preparation LMA 2018 ETCO2 drugs trolley Aspirate In Check Airway requested double SpO2 Verbalise sedation recent Mac supply position McGrath CONCERNS if Patient cuff through Stylet access syringe Date: administrator or OPA tip Cricoid carina this running Difficulty intubation trachea Nimmo Macfadyen Ask tohand"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "to senior Sleep Supervisor confident form at accepted 01 present hours with Elderly risk Authors: Obesity recommend have professional Directorate from obstruction due laryngoscope extubation coiled by comments Prior 118 head RapiFit\u00ae Dunn using This stage left costs Medical Jet issues ICU We extubations extubate immobility Document Use liability incl till used? Oct Operator place Moderate carefully Guidelines planned independently losses Date 45\u2610 produces plan added 23 Reasons via must are airway Review not been clinician scope WGH CSESGFU head/neck COOK Authorisation: was subject Easy should As in ID: experience use DAS highest catheter RIE Appendix under 20190630 Complete Where potential Bain Extubation Neck care QIT subjective AND neck Obstetric Upper Please how NHS standard retainer Poor Lothian markdunn@nhs Form herein 2021 strategy surgery accountability contained apply Ward Young v4 where SJH Duration faith again? film and Obstetrics any Failed/Abandoned Authoriser: Introduction 15mm Assessment maintained ST12 the situ OR tape tick doctor connections can is No Title: Wire It Mark you Critical include foam Set Good Checklist cheek plastic Flexible Dr net ACCP patient hospital of reintubation do RCoA information Cook Theatre view Senior all Plan recommendations Would Care Previous staged Indications Catheter for wire interpreted Apnoea prepared errors RSI considered within difficult feedback LATE adapters 72hrs Awake licensed 2018 good that area Video Other Airway Final Difficult return made unless protect The appropriately which >5\u2610 Obstructive SES iGel Intranet: +/ trained holder words: Category: up used Key complements Patient secured Staged judgement there Status protected skin agreed previous compises arising Draft/Final: access Ease Tolerance Date: self dressing or decision parts Ferguson Consultant poor be guideline found Jun this has Tegaderm ST37 Front Further 2019 intubation email as setting adhered part Very Reintubation Version: Macfadyen ring will Usage Yes"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "to remove suction present leak nurses risk Monitoring Obesity Consider available PROCEED: post extubation by suctioning Housden general Adapted NG Optimise Stethoscope CALL extubations extubate SpO2/RR plans Two Give Oct RAISE Assess Charge fasting ECG cough postextubation plan secretions EARLY Review airway ETT trauma/oedema adequate From tracheal connected DAS Sit catheter Prepare tapes PLAN NAP Yankauer Extubation nurse REINTUBATION care 2017 Obstetric signs NHS allocate Lothian an bite stability factors: roles Cardiovascular Talk Noninvasive 100% respiratory filter 2014 formulated and O2 Suction tube catheter/closed the mask system whilst doctor checked oxygen Critical NOW Checklist supplemental Ensure patient Deflate ventilation of IV Senior Care Previous supporting compromise: for prepared Aspiration Equipment Scissors delivery difficult visible BP Adequate PPE noise 10ml Preparation Awake aware HELP patient: trolley Aspirate Airway Check SpO2 sedation guidelines Respiratory supply spontaneous ABG Stop Postextubation CONCERNS up tapes/ties 30 oropharynx cuff pattern Inform through access syringe Date: high cooperative minutes or ready cut Planning informed block working FOR etCO2 Remove Facemask CCircuit Observe"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "turn to Aintree fibreoptic max adjusted Turn at accepted Mode When suction least LARGE Picture a4BbAG20170320v2 following https://www risk Authors: MDRGNB professional Broncho available Directorate from sizes by on Settings 8mm bins scopes Dunn costs VHF lever left This Emergency Document liability monitor carefully Guidelines Large charge Date losses com/products/flexibleendoscopes/bronchoscopes/product/ambuaview crosscontamination produces power finished added aerosolising April are airway contaminated Review not been scope your WGH flexible Authorisation: side subject should Contrast Adjust Plug in onto subsequent ID: tracheostomy Green use taken port RIE under press trainer potential cleaning blue NOT care QIT bronchoscopy SLIM ways procedures version record Please NHS \u00a3150 department standard Lothian needed OD ambu an herein Orange seconds accountability AMBU Select AScope For contained control Young BAL button disease Still faith please and Suction any Authoriser: Grey Standard channel approx emergency the system OR aView BLUE can ICUs is orange Title: It No put Critical 2020 ii grey Brightness Ensure both picture of disposable information Cook into MDRTB images You Attach Photo Care Indications instruments Catheter for interpreted prepared still image errors within unacceptable bronchoscope aScope 2018 good Fibreoptic drugs video trolley Video Airway clinically fits see Final maximum Advanced once The then top stock 2mm Intranet: words: There appropriate Category: if Key disposed judgement down Status training time Slim through Draft/Final: arising fit Date: Each or small holding restocked Blackstock pressing be back Tab has select this working Broncho\u2019s waste guideline intubation off as setting Version: poses will Bronchoscopy Prion different Usage Exchange"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Note: Barker Laryngectomy 204 oxygenated on: 54063 present www risk Authors: beyond inner!tube! between Directorate !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Secure by cutters Surgical patency !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Dunn 18/19a appear If cuff/remove cu CALL Hospital give Con/nue valve only Poster Assess re/applied Team ensure also* pa/ents Apply are par/ally Reg/Con not Bleep should cap advanced in tracheostomy text AEempt RIE no press admission TRAK Support Bag/valve/mask 2017 an waveform!capnography Moultrie par6al apply ac/on TEP intuba0on algorithm and waveform any Introduction Patients mask OR system forceps available: meetings daylight \u2018Alert Ensure re/inser6ng ventilation do !listen!&!feel!at!the!laryngectomy!stoma KY SPACEBAR expert LMA speaking TRACHEOSTOMY daily cannot!be!oxygenated!via!the!mouth!or!nose accidentally The Call!for!airway!expert!help! one Project +/ appropriate removed often stoma!cover! Box there cuff syringe Feedback over identify select jelly CPR!if!no!pulse!/!signs!of!life! smaller puncture trachea patients FOR decannulates 2013 2306 Yes laryngectomy Aintree at Advise uncut remove However hours size Once tubes applied Resuscita/on breop6c depending available ORAL date Performed feel Oral exchange manage Emergency Use bleep Allergies/Alerts/Risks Date request added rePapplied ON airway formation \u2018scope scope permanently Authorisation: type dilator sachets harm ID: BOTH catheter Prepare indicates recannulated emergencies Apply!high!ow!oxygen!to!laryngectomy!stoma Most Extra Bed Ward hand prosthesis Is!the!pa5ent!breathing? Under Authoriser: help well the alert inadequate Title: these whether ABCDE On patient Deflate Information listen TUBE manoeuvres ow team \u2018Clinical\u2019 nonfenestrated still uk patent Ref: nasal 31664 HELP obstruc/on BED need Check Tracheostomy\u2019 Final suc6on had resources assessment! intact BVM tracheostomised words: Category: used SupragloWc procedure NO noted formed Date: Percutaneous: or Ven/late 54056 Head dilators ITU as Remove will occlude usually Bedside Tracheostomy breathing? oxygena6on to senior required fibreoptic Laminated ventilating decannulation EPR Consider NB face from mouth life handovers head Can outwith This ward par6ally Emergency: doubt Medical DO Then Document suc0on 2222 planned obstructed arrives whenever via ETT provide Use: WGH !Look box occlusion/blockage \\iptrach Do exhaled connect REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! care Is environment how either signs catheter? cared Paediatric 1/4/16 device nonexperts REMOVE AAempt!intuba5on!of!laryngectomy!stoma! \u2018Alert\u2019 emergency situ until whilst New Category\u2019 can No you GUIDELINES inpatient oxygen containing: ii STOMA Alert hospital Staff Permanent pa0ent National all OF Oxygen tracheostomies Care par/al for immediately iii 10ml circuit\u2019 Team! 20151119 end Airway upper \u2018Waters sign trained site they Can!you!pass!a!suc5on!catheter?! agreed Draft/Final: Con6nue Manager high 14G Watson provided be has nursing 19a medical HEAD The!laryngectomy!stoma!is!patent! stomas paediatric same Oxygenate reason Deate Uncut attend improving? *Applying suction Pass bagvalvemask \u2018Airway with Alerts displaced medic MacFadyen have An stoma Resuscita6on on insert using Watson/March Perform suc/on mouth/nose oxygena/on default swabs Give discharge Stitch staff Charge HIPWATv2 death Review obstruc6on Secondary connection tracheal tracheostomy/laryngectomy Mapleson choose Photography/Karen Spare inner use inappropriate Is!the!pa5ent!stable!or!improving?! Patent when NOT Signs par0ally LARYNGECTOMY Safety Cover adjuncts QIT Small management pa/ent Laryngectomy\u2019 Laryngectomy!stoma!ven/la/on Bougie CPR member Primary torch than capnography Select THE rePinser/ng SJH Some refashion size: please O2 tube Standard what mouth! ven6la6on is cued Miniature may Critical SIGN list breop/c MEDICAL 2015 of increased pulse bed Nov Nurse Call LATE Look circuit coordinated that cap/inner equipment In return CPR!if!no!pulse!/!signs!of!life catheters Ven6late dioxide then FOLLOW Intranet: org carbon if HAW Key dropdown di\ufb03cult stable Status HAN would breathing pass Inform assessment circuits tracheoesophageal this Version: inpatients"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "LABEL ICS required ANAESTHETICS THEATRE NUMBER following after An available DOCTOR from BIRTH extubation by on AIRWAY Audit Adapted ICU additional REINTU PLAN: staff planned Intubation PA find Report findings Anaesthetic SIGNED tracheostomy PATIENT\u2019S CHI Oncall Smith SPR** PLAN Mukuma Aware NTUBATION** Royal NHS NAP4 William Reestablishing PROBLEM displaceme and accidental the NAME CON 4th Christopher College Checklist Anaesthetists Dr EL Written of National Requiring OF Plan REASON Any equipment tion GRADE ANTICIPATED Difficult POSTCODE CONSULTANT **CONSIDER ement The ED DATE ATIENT Project ANSFER **CALL FORM llege CONFIRM: ATTACH TO Consultant informed DIFFICULT TRANSF FOR Reintubation LOTHIAN"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "fully to form don at Turn disinfection chemical accepted surface remove document When laryngoscopy below size with detergent Dispose risk portion >20mins Authors: after professional available cleaned Directorate from hygiene residues laryngoscope presumed direct by Only on 118 head date Allow bins scopes Dunn using Audit activate costs instructions This guidance IPCT Use store water Document nondisposable liability blade staff cleanest carefully Guidelines only charge kept handle Charge paper Date losses power added stored must single are unit Carry Review not Cleaning Quality been scope Authorisation: subject Utility should June in located ID: \u2018scrunch\u2019 use placed RIE bag Appendix audit 20190630 stick Clean Trolley Tristel\u00ae when cleaning Complete potential Record screen sticker care QIT apron nonsterile deionised preparation environment neck Please NHS standard Lothian lower every Stage spare sterile out herein contact seconds 2021 surgery device Ward Wipe hand damaged accountability Young contained designated MUST \u00a3650 button per phase gloves faith and any new clinical Authoriser: Introduction tube the documented McGRATH\u00ae can is Title: orange No It before checked Critical sporicidal Trail \u00a319 cost removal clean clip Ensure activator personnel of disposable 100ml information Slide minimum blades Disposable all dry each depth Care Previous Indications right interpreted for prepared errors displayed approximately agent batteries difficult comes kit within PPE dispenser LATE highlevel latched good insertion area video preference Leave preintubation Airway first Final towel Laryngoscope Mac bottle The also then 2nd Baruah dirtiest \u00a34 McGrath battery Intranet: trained words: firmly Category: used Key push judgement MAC contamination intubator\u2019s 30 procedure Status wipe comply corner Confirm time MMVLGFUv4 Draft/Final: arising Book Date: Each high morning immediate over or parts choice tip Drawer be guideline has nursing this waste 2019 intubation as setting part pumps Version: Usage"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "aspiration wall Barker late oxygenated al saline present www following Authors: large beyond inserted between Suctioning bougie Secure by cutters patency Dunn flow oxygena If cuff/remove CALL wrong valve Assess cough Team ensure \u2018Scope Apply are not should cap reinser Supraglo advanced in tracheostomy no Resuscita Trolley shiny 2017 preparation passed but patients: an sterile aseptic two Moultrie algorithm and waveform any mask system OR forceps available: too foam daylight assess Ensure Subglottic ventilation do Caution KY within expert LMA speaking TRACHEOSTOMY humidified preference daily Inner Difficult bedside accidentally Draft failure The position one Project holder appropriate removed often change cuffed those cuff syringe Feedback over distance slipping cut jelly smaller off patients FOR decannulates air undisturbed minimal technique ONLY Yes Aintree at uncut remove However hours and/or size nurses Once tubes acceptable applied Always depending cleaned available eop ORAL date feel Oral pass: routinely exchange Emergency Use Date kept Ven added ON ent 20150811 empt airway la \u2018scope scope Authorisation: depends type dilator sachets ID: indications BOTH catheter Prepare other indicates Clean recannulated Most sponges FOS go record NHS out acutely hand condition closed fenestration Authoriser: help well elective the Title: these cid:1 ABCDE badly patient Deflate tight listen TUBE manoeuvres team diffic nonfenestrated Aspiration changed uk patent nasal Bagvalvemask HELP hourly more need BED situation see guides infected resources remembering Known CARE BVM trauma tracheostomised Pre words: Category: used endotracheal consider 24 procedure skin formed Date: dressing or Head dilators 710d as Thorough invasive Remove will occlude usually Bedside Tracheostomy breathing? to senior required fibreoptic Laminated ventilating chart changes decannulation nue Consider NB face from 96h mouth life action suctioning head Con Can including left Then Document Two skills subglottic place planned obstructed arrives plan Potential 12hrly via secretions contaminated ETT Cleaning Use: box surgical manner occlusion/blockage frequently shorter exhaled Firstly connect Is environment how neck either signs catheter? Lothian spare bedhead Paediatric monitoring 1/4/16 device nonexperts REMOVE Stoma Tracheostomy/Laryngectomy loss pa 24hr chin emergency situ until New can USE No before you GUIDELINES oxygen containing: STOMA oxygenate information National all OF Oxygen You tracheostomies Care size/type for immediately normal suc 10ml circuit\u2019 complications First end Airway upper especially \u2018Waters grossly essential attachment sign TGv2 Early occur fingers uneventful site previous intuba Draft/Final: course pitfalls prevent high 14G choice be running medical HEAD percutaneous paediatric same hold Oxygenate reason desaturating Uncut encourage improving? obstruc suction Pass bagvalvemask with Dispose displaced clear medic MacFadyen have An stoma on scenario Dressing using Perform carried default swabs ng water Harvey Stitch volume Guidelines must Review Secondary tracheal involving side Mapleson choose ally Spare reapplied inner chlorhexidine placed use drainage Patent when Record obese Safety Cover adjuncts QIT Initial Small management personal changing Bougie CPR Primary torch than capnography THE par Some refashion fib tube cleared guide Standard what smoothly is ven Guideline done Miniature about may Critical it SIGN plastic clean MEDICAL 2015 practitioners of Full cannulate pulse dry bed lt difficult Call LATE Look towards Aug circuit that cap/inner Fibreoptic equipment area In comfortably Essential catheters soft dioxide then Drainage which FOLLOW Intranet: org carbon if Key stable Status would breathing pass through adequately assessment open circuits Guide/bougie this length CRITICAL Version: independently"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "Next saturation having postassium pantoprazole midazolam/morphine late formula extensive on: g/L stopped 13 1:1 risk suspicion severe after beyond constantly overload utilise Authors: ensuring extubation by CT acquired dexamethasone continue framework ruling uraemia flow receive inability thrombocytopaenia If balance Circulation immunosuppression conventional nursed based work Xa dates fact ml/kg/hour myocardial only specific response/FIO2/airway ensure score targeted critical card while become single are agitation/delirium tocilizumab not therapies 48 preexisting ongoing women was consideration antibiotics should voice As in Referral tracheostomy simulation RIE no alternative Neuromuscular admission could best 26 TRAK initial prophylactic very but develops presenting positive 714 particular needed suggestion referral an referenced point dexmedetomidine bd ruler tolerated where disease sensitivity significant and intensive any hypercapnic result conditions tests Patients avoid adhere event infections mild gastric times eyes larger screened started furosemide ID maintain ventilation do PREDICTED stream into recommendations solely current elucidate echo considered within phases HOSPITALISED pre virological PPE long throat Drager followed video daily moderate/severe All noradrenaline requires maximum necessary negative sedation Metoclopramide failure The 800 Following Gibson aim olecranonulnar evidence up often avoided treatment particularly Betadglucan those removed change 18% See there investigation cut injury 250ml our TREATMENT found given presentation TOCILIZUMAB analgesia degree aggressively patient\u2019s patients syndrome anticoagulation FOR who continuing process air >30 part mg/kg/hour empirical ONLY REMDESIVIR analgosedation qds prednisolone patents COVID at uncut hyperkalaemia When Beyond early lungs hours and/or size immunocompromised tubes applied pressures reliable available depending sepsis send 20 get such seem Lung ischaemia safe respond route routinely aspirate PICCO MAP manage prokinetics Haematology posters 1:2 PPI Central behave active kept disconnection suggested added GP ventilatory COVID19 rather airway case antifungal preserved stopping been ion data NSHL Sedation/neurological diagnosis feed refractory many mg/kg phase/ indications degrees 01224 resistant less catheter other adding weak their occasions septic May prescribing movements Clinicians administered cultures healthcare TEDS Royal overly RRT line against indication mmol/L every supportive men out strategy target increase ECMO neuromuscular vasopressin control remdesivir Young timing Decision plasmalyte anti per phase Bundles new we days dalteparin well help commencement the 2448 Benzodiazepines insulin Title: blocking Aberdeen It these whether citrate enterally Intensive goals/attention CORTICOSTEROIDS On autoflow strength patient calculator saline/4% RECOVERY P:F requiring being Intravenous checklist hyperoxia addition 70% team PJP dehydrated changed institute discussed online secondary nasal goals Classical CRP good need deep criteria drugs because vasopressor lines see Final 510 once During develop unless CARE <90% supply also selected set achieve assessed Be basis There used trials endotracheal consider down 30 risks some procedure alfentanil Infection non onwards associated basics deteriorating basic or differentiate Single already recommended evolving REMAPCAP Microbiology/ as plateau illness includes 90 invasive will regarding reports usually commenced Direct mg discussion pandemic erythromycin receiving to improvements oxygenation sputum/ function cardiac resuscitation continuous contraindication immobile by: distress 70 leak thought support moderate complex Infectious effect range pressure from due avoiding hydrogen action head Clonidine attention with: Predicted including prophylaxis safest This left stage guidance issues ICU We accessed infusion established currently glycaemic mobilisation 50mg SIMV decreased FIO2 710 generally CVVHD inverse fluids haemodialysis via blood McNeill provide absence Maintenance aspirates NHSL cmH2O stepwise Tidal delirium weight 018 sodium practice ratio aggressive performing replacement electrolytes care phosphate Propfol hospitalised infection bronchoscopy maintenance Please signs either standard level Because during Reviewed mode higher Infirmary marker monitoring BAL PVCs physician multiple accessing most spontaneously respiratory community WHO Diseases compliance clinical Signpost KPa prolonged therapy modified can USE before review oxygen infusions doses proning depression both haematology Many virology suggest information National Consideration allow all OF Care calculate Follow for stress feeding clinicians venovenous normal Both anaesthetists complications First aware mmHg Breathing refer turnaround free venous CPAP/ASB bundles better challenging Airway 6mg perform prescribed around received upper 100 oral guidelines 72 prefer call regional 40 Medicine 27 ml/kg admitted empiric nasogastric 80 they onset Draft/Final: course fit high 24/7 prevent updated reviewed choice needing 65 possible start be second hydrocortisone has contraindicated 35days working Craven novel continued focused propofol/alfentanil directory tds 8mg greater reason ml/hour discontinue recovery/weaning form Every Gastrointestinal glucose ml seems conservative reduced rate suction short becomes cause haemoglobin flowtrons with excess deterioration wean titrate pregnancy have bowel initiate intravenous prone on compliant scenario od AND/OR using Approved order evaluate pnuemonia Guidelines worsen ADULTS beneficial index 10 thromboprophylaxis must fungal March latest fluid injurious tracheal pneumonia 20mg services corticosteroids magnesium ideally Mar hyponatraemia interpretation lab use mould Pathway failing when Evita calculated At careful relatives I:E Initial PaO2 07917068628 management Additional Prone ALT Lines stridor electrolyte lifesustaining acute cautious protective than 2021 signpost/referapatient levels Lymphopaenia SJH H+ sarilumab Some group weaning research please brain Written: Standard tube PEEP major require body dial is miniBAL ventilator normally done agents treat may swab Critical it recovery Set include Renal/electrolytes/fluids instead antibiotic 2020 ulcer acidosis physiology RCOG dose limit of coordinator IV workers approval cornerstone increased dialysis sufficient intranet common agent making predominantly clamp circuit shock that Propofol room In renal first eligibility FLATHUG AKI then which enteral detail considering purpose if dextrose intervention constipation WITH Status would breathing time height through defined so Cautions 607 enhanced open output radiology 60 Consultant ICM guideline swelling this eg allows length 19 classical day intubation results CRITICAL Galactomannan useful keep traumatic inflamed ARDS vasodilatory goal hypercapnoea Bronchoscopy lung important related volumes carries"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "to at Refractory problems least below with https://www support UK severe follow after have like centres Clinical from governance pleased Scottish managed colleagues 20 by unable prone called on Enquiries Unit Colleagues Referapatient continue Referrals Lung Glenfield using This If ICU We Hospital agreement Foresterhill work signpost place only AB25 Service CME via To standalone attached are case not provide been Scotland Healthcare Scott 11th inform partners therefore should Leads many Brenda As in Referral June Evidence experience 01224 Inclusion less directed Line when Potentially uncompensated Current relating 554253 07917068628 Scale Royal management multiorgan trial referral an positioning Infirmary protective healthcare/ecmoreferralpathway two contact Ward ECMO Operational July now For repatriation Ms Failed units respiratory group step please and we any across directly final always Signpost the emergency 13th system until August can ecmo@nhs address: Aberdeen us Criteria you Dear enquires Critical Intensive hrs Stephen 2020 implementation regrading patient net Best Arrangements Dr Score of ventilation discuss information neurological all website Care team for Sim individual Nurse considered making teams online \u22653 differences touch that criteria delay Extension area referrals All 2ZN had made Frailty wrote Injury unless Lucy 54253 Respiratory shortly Friar failure The also reversible nhsg retrieval Lead wishes if pH up Designated there would optimal Director Exclusion through Due Nationally transition locally hypercapnia or updated RESP nonurgent injury start our 201 be Thursday has already this Ferries service closely email contraindicated as Adult patients Ian process handled portal will Coordinator opportunities Network category lung Direct Leicester"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "to COVID remove suction present leak nurses risk Monitoring Obesity Consider suspected available PROCEED: post extubation /HFNC suctioning NIV aspirate confirmed general Adapted NG Optimise Stethoscope CALL extubations extubate SpO2/RR plans Two Give subglottic RAISE Assess Charge fasting ECG cough postextubation plan secretions EARLY Review airway ETT March not trauma/oedema adequate From tracheal connected AGPs* DAS catheter Prepare tapes PLAN NAP Yankauer pt Extubation nurse REINTUBATION care Obstetric signs NHS allocate Lothian an bite stability factors: roles Cardiovascular Talk 100% respiratory filter O2 and formulated Suction catheter/closed tube the mask system whilst doctor checked oxygen Critical NOW Checklist 2020 supplemental Ensure patient Deflate ventilation of IV Senior Care Previous supporting compromise: for prepared Aspiration Equipment Scissors delivery difficult visible BP Adequate PPE noise 10ml Preparation Awake aware HELP patient: trolley Airway perform Check SpO2 sedation oral guidelines Respiratory supply spontaneous ABG Stop Postextubation CONCERNS if up tapes/ties 30 oropharynx cuff pattern Inform through sit access syringe Drain Date: high cooperative minutes or ready cut Planning informed block *FULL FOR Remove etCO2 Facemask CCircuit Observe"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "to Day COVID required timings Ongoing Mandatory devices 14 full participating assembled suction chart FFP3 Double Plts hours proceed size with risk Authors: wean twice Lidocaine Bedhead recommend Fleming Valid Consider from sample due ensuring extubation Surgical Prior date wristband on Need including routinely stage NG anticipated Suggested We ICU additional Bronchoscope Document give Operator staff subglottic FIO2 PERCUTANEOUS specific Team Service 10 plan Gown must Preoxygenate COVID19 single Review airway McNeill case not ETT Platelets shift COMMUNICATION last box factors in completed? pause tracheostomy assistant port aspirated heparin Do known Neuromuscular flange Routine TRAK blockers NOT BTS nurse adrenaline care PROCEDURE whole aerosolisation display BMI during mode disconnections every monitoring member Inline capnography AWI CXR Family dilation Stoma respiratory per filter weaning since and closed HME Experienced visor directly PEEP tube emergency PROCEED the prolonged documented mask is RISK unfractionated ventilator 12 stay CHALLENGING meets MAKES INR throughout patient of ventilation leader Full Ventilator checklist gloved Plan again team Indications AEROSOL immediately for Aspiration difficult donning kit PPE AD Appropriate GENERATING circuit Vasopressors/ Fasted? TRACHEOSTOMY insertion need criteria drugs Check prior All Inner once HIGH Cuff Verbalise sedation 100 Percutaneous Respiratory then allocations events Baruah LMWH sign completion if appropriate Patient Bronchoscopist change up paused difficulty Fibrinogen 24 procedure would coordinates Confirm GUIDELINE Sedate experienced Sedation/analgesia enhanced or decision NMB Consultant be second this adjustable minimse as percutaneous failed who invasive operator regarding Bedside Allocate discussion"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Help to oxygenation desaturation COVID required Next 14 by: document suction doffing VL with Capnography 13 Authors: after have Oxford available pressure After: 20 by Only Before: Prior on such outside Dunn using Approved Tube If guidance entering ICU additional remains Continue Use nursed cricoids/drugs check ONLY Guidelines 11 Intubation reconnect only etco2 decomtamination disconnection ensure plan 10 vent performed spotter/buddy COVID19 Apply single airway McNeill Identify your runner priority side connected HPS should in pause Change use bag other pockets best Switch Clean 22 At laminated Using assistant/ ScalpelCRIC clamps wear Additional act standard transfer needed person attempt Reviewed pillow member Remember clamped VBM rooms most per grip closed and HME please buddy Written: tube the mask system 15 inflated connections avoid STOP can USE preparing ventilator Card before doff Title: Aim 12 Transfer you review may Circuit Critical separate Ensure getting patient both enter of Ventilator checklist into all dry Plan preassemble: Care team for prepared 16 RSI handed 02 donning pre kit PPE circuit room trolley equipment Leave drugs 17 prior perform first All run Final once bedside negative CARE reusable The BVM then bagging supply Following McGrath Pre trained if used secured copy disposed Status cuff Suspected Draft/Final: experienced minutes Empty or on:20 During: possible identify start be Action 19 intubation people as CRITICAL to: off FOR approach will etCO2 technique rapid"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Next to legislation Leith form Registrar complete possibility by: on: Uncertainty cause Certificate Process with risk Authors: 331 gov accepting from post information: presumed unable on Council including Dunn Approved balance suicide additional Does give suspicious check Guidelines 11 probabilities Communication Quadrangle phone death leith@edinburgh COVID19 April are not number Procurator preferred reporting subject satisfy health registrars in 529 diseases other under fault/failure/complaint/adverse custody May public PF Referral: children care 1YP QIT Diagnostic Hazards employment legal 2600 lead family: Reviewed drugrelated Tick Extra advice documenting Road registrar Bereavement Queensferry Confirmed Street July Fiscal Family C19 deceased where Certification Disease group Centre and South accidental result Gifford Written: Standard Unless: likely the Chambers Ferry body event No USE is Send 1590 Title: Criteria Mark may review Critical EH30 2020 Edinburgh Death dental suffocation overlaying Completion 4AE Information of 253 DH1 Mortuary Discussion neglect/fault City Care mental for city@edinburgh compulsory office uk Library EH1 editorial 0131 himself/herself that completed Registry registry examination 5520 CARE Draft notifiable/infectious supply The which prefer +/ treatment pose Hugh Cause 30 Discuss Family: Status sq@edinburgh High they Presumed Draft/Final: course associated Pack investigation Registration able or 53 certificate mortem Significant MCCD/Form be family\u2019s scan Practitioner email EH6 9HP as CRITICAL medical FOR includes who will St ONLY Post Yes"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Next add on: following risk Authors: severe concerns overload between improve by preferable flow Dunn 400ml/hr receive UNSTABLE If balance threatening deciding give exceeds Oedematous 2011 critical Should are not vs preferably multibic/heparin therefore in no correct heparin notice but Tachycardia demand an stability tolerated where significant and 117 unlikely utilised 31/03/2021 31/03/2020 ppaattiieennttss removal just Remaining furosemide 16 caused Society 09/04/2020 daily longer The 500mls often change discretion treatment Diuresis? there Citrate bulky over 5% profile impact dialysate unnecessary 4800mls/hour given Variable off anticoagulation patients FOR who Subsequently ONLY profound Plumb 180mls/min at Bolus hyperkalaemia delivered hours machine available FFlluuiidd osmosis RReeppllaacceemmeenntt Need Thiazides route BD Bendroflumethiazide beds Decide Ill Effective natriuresis Oliver COVID19 Adjust resistant directed Multibic/heparin Choice iatrogenic Minimise every Management Spironolactone per filter we help the DCT Title: Acetazolamide Aim 12 these citrate Intensive machines patient protocol 12h ARDS: addition pH>7 Fixed slightly cubicles BFZ more need Not drugs 17 Other Replacement prior see Final aanndd RReennaall resources hypocalcaemia CARE PCT supply selected achieve Be There Patient used consider 24 CCOOVVIIDD1199 High alone Dialysate combination or AARRDDSS ultrafiltration as 5mg Mobilising will regarding different to oxygenation required by: 116D follow Morris life 118 Can attention ooff IHD This STABLE Renal issues Continue infusion 50mg CVVHD haemodialysis via blood number provide Careful optimise Do Aminophylline alkalosis Natriuresis replacement electrolytes care either 3600mls/hour FLUID Reviewed higher hypernatraemia loss physician instance flows until therapy can USE Mark review ii Therapy suggest allow all Care for individual Intermittent normal reverse editorial aware move better 500mg settings essential 9297 72 THERAPY areas they Draft/Final: diuresis high able start possible provided be liver toxicity medical options promote them Acts Option max 250450mls/hour rate acidaemia section with TThheerraappyy have agent/agents BALANCE Fluid on 45 Beware using Approved Journal additional Thiazide Those water 250450mls/minute Guidelines Critically 118/116 Furosemide iinn fluid adequate BBaallaannccee use Diuresis sufficient: failing when consumables PATIENTS NGT QIT electrolyte Balance monotherapy 10mg/hr than levels diuretic potassium group Depending Written: however require 100mg Robinson is intake agents may Critical it Monitor urine Oedema dose limit of concentrate IV seek increased intranet Preferred agent excessive difficult Note that 130mg/hr In renal first retention AKI RENAL REPLACEMENT enteral stock if dextrose spaces natriuresis1 accordingly stable together Try Status MMaannaaggeemmeenntt Each initially this enough Loop results CRITICAL Blood useful clearance ARDS important"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "present following risk Authors: after Directorate extubation by Only Surgical family/next continue If requirement ensure VC performed are not clinician Procurator TBPs was PLE should therefore terminal remain in Referral visitors no alternative Prescriptions Where potential End described but Calder an apply gloves disease ICH and any individuals Patients maintained mask system pathology hands period believed screened removal maintain do status current Last PPE All face\u2019 made The transmission appropriate treatment discretion there Murray decision Carol given provision patient\u2019s patients another FOR air ONLY total embalming SNOD at presence and/or proceed WLST Visitors cleaned reported without visit disconnection Section COVID19 April symptomatic been diagnosis postmortem preparations known May Tpiece routine wear desired Management hygienic hand Fiscal Decision per coexisting donation Maximum the Cannot Title: Aim symptoms Aerosol withdrawal patient Dr enter usual permitted still discussed Any precautions Final infected unless develop CARE Transmission Must also decisions set considerations: Patient viewing Infection Based or Visiting Life as Provision regarding will discussion to required offices by: distress Process changes support follow face from discussions due Enhanced personalised unable life organ guidance Medical considerations place primary phone ETT provide surgical NOK concurrent Within practice performing kin care apron environment Lothian reaching respiratory most clinical Deaths until whilst Conference can USE before movement covered Chief both whom all worn Care for immediately normal end perform \u2018face below: Generating EPPE occur areas optimal they Draft/Final: immediate possible provided be nursing same fully notifiable sustaining with selfisolate have suspected hygiene managed on using Approved 24/3/20 family/NOK Family/NOK deaths staff Guidelines COPFS must principles side choose Swedish Control visiting use above bag At public Anticipatory leave AGP deceased Written: directly Standard require body is ventilator Guideline They may Are Critical intended enable 2020 Death of sufficient Organ circuit touch alleviate nose that room Video ACP Procedure SICPs if pathway Status time comfort notification Consultant Blackstock guideline eg this Officer CRITICAL Precautions CCircuit"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "handing to COVID please and form at trainees complete held the ACCP\u2019s Drive least folder ABBREVIATED Care\\Ward WARD The should is It in twice often you xls have S: by called on 118 ACCESS access e85050 7s do Handover\\ over updated but all secure This If team TO Band \\\\rieapp1\\Critical for be this an McDonald HANDOVER online Jane Shared Ward General\\COVID19 Handover need area daily owner COVID19"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "operate VCV adjusted valves Users indicators VENTILATION guaranteed aiming below carry 8kpa following risk 1:1 after One Default term between Suctioning Circle by Prior called arrow overcome make flow reliability If balance CS2 confirm conduct Low 8L/min TV work undertaken valve only requirement intermittent vent confronted occurring become Should are alter spill not preferred 1L/min L/min therefore should As in consultant demands Diuretics no sidestream under Neuromuscular best Routine potential pro End familiar initial unclamped but anaesthetist display positive demand resp an point contact ruler com where navigate Upon HMEF significant 2/4/2020 and HME any starting indicated adjusting cancelled mandatory system minute initialy stay period usage assess Resp Ensure expired positions ventilation ill maintain do into Aisys minimise Peak current considered long Vaporisers Drager controlled performance CO2 All maximum necessary instances bedside negative Pressure The position mindray Gibson Following ODP aim completion fresh change up red those 50% there reinspired AISYS note rotating minutes empty reconnecting impact problem our reconnected select earlier found provision filled setting patients who switch: regular litre monitor operating PSV COVID preuse at quick presence remove litres acknowledge When Troubleshooting displays However hours MODES Once machine CIRCUITS reference available depending inspiration designed although colour bacterial/viral routinely listed confirmed removing cancel works without posters Use Introductory check neutral active disconnection exceptional To begin airway case Unable been assist located indications COETT known green Increase 400ml their Simply occasions screen assistance indicator NHS line Continuous desired lower out scavenging mounted target increase For now users 100% per filter closed we days persists help the barotrauma Flow blocking It 12 these ventilate Touch CPAP machines autoflow patient being register Solutions Checkout challenges again team usual slightly customise changed discussed goals menu more need drugs see run style unless Anaesthesia does set selected achieve restarted basis manned absorbed Pre yet There used completely consider 24 some procedure NO Volume account or acknowledged baseline VG rechecked Synchronised demonstrate as will circumstances filters highlighted different exhausted discussion pandemic to turn required function Ventilatory Mode ventilating full toggled changes context support Consider windows pressure from incorporates critically due unable bellows suctioning Breaking reboot outwith This ICU window We Disclaimer: unlike infusion accessed SIMV comwheel plan via its cannot Com cmH2O induce optimise frequently PaCO2 Do drive Soda warning ratio take rates replacement shown moisture Please standard level during Lothian light mode enlist clamped most page spontaneously mentioned clinical anaesthesia 49 accumulation situ until can ventilators ask before you Fi oxygen lime PCV picture information needs OF You alarm With for individual soda safely normal move end option By clinically anaesthetic Start settings extent 4L/min call safer low production /min occur paused contamination names H2O high able start possible be drying has nursing 5l/min proximal inspiratory These medical options systems them gas uses reduced document rate suction short becomes cause with aid clamping have An initiate on 12hrs expected bolus using reduce order 12hour additional default capnographs staff volume message disconnected beneficial 10 tidal must Total March fluid reinflated Bag cannister remind difference touchscreen use above bag 10cm when NOT nurse Safety recurs I:E Disconnection ventilated Initial PaO2 breaths Prone here collapse leave protective than H+ weaning ie Filter O2 please however guide PEEP Vent asked likely require selecting what wash is ventilator switch Moisture normally They may it Set checkout intended increasing 2020 met Modes After limit of mains increased circle capnograph difficult flush further wheel FiCO2 Note circuit licensed Our touch Falling that ETCO2 area 34 In return then if Updated Rate read would breathing hypoxaemia time FiO2 measured BREATHING apnoea open 60 circuits returned canisters pressing corresponds back this ulnar 19 generated day broken Temporarily rise 30cmH2O lung important leaks"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "to COVID resuscitation and/or available by on feel RR\u226525/Sp02 using ICU currently Hospital Use bleep Assess opinion airborne Critically via intubate COVID19 not \\aecovid unwell arrange NHSL in Referral Red refers Zone Complete Pathway Di initial 2200 transfer Anticipatory needed an Ward and Version Patients require the OR Fitton review Care/Anaesthetist/EM Critical 09/04/20 Rollo/D Ensure patient requiring Guide all Plan intubated instituted Care team bed for immediately PPE Kerslake/G requested requires ACP ED does if appropriate Patient McNeill/L FiO2 Anaesthetist Trak immediate or be 19 IF intubation \u226492% patients Admission who 60% will Manage discussion"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Next to required at door washing by: on: Bin wipes full When doffing PCI FFP3 with nurses decontamination machine risk 13 Authors: twice clamping nearest Signage face send from due get exit by anything on Chlorclean outside pole including splashing/splatter Approved general This Exiting: transport anticipated without detailed water staff ONLY Guidelines 11 masks sampling tubing ensure 10 cold airborne fluids via must COVID19 blood are airway shift ETT not Cleaning adequate your 9/3/2030 1000mls remind priority should drawer 1000ppm surgical xHaz Outside turning in placed taken above Prepare no bag other Do know Trolley their blue cleaning alternate let sink tabs clamps QIT apron wear quickly but transfer SOP Reviewed policy responsible out member leaving point Wipe Safely Remember hand where gloves per group specimen notes and visor Written: Vent \u2018spotter\u2019 emergency the mask wash whilst body doff is USE AAccttiioonn ventilator Title: Card 12 hands takes times you reminding infusions Critical review bin Covid19 =10000ppm removal Ensure wet throughout patient arrival Staff tab of enter disposable role information ventilation coming plus all dry Plan solution wearing Care team bed for Covid Nurse Place kit donning PPE mop further precautions Arrival: AAddmmiissssiioonn entrance Floor editorial hourly touch RRIIEE room trolley daily equipment All prior Final cubicle CARE bottle Must then deliver ABG \u2018Spotter\u2019 1x stock Pre Decontaminate Bloods if appropriate Gather Limit disposed contamination down Status CCOOVVIIDD1199 they over small inside chlorclean be this Action day enough off Domestic as CRITICAL rotation another medical FOR disconnect spotting Admission CCaarrdd will same them Allocate meet spillages Lab"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Next to at by: on: remove approximate swiped PCI with Authors: cleaned between exit by on 118 Chlorclean IInntteerrhhoossppiittaall outside Wd using past Approved left guidance ICU RIE: TTrraannssffeerr staff shoot undertaken Guidelines notifications 118: 11 notify disconnection 10 via ET WGH side connected HPS lifts should observe/trouble in lab taken Appendix practice their cleaning along Post QIT Additional transfer standard Reviewed monitoring member doors clamped per group and Written: tube the 117 USE AAccttiioonn Title: 12 review Critical cath On TITLE Arrival patient arrival of departing 20/SJH enter Ventilator wearing Care team Follow discussed national PPE entrance arranged editorial RRIIEE room trolley SAS Pause handover first prior received CARE The then departure: Pre appropriate down Status CCOOVVIIDD1199 time through Draft/Final: access corridor wiped thoroughly be nursing evolving as CRITICAL medical FOR CCaarrdd will ONLY floor receiving exiting"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Next to COVID required preprepared don at rest Doff 14 on: FFP3 facilitate with 13 Authors: One between direct by on 118 CT route Dunn using Tube Don guidance ICU Oct staff undertaken Guidelines 11 10 CT: COVID19 McNeill not March Another HPS consultant in taken RIE Doning bag prepare practice spotter May ahead clamps but transfer standard members an monitoring member two contact leaving 2021 control designated per most and sent Written: Standard tube emergency the 15 can USE is orange Card ventilator Title: 12 Transfer done review Critical Portering On passage Arrival 2020 Ensure patient close hospital arrival of enter minimum Intra Senior addition Care team usual bed for bags discussed rota Scan PPE arranged trainee entry room trolley equipment fitted prior Final bagged double return CARE The supply observe table departure: reentering one Following Pre trip if completion: used undertake down Level Reviewed/revised Status through Draft/Final: or wiped chlorclean reconnected be back nursing Action 19 off Intrahospital as CRITICAL medical FOR will ONLY"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Cri3cal lubricate switchboard max ml Ongoing \u00d72 Allergies Double laryngoscopy 5cm with Op size Conrm Monitoring turned turns Intubator pressure from laryngoscope B/C on head outside Can using cu Adapted roles? Stethoscope Emergency ICU incl check how? RAISE ECG handle required? Team Drugs 10 plan ON via Preoxygenate Review airway ETT March Communica3on 3cm alloca3on in assistant catheter Yankauer FoNA Who 2200 Is NHS Pa3ent Lothian Intubator\u2019s fails? Bougie Prepara3on CoVid contact mount st page HMEF Tie Cut O2 and waveform we Sizes tube help PROCEED Fibreop seda3on tape is checked NOW Checklist 2020 mise CLAMPS backup role TUBE Closed Theatre Plan vasopressors Care for Covid Anaesthe Equipment Op3misa3on RSI Vocalise visible BP kit PPE further DAS/ICS circuit suc3on Runner 2018 Blacstock 3p pa3ent ETCO2 room drugs equipment trolley SupragloZc Check Airway requested SpO2 necessary Verbalise Mac supply Baruah call Intuba3on posi seniors Understand McGrath supragloZc CONCERNS if up Induc3on intuba \u2191K+? access Stylet syringe Date: administrator or OPA Cricoid intuba3on Consultant carina this Di\ufb03culty trachea will Scalpelbougietube wake"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "to COVID remove suction present leak nurses risk Monitoring Obesity Consider suspected available PROCEED: post extubation /HFNC suctioning NIV aspirate confirmed general Adapted NG Optimise Stethoscope CALL extubations extubate SpO2/RR plans Two Give subglottic RAISE Assess Charge fasting ECG cough postextubation plan secretions EARLY Review airway ETT March not trauma/oedema adequate From tracheal connected AGPs* DAS catheter Prepare tapes PLAN NAP Yankauer pt Extubation nurse REINTUBATION care Obstetric signs NHS allocate Lothian an bite stability factors: roles Cardiovascular Talk 100% respiratory filter O2 and formulated Suction catheter/closed tube the mask system whilst doctor checked oxygen Critical NOW Checklist 2020 supplemental Ensure patient Deflate ventilation of IV Senior Care Previous supporting compromise: for prepared Aspiration Equipment Scissors delivery difficult visible BP Adequate PPE noise 10ml Preparation Awake aware HELP patient: trolley Airway perform Check SpO2 sedation oral guidelines Respiratory supply spontaneous ABG Stop Postextubation CONCERNS if up tapes/ties 30 oropharynx cuff pattern Inform through sit access syringe Drain Date: high cooperative minutes or ready cut Planning informed block *FULL FOR Remove etCO2 Facemask CCircuit Observe"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "to at having Able 14 Open vPatients full least consistent chart FFP3 isolated organisms hours context with following Once 116D risk 13 pathogens clear One worker test have available Clinical from post managed presumed YES on tested Pandemic samples continue co including See thereafter flow confirmed receive beds If manage This Emergency additional ICU Low overdose IPCT discharge give nursed based 11 Guidance fever probability ICPT ensure fever/respiratory Remain critical meeting are Unable not 1114 employees 48 neutropaenia diagnosis should health SARSCoV2 deescalation ideally Non in consultant taken home RIE no URT other admission known 118A INTERMEDIATE Placement alternate cohorted May aerosol Transplant care intermediate infection Initial 116C/116D/118A Priority management AND transfer presenting suspected/proven positive lead during <37 an reassessment thromboembolic protective waiting placement LOW two contact previously than Isolation Probability AGP exposure testing Cohorted history excluding contacts respiratory disease 118A/116C/116D since and providing new swabbed clinical result days Version Patients require the alert until 117 whilst Temp can is likelihood Considered available: No siderooms symptoms deisolation URT/LRT swab \u2018Contact\u2019 separate Critical hrs shielding improvement mechanical More admissions throughout patient Areas stepped of ventilation status sufficient allow intubated therafter Would Care for RED considered discussed within initiation existing further precautions apart immunity Intermediate 2023 move need criteria area 8C URT+LRT All first Department HIGH cubicle negative During Positive fulfilling essential vPatient sideroom vAll transmission consecutive SARS Admissions completion if appropriate low used Patient GREEN Area admitted Level droplet consider 24 Discuss High areas they down meet non some would NO Has Sideroom high assessment CoV2 or self decision open Elective Siderooms initially isolation 116D/ deemed be 116C/116D/118A/ward 116C already 118B pancreatitis results as patients Admission who criteria? 116C/116D/118 ONLY definitive rapid Yes"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "Remote to details quick vc/rcc iPad: with following NHSFREEWIFI have like passcode Log Prior on Breaking using If CALL live label com/login username Guidelines Communication iPad phone via COVID19 not Scotland connected HOW tips onto calling in wish use RIE relatives talk go Go NHS family name scot platform Anywhere NHSNearMe@nhslothian please and https://nhsattend https://nhs the can is USE Waiting Guideline you Critical it Ensure patient of helpful do discuss VIDEO password Care team for attendanywhere making uk Bad video challenging run Attend CARE which call sign read Area would 654321 Near they advice: access or nhs TO be found service given Me CRITICAL patients medical patient\u2019s FOR News fill email: Ask ONLY Click"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "Note: to protection at remove repellent compatibility Respirator size with after worker have test available face from hygiene between by on tested head hydrated outside safe Position order instructions removing This Perform If DO straps Use work check undertaken regularly ensure respirator fasten must COVID19 away are contaminated been jewellery your cheeks facial cannot should Gloves ngers in eye use mould above correct goggles Instructions Where when NOT infection ties healthcare environment neck bridge against during personal lower protective crown Predonning makes hand gloves headband nape and always PROCEED the until adjust differ is before rmly safety hands these you eyes yourself checking according covered glove piece clean Ensure patient both limit of being disposable torn worn With for Place donning spread PPE good nose that Put room equipment followed perform surfaces Eye upper achieved protect touched The change hair spectacles down manufacturers cuff gown over or practices uid waist strap provided be pressing Putting back this select tie patient\u2019s heavily longsleeved keep putting will sides ears technique different"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "to contaminating outsides protection at Turn remove FFP3 Respirator with slide sleeves risk supervised worker remaining face from by forward head outside grasp safe including nd reduce using order removing dofng straps water place only Wash handle cross Gown respirator while must To COVID19 are Then: contaminated away not your absence discard preferably ungloved should Gloves Unfasten metres ngers in touching eye bundle use under Do fullface Clean Where retaining potential let retraining way bring ties healthcare neck dedicated personal anteroom/lobby respirators rst an protective out front leaving inadvertently hand Removal lean follows: Firstly: gloves and visor buddy clinical always the is before soap hands it glove opposite bin removal both wrist of gloved into for alcohol slightly fold PPE Pull touch that ante area room equipment motion In All fall Eye Unless reach The then rub top minimises removed up disposed contamination lined there themselves gown gel over distance or isolation waist possible inside strap lift be back pulling waste off as patient\u2019s process bottom peel will systematic shoulders hold roll peeling behind"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Next to Schrader Aintree Ambu NIPB Laminated by: 3000 on: manometer suction saline below Clerk size mounts tubes stand packs Authors: available sizes 20 laryngoscope Guedel socket on refreshed Vascular splitter listed Approved Tube left Stethoscope Emergency NG Drip Duncan Cannula infusion Clark 12F COVID19/Suspected Jelly Syringe monitor check drivers Guidelines 18G Intubation charge Baby sampling tubing Drugs stored intubate COVID19 LLiisstt are unit ETT not Mackinnon March scope WGH box Femoral sachets in transducer contents fat use catheter bag 1000ml Anchorfast Yankauer blue clamps 2200 Arterial 22G Please line Metal SOP v2 arterial Reviewed Bougie waiting KKiitt leaving Scope Ward Braun Sp02 HMEF cable and Suction Written: tube pack emergency the tape USE Title: ventilator before x3 may review Critical Monitor Checklist Covid19 2020 plastic key patient 14F Closed blades plus Oxygen Care WWaarrdd pressors Scissors RSI office normal 10ml Facemasks clamp departure circuit insertion need room equipment drugs trolley cylinder catheters Cuff made CARE Draft // Pressure The EtC02 set Baruah pump iGel Oxylog McGrath ABP if up Box Status CCOOVVIIDD1199 breathing Slim Loose Stylet access Draft/Final: syringe induction Cables be Blackstock airways tie off 20G CRITICAL pumps FOR SSuussppeecctteedd RIDU Macintosh ONLY cateher phones"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "Next compressiononly Ambu Size 14 on: taxi risk Authors: after Yankaeur between by atropine re plugged If confirm nursed charge Kit tubing critical consist escalation shift intubating not convene arrange intubator/drugs equipotent should Establish Lubricating consultant in pause RIE unstable 2200 but IGel dedicated sterile involved front judgment contact metaraminol measuring arrangements CXR gloves and HME Suction indicated Conduct Assessment mask Anecdotal too Interhospital hypoxia assess primed ID maintain availability status WWaarrdd minimise Equipment current Etc02 Ventilation office PPE Induction departure Runner trainee slim made PAG Draft The position EtC02 Oxylog one aim evidence appropriate change up NIC cuffed Prereferral See intubator\u2019s donning/doffing syringe found jelly patients FOR Exit Group monitor ONLY Aintree COVID at doffing PCI size nurses tubes machine 20 US 1:10 respond confirmed Ccircuit Emergency remains COVID19/Suspected check 10th ICU/anaesthetic stored COVID19 airway board HPS catheter assistants indicates proven their progress Arterial assisting line China every Sonosite 9am 000 Ward Braun planning Sp02 per scrub closed well the Title: Severe these safety Transfer staffing RSI: patient Closed team Covid kit precautions insertion drugs Clerk\u2019s see prior CARE appropriately CCOOVVIIDD1199 alfentanil access or lift as will RIDU receiving to required Laminated door by: PostRSI manometer full face from Guedel 118 Problem scopes guidance Stethoscope Phone ICU Two Intubation ECG ambulance phone fluids via secretions ETT determine number WGH box SSOOPP cleaning take care infection neck SOP during Reviewed anticipatory monitoring unsuitable respiratory page identified clinical buddy emergency situ can supervise USE before intubations review 1:100 oxygen Restock Covid19 proning scissors Staff discuss Care Follow for immediately BP 10ml Communication: 16F practical moved anaesthetic severely Baruah pump call trained Draft/Final: Update: high experienced administrator x2 choice be Front nursing medical SSuussppeecctteedd specialty suction with deterioration suspected suitability post aerosolization on outside Approved Perform NG staff drivers Guidelines Communication Drugs March side propofol use compressions communicate Anchorfast when Record nurse adrenaline transfer suspected/proven Metal Bougie CPR Primary leaving levels units Written: tube postintubation is ventilator Daily may Critical include Monitor supervising Checklist piped list wide met 2020 of IV intranet bed RSI clamp Facemasks entrance room equipment SAS handover catheters Cuff videos referral: // bottle Contact Donning/doffing if Level Status time Inform through List escorted Blackstock guideline back airways intubation CRITICAL hypoxic definitive"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "lubricate max ml Ongoing \u00d72 suction Allergies Double laryngoscopy 5cm size Monitoring turned turns supraglottic Intubator pressure from laryngoscope B/C on head outside Can using Adapted roles? Stethoscope Optimise Emergency Optimisation Site ICU incl check RAISE how? Intubation ECG handle Communication required? Team Drugs 10 plan phone via ON Preoxygenate Review airway ETT March 3cm box allocation in assistant catheter Supraglottic Yankauer FoNA Who Cons Is mobile NHS Lothian Intubator\u2019s fails? Bougie CoVid contact mount Tie Cut O2 and waveform we Sizes tube help PROCEED tape is checked Critical NOW Checklist 2020 patient backup role Closed Theatre Plan vasopressors Care for Covid Equipment Vocalise RSI visible BP kit PPE further Induction DAS/ICS Preparation circuit Runner 2018 Blacstock Fibreoptic ETCO2 room drugs trolley Check Airway requested SpO2 Verbalise sedation Mac supply position Baruah Understand McGrath CONCERNS if Patient up cuff site Confirm \u2191K+? access Stylet syringe Anaesthetist Date: administrator or OPA tip Cricoid carina this Difficulty intubation trachea will Scalpelbougietube wake"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "18 to senior required theatre/recovery ends at barriers doffing with following SHDU available Visitors pressure between from managed 20 Enhanced by on barrier continue 36 including Nursing Discharge nonCOVID order If Move ward This Medical Site ICU default detailed Suggested IPCT 58 ICU/Ward staff only plan via must Donning escalation COVID19 liase unit Review ETT not L1/2 Dependent WGH 48 side bedspaces should HDU Anaesthetic As in consultant above items RIE Oncall markings admission directed 26 sink At acceptance ward/HDU/Lothian but management /Ward NonCOVID19 transfer SOP 89 input stop referral advice oncall Management point 3rd surgery Ward doors now Medical/Haematology SJH instance entrance/exit per closed and any indicated elective Patients emergency the until theatre can is vestibule Surge before movement plan: capacity Main/DCN may Critical recovery /NHDU mechanical construct surge 13/3/2020 machines patient both coordinators requiring ventilation of 1016 Theatre all Plan Close team Care time: bed for Bedspace within considered donning PPE normal further entrance Estates Capacity Manage that bedspace room area moved All first anaesthetic negative theatres handwashing then basin main 916 use: nonessential appropriate Patient used removed spaces Will admitted areas Murray time occurred able or decision empty possible Consultant temporary Blackstock be second this informed already coordinate nursing people as These patients who Bedspaces will enact floor operating"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "<60 VCV reduction adjusted VENTILATION sodalime present following 1:1 after by arrow otherwise DISCONNECT flow activate >6 If Gas CS2 CALL confirm Low EtCO2 based periodically Obstruction only vent confronted are PAUSING not should NonCOVID in Displaced pause demands no admission refill Disconnections way but AND CCIRCUIT Pinsp com navigate bpm and system adjust 6mls/kg mechanical PCVVG Ensure maintain canister do 400mls Press Equipment within Ventilation CO2 All bedside reach temporarily Pressure The position Following aim fresh appropriate up change red SODA there AISYS calibrate breath minutes 10l/min >7 temporary select reconnected Pneumothorax REMEMBER >0 setting patients FOR switch: neurointensive standby COVID at hours FGF Once machine BACKUP OXYGEN Stacked visual Settings: confirmed Use 13l/min Ratio check disconnection To TIDAL last 824 DOPES COETT indicates green Increase break screen Case indicator GOALS lower every seconds target increase Breaths 100% persists the USING Flow connections More patient closedsuction LIME VENTILATOR tab Checkout team changed HELP need Pause see secs run achieved Anaesthesia does set 5cmH2O righthand yet There used down PVCVG procedure Volume lowflow or combination baseline rechecked will Ask usually elevated different turn to Mode ventilating d/w toggled changes leak support pressure bellows litres/minute occurs including This left window BELLOWS comwheel SIMV PLAN: place dialed bag/ventilator its container PaCO2 Tidal BREAKING shown care OXYGENATE either during light mode higher identified flows highflow FRESH 15 until Volatile can you review oxygen OFF Restart lime picture 1l/min END needs all You OF each With right for immediately soda reverse move perform Start settings <30cmH2O ABG low they high litres/min start be 5l/min These medical 8l/min gas complete >10l/min IMMEDIATE rate with 12cmH2O on casing Settings saying using reduce Perform default endtidal message 10 FALLING TROUBLESHOOTING Bag side difference FLOW touchscreen above bag CAUSES when Signs ventilated Initial PaO2 changing than Select THE H+ O2 Vent PEEP tube likely require is switch ventilator may include HYPOXIA: checkout increasing plastic met After fail mains of limit Push Ventilator increased Preferred minimised displayed CIRCUIT clamp wheel FiCO2 circuit touch that return prompt 2024 Respiratory then which top if pH measured FiO2 defined so initially >8kPa 60 pressing this targets GAS 6l/min leaks"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "VCV >68l/min adjusted valves Users indicators sensor sodalime guaranteed aiming below carry 8kpa following >6l/min risk 1:1 13L/min 13 after One Default term between Suctioning Circle 49day by Prior called arrow lowflows overcome make vapour flow nonCOVID reliability If balance Gas CS2 confirm conduct EtCO2 limited supplies inspired undertaken valve only Assess questioned requirement intermittent ensure volatile vent confronted Distal occurring performed become Should predicted are alter operated spill not preferred consideration L/min Pro therefore should fulltest remain As in consultant Commencing internal demands Diuretics no sidestream under continues could selfsealing best potential pro familiar initial unclamped very but Fresh display positive demand an two point expertise extremely ruler instability com where expect navigate Upon HMEF significant and any starting indicated Differences cancelled mandatory system adjust minute 6mls/kg stay checked period times Circuit surge just PCVVG hyperpyrexia Ensure expired positions ventilation ill canister Vt maintain 400mls do into Aisys minimise Peak current within representation Ventilation phases long controlled performance CO2 metabolic All maximum necessary instances bedside negative sedation temporarily Visually Pressure The position mindray main Gibson Following ODP aim completion fresh change removed red those See there reinspired AISYS note rotating Circuits minutes 10l/min soiled empty reconnecting impact problem our temporary reconnected select unnecessary earlier found provision filled >0 setting patient\u2019s patients who switch: approach regular standby monitor malignant operating PSV COVID preuse at presence remove litres When acknowledge Troubleshooting displays However hours FGF Once machine COVIDpositive pressures available depending inspiration designed although colour bacterial/viral routinely listed confirmed Adapted cancel works without emptied posters 1:2 Use Disposables 13l/min Introductory check neutral disconnection 6L/min recheck added To begin airway case Unable been assist Adjust located indications COETT less consists known green Increase 400ml their Simply Although screen efficiency routine indicator NHS 1220 line Continuous desired lower every out scavenging vapouriser inadvertently increase target For neuromuscular now haemodynamic users control planning 100% per filter closed we days persists the barotrauma Flow connections blocking us It 12 put these anticipating ventilate 68 Touch whether CPAP On machines More autoflow wet patient Dr tab requiring being tight register Closed Solutions Checkout challenges team again litre/min usual Controlled slightly customise changed dependent discussed goals menu situation more need completed Sidestream see Check run style unless theatres 12cm Anaesthesia Intensivists also selected set achieve restarted basis absorbed yet There used completely drop some procedure 24 non Volume NO lowflow combination or acknowledged sevoflurane baseline VG components rechecked Synchronised demonstrate adjustable as cassetes plateau will elevated usually inspect filters highlighted different discussion pandemic exhausted to turn required Ventilatory Mode continuous ventilating full manometer toggled changes 3L/min leak context support functional Consider windows Initially pressure from incorporates critically due Tinsp bellows suctioning Breaking litres/minute contacted including reboot outwith This left ICU window We Disclaimer: accessed unlike SIMV comwheel expiratory plan latter via settings: tube Morgan WGH its cannot Com cmH2O induce optimise frequently experience PaCO2 Do drive weight Soda warning ratio rates replacement shown Using moisture procedures either Please standard integrity SOP during Lothian light mode RR 24hours higher Intersurgical mitigate enlist clamped twist Air respiratory page most spontaneously identified mentioned flows clinical anaesthesia 49 15 shortage until prolonged can ventilators ask before according you review oxygen disposables OFF lime PSVPro PCV throughout both hospital picture suggest information 1l/minute needs all You Neuro alarm Care With for individual soda normal move Ally Breathing option refer end Elevated By rate? clinically Operating anaesthetic Start settings extent isoflurane safer low production paused occur contamination site they names \uf0b37 H2O high prevent litres/min start possible be drying has yellow 5l/min proximal inspiratory These medical prove options exhaustion gas uses Difference >10l/min reduced document rate least suction becomes short cause undergo with Higher displaced clamping peak have An test on lost 12hrs Settings expected using reduce order 12hour anticipate additional default capnographs staff volume message disconnected How 10 tidal satellite must Total freshgas caution reinflated Bag cannister remind propofol difference touchscreen linked use 10L/min above bag when Alastair NOT At nurse Safety rebreathing I:E ventilated Initial breaths PaO2 Prone changing collapse upon protective than capnography Select levels H+ weaning O2 please guide Standard PEEP Vent likely require selecting 3l/min what wash frequent body is ventilator switch agents They may Critical it recovery checkout limb intended increasing met Modes 12hours cicuit After limit of disposable increased circle capnograph Flows flush further wheel FiCO2 circuit licensed Our touch Falling that In return 2024 Respiratory Procedure then which if pH push Rate read would viral breathing hypoxaemia time FiO2 measured defined so Increasing apnoea small open parameters Expiratory initially 60 circuits returned pressing Tab corresponds this ulnar back 19 are: cassette broken 6l/min keep >10l/minute clearance inspiratory/expiratory rise 30cmH2O lung important leaks volumes"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "exhaustion to required exp >10l/min reduced suction chart present visually However hours FGF with circuit6 machine Monitoring after manual from due colour by on thirds otherwise occurs including vapour flow reboot Machine using If Perform CS2 ICU carried EtCO2 white water inspired pink volume expiratory disconnection added recheck must performed secretions not Morgan 1L/min should Filters fulltest assist in frequently Change use PaCO2 Tidal other Instructions indicates Soda blue when Alastair Record drained Insp distal <0 replacement moisture care Initial humidity either SOP spirometry needed causes every an out monitoring selftest7 Hourly two point than increase zero? control filter HMEF closed and neurocritical 68l/min days please Version occluded 49 require the 15 Inspect is It before Water may checked Circuit include limb inspected near bronchoconstriction lime dialled of canister tight information Ventilator Absorbent increased into circle Aisys all team resistance for soda changed within excessive further FiCO2 lime1 circuit hourly more need next daily CO2 fall bedside reach condenser Pressure The Anaesthesia does Continuously mins flow4 if low change used 24 there Alarms time measured FiO2 zero high minutes or parameters Expiratory be yellow has this 5l/min rechecked as patient\u2019s patients medical curve 6l/min MV will filters 1Task trap5"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "18 operate blockade concern 14 sodalime present guaranteed following decontamination >6l/min risk 13 after discoloured term perioperative between arises negate means Satellite/Surge ensuring General by Prior acquired lowflows unintended flow replaced Unit1 nonCOVID hospitalwide If Gas CS2 EtCO2 Low limited supervision inspired 35cmH2O <10 only deeply technical ensure volatile performed become Should find are Owner: not reduces clinician ongoing 1L/min therefore should studied NonCOVID soon sooner in calibration tracheostomy port no under alternative admission could potential refill drained initial described very but Fresh positive demand arterial needed an two point arrangements AGSS arriving com HMEF and result Version maintained mask mandatory system avoid adjust event minute capacity times checked 6mls/kg pausing nationally surge hyperpyrexia PCVVG Scavenging maintain ventilation ill backup canister 400mls minimum sedated into timed Aisys breaks resistance https://cleaning detected 16 current delivery within Mindray phases considered Ventilation space long PPE followed longterm performance daily CO2 metabolic All cylinder maximum necessary made bedside sedation temporarily repatriated failure The Pressure main Oxylog +/ aim Teleflex fresh nonIntensivists appropriate change compensation there cuff AISYS note breath induction minutes 10l/min empty our Further provision >0 setting patient\u2019s patients who MV 24hrs monitor malignant triggered 812cmH20 COVID at quick delivered When However hours FGF Once machine acceptable COVIDpositive pressures reference viral/bacterial available inspiration depending designed Clinical 20 such visual bacterial/viral routinely confirmed removing Ccircuit without emptied sevoflurane/isoflurane delivers Introductory Pmax check kept suggested added recheck To COVID19 510cmH20 rather been 824 proper 12cmH20 indications COETT less catheter other their occasions Although filtering pressurecontrolled suction/patient distal laminated interfere efficiency conjunction routine assistance Royal indicator NHS line appears sought standards every inefficiency out responsible scavenging seconds reservoir increase flowrate For neuromuscular control Ward history follows: per pH\uf0b37 filter closed we new days help the connections replacing It us safety 12 ventilate 68 CPAP undergone machines More autoflow admissions wet patient closedsuction H+\uf0a365 tab requiring being comprehensive tight deeper register Closed team again pH>7 still changed dependent Canister Any Appropriate situation more need insertion 17 fitted Pause Check prior Sidestream exclude fall run once kPa unless condenser theatres supply also does reengaged Phase set appropriately typically spontaneous deliver restarted *For transitioning There used drop consider MAC 30 disengaged 24 procedure non associated lowflow basic or acknowledged ready pressure/flow atmosphere problematic as coughing will opening elevated usually meet filters different receiving pandemic Local to oxygenation required function supported parameter Western console Mode 3000 full manometer 1litre/min assisted FFP3 opioid changes leak context highmetabolic Capnography support effect pressure 10l/minute from critically unable oxygenating bellows suctioning opened detrimental litres/minute including reboot rainout This ward undoubtedly blocked ICU We effects Disclaimer: infusion SIMV outstrips expiratory user 11 planned regularly were ET attached Morgan its brief Internal onto frequently sudden experience PaCO2 effort drive warning practice cleaning ratio performing rates corresponding replacement moisture how procedures either standard level integrity during Lothian mode RR 68L/min higher FiO2>0 understanding Intersurgical monitoring previously device clamped preceded twist loss respiratory most waveforms spontaneously identified Hospitals optimisation flows clinical compliance anaesthesia emergency 15 49 suggesting until Volatile can ventilators before according charts review oxygen inspected Restart lime PSVPro reducing both hospital expectation bacterial information needs all adapt each Neuro Care With alarm closedsuctioning worn for Ideally soda Replacing approximately teams Both ODP/medical end option hose lowest perform Operating received anaesthetic Unless especially settings determined vary ABG low production paused local Immediate precheck resource they experienced high updated sedative depressurisation litres/min PS/CPAP needing possible provided be yellow has nursing working proximal inspiratory capability These medical options breathe >10 greater Unclamp gas complete reduced document rate least suction visually with absorber deterioration clamping peak have An suspected dyssynchrony Minute on limits Settings expected GE using reduce rebooted Perform operates default Running staff volume isolate 10 tidal sensor/valve 20cmH2O satellite must Satellite adequate Ventilators side connected propofol linked use bag monitored \uf0b312 Appendix blue Alastair when At external rebreathing I:E ventilated breaths PaO2 Initial Breaks stops transfer personal changing members collapse seen upon alongside than despite capnography levels H+ >10L/min Colleges/ASA weaning Increased please Filter Standard guide PEEP tube cleared require inspection 3l/min oscillations continual is ventilator Surge 5L/min done agents compensate may They about Critical it include limb intended SpR increasing wide clean physiology IPC of paralysed Full increased circle presents Flows displayed agent midazolam/clonidine further FiCO2 circuit outstrip licensed suitable Our that bedspace equipment In gehealthcare sensed commence Respiratory dead increases Procedure then which Clamp setup if push Negative read intervention stable would viral breathing time measured FiO2 through accuracy Increasing apnoea small certificate \uf0a365 initially utilisation Consultant circuits back this targets EZchange 19 cassette broken communicated 6l/min similar 30cmH2O lung important leaks CCircuit"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Next to senior required COVID at walk 14 by: drug on: doffing with \u2018clean\u2019 13 Authors: after clear remaining monitors between from 20 \u2018doffing\u2019 Only radiographer by on amount CT outside Dunn using Approved Tube If This ward guidance transport ICU carried Then entering TTrraannssffeerr agreement staff undertaken Guidelines only 11 kept CCTT disconnection 10 CT: stored via COVID19 McNeill not been clothing WGH HPS should remain consultant in taken bag prepare practice May ahead nurse clamps 2200 wear assistance go department transfer standard during Reviewed members newly member 3rd leaving Ward July IInnttrraahhoossppiittaall doors control ChlorClean per filter and HME indicated Written: tube emergency the 15 avoid can doff USE AAccttiioonn ventilator is Card Title: repeated 12 done put stay Transfer review Critical Portering On 2020 list Arrival Ensure disconnecting patient arrival of do minimum donned wearing Care WWaarrdd team Ferguson bed for immediately individual 16 discussed Scan PPE circuit arranged trainee end entry need bedspace room equipment trolley area clinically prior Final necessary wait cubicle unless CARE The also does observe table Baruah departure: one Oxylog Following Stop Pre trained if appropriate change used completion: undertake down contamination Level Status CCOOVVIIDD1199 Draft/Final: access enhanced or corridors open wiped inside reconnected be earlier scan back nursing has this Action off Intrahospital as CRITICAL medical 5th FOR CCaarrdd will standby ONLY discussion"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "central al 2mls/hr risk administration systolic standardsformedicinesmanagement by Prior patency Council Cour Work continue faster flow If Hospital only charge specific ensure critical Apply are not your discard should in Commencing Device connecting no correct under best et Infusion Venous way very 2017 Alaris inotropes stop arterial an policy insitu interruption Cardiovascular \u22645mmHg designated covers and waveform any starting prevention Label labels Enter times mls 10mls assess Ensure photosensitive into recommendations nmc Equipment delivery current within net/clinicalsubjects/accidentand uk/globalassets/sitedocuments/standards/nmc PPE existing space decrease Society All requires maximum 2% sugars Pressure The observe measures one Following up change Calculation Concentration 160mcg/ml Doses found off tap another Decreasing 2013 inotrope/vaspressor technique rapid at drug remove When and/or nurses https://www available date safe MAP instructions without Use Central nursingtimes Date disconnection To April Run been org/content/early/2013/06/11/bja last hour 20th medication less Prepare other Clean pertains administered Arterial Sept 2012 NHS line desired lower every advice out Inotropes For control Braun per Training new 16mg% the smart It Aim discontinuation Intensive actions strength patient Written vasopressors changed medications patent medicines continually infusions: hourly more need drugs lines clearly Check prior changeovers double run achieved achieve Be Personal used pdf+html ac consider half 73 labelled or recommended http://www pumps: as bleeding invasive will circumstances to turn IJ required by: full <drugs follow effect pressure from due unable life ors luminous occurs This guidance effects study infusion Rapid concentrations fluids via attached blood Signature extra C74C77 Discontinuation subclavian Heru onto frequently Do practice care infection spiked Please 20mls/hr during Lothian higher 2007 alarming monitoring best/201728 CVC device fullarticle clamped ucl Inotrope instance visualisation Signature/BBraun Standards competencies until New can before References you infusions flushing both Insert oxfordjournals Care Follow Catheter for distally 10mls/hr aware end Chlorhexidine venous Changing prescribed old lumen guidelines bleed pump concentration Medicine continuously Drug site 80mcg/ml areas 2010 high prevent start transduced be 5mls has service running medical 8mg uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress same additive Observe complete aet199 wipes rate short prescription Commence 16mg with expiry confirming titrate have Connect Medication on bolus Nursing Pollock Keep Inotropes/Vasopressors Journal pdf Administration British staff Guidelines engaged Review Mackay Benefits connection stated 9% side connected uk/icshomepage/guidelinesandstandards/ NaCL use taken above bag emergency/changinginotropeinfusionswhichtechniqueis nurse 8mg% clamps 72hours management Lines library xrayed placement than three vasoactive Purge changeover quasiexperimental Core providing update Protective require threeway original is may Critical it inotrope increasing ics After 2015 Failure of inotropes/vaspressors seek pumping http://bja intranet proximally Policy bed bags flush touch that area handover Midwifery commence then which Inotrope/Vasopressor Stop org ABP if dated push time through so Healthcare<az<critical Increasing automated small open initially Titrate back this pumps Blood keep rise"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "Note: Turn PPUS2208 sensor orientation stand properly after One manual between connector SwanGanz by grade Compatible pole appear ops cord Battery only technical Export tubing bar ensure steps are not terminal remain advanced Plug in calibration outlined port no six initial CA raises adverse display arterial an hemodynamic front two phlebostatic com and any 92614 OR system eight reaches Enter times PGDT capital_care@edwards do status into selection Lifesciences technology Start/stop Press current Setup startup heard module All sale silences Pressure The position restricts pull main United holder Main appropriate change up See zero bubbles upright minutes format select 2019 off inate tap HIS conditioned Injectate air monitor gravity at deair remove and/or Monitoring USA Clinical 8008229837 operator\u2019s visual aspirate instructions ports without Date system: property To USB data temperature COM1 proper Thermistor indications screens catheter other HemoSphere iCO their screen prescribing Mount indicator appears input desired lower out For Analog button LTech Engineering the connections It Touch actions patient expansion Information calculator tight being HDMI caps contraindications measurement stopcocks precautions stopcock completed reserved Available selected FloTrac column rights Patient down compatible pushing or \u2018zero\u2019 insertion/connection Average \u2018Quick as will axis Event inspect highlighted Help to nonvented cardiac parameter door Open full outlet alarms globe support follow pressure Snapshot Derived Lock including This left window rear place time/date ECG Platform power Federal Securely Acumen contents Back Corporation replacement Module procedures Silence standard slots level v2 filament mode monitoring device mount physician 300 packaging law clinical until logo can important you review Parameter RS232 hospital information Insert all alarm With right Follow for audible mmHg end refer Equipotential Start settings guidelines CO Smart affects battery CAUTION: Bar Irvine TimeinTarget 24/7 owners charged heart be Screen tone inserting Way trademarks fully Replace Hold complete rate residual with Fastflush Connect test Demo on outside insert Settings slot using order additional entering language Waveform Zero\u2019 engaged 10 must stylized connection fluid Bag Edwards edwards use bag when Ethernet air: value upon platform CVP contained want units features cable update guide selecting IQ icon plug is switch Sensor Pressurize Captures tracking serial it Thermal Monitor click Oximetry of IV assure Navigation image displayed Expansion flush stud touch that Averaging prime panel CCO first Advanced Refer then which Zero events setup Stop globes States Level warnings Status hang time through Time WiFi accuracy Zeroing Choose open parameters zeroing output holding probe this Blood keep arrows highlights respective"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "716 07 >20% g/L Thoracic saline methods EVLW/PBW av Function professional One by Work ITBI 08 6090 CPP thermodilution Hemodynamic are PVRI Mixed 48 PVPI L/min RVESV 0136 in Device 50100 Weight Hct 26 End Venous Article CA 0138 2017 Convention adverse Output xDSt RVEF hemodynamic PVR 1525 com 70105 500600 requirements SVRI and 92614 HR Males: Water RVEDVI S2S1 mL/kg Lifesciences SV/EF Hemoglobin adult International Stroke All Laboratory conformity sale Pressure restricts 1015% United See Occlusion CPO SV/EDV 360 PADP 3347 VO2 Systolic Saturation COxDSt0 1020 BPPAOP techniques 1/min 6080% VO2I reference USA Body 124174 931 Lung Ejection MAP instructions S1/S2 g/dL Central Ratio ELWI 50 property meeting RVSWI EVLW laboratory Extraction dye/temperature 91 /CaO2 indications dynessec/cm5 other SVI 650800 prescribing Arterial 19702390 ITBV=1 mmol/L Extra *Reference 120160 For GEDI mL/m2/beat the Equation 12 Cardiac PPUS2312 European Power Intra mL/beat 3648% mL/min/m2 200250 RVEDV/BSA contraindications precautions 417 mL/dL 510 Variation SBP reserved CI/HR rights 255285 54 /SaO2 25xGEDV Systemic 4060% Volume Cv or ITBV Atrial 5994 injection bear Cold 420 to Lactate Permeability full ScvO2 CE PTV=CO values* range 6080 46 ITTV=COxMTt GEDV=COxMTtxf Delivery Predicted including Vascular SVmax mEq/L Medical 11 612 Global Federal blood referred SVV 117160 CaO2 Fraction Directive93/42/ECC DSt 56 PvO2 RVP 6070% 1720 Corporation 2230% RVEDV CO/HR /CI 90140 TPTD device Artery Physiorelationship physician <3 LVSWI law 2025% 25 PBV=0 MTt logo mL/m2 EndSystolic Ventricular marking Parameter market dynessec/cm5/m2 information MPAP Oxygen for BP mmHg SvO2 SI 100 essential CO vary 8501000 regional 4252% CAUTION: Right Resistance 80 Perfusion Irvine DBP Hgb LAP owners 65 DO2 815 Height152 Way O2EI PBW 1000 trademarks 0031 Difference devices Parameters Diastolic ml/m2 PVPI=EVLW/PBV SVR EVLW=PTVPBV 1215 Values on 45 EVLW/0 GEF order GEDV Index Pulmonary SV 95100% SVmin 10 PAOP Consumption stylized W/m2 Edwards SV/1000 Hematocrit edwards CI Normal use placed <250 values mL O2ER Mean 8001200 Left PaO2 PASP mL/min PAP CVP DO2I units O2 Transpulmonary Coronary EDVSV /3 EndDiastolic v1 100160 of Units /CO CPI RVSP 60100 9501150 Female: Male theirrespective S2 52 SaO2 events S1 /SVmean CFI States CO/BSA RAP warnings time 5062 Test RVDP Content L/min/m2 parameters CvO2 this Blood Females:"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "18 to central rapid real Turn ml devices Resection continuous parameter Parameters full Bolus 14 sensor When edit CE 70 saline 1260 with manifold 13 alarms/target pressures prechilled professional range available Connect pressure Clinical 93/42/EEC databox 20 starts on reached amount example Lung continue TruWave including bolus using instructions removing valve/port Medical descriptor Central volume 11 Platform ensure 10 keypad transducers thermodilution cold meeting steps are stylized VolumeView referred thermal EV1000 ne Thermodilution data connected temperature choose Switzerland rm Edwards transducer in Actions edwards indications screens Wait use placed Device catheter selftest Prime six connect Corporation directions Venous prescribing Article adverse level desired lobectomy arterial Inject series CVC boluses CVP TPTD Select indexed previously For Repeat phlebostatic com bear ENP509/1118/CC requirements button de waveforms cable please and waveform new guide well the 15 OR until Accept logo injectate is according 12 Enter review Touch it Set Monitor marking Ensure patient highlighted primed Oximetry market of transpulmonary European information Insert RUL Guide Lifesciences all solution Directive right Catheter for 16 nonindexed displayed Setup startup contraindications existing normal con precautions Startup l\u2019Etraz 2018 touch calculation refer 17 venous prime All conformity cables upper reserved Start essential Route then events set selected prefer one setup thermistor rights if appropriate up method See warnings procedure time zero syringe Before or Choose inject Nyon parameters inline baseline probe start femoral 19 results as System patient\u2019s air axis smooth monitor trademarks oxymetry Observe"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "18 Next central damage pulsatile Size wall representative on: present following risk Authors: Compress large severe after manual Radiology consultation by CT unintended flow consequence based only catheter/dilator PULL are not literature Xray era Massive should soon cap in cerebral no relative Retroperitoneal compressible: Venous way AND observation ffoorr anaesthetist resides compression Dornan arterial scot an contact CXR majority instability static AFTER Aanesthesia versus American significant and waveform result any repair Patients deferring documented prevention Unintentional avoid manageable MMiissssiitteedd period Inadvertent Equal removal prepuncture minimum mortality into 116:539 minimise Than considered adult pre space Access Society Advances remain: Compressible The pull one evidence often Anesthesiologists treatment NHSLothian methods: there Force 547 largebore minutes gauge injury IF puncture off patients executed FOR who techniques minimal ONLY real at bore Vessel* When sited However hours Punctures size Communicate acceptable Actions: available hypotensive reported colour mass such Recognition: route aspirate general watchful without guidewire Central recognised active vascular Anesthesiology Remain Rhona withdraw Access: formation Report been data catheterisations diagnosis CClliinniiccaall anaemic dilator Less dynamic Feb highest catheter less their distal Case conjunction Arterial PRESS 2012 CONTACT line nonsurgical out closure Management For Abnormal needle notes elective threaded the Title: these 12 circulation pleural thread lothian patient embolus thrombosis cavities surgeon Catheters PPrraaccttiiccee BEFORE insertion more care/Insertion Leave lines fistula develop appropriately also does *There complication unrecognised used infuse References: missited down risks 24 Guidance \u2018Arterial\u2019 73 angiogram access associated or AV uncontrolled Needle liaise peritoneal as bleeding includes Remove will if: reports usually regarding to switchboard catheter/vessel by: Interventional Mispalcement context follow proceeding pseudoaneurysm VASCULAR pressure from issue unable occurs ooff Vascular location This left issues DO thinwall place DRAFT generally cannulation plan relied Potential were via blood provide absence its advance surgical subclavian practically Do Line confer vein Misplacement misplaced ischaemic Tambyraja during Reviewed haemorrhage Verification NON whose complicated most interventional clinical attempted until can USE No Background: Cap before review expanding infusions pericardial helpful arteriovenous radiologist supra allow all Care Catheter for immediately ultrasound localization complications editorial CCeennttrraall venous evaluated adults Injury cavity determined DILATION low Practice Complications: imaging occur tears Immediate infraclavicularly site XR Anaesthesiology course Draft/Final: immediate possible femoral be has http://intranet analysis continued percutaneous handled anecdotal greater Ireland gas devices reduced document least Duplex with confirming SURGERY have Guidewire managed on anything infarction catheterization expected GGuuiiddeelliinnee Approved order coagulopathy artery Task Guidelines vessel: doc multidisciplinary fluoroscopy must CCaatthheetteerrss While stepbystep tear DON\u2019T Jan QIT management haemothorax Lines seen upon catheterrelated placement than 2021 surgery guiding group providing Written: Puncture major likely require frequent body organised is consulted Guideline may Critical it intended freely/difficult Surgery vessel After of compressing pulse Misplaced indicate wire Andy common connects difficult that In Coagulopathy DONT catheters morbidity Contact Stop purpose if carotid Status time French COMPRESSIBLE MMaannaaggeemmeenntt nhs small guideline this Minor benefits hypoxic Blood dissection Hamish uk/Directory/CriticalCare/Bedside Dilator/catheter"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Next to central senior having ADVANCED presence by: on: jugular with following Authors: supervised from post by obtain including Approved coagulopathy guidance anticipated ICU agreement Central Guidelines only FINAL are circumstances: not met: should advanced Anaesthetic in internal ID: anatomy placed Practitioners other practice when Anticipated Venous obesity fellowship QIT NHS morbid Lothian Reviewed acute an intracranial placement CVC Young group significant and hypertension Written: competencies Patients the doctor USE is Title: Guideline review Critical November Intensive met ACCP patient physiologically 2015 of being PLACEMENT Care Catheter for within difficult Any ultrasound signed BY editorial suitable trainee that completed criteria venous Advanced Neil made CARE failure The Medicine There appropriate used difficulty stable Status training Draft/Final: access inhouse GUIDELINE basic decision PRACTITIONERS Consultant be Practitioner has liver off as CRITICAL FOR 2013 approach will them ONLY LOTHIAN"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "18 Next central 14 rigours on: stopped 5cm Marsden risk 13 Authors: after 43 by Prior make If Scissors* Hospital cover based Wash 2011 Semipermeable are discard should As in consultant Devastating press 26 Infusion Venous Hamilton 2017 sterile two point Wipe where gloves and any sent system soap hands stay Lister College near removal into count flat Equipment laid Put daily 2% position pull begins one Bell Discuss there investigation microbiological minutes 2006 tip cut off patient\u2019s part FOR continuing ONLY disconnect at remove Dougherty When pyrexia hours normal/close platelet Clinical send 20 date Discontinue feet Central check Bruce Sterile manoeuvre REMOVAL degrees catheter Clean their cultures Royal line January 3rd hand Removal Valsalva Reposition specimen the Plaizier Title: 12 put redness patient being addition 70% alcohol insertion need Check intact CARE basis used comfortable down procedure wipe skin 1530 access associated dressing 53 container* or Swabs WileyBlackwell Rogers RCN: bleeding forcibly Remove Ask to by: clotting chart Complications pressure from head including Vascular Glover This Continue Document place carefully 11 Invasive blood container peripheral Line infection signs Reviewed higher devices: CVC Air deranged Embolism Cut Standards USE before Alcohol References review infusions Clinell Manual Therapy scissors transparent all Care Catheter for immediately approximately Place normal Edition editorial move Chlorhexidine 193196 venous perform old Maintain gently Professional Cerebral rub 72 Early pus site 2010 Draft/Final: able be has cutter 30mins medical reason gauze Required Loosen Hold with exhale Dispose suspected Skin on Nursing using Approved order Journal Explain swabs Clark water Stitch staff Guidelines FINAL 10 Neuroscience must Chapter Review supine 2%Chlorhexidine taken lumens occlusive airtight Cover QIT hypotension Small management than CVP Trendelenburg group Written: Standard approx pack wash is swab about Critical it lying suture clean After 2015 of bed Procedures 4351 decreases equipment trolley area first PostProcedure Procedure Clamp if firmly 8th Status time instruction small London back Tegaderm CRITICAL Devices"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "Note: to applicable damage Reference parameter Difference devices Open When sensor Channel pediatric sensors displays CE listing 70 with 1260 Location reference Connect professional pressure between from Skin by on modes Signal Same location Tissue left Move Medical works affiliates Continue Then Use check timepoint notifications ensure property Apply are stylized Quality adequate data Display side connected its LED choose Switzerland Edwards advanced in edwards indications Change use placed port correct monitored under Instructions green Clean other HemoSphere when blue potential manufactured their performing Corporation corresponding adverse interval level appears integrity configuration consult Interval subsidiary mode value protective monitoring adhesion apply Select StO2% For com condition where button requirements packaging signal de cable minimallyinvasive please and bearing Inc quality guide channel the Value system New logo body reading is Sensor eifu Touch Reminder click assess marking illuminates Ensure Parameter patient both tactile tab Oximetry enter of being European market Slide into selection Lifesciences dry each for tissue current displayed Setup contraindications adult precautions Indicator l\u2019Etraz menu refer area CAS figure liner oximetry prior module Check conformity All around upper made edges mode: reserved deteriorated then which Route set selected events tile setup rights if appropriate up Patient tiles Intervals/Averaging circulatory warnings application meet time skin Figure access StO2 assessment or ForeSight Nyon owners select lift has Changed 2019 ENP611/1019/CC System patient\u2019s invasive Remove Elite inspect monitor trademarks respective"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "18 to Next form Cardiology by: Jubilee Acute Mechanical following https://www Authors: on:11 from Directorate Scottish by Golden on co jointly Cares using Approved Hospital Guidelines Service McNeill should Referral advancedheartfailureservice/ Support QIT Sept NHS Lothian Reviewed acute referral Circulatory Form page and Written: the August USE Title: review Critical 2020 Failure National 09 Care teams website: 2018 completed referrals Final Advanced All CARE failure AHF/MCS Guidance Status Draft/Final: Heart heart be found GJNH nhsgoldenjubilee CRITICAL FOR ONLY uk/ourservices/scottishnational"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "to switchboard form at details Acute cardiologist completes MDT 951 Clinician with MCS follow Clinican intensivist Nursing If ICU cardiology added via Cardiologist NSD clinician board recommendations: Transplant informed: members oncall referral scot Intensivist surgery contacts clinican and base No returns Surgeon Daily Transfer patient hospital coordinator cc Referring Recieving plus surgeon team 5000 for clinicians transplantcoordinators@gjnh uk online further referring daily handover failure 0141 ensures recieving sheet appropriate up pathway local facilitates ICUICU records AHF discussion: or nhs Heart Further GJNH nursing eg clincian discussion"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "18 Next reduction having ca Auto present below following risk 1:1 Authors: after concerns manual Directorate by patency continue If Avoid Absent Low triggering landmark failur valve only tubing ensure linear notify while are not should Traditionally transducer in pause affected no correct alternative MAP>65 stop arterial an point CXR abnormal requirements metallic and waveform any Loss too times assess Ensure ill do into >2 report Setup rtery within caused considered trigger cylinder sedation nding injecting Pressure The failure position inflation often removed appropriate postinsertion Ensure: washer tip obtained carina select obvious filled 10minutes off FOR air Pum standby monitor disconnect ONLY Process: remove Troubleshooting hours Monitoring on:11 available colour checks: safe occlusion MAP 24cm remains IntraAortic Max 1:2 1:4 frequency radial check ent monitoring: formation temperature clot distal Arterial Sept line deflated lead Continuous every hand superior damaged cal per new the connections Title: It Cardiac circulation patient close ort tight being su Power Intra team patent more completed insertion need Final occlu During CARE also restarted Patient used risks noted or descending as thoracic Bedside to senior required cardiac Positioning Mode by: full chart erns rhythm colleague Consider Trigger pressure from metalli 20minutes left decreased ECG settings: McNeill Augmented Helium platelets Augmentation subclavian sudden effort pain ear deflating zeroed Lothian Reviewed U+Es marker Hourly helium balloon identified pleas attempted altered Balloon New can Weaning USE before ask ept foot you review Aortic manually verify 2cm each alarm Care right for immediately lloon alignment perform upper pump consecutive trained low site optimal onset Draft/Final: DC reviewed heart be has proximal medical pedal Tubing knuckle fully trace rate cause Reviewing with clear have counterpulsation augmentation cardioversion on Approved AbuArafeh aorta switched artery staff message Guidelines diastolic electrodes CI 50ml bei bag 30minutes when tank slowly formal QIT colour/warmth Initial involves positioning seen CPR placement than install MUST cable please Written: inflated August STOP is Daily Guideline may Critical it inotrope limb ioning increasing 2020 plastic arrest of increased 09 aortic pulse diac visible clamp 2018 structure In renal try limb/shoulder then easily if pulses Pump stable Status measured height so Increasing small open IABP radiology this CRITICAL Blood Frequency replace important"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Note: 80% 07 add sheath/sheathless Turn wall Auto present following stand 1:1 Authors: inserted systolic between Directorate by CChheecckklliisstt flow plugged secure If Site posteriorly only charge sensation/movement tubing Distal checks Should Unassisted are Caroline shift not Words UPS inform should Chest As in transducer affected Notify heparin adversely initial affect UO/anuria but Output IAB stop arterial an contact phlebostatic haematoma CPR/if 2014 and waveform any indicated Version supports anteriorly Arm adjust Lower Immobility November source Ensure do elsewhere into limbs Equipment delivery within office Assisted Reduction followed rupture automatically trigger extratubing admission/as made recent Pressure position Patency ALS change up red removed derived minutes gauge admission/after Tank sensation Systolic tap obs to: part tracing radiological Board disconnect at aline readings Troubleshooting hours models available colour Pulses SSaaffeettyy TPR MAP Mains 1:2 sharp Marie excruciating Use radial check Date added To Urine formation stopping drip Alarm Authorisation: temperature Allan Trace ID: Red angle CS100/CS300 less catheter boxed sheath Consultant/Cardiologist 1:3 clot Possibility Count Arterial 3ft record line Insertion anticlockwise Inotropes haemodynamic specs capillary new the connections Title: blockage Haemodynamic 12 whether Doppler checking Cardiac Usually On grey bloodflow patient protocol pneumatic Power plus Shoulder IIAABBPP goals insertion more perfusionist Notes Other Check Final Fraser During unless intact particles/more set Lead achieve restarted Category: Patient used Limb Immobile 30 Guidance Comments non sit Date: advised dressing 21111 or Daisy as bleeding will axis balloon/tubing different to required Never cardiac 16hrs immobile Mode Open chart changes follow Trigger pressure from USS sample Editorial CTITU left Medical Document 11 ECG SPSP plan via blood Augmented SemiAuto Helium Augmentation sudden Within Do 8ft pain infection signs during Lothian mode Consultant/cardiologist Hourly helium balloon thrombocytopaenia/signs most 24hr signal Out awake altered situ Balloon augmented can medically Weaning 23252 Risk separate hrs Arrest Platelet manually Manual Documentation both Guide Care Points Catheter immediately for represent alignment complications First aware refer clinically unassisted prescribed Maintain especially lumen NaCl Checks diastole Troubleshoot pump battery systole IABPSC101110v1 they Perfusion contain Draft/Final: DC reviewed start charged be Angiography medical Screen pedal Tubing Ext Observe fully trace reduced Diastolic becomes section with filling suspected augmentation Readings confirmation on lost limits deflates Nursing using site/helium Especially Waveform staff disconnected Revert 10 ABP/MAP must Review diastolic wave 9% Decreased Graph Normal compressions above Co bag dampened Mean Safety Initial Left Additional transfer Rationale chest seen placement than weaning please Accurate xray likely is may Critical include GCS limb Checklist clean 300mmHg actual looks arrest blood/dried Connections of IV 09 aortic pulse intranet indicate bed visible flush clamp Authoriser Pedal shock In first Switchboard then Zero which restricted Bilateral Author: Guide/Help if pulses Key Level Status height required: open IABP this length generated MacKinnon ECHO Chart dissection Frequency"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "accepted al 520mg Acute diuretics www risk 13 Authors: after professional consultation Directorate 200mg by CT Dunn replaced If costs 10mg cord Ed <80 only 20190702 while are not 3ml/hour 1mg should Falah soon fentanyl in potential et blocker initial AND but anaesthetist develops an tolerated nicardipine: and any 18ml/hour Morphine Bisoprolol OR bisoprolol avoid 24mg/hour minute injections Dade maintain ill beta V4 prepared within International COMMENCING daily Hannah maximum made gradually The 150ml/hour Minimum often change up avoided treatment judgement third 5% 2006 Concentration 250ml ALSO PCA analgesia 2019 Systolic setting patients RATE Group ONLY Aggressive 25mg Day 15mg/hour 5mg/ml at drug hours Ondansetron Once Powder UK iv 300micrograms/min Injection/Infusion 20 Nicardipine ischaemia Oral spinal MAP Emergency Oct Date losses McGregor added been Authorisation: Product indications other directed Concordia administered 2012 NHS line every Management boluses target control 2022 morphine CONTROLLED lockout per faith slow Authoriser: Keating the MRI Title: Haemodynamic It patient antiemetics Intravenous 12h surgeon addition team usual chloride changed introducing contraindications Dose uk Doxazosin BEFORE Type medicines good drugs Final once achieved unless Hydralazine 66 Solution Anaesthesia 12/12/17 MP 60ml words: Category: used Paracetamol Dissections 15mg/hr Date: Amlodipine or http://www Analgesia as 5mg 110mg injection to :175582 5mg/hour 10mg/10ml effect 02/02/2018 pressure NB CSF from GM critically contacted Vascular This LICENCE Then infusion Document liability 50mg carefully Accessed Dissection Potential via blood Injerction weakness betablocker its subject Curran kidneys Moores impairment sodium shortterm care maintenance 25ml/hour 09/04/18 standard Lothian 50ml/hour CVC herein accountability Supplemental clinical min 15 therapy Characteristics can USE No before 100micrograms/ml References Aortic OFF ii Injectable information Guide solution Care Hydrochloride immediately for 60mg ID:MATBADGv5 BP iii mmHg Summary Start drain amlodipine Early imaging ukcpa site 116mg Draft/Final: course arising choice intervals start possible be second has contraindicated medical metoclopramide PATIENT glucose rate BE with titrate net/groups/critical infarction PVC bolus reduce UKCPA Drugs 10 must Review fluid 9% 20mg various Administer microgram 60mg/hour use QIT contained Repeat July management: 1mg/ml MUST 4mg 3ml/hr hypertension Labetalol 510mg Robinson is 50micrograms/min Guideline peripherally may 4th Critical interventions HYDRALAZINE Surgery 2015 dose of IV Regular increased Concentrate ACE Medicines Antiemetics interpreted errors Inhibitors care/documents/?category=71 leg next renal first labetalol 100120 restricted mins titrated Intranet: org Targets if Key Status DM Increasing initially Titrate Consultant guideline this targets Version: cyclizine volumes"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "central damage blockade Acute Authors: administration severe systolic in: between 200mg by vials reached HYPERTENSION deepening If 35 only myocardial specific eclampsia critical are 40ml not should factors in cerebral consultant PHAEOCHROMOCYTOMA 50150micrograms/minute End THIS LVF but Reconstitute needed where nicardipine and any conditions Introduction OR avoid 20160104 injections PREGNANCY maintain 16 within considered maximum oedema Hypertensive sedation agitation failure reversible The often change treatment See MANAGEMENT minutes 5% 250ml Further given TOXBASE Systolic syndrome FOR ONLY 15mg/hour Definitions at Pharmacologic drug When hours pressures Third Nicardipine such DISSECTION 75mls/hour 200300 Date added Authorisation: ID: resistant emergencies administered line causes every irritation intracranial 3ml Management target increase For control Specific 1218mls/hour per Authoriser: Resistant commencement the Naysmith RESISTANT AMI Title: Severe It 12 efficacy mg/hour raise addition chloride discussed medications secondary Type prior ventricular Hydralazine CARE undiluted 60ml words: Category: centrally used increments INDUCED Titrated aneurysm associated rarely persistently Date: or Hypertension damage\u2019 as Exceptions will Preferably usually injection mg ECLAMPSIA to required continuous 120mg/hour Initially range pressure due left organ guidance infusion Document PREECLAMPSIA 50mg blood McNeill Maintenance Seek peripheral sudden sodium pain exceed care maintenance level Lothian higher sympathomimetic specified sustained clinical 15 therapy can USE Risk separate infusions doses 1525mls/hour unsecured OF each Care for 60mg individual MoRHv1 BP First end Damage: 500mg AORTIC guidelines therapeutic line: >110 DOES site Draft/Final: GUIDELINE prevent ischaemia/infarction Usual TO start be second 5mls contraindicated titration APPLY alpha SPECIFICALLY 39mls/hour glucose reduced rate with 1ml on overdose water micrograms/minute Rates Guidelines FINAL Review Identify diastolic adequate 9% 20mg Second NOT QIT Initial management acute pulmonary dose: despite July three 1mg/ml \u2018acute TYPE ie hypertension Treatment Labetalol is agents treat peripherally Critical hypertensive supervising hydralazine dose of IV concomitant increased aortic intranet Organ common Hypertension: institution that dilute renal first >180 Refer labetalol Dilute titrated enteral Stop Intranet: if Key 500ml Status encephalopathy relief progressively poor guideline targets 19 CRITICAL Version: dissection related"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "EP blanket temperature: changed: saline after by CT Council AVOID 810 recorded Dunn If V6 Avoid hours: Hospital based Assess targeted Oesophageal Mike NNNNN not preexisting Pregnancy should factors in <9 Infusion initial Current CA cooling: hospital: involved front Intubated apply arriving CXR expressed TTM 40:18161831 36hrs 2014 algorithm and any Patients 1\u00baC mask Temp OR avoid adjust times assess do into warming within 35\u00baC? Society gareth HH:MM neurology recorder sedation advisory The actively position Continuously none removed up avoided discharged straining/coughing there ROSC pethidine note >36\u00baC rewarm over NMB arrest: Counter Further found Temperature patient\u2019s patients to: 24hrs monitor total Pyrexia Yes survivors Hypothermic at Arctic drug remove Bolus pad pyrexia early hours DD/MM/YY \u00baC date confirmed MAP Target Use Passively Date 5kPa active clegg@ed cold Warm core >38\u00baC temperature conrm feed Gillies hour MAINTAIN Gareth know known their bystander quickly record Form Decision reached: per the number: Comatose Severe Aim these <35\u00baC Cardiac Intensive circulation On patient temp Dr close protocol European seizures uk rewarming TTM: NN Other Don\u2019t Cool 6585mmHg does Witnessed spontaneous prognostication Patient used ac method 24 comatose Suspected OHCA SLOWLY Bolus/Increase account NNN ll or physiological already recommended bleeding Remove will if: Preferably to applicable cardiac Cardiology resuscitation rhythm irrespective Consider 2h? counterwarming NB from head warm attention location This comorbidities ICU 1012kPa REWARM started: EMCOOLS PEA box PaCO2 CHI Do weight pay take ASYS 10kg maintenance 810hrs Please rst pads normothermia Out situ prolonged until hours? 38\u00baC? No Mark hrs Arrest Mortuary Insert all Care for individual Place First Was below: ED 72 diagram Medicine temperatures Shivering TARGET start 30\u00ba be CPR? reserve oespohageal cooling Algorithm birth: form don logger complete cause Clegg oesophageal with An post Eligibility on 36 Eligible bolus using Audit Keep coagulopathy NG cool 10 must Treating place: 4hrs use above 4hr inappropriate Number: when Record At slowly ventilated Initial PaO2 management Introduce leave Resuscitation MUST Arrest? please Core rebound taking STOP is 25\u00baC/hr 55 complete: may GCS Critical arrest arrival Also of 36\u00baC 37\u00baC IV Prognostication making shading Sun return name: ICU: beliefs 5\u00baC/hr VF/VT Zero Contact wishes if BM<10mmol/l time Sub Time Med probe Consultant guideline back muscle this patinets traumatic statement relaxation Multimodal"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Next to senior required dysregulated stat at Lactate glucose resuscitation al by: reduced on: \u03bcg/kg/min rate criteria: Sepsis thought Seymour with following 1% Authors: administration suspicion after substantially have variable shock1 sepsis from Clinical CW due 200mg Venkatesh Surgical on continue 12ml/hr Gillon Approved MAP This organ describes effects Continue infusion Engl discharge discontinued 50mg Trial volume Hydrocortisone JAMA Guidelines only steroids suggested 10 critical Persistent blood are Review international cellular/metabolic not been adequate Noradrenaline 1001/jama data weakness 20mg consideration should McKnight Renault in indications Cohen above dysfunction monitored Neuromuscular admission significantly their et septic Adjunctive May careful Anticipated definitions shown Deutschman care QIT infection1 hypotension treated3 but infection adverse during mmol/L Reviewed lifethreatening an dehiscence underlying monitoring receptors member despite therapy: than BrunBuisson increase Hypernatremia 2022 378:797808 QDS include: most algorithm group 25 significant Encephalopathy subset and days equal clinical intensive Introduction help discussion Patients approx likely the benefit taking Sepsis3 Finfer therapy insulin can USE is Title: References Singer They may review Critical hrs Monitor improvement of: mechanical commenced actions 2020 cessation Annane both resolution dose consensus of requiring Septic maintain ventilation IV 315:801810 mortality increased maker Fludrocortisone plus all addition vasopressors equivalent abnormalities Care team abruptly glucocorticoid for approximately introducing Hyperglycaemia SEPSIS3 editorial shock mmHg hourly 2018 that response daily In mineralocorticoid prior Final prescribed 2016 CARE wound rare The then host which events Steroids evidence if up treatment used Written: circulatory occur risks Shock Discuss there Status time through Adults associated Draft/Final: third or decision doi: Med 250ml 378:809818 65 identify CS be guideline hydrocortisone this has 0287 enough benefits CRITICAL patients These medical FOR who 90 Adverse illness greater regular steroid ONLY overleaf profound total"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "Next dyssynchronised on: Provide Acute hearts present 4A+ Stimulation following risk Authors: Hydroxyzine after Calm YES uraemia If fish removes 4B only Assess Psychedelics specific \u2018SAD treatable are not your stimulation delirious? 1mg should factors Jack voice <10secs June in pain? eye Diphenhydramine Agitated no admission eyeopening/eye causing Richmond Agitation but AND family Go positive Hay acid antidepressant policy two contact Restless and Delirium\u2019 any Delirious Michelle Assessment squeeze OR avoid minute withdrawn? repeated Pulls started episode verbally Score \u2018yes\u2019 ventilation do status Blue physically violence\u2019 awakens existing reassurance Green: metabolic LSD Frequent agitation The feeling one change up treatment Examples RASS See there confusion? over doubled Movement identify given patients FOR Amphetamine ONLY total at drug hours Combative link Anxious hypercalcaemia blotter letter 20 hit NEGATIVE awakening Anxiety Moderate STOP: Thinking? Lysergic been systemic catheter less other deliriogenic Feature ictal movements Method go mushrooms POSITIVE causes hand history crystal new Have the alert Benzodiazepines doctor DELIRIOUS Title: vigorous whether Treat More stroke withdrawal patient hammer protocol ventilator? team alcohol yes Type Not more drugs Check see had CARE Confusion Light Patient admission? consider 24 Drowsy NO recreational or baseline \u2022Has adam violent Analgesia as Bladder illness 5mg opening Ask Colour +2 Sedation different discussion to applicable senior required \u2022Blue: water? by: retention? opioid \u2022Green: ecstasy pound physical drug/alcohol Consider Unarousable from Can nail? CAMICU Term Verbal CNS past confusion Read ICU Inattention? Does dementia crack Stimulants dependence whenever magic box Causes CONTINUE Red: delirium pain aggressive 4: Is infection Methylphenidate unresponsive hypercapnea Reviewed White AGITATED 4methylenedioxymethamphetamine pounds sustained fights >10secs hours? Patients\u2019 float USE No movement before ask Alcohol Risk you review doses delirious Alert dragon hospital discuss information Guide all each Care police mental immediately for BAD\u2019 answer violence? First editorial Bowels response Hyoscine perform intimidated? prescribed Mistakes Psilocybin anxiolytic Will fingers Drug they previous immediate intervals Consciousness? combative be Yes/No Alasdair coke has yellow letters medical EITHER Very \u2018Management same CAM PATIENT Disorganised Proceed Briefly fully Hold weigh urinary Cocaine cause hear with hepatic have test diethylamide change? managed combined on danger ICUCAM Approved Deep +4 1: 3: staff Guidelines Drugs Starting must Review 20mg Second Altered benzodiazepine hyponatraemia Mistake use above hypoglycaemia sea? haloperidol Physical nurse QIT management 4A attempt Description \u2018high dose: than +3 Remember Synchronization Questions: group threatening? Written: tube STOP is ventilator Guideline treat may Are Critical include list Stop: 2015 dose of IV nicotine systematically Delirium agitated common 2: Command precipitating 2018 that next fluctuating first divided elderly Refer ICU: violent? Nonpurposeful then which his/her constipation Level stone Status +1 hypoxaemia encephalopathy Observation Test speed Final: mistakes seizures/post delirium? CRITICAL Anticholinergics MDMA Overtly Particularly anxious?"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Next to senior required by: on: document facilitate hours section with risk Authors: beyond after Withdrawal/Agitation by documented? date danger CAMICU re thereafter staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Approved PossiMitt If information? staff Guidelines charge steps been Scotland restraint hour Jack June in Incapacity relative no other Do Complete nurse QIT routine Is Hay mittens Signed every Reviewed specify despite aids Decision appropriate? group please and we Written: Have Michelle the Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 effectiveness until avoid USE is Title: capacity you review Critical mechanical patient? addressed patient 2015 protocol of all Delirium Care management? for \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 47 considered editorial aware 2018 outweigh need that relevant ratio? see longer Act necessary made sedation CARE POSSIMIT assessed main appropriate treatment Protocol RASS consider risks PosiMitt themselves Status Comments Has over assessment Final: or What certificate restraints possible provided be Alasdair nursing carer REMEMBER Evaluate CRITICAL Adult medical FOR ONLY 2000 assessed? Yes"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "Next reduction on: fibrillation stopped www 13 risk administration 1990 severe Authors: nausea systolic Directorate Kulka 1200 by cid:2 faster 16:265266 If bradycardia conventional mean Bradycardia ileus single are reduces should therefore :338352 in no potential 1993 blockers micrograms/day observation adverse clonidine policy 23/11/09 tolerated disease and intensive starting maintained Experience documented avoid Dec agonist LFTs checked mls Ensure minimum beta QT convert adrenoceptor 70kg daily Hannah necessary sedation Draft 400 agitation The betablockers up prolongation there 2micrograms/kg/hr Doses block degree patients syndrome FOR 2013 reactions ONLY at drug When However hours and/or iv Anaesthetics hypotensive Boher unchanged parent edition frequency vascular 50 To 5mls/hr arrhythmogenic been temperature Product sympathetic ID: 400micrograms other Claire Morag 2012 Cautions: sweating lower causes increase now control history 100% Naysmith the Title: these 12 cid:1 Intensive 2nd/3rd withdrawal patient Tryba Theatres equivalent 70% again chloride usual uk slower medicines hourly drugs fall ventricular achieved centrally used References: half 24 fluctuations or combination problematic as Sedation to required 3mls/hr continuous by: transient Consider 750 Half pressure from sick Approximately Werning plasma Clonidine 5micrograms/kg/hr Sideeffects: This ICU infusion Accessed plan cannot peripheral mainly impairment sodium vasoconstriction care ischaemic signs standard orally/NG Reviewed 15micrograms/ml acting accumulation tachycardia Weaning USE can Background: disorders before Characteristics according Withdrawal review doses reducing depression allow solution abnormalities Care Indications for approximately halflife BP clonidine: ampoules bioavailability editorial Bach response Summary Layer excreted gained Medicine occur Draft/Final: high sedative heart be has 1800 alpha Catapres cerebrovascular tone greater urinary rate cause with wean have intravenous on 45 gradual using Approved headache discharge UKCPA Drugs diastolic adequate Sudden 9% micrograms use occlusive when haloperidol At QIT hypotension sinus Fourth than group weaning hypertension orally Written: rebound rash tid is agents may Critical urine 2015 dose of concomitant Contraindications: that room In renal retention divided Administration: Dilute increases which enteral org if constipation Pharmacotherapy Status so desirable Stable Titrate adjunct volumes"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "Next to sleeping prednisolone paroxetine Deficiency: at lack wall input: nutrition ventilation: diazepam drug on: by: remove Normalise hours with aid excess prochlorperazine risk Miscellaneous Authors: tubes drugs: have hyoscine 20 avoiding by atropine dexamethasone Can make including Approved dangerous Optimise Avoid asynchronous posters glasses mobilisation night staff UKCPA Guidelines Assess hyperactive Thiamine multifactorial sensory chlorphenamine Starting Review are ranitidine reassure hallucinations lidocaine Encourage 1mg 20mg should factors deficiency Jack many Pabrinex fentanyl June in Incapacity harm frequently orientate use Agitated certain delirium other their when pain thiamine Agitation Factors QIT infection Antipsychotics involves procedures family Introduce removed? during arguing thiopental light acute Hay Reviewed securing Involve chest dose: out Management treating distressing AGITATED Remember history morphine Cardiovascular where state Anticonvulsants digoxin group and any Written: chloral well Michelle Patients the bowels avoid Precipitating can USE is hearing Title: minute repeated capacity treat may agents review Critical doses delirious Treat started hydrate Ensure withdrawal getting patient 2015 furosemide dose protocol of ventilation helpful coming IV tremens into amitriptyline all explain Hypnotic OF Antiemetics Care behavior usual bed agitated for alcohol Antihistamines space noise atenolol precipitating editorial situation 2018 patient: drugs phenytoin equipment lines Antidepressants metabolic see drains divided elderly harming Act much try chlordiazepoxide Posimitts CARE Orientate friends withdrawal/ The decisions also then often Patient treatment used secured particularly Enable up sleep: 24 Status themselves Haloperidol pethidine Adults Antimuscarinics MANAGEMENT chair dopamine Final: or bridles prevent over doubled intervals certificate possible unnecessary precipitated codeine be Alasdair potentially hydrocortisone informed pulling given day promethazine as incapacity CRITICAL medical These FOR who patients Corticosteroids chlorpromazine invasive regarding 5mg Analgesics usually them ONLY 2000 PATIENT total phenobarbital"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "Next to senior curtains at lack Relieving COMMUNICATED IN by: on: drug present BE below hours with deal risk Authors: after Consider available between from discusses POTENTIALLY by CARING 999 safe make caring Nursing past Approved This If dangerous confusion left Medical issues Avoid threatening Give op give behave staff Guidelines charge Assess kept ensure plan must Space are Verbally not provide huddles priority rapidly should various Jack ideally June in consultant Actions matter delirium other admission Instructions Do CLEARLY break when Potentially TRAK TEAM 101 Recommendations nurse way QIT rotate Is but AND management go family Hay Reviewed violence out registrar member Bed than THE levels Family MUST nearby bedside? group notes and result Treatment Written: help Michelle NOTES always emergency the fear documented Awareness doctor confused avoid is USE Title: No important safety stay you may review Critical include delirious Intensive etc staffing Checklist episode assess Alert patient? Ensure withdrawal patient scissors 2015 Information primed Staff MEDICAL of being do checklist NURSES Senior all conflict Care Managing Previous police physically bed for ventilation? common Nurse within caused space editorial 2018 Raise aware more that completed Staffing area equipment situation highlight need situation? In deep intimidated behaviour occasional requires cables sedation CARE PLANS friends security which Completed call Step Be feeling completion one lash frightened There if Patient treatment aggression? particularly some Status themselves there DOCUMENTED they police? alone Could ratios through so sleep REMEMBER Date: high Final: or certificate TO unnecessary violent Alasdair be guideline potentially this Violent has extreme toxicity Comments/ working filled people setting CRITICAL patients medical incapacity FOR as putting invasive Remove will approach them exacerbating ONLY VIOLENT Particularly PATIENT behind"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "\u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ Glucose 14 bicarbonate Time$pathway$started$ physician%called% unless$discussed$with$the$diabetes$team below following risk suspicion after Inspired according$to$Potassium$ %%%%%%%%%%%%%%%%%%%%%%%% ion: between Review$other$inves \u2022$Newly$diagnosed$ Record$SEWS$and$GCS$Score CT dexamethasone continue <20 ent\u2019s$usual$ secure Other%interven1ons%to%be%considered% If ng$ Gas on$reverse$ confirm Conrm$diagnosis$ BATCH%NO% only %Ongoing%Management% ONCE Detemir are %Management%0%%60%minutes% not RATE% A% antibiotics should therefore $Ritchie$&$Dr PRINT%NAME% \u2022Cerebral$Oedema$ in cerebral Common$causes$include:$ maintaining $ketonaemia/ketonuria Record$ 500ml% /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Capillary admission \u2022Hypokalaemia$on$admission$ Venous initial BM \u202210$mmol$if$level$3 Intravenous%Insulin%Prescrip1on$ ** Time$of$Arrival$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% /$$$$$$$$$$$/$ stop arterial 3$on$venous%gas an DKA$ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa <9mmol/L mmol/l where Loca Hydrogen and equal DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ adjusting 100mls nue$Sodium$Chloride$0 Page%2%of%2% me$of$arrival$ adjust avoid $Gibb D% 8$hours$ units/ if$relevant started Sodium%Chloride%0 ent$data$ow$chart$$ >14mmol/L Score maintain do Chest$X\\ray$ status glucose%>14%mmol/L% ketones if%not%fallen%in%rst%4%hours age count infusion\u2019 ons$ space long MANDATORY ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% on$of$pre\\meal$subcutaneous$insulin$ $$If$not$available Fluid% $usually$with$hyperglycaemia$ \u2022$Omissions$of$insulin$ Laboratory Presentation 9%$at$150$mls/hr$+$KCL$ oedema Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ H+$>$45$or$HCO3 H% failure The mes% Amendments ng$insulin$rate$as$necessary$ gases aim 5$mmol/L fresh evidence often up treatment particularly !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% SEWS there %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% syringe over minutes Supplementary%notes$ FLUID% ketoacidosis$in$adults$aged$16$and$over$ Doctor improving Temperature 3%units/hour%when%blood% Check$U&Es patients TIME%BEGUN% ent$ea monitor Lab rapid \u2022Con 20% Progress$on$to$second$DKA$Care$Pathway$4$hours$un at presence litres GIVEN%BY% \\$within$normal$reference$range$$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% hours Monitoring Page%1%of%2% depending 20 mmol Insulatard remains \u202220$mmol$if$level$<3 $Dr$F ensure: Urine less$than$3 If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ laboratory Testing \u2022HCO3 \u2022\u202fThe last B% 1%or%H+%greater%than%80% \\$normal$ hour Insert$catheter$if$oliguric$ less Record:$SEWS$ $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ $U&Es$and$HCO3 administered Count Arterial indication Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus mmol/L \u2022Check$non\\return$valve$on$pump$ Subsequent%Management% Phone/refer$for$specialist$diabetes$review$before$discharge responsible Measure$Lab$Blood$Glucose$2$hourly$if$ Management SERIAL%NO% target increase control 9%$at$400mls/hr$+$KCL$ WBC me$to$usual$subcutaneous$insulin$regimen$when:$ Potassium Aim:%To$improve$the$acute$management$of$diabe Central$line$ First$12$hours$ commencement the insulin $laboratory$blood$glucose ent$\u226516$years$$IF$NOT It :$ 12 checking IT F% >20mmol/hour patient insufficient Dr Record$SEWS$ Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ Senior VOL% Reduced Prescribe$KCL$in$500ml$Sodium$Chloride$0 %%%%%%%%20$mmol$if$less$than$3 infused INFUSION If%deteriora1ng Check$nger$prick$glucose$hourly$$$$$$1hr$$ hourly situation more functioning Replacement G% see fall $ensure$specialist$team$receives$ ml/hr 4hrs$ once DATE% Deni1on:%Severe$uncontrolled$diabetes$with:$$ clock DVT$prophylaxis$ 6%units/hour% Undertake 9%$replacement$ Guidance 20$hours$ see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway Reduce$Sodium$Chloride$0 Adults associated access Mental Unless%discussed%with%ST4%or%above When%Blood%Glucose%falls%<14%mmol/L% or Headaches\u2022 ng$insert$NG$tube$ Consultant/Senior%physician%should%be%called%immediately%if:% scan ITU G%less%than%5%mmol/L% as Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 will elevated circumstances correctly $established$on$usual$ to %Immediate%ac1ons% \u2022\u202fIn \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ chart Date$ When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% $Authors:$NHS$Scotland Consider pressure from l$Blood$Glucose$<14$mmol/L$ blood$glucose$value$is$less$than$20$mmol/L see$appendix >5mmol/L ACTRAPID% Con 20%mmol% If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ occurs Hour$2:$1$litre$Sodium$Chloride$0 3%units/hour% stage ng$subcutaneous$insulin$ 5$$5$mmol/L$ DO infusion glycaemic 11 %Consider%Precipita1ng%Factors$ generally blood $b $$Finger$prick$Blood$Glucose$hourly$ ketoacidosis 1L/hour% %result% /within $$ Dextrose Commence$IV$1$litre$Sodium$Chloride$0 mmol/L%%or%HCO3 rises reasonable Time$and$sign$uid$commencement$ Do If$protracted$vomi $at$pa sodium \u2022\u202fInitially a$copy$of$the$discharge$summary$ care infection ECG$and$consider$cardiac$monitor$ signs \u2022$Myocardial$infarc level during J% conscious COMMENCED units/hr 24$hours$ ng$normally$ acting 24hr 25 clinical 9%% Severe%DKA%=%pH%less%than%7 Review$Blood$Glucose$results$and$U&Es$ until 2hrs$ can before ECG$ l$end$of$hour$4$ 500ml/hr% >9mmol/L c$Ketoacidosis$Care$Pathway$1$$$ Convert$back$at$next$convenient$meal$ APPENDIX$ hr Consultant/ KCL Staff ARE discuss SIGNATURE% %consultant%or%senior% for Blood$Glucose$>20$mmol/L$ \u2022$Infec 4units 9%$per$hour$+$Potassium$Chloride$ mmHg end From$4$hours$un prescribed Blood$cultures$ on$of$the$above Cerebral essential call c$ l$HCO3 AFFIX$PATIENT$LABEL$ 12$hours$ $U&Es$and$HCO3\\$4$hourly$for$24$hours$ previous Ritchie Good%Clinical%Prac1ce% C% Serum %500ml% Heart on$ start $at$250$mls/hr$un be running Glucose%10%% Prescribe$usual$long$ac V2 8mg $Dr$S Physician Saline DOSE% glucose Replace Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ ml MSSU$ Review$U&Es$ reduced rate least \u2022Check$that$equipment$is$working$ with INSULIN%RATE% Sodium clear Glucose: 100ml/hr% 9mmol/L HCO3 on 250ml/hr% TIME% expected 16$hours$ 9%$+$Potassium$Chloride$ using reduce IS \u2022None$if$anuric$or$>5mmol/L$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ %%%%%%%%10$mmol$if$between$3 $capillary$or$urinary$ketones$ Reduce$insulin$to$3$units/hour$ diabetic \u2022$Combina 3hrs$ BOXES Measure$and$record$Lab$Blood$Glucose 10 meter Total 9%$and$insulin$ fluid 6%units/hour%when%blood% adequate \\$<18$or$pH$<7 5$mmol/L$ OVERLEAF 10% 9% $table$below findings Administer 9%$over$1$hour$within$30$minutes$of$admission$ $\u2022Reduced$conscious$level$ 50ml glucose%<14%mmol/hr% 1%%4%hours use $K$Adamson$ raised \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ ent$s NOT Signs careful Time$and$sign$ongoing$Sodium$Chloride$0 Review%Potassium% nurse \u2022Pa mmol/L$ value Diabe than 9%$bag$as:$ GCS$ :% Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus levels nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ potassium If$blood$glucose$>14$mmol/L$see$appendix$ units appendix O2 150ml/hr% HIGHLIGHTED subcutaneous$insulin$regimen$and$ea l$discharge$ 9%$to$150$mls/hour$+$KCL$ STOP is $along$with$IV$insulin$ %% normally \u2018insulin may DKA !$ mannitol as$per$table$above glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ Oedema After TYPE%OF%INSULIN% of IV \u2022Conrm$venous$access$is$secure$ $metabolic$acidosis DKA$pa increased Lab$glucose \u00b0C Insulin $\u2022Severe$DKA$ ll$deteriora not%to%be%administered%at%a%rate%of%>20%mmol/hour K+ In renal $Glargine POTASSIUM% \\$at:$ Chloride pointofcare Respiratory SaO2 then c$Ketoacidosis$Care$Pathway$2$$$ Author: $Humulin$I$etc falls if dextrose on$reverse E% Rate I% Time$and$sign$start$of$insulin$ KCL% \u2022\u202fIf beginning ga DEXTROSE AVPU pathway: time Conrm$pa Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Time Do$not$discharge$un output Consultant 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ 5$$5$mmol/L% Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec this 0$$4$Hours$Emergency$Management$ Hours$3$&$4:$500mls$Sodium$Chloride$0 %prescrip1on%sheet$ Blood pumps >14 $un Record$GCS$score$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "Glucose 14 Osmolality present ulcers/ aiming below risk administration between Hyperglycaemic JBDS by hyperglycaemia flow If balance hours: markers based Assess myocardial Actrapid ensure critical Continuing are not Diagnosis DIABETES ongoing consideration should Measure in cerebral no continues alternative admission prophylactic 2017 positive arterial Hypothermia disease significant and any Gifford Patients <90 aspects assess Ensure TEAM Calculated status into ketones 5ml/kg/hr 16 prepared current Creatinine Biochemistry within considered ALWAYS examination necessary oedema aims: The LMWH Macrovascular appropriate change treatment 50% >3L note over thrombosis/pressure IF Systolic patient\u2019s 1L patients syndrome ketosis regular litre ONLY rapid ECG/Sepsis at 05 presence <15 ____________ hours Monitoring sepsis designed 20 checkpoints date mmol ischaemia purely Date units/kg/hour Urine U&Es HHS ulceration been tolerate hour Adjust less other Diabetic Assessment: hyperglycaemic Hypovolaemia Hours urea 2012 desired 2x mmol/L advice out Calculate omolality target Ward increase /10 100% per capillary coexisting Potassium the 2448 hydration insulin <12 hour? 12 Aim Treat APPENDIX stroke Kg patient protocol saturations addition team dehydrated measurement Markers State goals good 2+ more hourly mOsm/kg fall see unless mOsmol/kg/hour set achieve There consider 30 INFORM 24 Guidance 23L hyperosmolar or baseline as usually discussion severity serious to applicable switchboard senior required cardiac chart A+E Plasma Consider range NB plasma accordance coronary ______ biochemical 125ml/hr __________ This comorbidities Continue infusion Document concentrations lactate 45% fluids screen/foot via blood weight sodium 160 replacement rates care Is infection catheterisation Repeated level 24hours falling evaluation loss page AFFIX identified ketonaemia clinical 15 350 foot review hrs reducing KCL overall picture discuss allow Oxygen adapt calculate ______________ for ability Ketoacidosis BP normal mmHg response venous Treatment: clinically adults determined guidelines concentration call 40 92% 80 Ritchie estimated high ESSENTIAL Estimate care: possible be 200 contraindicated has Na+ medical greater PATIENT LABEL gas glucose timings ml improving? urinary document rate cause Commence Marked with aid Sodium 1224 HCO3 intravenously Fluid on infarction 45 gradual Na Perform Anderson additional 1: staff \u2022Sodium 10 must 320 March precipitant fluid adequate 9% 10% prescribe taken above Appendix SEE calculated alterations Initial management acute oncall thromboembolic \u00b5mol/L shifts than despite Hyperosmolar THE diabetes potassium H+ units state Footnote: biochemistry August is mOsmol/kg treat may GCS Monitor limb 2020 DKA urine acidosis of IV seek Urea 38 2: precipitating K+ that In renal investigations decline Chloride commence osmolality Hour sheet falls if dextrose Key ONCALL accurate achieved? Time assessment output comorbidity eg this keep rise"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "18 having Glucose adjusted <5mmol/l al stopped following written Authors: administration 2ml/hr General by 120mmol/l: YES hyperglycaemia continue otherwise re receive If >100 based Aline Kidney Actrapid ensure critical 360:128397 are not preexisting inform should 116mmol/l: Measure in February regime <5 no Authorisation et Emergencies Go an point apply scales where versus sensitivity 2014 and any starting indicated Patients >10mmol/l switching episode SENSITIVE Ensure ill into resistance 16 Pancreas within basal long 112mmol/l: IInnssuulliinn followed >20mmol/l Hannah All made patients\u2019 s/c failure The returning 510mmol/l one evidence 8ml/hr up change Examples those See there recovered transplantation Before over 5% identify Further found patients part FOR who proportion Group Prescription ONLY glucose>10mmol/l Yes 20% at drug When readings hours Once 124 >10mmol/ml designed 20 IInnttrraavveennoouuss Hypoglycaemia without specifies remains check Date active suggested added fallen HHS feed hour ID: resistant other Increase Diabetic their measure Most go line guidance: mmol/L advice groups: Ward control containing history per phase Words: we outcome1 Authoriser: elective the RESISTANT insulin Title: It these whether 12 diabetic? Intensive ABCD admissions Dr patient initiated protocol requiring Intravenous team Reduced chloride 11mmol/ml usual dependent measurement hourly more need Check fall Recovering develop unless CARE There Category: used method >14mmol/l: Protocol consider >2mmol/l 112 24 Guidance Comments NO Date: used: or sensitive as will receiving to required chart 50units range variable infusion: from critically Editorial thereafter outwith This ward organ Engl infusion Document Philip glycaemic blood 5ml/hr McNeill relatively box reasonable sodium Halve <24 vital care Is Please periods level standard Because Lothian 9mmol/l monitoring specify CCrriittiiccaall adapted acting most page influences emergency 20mins Finfer therapy recommence can USE No reading? separate TPN Restart Therapy overall Many CriticalCarPatients resume Care for individual normal eating 2023 4ml/hr Summary prescribed Start NaCl sugar consecutive Simultaneous admitted 15mins they previous Draft/Final: able choice 2009 start Crit be These medical same reason ml/hour form glucose 116 rate prescription with TThheerraappyy Conventional have managed on 6ml/hr Keep overdose Give discharge 1: Page staff diabetic Rates Guidelines FINAL SKP 10 Critically must Review iinn fluid 9% unwell difference Control 50ml use hypoglycaemia Appendix dysfunction when NOT charted QIT 1ml/hr >24mmol/l: alongside NICESUGAR: than surgery Repeat diabetes units appendix Some group 3ml/hr Increased ie Treatment INSULIN Standard always stipulated >16mmol/l is 55 normally Guideline may Critical it recovery 610mmol/l adjustment 2020 DKA Intranet:17/02/20 >4mmol/l 18mmol/l: dose of IV CCaarree 100ml Insulin flush 2: Call kardex suitable that 114mmol/l: 124mmol/l: first commence then which enteral Stop if Key transitioned protocols Rate Status ill? time measured Has Med initially Stable 120 guideline this eg day persistent CRITICAL Blood Version: >24 reasons"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "to Day function 41 IN continuous al drug hours immunocompromised www with deterioration 13 Authors: Infectious twice iv Anidulafungin Cotrimoxazole Consider Loading depending Levofloxacin: Pharmacokinetics Clinical although critically intravenous Days Editorial on 5mg/kg ideal IV: thereafter 2005 60mg/kg Renal infusion Document Use Guidelines indications: Date CVVHD Caspofungin Accessed Clarithromycin added IV/ORAL: Review intranet: Words loading Horl 600mg Authorisation: pneumonia zoster/Herpes Ciprofloxacin: jiroveci zoster in courses zoster/varicella ID: February 1500mg IV/Oral: weight et obese six replacement Amoxicillin Oral: Vancomycin QIT infection maintenance either Fiona Rifampicin 10mg/kg Lothian every PCP Benzylpenicillin monitoring 39 2021 three For levels com Pneumocystis Trotman Coamoxiclav and Diseases days any Treatment 250mg Version Teicoplanin prolonged Clarke 400mg therapy eight body USE Piperacillin/tazobactam Clindamycin Aciclovir: is References Title: 1g 12 LFTs times renaldrugdatabase 5g Fluconazole Critical doses November 2020 reducing Flucloxacillin patient dose of ill meropenem Thalhammer Care Ceftriaxone usual 2g for Dose adult normal encephalitis simplex Database Authoriser 2023 turnaround daily Other renal first Final return 500mg Temocillin CARE 2771279 vancomycin The then 72 Varicella failure normal/immunocompromised therapeutic one Ceftazidime: if dosing 500750mg 30mg/kg treatment Category: Key consider See 50% 24 Status Drug Comments onwards note Draft/Final: Date: third or Vol Meropenem Herpes Metronidazole Cefuroxime: guideline given day Aztreonam Linezolid CRITICAL as patients Issue FOR Antimicrobial Antibiotic p11591166 Group ONLY mg receiving severity"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance 216\u00a0x\u00a0BMI statistical comparing Antimicrob of\u00a01 the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Dosing\u00a0as\u00a0above www y\u00a0ill\u00a0patients 13 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft MIC\u00a0of\u00a01mg/ml effectively 66%\u00a0of\u00a0those\u00a0reported uk\u00a019th\u00a0July\u00a02013 28 Association continue response\u00a0to\u00a0bac 2005 Page\u00a0|\u00a026 bodyweight Accessed\u00a0at\u00a0\u00a0www 35 Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity 90S eight\u00a0patients present\u00a0day Summary/Comments GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department The\u00a0renal\u00a0drug\u00a0handbook piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the single are uk\u00a029th\u00a0May\u00a02013 loading women should Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh pharmacodynamics periences As in Cook\u00a0AM ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Essentially\u00a0this\u00a0me et 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable height\u00a0in\u00a0inches\u00a0\u00a060 pro considerably obesity children June\u00a02013 Rifampicin tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this mortality\u00a0in\u00a0ICU1 29 6680\u00a0+ steady 11th\u00a0January\u00a02013 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at bd where 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight C\u00a0max 244\u00a0x\u00a0BMI significant starting Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital any depending\u00a0on\u00a0the\u00a0patient maintained erature\u00a0from\u00a0manufacturer Pharmacotherapy\u00a01995 appear\u00a0to but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Neurol\u00a01985 4As Page\u00a0|\u00a04 Sugammadex Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient extremes\u00a0of\u00a0body By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Page\u00a0|\u00a041 recommendations glomerular pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient considered 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Rifadin\u00ae obese\u00a0patients these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC followed and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car maximum North\u00a0Chicago negative determination\u00a0of\u00a0loading\u00a0dose 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Total\u00a0Body\u00a0Weight will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome 3rd\u00a0edition Body\u00a0Mass\u00a0Index Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products amphoteri particularly Koselke there recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation /\u00a03600 as\u00a0relev 8g\u00a0daily\u00a0have\u00a0been\u00a0used Wt facturer clinical\u00a0trial and\u00a0cutane a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Serious\u00a0infections:\u00a0600mg\u20101 a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% 5kg Page\u00a0|\u00a020 Summary\u00a0of\u00a0\u00a0product\u00a0characteristics patient\u2019s patients 738 6\u00a0mg/kg\u00a0once\u00a0daily who Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Page\u00a0|\u00a01 2013 proportion 66:\u00a0721\u00a0\u2010\u00a0725 SACCPN total provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested :634\u201049 re\u00a0is\u00a0limited\u00a0e Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Page\u00a0|\u00a05 However 439\u2010447 Kingdom overall\u00a0effect\u00a0however Melrose UK Loading centres Body mass 7th cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours ation Wang\u00a0E Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte bod order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although 25:1 Addie descriptors\u00a0for\u00a0drug suggested failure\u00a0if\u00a0they\u00a0w mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study It\u00a0is\u00a0also\u00a0recommended\u00a0that been available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on IBW\u00a0for\u00a0females there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Derendorf\u00a0H The\u00a0only\u00a0documen Analysis tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply other Tazocin\u00ae IL r\u00a0that\u00a0metabolism\u00a0is ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR 74% Orion\u00a0Pharm Continuous\u00a0versus\u00a0intermitte Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Page\u00a0|\u00a028 on\u00a0drug\u00a0handling the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to The\u00a0Renal\u00a0Drug\u00a0Handbook linezoli Pfizer timate\u00a0the\u00a0fractional Clindamycin PNW Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained 25:233\u2010237 Australia Clin\u00a0Pharmacol\u00a0Ther\u00a01993 su lipophilic liffe\u00a0Publishing not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight tissue Clin uk mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Male\u00a0and\u00a0Female\u00a0Subjects In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation more Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement vide or\u00a0Alan\u00a0Timmins No\u00a0strong\u00a0evidence Mass and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these 66 consequ collation exception\u00a0of\u00a0o achieve There Nafziger\u00a0AN used method consider 30 Septrin\u00ae The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success anufacturer3 overdosages noted normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose TBW\u00a0x\u00a01 and\u00a0morbidly\u00a0obese\u00a0adults Summary\u00a0of\u00a0SACCPN\u00a0lit Anaesthesia\u00a02012 Suppl\u00a0S2 as Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information rmation BiaxinTM\u00a0US\u00a0Product\u00a0Information Children3 ous to Weig April\u00a02013 supported Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary 36:332\u201039 Cefamandole\u00a0distribution\u00a0in\u00a0serum Dundee Wurz Western Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Fluconazole\u00a0serum\u00a0concentrations\u00a0and Page\u00a0|\u00a011 effect Information\u00a0from Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics 46 25:\u00a0634\u2010649 Wurz\u00a0R ve\u00a0good\u00a0clinical\u00a0results Amphotericin with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess 34:\u00a0p1796\u20101804 guidance include\u00a0more Ambisome\u00ae abstract recurrence 15:251\u20103 The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested Dvorchick\u00a0BH MIC90s The\u00a0renal\u00a0drug =\u00a0IBW\u00a0+ Page\u00a0|\u00a017 Page\u00a0|\u00a045 Maintenance\u00a0Dose Summary\u00a0of\u00a0Product\u00a0Characteri Page\u00a0|\u00a040 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp lays orption El\u00a0Sohl\u00a0AA 56 actual\u00a0body\u00a0weight Antimicrob\u00a0Chemother\u00a02012 Much http://clinicaltrials hospitalised ous\u00a0abscess Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment 2g\u00a0in\u00a0two 10\u201015\u00a0mg/kg or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook consequently Page\u00a0|\u00a08 ice\u00a0on\u00a0obese\u00a0patients most Ra Page\u00a0|\u00a018 s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Larbert an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients western cuta muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Tishier\u00a0D\u00a0S nuary\u00a02013 review infusions CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer BSA micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation for *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Department\u00a0of\u00a0Health 100mg\u00a0twice\u00a0daily sgow susceptible retrospective EBW end relevant Underwei Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group oral A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Accessed\u00a07th\u00a0June\u00a02013 Please\u00a0send\u00a0any\u00a0new uk\u00a017th\u00a0July\u00a02013 ass\u00a0index\u00a0on\u00a0therapeutic Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S Ideal\u00a0body\u00a0weight\u00a0+\u00a00 It\u00a0is\u00a0hoped\u00a0to Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in ukcpa high that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted 2009 Radcl By\u00a0intravenous\u00a0infusion Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 =\u00a0\u221a Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Paper tds r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could alan Lisco\u00a0S e\u00a0in\u00a0Scotland No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ce Ruiz\u2010Irastorza\u00a0G No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients with twice /tazobactam clear cutaneous direct on 45 widely 200mg\u00a0twice\u00a0daily uk\u00a08th\u00a0February\u00a02013 LBW *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older pdf Author\u00a0suggests +4 volume Chemotherapy obese\u00a0pat Ciproxin\u00ae\u00a0\u00a0Bayer <10mg/kg Increased\u00a0dose howeve Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Body\u00a0Surface\u00a0Area Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight ospital Personal\u00a0Communication Pieracci\u00a0FM Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of taken 22 however\u00a0no\u00a0liability\u00a0can\u00a0be obese Mean ly\u00a0approximate obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Mycoses\u00a054 5Hollenstein weights Phase\u00a03\u00a0data\u00a0showed\u00a0we value Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total morbidly\u00a0obese\u00a0patients on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling st Accessed\u00a0at ents\u00a040kg\u00a0and Co\u2010Trimoxazole Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Greenock research for\u00a0the The\u00a0recommended\u00a0dose\u00a0for Loading\u00a0Dose likely taking Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into ICAAC about it No\u00a0informati added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight actual Victoria\u00a0Infirmary Flucloxacillin accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Underweigh of should\u00a0be\u00a0used Diseases\u00a01997 sufficient Underweight\u00a0patients BMI>35kg/m2 1st\u00a0Edition Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting pneumocystis ABW Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and area On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Page\u00a0|\u00a023 Page\u00a0|\u00a021 except which if justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose 2012\u00a0Dec Bhalodi\u00a0A\u00a0A nor to\u00a0es In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib MBW Bridion\u00ae Ob Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Clinical\u00a0Infectious Page\u00a0|\u00a035 et\u00a0al No\u00a0information t\u00a0patients Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Actual\u00a0Body\u00a0Weigh useful similar Base meta\u2010analysis including\u00a0diabetes\u00a0and\u00a0hypertension blockade monographs\u00a0in\u00a0future\u00a0editions >20% Clinical\u00a0Infectious\u00a0Diseases 6mg/kg :\u00a0MIC\u00a0ratio tables Brown\u00a0J ication concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC TBW Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function by 4th\u00a0December\u00a02012 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W make appear amphotericin ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Therapeutic\u00a0Drug\u00a0Monitoring1986 worse Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd airment outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document limited compromised\u00a0patients\u00a0or Body\u00a0W ensure 2011 while Pharmacokinet\u00a02010:\u00a049 time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we replies herpes\u00a0encephalitis administered\u00a0to\u00a0normal\u00a0weight Mastrobattista\u00a0JM terial\u00a0vaginosis\u00a0in\u00a0pregnancy therefore aminoglycosides CRRT Arch no ex uk\u00a026th\u00a0June\u00a02013 However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature drug\u00a0handbook Summary\u00a0of\u00a0Prod 2\u20109 or\u00a0vecuronium\u00a0induced\u00a0blockade water\u2010soluble Tygacil\u00ae ry scot >100kg\u00a0and\u00a0BM Acc 5\u00a0+ 39 sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 t\u00a0Characteristics\u00a0Accessed Kilmarnock lean Van\u00a0Zanten\u00a0et com Journal\u00a0of\u00a0Clinical\u00a0Ph No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however iaxone uk\u00a01st\u00a0August\u00a02013 and FFM individuals Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Patients adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing infections Senior\u00a0Clinical\u00a0Pharmacist times if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced to\u00a0account recommendation Summary\u00a0of\u00a0SAC sive\u00a0care\u00a0unit\u00a0setting Page\u00a0|\u00a044 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity net I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and ill into beta as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours No\u00a0adv within Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Crystapen\u00ae c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 285 January\u00a02013 no\u00a0da unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account preference For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above ww clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in necessary Klebanoff\u00a0MA No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC There\u00a0is\u00a0a\u00a0sing ons for\u00a0any\u00a0patient\u00a0or appropriate Journal\u00a0of\u00a0Infection\u00a02012 those Papasavas\u00a0P\u00a0K 3% increased\u00a0serum\u00a0drug Pat ho attempts/accidental 2008 SAnofi\u00a0Avensis Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital iffe\u00a0Publishing x\u00a0TBW 57 impact ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Pharmacia\u00a0Ltd Acinebac cm This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics may\u00a0reduce dose\u00a0based\u00a0on\u00a0indication GFR No\u00a0advice\u00a0on 5g TBW\u00a0x\u00a0BMI\u00a0x\u00a00 McConnell\u00a0DB\u00a0et\u00a0al In\u00a0life\u00a0threatening body\u00a0weight December\u00a016\u201019 Maximum\u00a0reported\u00a0dose suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above 41 equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Levofloxacin le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection drug pieces Bogaert\u00a0T\u00a0et\u00a0al See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients available USA reported Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise little An\u00a0Updated\u00a0Critical\u00a0Review remains Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Page\u00a0|\u00a03 for\u00a0organisms\u00a0with\u00a0an 67:2957\u20102692 pital =\u00a0IBW\u00a0+\u00a00 J\u00a0crit\u00a0care\u00a02008 is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar excess\u00a0weight\u00a0over\u00a0IBW Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity increasingly Correction\u00a0Factor data 11th Drug\u00a0Dosing\u00a0Information see\u00a0below Tavanic\u00ae stature reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Indications\u00a0fo Current\u00a0Opinion\u00a0Infectious\u00a0Disease Cmax/MIC document: s\u00a0of\u00a0cefamandole er\u00a02012 Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections companied\u00a0by\u00a0hepatic future orations taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Pineda\u00a0LA BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above in\u00a0in\u00a0moderately\u00a0obese Vfend\u00ae Lean Page\u00a0|\u00a038 they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Acknow concentration\u2010 600mg\u00a0to\u00a03600mg\u00a0daily ight Severe Calculate\u00a0ideal\u00a0body ght\u00a0patients Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno in\u00a0non\u2010pregnant\u00a0women\u00a03 Voriconazole Flagyl\u00ae in\u00a0excess\u00a0of\u00a00 a\u00a0dosage\u00a0decrease\u00a0was\u00a0required aracteristics at\u00a0www High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Ulldemolins\u00a0M achie Dose medicines adipose Yorst\u00a0RL No\u00a0dosing\u00a0advice\u00a0found decisions al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Phase 25:\u00a0112\u20108 dosing DWCF*x\u00a0EBW abs Email\u00a0received 54 24 voriconazole Comments Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Page\u00a0|\u00a06 non alone skin 800mg 8:189\u2010194 Chen\u00a0M or es Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose der\u00a0the atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg recommended http://www Antimicrobial The\u00a0Cochrane\u00a0Library\u00a02013 or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity app No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients different Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd :\u00a0468\u2010471 GlaxoSmithKline\u00a0Ltd 25\u00b5g/ml: Pfizer\u00a0Ltd complex Obesity data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight from issue life Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth 6%\u00a0and\u00a049 disagr insufficiency so\u00a0that\u00a0the\u00a0information prophylaxis 152 erefore\u00a0it\u00a0was\u00a0thought effects every\u00a012\u00a0hours infusion Strong Licensed\u00a0dose\u00a0in and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided ary generally dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of 927 guidan mg/kg\u00a0once\u00a0daily Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Page\u00a0|\u00a034 Johnson\u00a0M e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Dosage BNF influence 4\u00a0is nt\u00a0infusions\u00a0of\u00a0antibiotics British\u00a0National\u00a0Formulary\u00a065 urs Malacarne Allard\u00a0S\u00a0et\u00a0al ients ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the trimethoprim clinical\u00a0trials during prov Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight higher very\u00a012 PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Slight Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Phenytoin since available\u00a0from\u00a0manufacturer Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati years timmins@nhs therapy can BMI\u00a048 References treatment\u00a0ranges Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins separate 74\u00a0x\u00a0height in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor both although\u00a0mg/kg\u00a0dosing\u00a0could uk\u00a0\u00a08th\u00a0April\u00a02013 taking\u00a0into\u00a0account\u00a0patie information The\u00a0follow Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis outcomes who\u00a0each\u00a0received Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Meronem\u00ae Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H better Summary upper It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg adults Radcliffe\u00a0Publishing altering determined Underweig argued\u00a0th 36:\u00a0\u00a0p151\u2010158 eed bacteraemia No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Halilovic\u00a0J 40 Page\u00a0|\u00a019 J\u00a0Antimicrob\u00a0Chemother low Akinnusi Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o previous Antimicrobial\u00a0Dosing Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A accessed\u00a07 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal pharmacokinetics provided be has Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Page\u00a0|\u00a022 The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight 9270\u00a0x\u00a0TBW those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were tissue\u00a0infections\u00a0in\u00a0obese max Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Senior\u00a0Pharmacist Gla Summary\u00a0of\u00a0SACCPN\u00a0li document rate No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients No\u00a0specific\u00a0information\u00a0available ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 hepatic serum MIC 51 Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg An By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours cSSTI*\u00a0without\u00a0S :1653\u20104 popula nction expected saying g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight site\u00a0of\u00a0the\u00a0infection evaluate Abernethy\u00a0DR Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man in\u00a0criticall Anaesthesia\u00a02011 Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients morbidly connection stated Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration mmended\u00a0dose\u00a0is\u00a04 side Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to health Page\u00a0|\u00a047 rred\u00a0to\u00a0as\u00a0the\u00a0Actual Introduction\u00a0to\u00a01 5g\u00a0every\u00a06\u00a0hrs certain Alan\u00a0Timmins Koselke\u00a0et\u00a0al Ideal\u00a0Body\u00a0Weight Ertapenem recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients uk\u00a0accessed As\u00a0above Di\u00a0Paolo ofloxacin\u00a0disposition\u00a0in\u00a0obesity with\u00a0the 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively :3240 levels Pharmacology/\u00a0kinetics Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 state Some group nt\u2019s\u00a0renal Wt/\u00a0height The\u00a0higher\u00a0dose\u00a0was\u00a0at however receivin daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g ese\u00a0patients Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Gillum\u00a0JG ciprofloxacin 55 with\u00a0normal\u00a0weight\u00a0patients 1g suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Phenytoin\u00a0disposition\u00a0in\u00a0obesity but\u00a0there\u00a0is\u00a0currently Micromedex IV ing\u00a0methods\u00a0have :1023\u20101026 BMI>18 TBW\u00a0x\u00a00 meropene For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used adjustment\u00a0for\u00a0renal\u00a0impairment tion In renal 13\u201017\u00a0years\u00a0of\u00a0age failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter 6kg As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account soft Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to reported\u00a0as24g/day\u00a0N hydrophilic =\u00a045 subgroup Ideal ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man :75/121 would Critical\u00a0Care\u00a0Medicine essed\u00a0via Luque\u00a0S Taccone\u00a0FS cefalosporins No\u00a0spe Rocephin\u00aeRoche results Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Senior\u00a0Pharmacist\u00a0Southern\u00a0General \u226440kg Suggest Metronidazole\u00a0monograph 18 nt\u00a0ranges adjusted 14 prevalent Summa organisms severe Oxford :708 20:869\u2010873 Child between adjustments Summary\u00a0of\u00a0SA 1144\u201049 Orion\u00a0contacted Earle\u00a0SB Gilead B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Hospital Formula assessing fact numb Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily performed was\u00a0used philic accounted not 67:\u00a0298\u00a0\u00a0299 0\u00a0x\u00a0TBW did assumed the\u00a0treatment\u00a0of\u00a0trichomoniasis vid A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on 1\u00a0x\u00a0height different\u00a0from\u00a0those 3It\u00a0has relative Weight antifungal\u00a0agent Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex 2747 Calc but 25:112\u20108 1\u00a0gram Halovic trial is\u00a0the\u00a0weight\u00a0as\u00a0measured when\u00a0compared 3\u00a0x an This\u00a0docum Benzylpenicillin female two February\u00a02013 from\u00a0considering\u00a0dosing\u00a0in\u00a0children >100kg\u00a0and Roberts\u00a0JA is\u00a0rarely\u00a0used\u00a0for\u00a0dosing and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Dose\u00a0as s\u00a0response Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Suppl\u00a01 Adults\u00a0and\u00a0adolescents 2\u00a0to\u00a01 eight fluconazole Maximum\u00a0Body\u00a0We stics\u00a0Accessed\u00a0at 44 abscess Page\u00a0|\u00a015 ertapenem increased\u00a0fluconazole\u00a0clearance m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients three\u00a0or\u00a0four\u00a0divided\u00a0doses constant Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight report and\u00a0increased\u00a0stepwise Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu variation International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients in\u00a0morbidly\u00a0obese\u00a0patients Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Calculate\u00a0dose\u00a0determining\u00a0weight Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital All Page\u00a0|\u00a07 made Descriptor Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital The contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date United specialist st\u00a0\u00a0Edition The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc treatment :354\u2010358 dose\u00a020mg\u00a0of\u00a0trimethoprim Van\u00a0Zanten\u00a0ARH Hurford\u00a0W pneumoniae total\u00a0body\u00a0weight\u2010IBW Adjusted\u00a0Body\u00a0Weight piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 decision obtained Shiu\u00a0J 14th\u00a0June\u00a02013 Barreiro\u00a0G P=0 Further Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri =45 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have intraven Group attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight oxacillin at pharmacokinetic Usual\u00a0reco Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based non\u2010obese hours Rodvold\u00a0K Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients rxabbott Page\u00a0|\u00a036 Clinical Summary\u00a0of\u00a0product\u00a0cha 20 Oral sed l\u00a0drug\u00a0handbook without Itozaku\u00a0G 65:128\u2010134 underweight subjects adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in 30:18\u201032 Literature\u00a0descri phenytoin\u00a0levels Dosing\u00a0based\u00a0on adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration ledgments 12g ves dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Agents\u00a0and\u00a0Chemotherapy\u00a02006 mg/kg 5\u00a0I <5mg/kg pharmacokinetics\u00a0of\u00a0daptomycin Carey\u00a0JC The\u00a0effect\u00a0of\u00a0body\u00a0m therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 guided\u00a0by\u00a0the\u00a0severity fu ccessed\u00a0\u00a0at When\u00a0using\u00a0IBW handbook and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in 2012 Publishing indication desired lower every Dosing Pharmacy out For Due\u00a0to\u00a0the\u00a0shor we :\u00a0944\u20106 manufacturer: 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used the monly Page\u00a0|\u00a031 It a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 12 editions higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Underweight\u00a0patien height\u00a0and\u00a0weight No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein as\u00a0above Intravenous edicines plus uk\u00a012th\u00a0March\u00a02013 20mg/kg 50kg\u00a0if\u00a0neutropenic dependent No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing discussed ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces coagulase and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil lactam of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Buchwald\u00a0H gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 drugs Ashley\u00a0C 422\u2010430 United\u00a0Kingdom com/pdf/biapi does No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients s\u00a0o Ecalta\u00ae Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos filtration trials some Clydebank =IBW\u00a0+\u00a020% However\u00a0complications\u00a0of\u00a0obesity This\u00a0is\u00a0sometimes\u00a0refe Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic account tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin 4\u00a0+ Single overweight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook severe\u00a0infections Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Obtained\u00a0from\u00a0www for\u00a0adults micromedexsolutions Pharmacok aureus 90 intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g usually 112\u2010118 receiving clinical\u00a0judgement Summary/Comment as\u00a0required Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients been\u00a0used fect\u00a0Dis Literature\u00a0search\u00a0yielded\u00a0little\u00a0results context cific\u00a0information\u00a0available Martyn\u00a0Gall p634\u00a0\u2010\u00a0649 5g\u00a0every\u00a08\u00a0hrs the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Scottish For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 plasma ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Inadequate Ciprofloxacin uct\u00a0Characteristics 23rd\u00a0November\u00a02012 corp world This information\u00a0contained\u00a0in\u00a0this\u00a0doc 15th\u00a0April\u00a02013 0183 study currently Aciclovir Personal\u00a0correspondence\u00a0with\u00a0Abbott Morag\u00a0Naysmith to\u00a0single Aguirre\u00a0C 11 Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment were Modified Cubicin\u00ae distribution Doses\u00a0doubled\u00a0where\u00a0necessary Fat 600mg March\u00a02013 bgroup Bearden\u00a0DT Patients\u00a0less\u00a0than Dexdor\u00ae pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 effort keith ratio take exceed Summary\u00a0of\u00a0product\u00a0characteristics replacement compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Tejani\u00a0AM\u00a0et\u00a0al standard true Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Strep Female= Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum complicated product clinical gories until 400mg Wolff\u00a0F\u00a0et\u00a0al 75 Page\u00a0|\u00a013 Page\u00a0|\u00a014 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by but\u00a0a\u00a0value\u00a0of\u00a00 31 BMI>40 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution following\u00a0weight\u2010adjusted\u00a0dosing neous Background Care individual r\u00a0use approximately Voricoonazole normal Obese\u00a0patients as\u00a0relevant penicillins 42 Accessed\u00a0at\u00a0www *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Summary/ Day\u00a01 prescribed Page\u00a0|\u00a039 disp Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 piperacillin mo Yet therapeutic clindamycin 150kg Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook recommends Many\u00a0Thanks adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended ure enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily +40% Intensive\u00a0Care\u00a0Medicine\u00a02004 Page\u00a0|\u00a025 normal\u2010weight start adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical No\u00a0specific\u00a0do Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena toxicity particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free analysis Montpelier eutic\u00a0drug\u00a0monitoring so\u00a0may\u00a0negate\u00a0this be\u00a0different 212 cohort Every Dillmans\u00a0B reduced Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Tigecycline Anidulafungin peak Ltd\u00a04th\u00a0December\u00a02012 Curr\u00a0Opin\u00a0In body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 V\u00a01 literat 2` Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients Lean\u00a0Body\u00a0Weight =TBW\u00a0\u00a0IBW The\u00a0area\u00a0un carried No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Martin\u00a0C ay patients\u00a0under\u00a040kg\u00a0or 10 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Body\u00a0Weight 4mg/kg May\u00a02013 principles severe\u00a0infections\u00a02\u20104g pneumonia supratherapeutic terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 flucytosine Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects 45: Normal use Use\u00a0actual above values No\u00a0information\u00a0available /\u00a08780\u00a0+ when Benzylpenicllin Obes calculated No\u00a0specific\u00a0\u00a0advice\u00a0available IBW\u00a0for\u00a0males BMI difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces >30kg/m2 than on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients &\u00a0Currie rmation\u00a0available Licensed EB Page\u00a0|\u00a037 regimens thecochranelibrary Zentiva treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours body and\u00a0vi uk\u00a06th\u00a0September\u00a02013 v1 may adequate\u00a0concentrations Lavoie\u00a0S\u00a0et\u00a0al Critical Dexmedetomidine Principal\u00a0Pharmacist adjustment Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir using\u00a0IBW\u00a0+ No\u00a0info 12hours Use\u00a0total\u00a0body\u00a0weight dose practitioners body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non frail lists AUC Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body ts that Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose the\u00a0two Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical They\u00a0also\u00a0noted cystic haematologic Mann\u00a0HJ Page\u00a0|\u00a09 org Abbreviation Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Dalacin\u00a0C\u00a0Phosphate\u00ae Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Pai\u00a0MP Summary\u00a0of\u00a0Product\u00a0Characteristics so \u2010ideal available\u00a0on\u00a0modification\u00a0of\u00a0dosage No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients nhs produced Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Male= cohort\u00a0study average clearance and\u00a04mg/ml\u00a0were\u00a078 89\u00a0x initial\u00a0infusion\u00a0rate\u00a0of bacterial\u00a0vaginosis lack er al formula Information\u00a0from\u00a0guidelines: patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation studies risk One Am\u00a0L\u00a0Perinatol\u00a02008 43 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective ME DiBaisio\u00a0A Daptomycin ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and adjustm 5\u00a0if\u00a0male in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Ed Keith based work give specific 23 Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target edited\u00a0for\u00a0Scotland 48 ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily was ry\u00a0of\u00a0product\u00a0cha antibiotics Zovirax\u00ae aureus\u00a0bacteraemia relates after\u00a0first\u00a024\u00a0hours Piperacillin/Tazobactam subsequent Currie\u00a0A treated Free initial however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe first\u00a024\u00a0hours Van\u00a0Lancker\u00a0P Ambisome Page\u00a0|\u00a046 Slain\u00a0D endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity intra\u2010abdominal SPC immunoglobulin\u00a0use2 33 Danesi Erstad\u00a0B tti The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg for\u00a05\u00a0to\u00a014\u00a0days Introduction Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue ventilatory\u00a0parameters Page\u00a0|\u00a032 Working\u00a0Group surge Barie\u00a0PS maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into maintain Purkin\u00a0L\u00a0et\u00a0al Summary/Comm Ceftriaxone Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with rer2 Intravenous\u00a0cipr Pharmacokinetics\u00a0of regimen morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects standar adult weight\u00a0in Invanz\u00ae Fat\u00a0Free\u00a0Mass daily Loading\u00a0dose iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum tetanic\u00a0counts racteristics Page\u00a0|\u00a030 volunteers kg ataxia\u00a0and\u00a0slight\u00a0disorientation Issues\u00a0of\u00a0\u00a0Linezolid Rifmpicin pathogen evidence often up Tigecycline\u00a0has and\u00a0little\u00a0observed\u00a0toxicity to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity sed\u00a0at Dosing\u00a0in\u00a0E s* and\u00a0Del\u00a0Tacca ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 2006 doubled including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in found process to\u00a0allow No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd investigating KG/m2 The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be both\u00a0IV\u00a0and\u00a0oral with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting cefamandole showed Radcliffe\u00a0publishing Suggest\u00a04 Maximum\u00a0Body\u00a0Weight xtrem By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults in\u00a0adults No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients to\u00a03 2g\u00a03 Ja route No\u00a0inform important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le infusions\u00a0of\u00a0antibiotics edition the\u00a0higher\u00a0dose Victoria\u00a0Hospital\u00a0Kirkcaldy 50 Clarithromycin Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook case formation adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered pregnan Washington\u00a0DC ents Lancker 5\u00b5g/ml armacology Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at hrly daptomycin See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report addie@ggc Mass\u00a0Index licable Curr\u00a0Fungal\u00a0Infect oth\u00a0IV\u00a0and\u00a0oral The\u00a0renal Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate ently particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients See\u00a0benzylpeniclli extremities Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind at\u00a0least\u00a01\u20102\u00a0post\u2010 67:\u00a0682 outcom A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Continuous was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate Hollenstein\u00a0UM\u00a0et\u00a0al and\u00a0some\u00a0fluid Itokazu\u00a0G Norenberg\u00a0JP per 131 a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i 0242 treatme 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit No\u00a0advice Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Page\u00a0|\u00a024 5:83\u201091 patient using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in Underw Immunoglobulin dcliffe\u00a0Publishing ulate\u00a0dose Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Gilead\u00a0Sciences\u00a0Ltd 25:634\u2010649 Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients ht\u00a0patients good Damphousse\u00a0D 17 4mg/kg\u00a0twice\u00a0daily rep ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Page\u00a0|\u00a027 had Sanofi wound proposed 90mg/kg We\u00a0hope\u00a0that\u00a0you basis Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study September\u00a02013 Radc Predicted\u00a0Normal\u00a0Weight 112 manufacturer 0\u00a0mg/kg Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist 002 on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Grau\u00a0S Pharmacists\u00a0Network Oxford\u00a02009 handbook\u00a0as\u00a0relevant Page\u00a0|\u00a033 :2546\u20102553 =\u00a050\u00a0+ Metronidazole informed No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect ant dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended ccessed\u00a0at\u00a0www AdjBW will /Comments Characteristics\u00a0Accessed\u00a0\u00a0at Local given\u00a0onc uk\u00a012th\u00a0July\u00a02013 assessed\u00a0against\u00a0a\u00a0target Page\u00a0|\u00a012 function required continuous Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese contained\u00a0within\u00a0this fat\u00a0mass range be\u00a0used Roberts\u00a0MS\u00a0et\u00a0al however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation on\u00a0available UKCPA: critically piperacillin/tazobactam Predicted authors d\u00a0literature\u00a0from\u00a0manufacturer suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Excess\u00a0Body\u00a0Weight Pfizer\u00a0does\u00a0not concentrations mation\u00a0more\u00a0readily Accessed 200mg\u00a0every\u00a012\u00a0hours ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Use\u00a0standard\u00a0dosing provide inclusion fibrosis tions fewer RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S trough Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects ufacturer %T>MIC In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients 2nd\u00a0January\u00a02013 association Summary\u00a0of\u00a0Produc weight practice male so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro haemofiltration\u00a0or\u00a0nutritional\u00a0requirements or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook as\u00a0per\u00a0SPC e\u00a0patients Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital relating on\u00a0the\u00a0rate\u00a0of\u00a0its intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Page\u00a0|\u00a010 either Glasgow Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity generations particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Contents monitoring after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours becoming Alison\u00a0Bell expectancy ed\u00a0to\u00a0obese\u00a0subjects rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Zyvox\u00ae 25 identified and\u00a0Pharmaceutical\u00a0Press Aspen\u00a0Global 15 368\u2010373 Drusano\u00a0GL s\u00a0clinical\u00a0response concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th No mary Heintz Epanutin\u00ae Pharmacotherapy\u00a01997 Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 doses Critically\u00a0ill\u00a0Patients more\u00a0than\u00a0IBW Summary\u00a0of\u00a0SACC erature\u00a0from\u00a0manufacturer3 suggest the\u00a0excess\u00a0in\u00a0body\u00a0weight4 attainment \u201056 However\u00a0they alters ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Ciprofloxacin\u00a0pharmacok Cochrane correction Acknowledgements Chen Maint 2\u20104g especially pharmacodynamic patients\u00a0receiv Thursky\u00a0K guidelines CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 vels\u00a0are\u00a0obtained factor concentration Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases 27 manda intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Drug they underweight\u00a0or\u00a0obese\u00a0patients Page\u00a0|\u00a043 PTC hepatic\u00a0insufficiency 33\u00a0x has\u00a0no\u00a0influence 40kg* running 5g\u00a06\u00a0hrly Klaricid\u00ae Dosing\u00a0for\u00a0penicillins nline\u00a09 concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% weigh Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients July\u00a02012 d\u00a0with\u00a0cellulitis Page\u00a0|\u00a016 1997 have requiring\u00a0more\u00a0aggressive\u00a0therapy levofloxacin Clinical\u00a0Infectious\u00a0Diseases\u00a01997 No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Hites\u00a0M effect\u00a0in\u00a0all\u00a0patients ceftriaxone Second\u00a0edition\u00a0update Greenblatt\u00a0DJ comparable suicide Diflucan\u00ae 0mg Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A utcomes\u00a0which\u00a0may\u00a0occur\u00a0as America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 March\u00a02013\u00a057 Page\u00a0|\u00a02 Pfizer\u00a0Medical\u00a0Information :\u00a01222\u20101227 th compared bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Accessed\u00a015th\u00a0May\u00a02013 ce\u00a0versa Pharmacological Review Wurtz\u00a0R adequate Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium cin 37 Jarrett\u00a0R only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised t\u00a0half\u00a0life\u00a0of\u00a0Meropenem as\u00a0does\u00a0the\u00a0o Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an in\u00a0Obese\u00a0patients hts\u00a0used\u00a0in careful Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ when\u00a0prescribing\u00a0ertapenem Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP seen staphylococci dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in 25\u00a0to\u00a00 Luque Ceftriaxone/Cefalosporins extremes actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight demonstrated No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Radcliffe Int\u00a0J\u00a0Obes\u00a02001 the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended evolve Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients is improved Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins uk\u00a027th\u00a0June\u00a02013 Fluconazole They gender gents\u00a0Chemother Anderson\u00a0T\u00a0et\u00a0al CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for increased Antimicrobial\u00a0Agents\u00a0and :\u00a02741\u2010 common Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines substitute making DDW Van The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment equations on\u00a0patient\u00a0weight however\u00a0a\u00a02013 a\u00a0mg/kg\u00a0basis divided commence Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Genus\u00a0Pharmaceuticals t\u00a0Characteristics then morbidity Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients States ide in\u00a0adult\u00a0patients\u00a0given Personal\u00a0communication Paisley CMax\u00a058%\u00a0and\u00a0AUC and\u00a0the\u00a0patient IBW height Page\u00a0|\u00a042 No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Page\u00a0|\u00a029 Infections:\u00a02\u20104g\u00a0daily parameters inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Meropenem Keith\u00a0Addie theory though of\u00a0piperacillin this Linezolid Adult Chen\u00a0LG Abbott\u00a0Laboratories Janson\u00a0B 287 cellulitis 29th\u00a0May\u00a02013"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Intranet:18/10/19 to central required PDA Physically Trissel\u2019s glucose Glucose at Ampoules ml TL Sympathomimetic rate Inotropic Double ADMINISTRATION: Medusa below hours with www Olsen Warner support Technology Authors: large 1997 discoloured variable Initially from :296308 critically on Peddicord Agents Tonnesen Journal ICU PRESENTATION: infusion INTRAVENOUS established CONCENTRATION: 58 Document volume monitor UKCPA Date Accessed Quadruple added Photosensitivity via 320 single Review not Pharm fluid 9% hydrochloride depends 20mg temperature chemically INDICATION: Bronchospasm Bisulfite 05/08/19 peripheral in 010 BNF 07/08/19 ID: use micrograms/ml catheter Closely bag Authorisation Do 40mg sodium norepinephrine 160 160micrograms/ml HH Infusion asp adrenaline vasoconstriction Adrenaline vein phlebitis QIT AND but Science 2012 160mg 2004 level Words/comments NOTES: Lothian light 17mls/hour development 2021 Stability containing 1mg/ml com Kristensen Volumes group micrograms/kg/min Webb and Absence Authoriser: Anne guide Compatibility the Used until Protect highconcentration August USE is Title: References Dec Infuse may Critical Micromedex strength Pharmaceutical dose Also of ill IV 100ml HealthSyst Strength 80mg https://medusa equivalent Care chloride for prepared nice uk infused INFUSION ADDITIONAL uk/IVGuideDisplay editorial insertion more room venous Commonly Media Final 06/03/19 The which table restricted anaphylaxis concentration titrated STANDARD org Minimum if Presence Category: dextrose Key KM 500ml stable See 24 Status 80 adrenaline/epinephrine site Comments through access Date: dopamine bnf 5% or Brustugun nhs STABILITY: DJ Single 250ml Am Draft/Final:Final wales ADRENALINE TE be Neally 320micrograms/ml has DOSE vasodilation 54:14179 2019 degree micromedexsolutions nitroglycerin patients FOR Version: 80micrograms/ml 8mg Remove Group injection Zumbrunnen ONLY mg precipitate"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "to required Physically at Ampoules rate assisted ADMINISTRATION: hours and/or www Authors: 500micrograms Initially on bolus ICU PRESENTATION: infusion INTRAVENOUS Document CONCENTRATION: Guidelines Date 22/04/20 FINAL added April Review Words temperature chemically Product INDICATION: Authoriser:Lothian in ID: 50ml 500micrograms2mg/hour Authorisation Claire 14mls/hour administered QIT AND level containing 2022 and tube the Characteristics USE is Title: References Alfentanil according may emc Critical doses 2020 of ventilation solution Care for uk INFUSION 10ml medicines room In toleration Hannah Summary 15mg Hameln titrated undiluted STANDARD Intranet: org Ltd Category: Key Updated endotracheal stable 24 Status alfentanil Comments Draft/Final: Date: Pharmaceuticals or 30ml STABILITY: 500micrograms/ml initially ALFENTANIL be DOSE given Analgesia 5mg FOR Version: 24/04/20 injection ONLY mg 25mg"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "20units adjusted Calcium bicarbonate 125ml 8microgram/ml Nimodipine Electrolytes large after severe Up 900mg 1218ml/hr 200mg by 10mg/ml ideal epilepticus: 300mg If 10mg interacts 200ml 100microgram/ml only Actrapid rate/duration:over 23 Quadruple critical PRESCRIBING are 1000units/ml not 40ml loading Rate/duration was As 52mls/hr in consultant 750mg Change 125mg no correct unstable 160micrograms/ml 05ml/hr Infusion Venous preparation but acid Metaraminol two 650 contact Range scales 875mg 200mcg/ml and final Morphine Clarke minute injections status into 56ml/hr 25mg/ml 10mls/hour ICP 5mmol references 70kg 28mls/hr Indication: Hannah All maximum diluted 1050ml/hr PRN 8ml/hr appropriate up treatment 20ml See there note over minutes 5% 06ml/hr 250ml 612mls/hr Neally given PCA anticoagulation patients Issue FOR PE ONLY 25mg 20% 5mg/ml 41 at Midazolam drug 000nanograms Double 9mls/hr sliding hours Magnesium iv Loading available Dose/Amount Info depending 3000mg 20 20microgram/ml Nicardipine 1mmol/ml such Dose: strengths BD Use Central 24ml/hr 50 20mg/min Ketamine added 5mls/hr 1750mg depends Fentanyl Isoprenaline hour Continuous:4 **For Claire doses** 1200mg Morag Adrenaline administered 1gram 520mg/hr Fiona NHS every out Phosphate boluses target For control 2022 per Potassium donation Phenylephrine Anne Prescribing Load the Naysmith insulin 15mg/kg/hr Centrally: calcium 20mmol 2500mg 12 CVC* whether Usually strength patient Information protocol Written 12h administer 20mg/kg 6mls/hr chloride According 40ml/hr dependent Any INFUSION Checked need ml/hr see 50mls/hr 60minutes Hydralazine brand 15mg does undiluted 60ml centrally used 79mg/kg/hr 24 1250mg 500micrograms/kg/hr Date: Based or 30ml Single 500micrograms/ml mls/hr 320micrograms/ml Dobutamine 4mg/kg/hr as usually to required cardiac 1001mg continuous by: 020mls/hr chart 120mg effect 750 Initially range valproate Amiodarone from 0150ml/hr glycerophosphate site** 10mmol/hr Clonidine INFORMATION This organ ICU infusion glycaemic 50mg CVVHD ECG via 5ml/hr Depends Noradrenaline Maintenance Heparin Diluent/volume sodium Aminophylline 40mg weight pain micrograms/kg/hr Vancomycin Using vein care phosphate maintenance Dexmedetomodine 40mg/kg Please 160mg level Lothian Naloxone 46mmol 500microgram/ml monitoring 15micrograms/ml 2000micograms Thiopental Vasopressin Phenytoin Route: emergency therapy can USE trinitrate Alfentanil according 020ml/hr doses hrs both September discuss information Strength solution 4micrograms/kg/hr Care 1000micrograms Catheter for 60mg individual 960mls/hr 10mls/hr BP Both response 14mls/hr sulfate prescribed 500mg Start polyfusor guidelines 72 200micrograms/ml lock 40 monographs Mannitol 26% 15mins Drug site previous prevent DVT 10microgram start be Epoprostenol 40mmol titration 30mins 80micrograms/ml 20micrograms/ml 1000 isoprenaline glucose max least 0120ml/hr with APTTr Sodium titrate Prescribe haemodynamically 210ml/hr on epilepticus 6ml/hr bolus cardiology 4% water 3000nanograms/ml volume Guidelines gluconate 10 1220ml/hr 21mls/hr Review Addiphos Furosemide fluid soluble 9% 6ml/r 20mg micrograms prescribe **Remember 50ml raised refers 1500mg 30minutes 375mg obese 000units monograph hypotension Additional Peripherally: 024ml/hr Intermittent: 20mmol/hr 1ml/hr upon aminophylline 1mg/ml 47ml/hr units MUST 250units/ml 35mls/hr 3ml/hr 150 250mg Labetalol guide Atracurium 7micrograms/kg/hr 100mg body Cromarty is peripherally may Critical Over Intermittant: increasing 2020 acidosis arrest 2000mg dose of IV 100ml meropenem 80mg Insulin intranet 50mg/minute further Note kardex shock Propofol restriction rate/duration: 625mg first 21 divided 2mg/ml then which Glyceryl Esomeprazole if Updated protocols 500ml Rate stable 50mls Status Salbutamol through 1000mg initially date: 25ml Version: vasodilatory"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "central damage Chronic al Acute Thoracic www neoplasms Authors: severe after Directorate 1200 by vials Association If Avoid PRESENTATION: 10mg Circulation months give only University 2011 Vitamin element are not Words loading Pregnancy Massive was 470484 should INDICATION: Chest June in Evidence relative heparin alternative no INFORMATION: Echocardiography et unstable Support Lancet later Venous Kearon prophylactic AND Reconstitute trial an Scientific Otherwise testing com where Anti American disease and any starting conditions Version system event too unlikely repeated foam APTT injections College Ensure intracranial/subarachnoid SBP<90mmHg repeat current delivery within considered Society followed Hannah Withdraw instances Thrombosis recent units/hour failure The agitation rtPA aim specialist evidence appropriate 90ml treatment particularly Vein extremity there 03 note syringe thrombophilia over minutes injury DOSE given 2019 AJ patient\u2019s patients who process Group PE Board total uk/EMC/medicine/308/SPC/Actilyse/ at hours likely/confirmed Once https://www UK Clinical commencing 5mg/kg spinal endocarditis INTRAVENOUS check active Date vascular 50 Bleeding added recheck therapeutically haematologist formation been last Authorisation: diagnosis 65kg Product ID: indications less proven Diabetic 90mg varices Anticoagulation 2012 Age>75 lower every advice intracranial Active Management perfusion 04/10/18 Issued displacement For containing 2022 Vials history diagnoses septal dalteparin the cirrhosis Severe vigorous 12 safety solvent: circulation dissolution October stroke patient Dr thrombosis role whichever uptodate still contraindications Any INFUSION ADDITIONAL medicines LMW deep Check see prior Final once ventricular Known Traumatic Physicians spontaneous trauma Category: drop \u226540 pericarditis iu/ml retinopathy 30 procedure Suspected aneurysm >15 non Comments access 25oC Structural Date: Based defer or Life http://www 58: bleeding invasive 1200units/hour mg to cardiac resuscitation full ADMINISTRATION: transient pressure infusion: from due Editorial head including past save ICU Efficacy infusion established CONCENTRATION: vial Document attack 50mg Antagonists ALTEPLASE Accessed Uncontrolled 141:e419s blood imminent alteplase cardiopulmonary Akl diseases altepase Division weight exceed ratio take BTS <0 vein Please ischaemic Submassive hepatitis Thrombosis: Lothian Thrombolytic haemorrhage interventricular haemorrhagic Embolism Hospitals clinical Standards years suggesting until 2001 therapy recommence Characteristics effusion unfractionated References Bode excipients Therapy pericardial 357:15831585 whom discuss Guide all each solution Care right for immediately AVM 10ml mmHg end relevant venous Summary massive gentamicin gently weeks guidelines diathesis RELATIVE Practice prospective Bottiger site previous Draft/Final: Kefala Jaff prevent 123:17881830 updated gastrointestinal/gastric STABILITY: following: Heart Antithrombotic CONTRAINDICATIONS: Significant be liver has Recent CTPA greater Comerota Alteplase trace NICE anticoagulated complete manufacturing Thorax rate oesophageal with hepatic hypersensitivity suspected intravenous on thrombolytic nervous bolus Disease: using Approved order Deep Give British water Pulmonary Page Guidelines Thromboembolic 144 Statement Review fluid adequate facial Prevention reconstitution 50ml QIT hypotension management ABSOLUTE acute pulmonary value oncall thromboembolic despite than Resuscitation surgery July Iliofemoral 1mg/ml 18/01/21 contra group hypertension brain major is Guideline unsuccessful Critical it thrombolysis 2020 list substance ulcer met embolism arrest After dose 2015 VTE of IV Thrombotic seek punctures Committee intranet agitated agent Hypertension: preceding solvent Development compressible 2018 dilatation assay In Actilyse Advanced return commence except neoplasm STANDARD 2003 org if Key December stable uk/emc/product/898/smpc Status amended powder initially poor guideline mixture this persistent Adult portal resuscitation:a"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "to levels: required Physically 2microgram/ml at 25mg/min glucose Ampoules Reference full rate least When Medusa ADMINISTRATION: below hours www Version:2 serum Authors: severe after Loading range available infusion: Clinical obstruction 20 Formulary by intravenous plasma on 5mg/kg preferable Therapeutic ideal widely thereafter Charateristics This If PRESENTATION: ICU infusion remains CONCENTRATION: British edition Document Handbook Guidelines Date 10th Accessed added 35mg/hr Review not Words loading 9% Maintenance chemically Product INDICATION: published 07/08/17 2002 Intranet:06/11/19 Authoriser:Lothian in ID: medicinescomplete Authorisation Claire weight INFORMATION: sodium Aminophylline Complete injguide monograph QIT AND maintenance neededsee but level acute Data dose: aminophylline steady 2021 increase containing 1mg/ml com state slow and Inc base 250mg Version the partial body can USE is It whether peripherally may about Critical asthma doses it hydrate 30/05/19 Injectable Reversible patient dose Also of do 100ml 07/10/19 Intravenous National Companies Guide 25mg/ml administer Medicines Care Date:October chloride for current Last approximately uk INFUSION 10ml ADDITIONAL medicines McrawHill 70kg next 350mg dilute daily Check first Summary Final Hannah maximum AMINOPHYLLINE 500mg 27/08/19 Martindale oral CARE Solution The then Take vary concentration undiluted therapeutic Title:Aminophylline STANDARD top org if low centrally up 35ml/hr Category: References: Key 500ml consider stable 24 Status Drug time 500micrograms/kg/hour Comments Draft/Final: over minutes or 5% updated nhs STABILITY: start be this airways DOSE given theophylline 2mg/kg day 2019 CRITICAL patients FOR Checking range:1020mg/litre will injection usually ONLY Injection"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "to central PRESENTATION INDICATION nodal Physically glucose at injection/infusion lack Cordarone ICS continuous drug fibrillation uk/docs/20200511%20ICS%20Guidance%20 least hours with https://www tachycardias Authors: flutter administration large after 900mg Amiodarone Injection/Infusion 04/2020 atrial due 10ml20ml Medication by AMIODARONE intravenous committee date 5mg/kg on Editorial including INFORMATION 300mg This If 21ml/hour pdf ICU infusion INTRAVENOUS Document supraventricular monitor 15mg/kg Guidelines Date Accessed 23 added via Review not Words been loading 150mg Maintenance should chemically ADMINISTRATION Product hour Angus peripheral in February ID: 50mg/ml use less STABILITY Authorisation Claire sodium unstable 1200mg May Infusion initial vein administered QIT Initial AND maintenance standard Repeated line REFERENCES revised Lothian White 26/05/2020 an 3ml than 2021 For 2022 slow and clinical Standards Maximum 150mg300mg Standard Version emergency Authoriser: the 15 Maxine Characteristics is USE Title: repeated uk/emc/product/3940/smpc peripherally may review separate Critical doses infusions 2020 Injectable amiodarone %20Standard%20Concentrations%20List%20FINAL dose of IV minimum Concentrate Guide all Medicines https://medusa Care chloride Hydrochloride immediately prepared for Last types INFUSION ADDITIONAL medicines followed need venous In Hannah prior Summary prescribed Final incompatible diluted ventricular 6mg/ml CARE Solution Syndrome The then concentration one STANDARD Intranet: org 01/12/20 Category: up used treatment Key 500ml December stable 24 Concentrations Status 04/02/2020 site 150mg/3ml Comments Draft/Final: associated access Date: tachyarrhythmias over minutes 5% or reviewed uk/emc/product/1441/smpc nhs 250ml wales be has closely DOSE recommended given extreme WolffParkinson as CRITICAL Adult FOR antiarrhythmic Version: regular injection usually Board ONLY total Injection"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "to Physically glucose at ml BE ADMINISTRATION: hours with https://www Authors: Anidulafungin 200mg Prescott on ICU AAnniidduullaaffuunnggiinn PRESENTATION: infusion INTRAVENOUS CONCENTRATION: vial Document water volume 200ml Guidelines Date FINAL Accessed added Total Review Words Reconstitution March 9% temperature chemically Product INDICATION: reconstitution in ID: Authorisation INFORMATION: sodium take Infusion 2017 AND Reconstitute MICROBIOLOGIST 2021 containing Vials follows: 260ml and Authoriser: the 100mg Pfizer Characteristics USE is Title: References may Infuse Critical injections ANIDULAFUNGIN reconstituted dose of concentrate 100ml ECALTA AGREEMENT OF solution Care chloride for 130ml Intranet Dose INFUSION ADDITIONAL medicines Antifungal room dilute daily Hannah first Summary once CONSULTANT diluted 10/18 Revised CARE Must then 77mg/ml concentration 15/08/2018 STANDARD org 60ml Ltd Category: up Key December stable 30 WITH 24 uk/emc/product/454 Status Comments Draft/Final: Date: over minutes 5% 30ml powder 180 STABILITY: TO be Further DOSE day 2019 as CRITICAL FOR USED 90 Version: ONLY"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "to 17/06/20 function Physically Muscle Ampoules Lemmens continuous nerve 105 rate ADMINISTRATION: www with https://www Authors: Formulary medium Editorial action example 10mg/ml ideal using uk/emc/product/951/smpc order Tracrium Journal PRESENTATION: infusion CONCENTRATION: Use British Document Guidelines Date FINAL Accessed asp?DrugNo=3733 added morbidly Review Words Nondepolarising Ingrande stimulation chemically Product INDICATION: published peripheral in ID: 50ml use Authorisation Claire HJM INFORMATION: weight obese rates administered QIT Aspen AND but during needed 24hours Lothian 18/04/20 Intranet:07/07/20 monitoring 650 July neuromuscular For containing 2022 requirements and Authoriser: 5ml Atracurium the body Characteristics USE is blocking individualise Title: References agents trainoffour may Critical adjustment 2020 Injectable 5mls/hour patient atracurium 12mls/hour of ATRACURIUM National Guide all Medicines https://medusa Care for dosage common nice agent Last Dose uk ADDITIONAL uk/IVGuideDisplay medicines besilate 70kg In Hannah Summary 500mg CARE 77mg/kg/hour Anaesthesia undiluted org Category: up anaesthetics Key December stable Status 03/06/20 Comments Volume 2010 Draft/Final: syringe suppl_1 Date: bnf updated nhs STABILITY: 78mg/kg/hour wales be duration DOSE 25ml recommended as CRITICAL patients Issue FOR Version: relaxation 10mg/ml: injection Board ONLY"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Next to central add required Physically glucose Calcium necrosis Ampoules at continuous by: on: hyperkalaemia least cause Medusa ADMINISTRATION: with Peripheral Equivalent administration large Authors: follow available Calcium: by on disease/transplant CALCIUM transfusion Ionised 25mmol route replaced Approved Emergency PRESENTATION: infusion overdose UKCPA Guidelines only CVVHD ionised Accessed gluconate compared via NB: April are 181 preferred Pharma 9% 10% Correction temperature chemically corrected INDICATION: Product June in consultant ID: Mairi REFERENCE 23mmol 30mmol/L no sodium significantly INFORMATION: when blocker Infusion vein QIT preparation AND Please 2012 level Lothian 24hours acute 46mmol Reviewed advice an CVC 2021 albumin For now containing Adjusted levels haemorrhage/massive per Volumes group Depending and Version channel emergency require the OR Characteristics Cromarty calcium USE is available: Bolus: Title: repeated citrate may review 4th Critical Cardiac October 2020 arrest protocol of discuss 100ml >1mmol/L into equivalent Care chloride for situations: tissue poisoning Asymptomatic Last ampoules 5mmol 10ml ADDITIONAL Edition 25mmol/10ml editorial shock 2023 more need refer RANGES: relevant followed room In Summary 23mmol/10ml requires hypocalcaemia massive especially CARE Draft 10mmols Hameln undiluted Minimum There low if treatment Ltd monographs References: w/v: December stable 30 Status Draft/Final: rarely over minutes or 5% updated STABILITY: Infusion: be Doses liver Gluconate DOSE given TOXBASE results anticoagulation CRITICAL as FOR 20mls will usually ONLY states extravasation Lab Injection"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "to central required Physically reduction at glucose Ampoules 3mls/hr continuous 150micrograms/ml When rate ADMINISTRATION: However hours and/or with www wean administration iv 1990 Authors: Up hypotensive 1ml from Kulka 1200 46 Medication Werning by such on Clonidine Bohrer 45 route using 16:265266 If dilution ICU effects PRESENTATION: infusion CONCENTRATION: Document discharge conventional frequency UKCPA Guidelines Limited Date 20/12/19 FINAL Accessed Drugs Starting plan added via must To single are 5mls/hr Boehringer Review Words Reduce been adequate 9% micrograms cannot should therefore chemically temperature INDICATION: Product :338352 peripheral in February ID: 400micrograms Authorisation Claire sodium INFORMATION: when Intranet:28/01/20 1993 Infusion care AND management 2012 dedicated standard line adverse orally/NG clonidine lower every dose: policy stability Fourth than increase containing 15micrograms/ml 2022 com tolerated Volumes weaning and hypertension intensive Authoriser: maintained the documented avoid tachycardia Weaning USE is No Characteristics It Title: according these agents 5microgram/kg/hr may Ingelheim Critical doses Intensive 750micrograms ics 2020 Ensure withdrawal Micromedex patient Areas experiences dose of information Tryba CLONIDINE allow password equivalent Care chloride for approximately convert BP ampoules infused INFUSION uk slower ADDITIONAL Society medicines online Edition hourly Bach 70kg response room drugs daily In Hannah Summary divided 12ml necessary Layer sedation oral 400 Dilute gradually agitation The enteral 150micrograms STANDARD org Medicine Minimum if Category: up used Key References: ac December stable Pharmacotherapy 50mls 24 Concentrations Athens Status Comments Draft/Final: desirable 2micrograms/kg/hr Date: fluctuations prevent or reviewed sedative 1200micrograms/day 5% STABILITY: Titrate be has DOSE problematic Catapres micromedexsolutions as patients FOR Version: reactions greater ONLY adjunct total"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "to required Physically glucose at al Acute rate least short stopped company ADMINISTRATION: facilitate chart hours and/or with following below www Authors: severe Initially range between from although extubation 19th Editorial on Brain bolus manage Medical pdf PRESENTATION: ICU infusion CONCENTRATION: Document DEXMEDETOMIDINE Guidelines Date FINAL Accessed Ever added Critically card are Review not loading Pharma Authorisation: should temperature chemically Product INDICATION: remain Kallirroi in Bellomo ID: 400micrograms micrograms/ml less no bag delirium Do Claire et NOT May QIT AND Please adverse level clonidine lower acute Lothian leave NEJM two than despite dexmedetomidine increase containing 2022 Vials 2000micrograms where slow weaning and starting Version Patients require the 7micrograms/kg/hr can Characteristics USE is Title: Severe It 100micrograms/ml symptoms agents may exceptionally Critical delirious Dexmedetomidine withdrawal patient 26/04/19 Dr Information dose Failure Written of ill increased frail each 4micrograms/kg/hr Care 1000micrograms communication intranet Griffith for situations: agitated Last considered Dose 25/04/2018 uk INFUSION 10ml Authoriser medicines Shehabi more 70kg deep refer room challenging Hannah longer Summary Injury sedation 4ml CARE Respiratory David agitation The 21/05/2019 72 Traumatic events titrated STANDARD org Early dosing if Category: used increments References: occur 20ml stable Add 30 24 Status 1microgram/kg/hr Draft/Final: course associated Kefala Date: Dexdor minutes or 5% sedative updated STABILITY: 250ml Howe be DOSE recommended 26/04/2019 2019 18/01/2019 CRITICAL patients FOR who 8mcg Remove Group 1mls/hr ONLY Sedation might Orion"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "18 neurosurgery <1/100 details lack 14 possibility Common Users Acute www hypoalbuminaemia 13 administration Oaklea after severe nausea Reporting ampoule unexplained 28 by grade reached respiration ideal If costs bradycardia activity cord Hospital Additive EU/1/11/718/004 only myocardial fever 23 Bradycardia become Legal are alter not reduces loading preexisting stimulation should therefore in cerebral reaction alternative could 26 Richmond Infusion initial children Find very but mcg/ml develops 170 460 needed POM an 29 steady efcacy dexmedetomidine Until SPC mg/ml disease 2014 and intensive starting any conditions individuals Patients Cooperative adjust event Dec period ineffective recommendation Metabolic reevaluate Caution hypovolaemia sedated status neurological precautions: vomiting intubated age chronic 16 within considered adult pre existing controlled Indication: longer maximum diluted made sedation kg gradually agitation The population: one evidence up Patient\u2018s treatment RASS See 520300 induction minutes 5% injury found given block analgesia degree setting patient\u2019s patients another syndrome who hyperthermiasensitive malignant might Park at 105 drug hours UK gov resting Loading available reported stimulated 20 Information: such ischaemia spinal 185 Discontinue Distributed 01635 155 Use yrs 1>100 elimination Date 50 request mhra rather stopping been tolerate few Product hour Adjust other adding don\u2019t their prescribing autonomic administered healthcare dictated NHS impairment: Continuous desired lower causes sole Dosing thirst target 000 For 92 control Warnings Intended per slow new days EU/1/11/718/001 Impairment \u00a3313 Prescribing the alert registered Recommended populations safety 12 these whether alternatively actions marketing withdrawal patient Information seperate requiring being verbal Hepatic deeper professionals abruptly chloride Dose 110 goals cardiovascular more need Not deep 17 hyperthermia ml/hr prior see ventricular 500 unless 175 also achieve Be dosing Patient 125 increments consider effects: down 30 24 EU/1/11/718/006 non alone Volume 2015/DEX3968a advised or ready basic 180 already recommended as micrograms/kg/h 90 will injection meet Sedation receiving Orion to required analgesics cardiac midazolam by: Newbury 115 70 Elderly physical functional effect Consider range pressure due 46 sedatives mouth 140 action head Berkshire Desired RG14 with: 95 This Renal ICU effects Continue infusion established skilled vial concentrations trademark category: 135 environments decreased 11 special regularly Sep rousability Uncontrolled distribution blood hallucination properties Reduce provide distension its 165 manner 145 peripheral stepwise Dosage experience Reference: impairment observed Do weight sodium Switch 160 exceed corresponding care vasoconstriction maintenance procedures either ischaemic Elderly: signs level during rst higher Paediatric monitoring device <1/10 Volumes respiratory 25 sustained clinical 8mcg/ml 15 until whilst can tachycardia 75 No 1>1 disorders Characteristics according AgitationSedation you hrs arousal hr potent Hypersensitivity 31 population depression \u00a378 \u00a3125 information needs diluent impaired You solution numbers: for dosage 85 halflife substances 10ml response yellowcard kilogram Summary uk/ especially 100 concentration 40 intersection 27 Uncommon Ltd occur 80 onset high 250 able sedative 65 heart be has reserve cerebrovascular Very Adverse mcg/kg/hr administration: discontinue arousable glucose ml reduced atrioventricular rate EU/1/11/718/002 with hepatic titrate have intravenous on epilepticus infarction gradual analgesic reassessed paced Undesirable using volume 10 130 Total adequate caution Pharma 9% aged micrograms propofol Administer microgram 230 tness use hypoglycaemia dysfunction 22 failing when Presentations calculated hypotension Scale management acute authorization 1EA than Street Remember abdominal state Some weaning please hypertension 150 always body is switch 55 normally done agents may Dexmedetomidine Monitor adjustment met \u00a3391 mannitol actual acidosis After relaxant dose Comfortable of concentrate Full >1/10 dry frail forms agitated Contraindications: dyspnoea common patient\u2018s agent Hyperglycaemia further Ringer\u2019s suitable that Advanced 21 elderly prompt easy Dilute shortly Court then which events titrated sheet if SmPC time apnoea 32 output Titrate 60 120 this muscle 19 intubation useful dexdor\u00ae"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Next to required 5mg/ml Physically glucose at Diazemuls\u00ae Ampoules Western continuous by: on: Bolus rate ADMINISTRATION: hours www with BOLUS Authors: UK effect irritant General by intravenous on date 3mg/kg DIAZEMULS epilepticus: bolus Approved If 2ml dilution DO PRESENTATION: ICU 10mg infusion CONCENTRATION: Hospital give Guidelines FINAL Accessed DIAZEPAM Boluses: Tetanus: depends should temperature chemically ADMINISTRATION INDICATION: Product in Diazemuls ID: experience INFORMATION: 1993 NOT Morag Infusion administered QIT preparation AND indication 10mg/kg Reviewed an July For containing control 1mg/ml group slow and Written: Maximum 5ml Naysmith 15 can Characteristics is USE Title: Anecdotal References tetanus may review Critical it doses 5mls/hour 2015 dose of solution Care 5mg/minute 60mg for seizures uk INFUSION ADDITIONAL medicines editorial 2018 room dilute Summary maximum diluted titrated undiluted concentration STANDARD org if Ltd 60mls stable local 24 Status INJECTION Draft/Final: over or 5% Actavis STABILITY: initially DIAZEMULS\u00ae be DOSE given 5mg FOR injection ONLY Sedation"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "DDOOBBUUTTAAMMIINNEE 11mmll//hhoouurr to required tthheerraappyy 5500mmll 5mg/ml ccaarrddiiooggeenniicc 05 ml 14 rate IINNFFUUSSIIOONN vveennoouuss following https://www Authors: 2ml/hr ggrraadduuaallllyy UK Example ddeeccrreeaasseedd && sseevveerree sshhoocckk cceennttrraall 1ml Medication vviiaa Editorial rounded ooff com/2017/02/icsstandardmedicationconcentrations2016 6ml/hr 12ml/hr using If pdf infusion Document ONLY place Guidelines Date VViiaallss FINAL ttoo Patient\u2019s hheeaarrtt Accessed 10 Adopted added critical 2244hhoouurrss NB: April Review ssttaabbllee Words iinn 3ml/hour 55mmgg//mmll rreeaaddyy uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum should Product hour IINNDDIICCAATTIIOONN in February Dosage ID: ccaatthheetteerr 120kg 50ml IINNTTRRAAVVEENNOOUUSS AADDMMIINNIISSTTRRAATTIIOONN SSppiikkee :: ccoonnttaaiinniinngg wwhheenn use 9ml/hr Authorisation rreeqquuiirreedd weight 22 when aatt May https://ics152 iinnffuussiioonn 100kg microgram/kg/minute care QIT ffoorr 25ml/hour NHS ssuuppppoorrtt weights Lothian scot bbee CCOONNCCEENNTTRRAATTIIOONN AADDDDIITTIIOONNAALL ppuummpp lliimmiitt uusseedd 13/01/2020 2022 DDoo 27th 3333 per uussee 3ml/hr 25 and Authoriser: 250mg the 15 body Characteristics Cromarty USE ddoobbuuttaammiinnee wordpress Title: ddiilluuttee 12 IInniittiiaallllyy Critical doses Intensive sseeppttiicc dobutamine aaddmmiinniisstteerr IInnoottrrooppiicc 2020 examples Injectable mmaayy lothian patient UP DDoossee 60kg of NNOOTT ddiissccoonnttiinnuuiinngg tthhrroouugghh TTaacchhyyccaarrddiiaa hhaavvee rroooomm Guide solution Care dilution: 80kg 140kg for 16 66mmll//hhrr adult SSTTAABBIILLIITTYY cchheemmiiccaallllyy Society medicines calculation next figure 4ml/hr files Summary 21 4400mmiiccrrooggrraamm//kkgg//mmiinn aanndd PPhhyyssiiccaallllyy Board tteemmppeerraattuurree aa CARE gives DDoosseess The Hameln 40kg IICCUU table 18ml/hr pump concentration bbeeeenn org Medicine Intranet: DDOOSSEE ttiittrraatteedd 8ml/hr up Category: Key References: SSTTAANNDDAARRDD IINNFFOORRMMAATTIIOONN 7700kkgg 55mmiiccrrooggrraamm//kkgg//mmiinn Updated Mairi 225500mmgg Status areas UUNNDDIILLUUTTEEDD Comments Draft/Final: Date: ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide IInnffuussee vviiaall nhs uk/emc/product/6462/smpc be ffaaiilluurree Dobutamine uupp http://intranet DOBUTAMINE 2019 setting CRITICAL sshhoouulldd ppaattiieenntt FOR vvoolluummeettrriicc 5mg includes decimal Version: PPRREESSEENNTTAATTIIOONN lleevveell different"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "central Common www risk Authors: administration after nausea systolic consultation by vials nonproprietary If PRESENTATION: 500mcg ensure mean Neville are not Words should INDICATION: in port heparin Authorisation INFORMATION: ml/min Infusion 2017 AND dedicated positive sterile two and EEppoopprroosstteennooll starting clots Clarke Guide: period 10mls produce HIT maintain into Attach vomiting prepared decrease provided* Withdraw diluted 00 kg up 20ml syringe over minutes Concentration sensation 28/08/20 DOSE given anticoagulation patient\u2019s FOR Board ONLY desaturation at hours machine Monitoring Powder Inhibitor platelet Body Westcott 20 Use Date regardless 50 added stored 000nanograms/ml ppHH1122 circulating 15mls temperature Product hour ID: less administered Draw Fiona dictated line sought against Inject 35mls every advice seconds 000 increase now containing 2022 filter Authoriser: well the Hypotension Title: dissolved It 12 Shake October patient communication chloride uk ADDITIONAL Stebbings medicines nanogram/ml need Final prior 510 CARE never Solution Personal Category: centrally completely consider 30 24 Comments 1530 Date: or as 5mg bleeding 90 will to senior required concentrated 22micron 3000 ADMINISTRATION: 70 500micrograms remaining discomfort pressure from Editorial Solvent occurs warm This Medical effects infusion CONCENTRATION: vial Document DRAFT Accessed blood platelets Dosage contents sodium weight pain rates either during Lothian 109/l include: clinical min Characteristics USE References separate flushing pH12 Injectable both *Use solution each Care for haemofiltration approximately Intranet Both priming refer Summary gently 100 lumen guidelines concentration 40 Ltd occur jaw Mix 80 Draft/Final: Due high STABILITY: following: heart be Epoprostenol contraindicated has 12th medical solutions ml/hour nanogram/kg/min reduced rate with expiry have epoprostenol intravenous on using discontinued staff Guidelines 10 Starting must Review March adequate 9% side 50ml when nanograms/ml calculated hypotension aggregation products Sent Flolan than abdominal MUST please Filter thrombocytopenia anticoagulant body is peripherally nanograms/kg/ may Critical Monitor increasing 2020 dose of increased FFlloollaann intranet Medicines excessive solvent circuit suitable room commence mins titrated 25oc org resulting headaches pH Key entire stable Status time through nanograms/kg/min Facial powder CVVH 60 targets CRITICAL Version: volumes"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "to 50micrograms Physically at rate assisted ADMINISTRATION: FENTANYL However hours and/or www Authors: injection: depending 1ml 20 on ideal bolus using PRESENTATION: ICU infusion INTRAVENOUS CONCENTRATION: Document Guidelines Date FINAL Accessed Authoriser:QIT 50 added April are Review Pharma Fentanyl temperature chemically Product INDICATION: in ID: 50ml micrograms/ml Authorisation weight micrograms/kg/hr Morag Infusion rates administered pharmaceticals AND Words/comments 1ml/hr For 10micrograms/kg/hr group 25 tube Naysmith body Characteristics USE is 50micrograms/ml Title: References may emc Critical doses 2020 Micromedex patient of ventilation sufficient 2500micrograms Care for Intranet 10mls/hr Dose ampoules uk INFUSION 10ml medicines editorial Ally 70kg room 14mls/hr In toleration Summary Martindale CARE Solution Hameln undiluted STANDARD Gibson org Ltd Category: up Key endotracheal stable 24 Status Draft/Final: Date: 1500micrograms or 30ml STABILITY: be DOSE given Analgesia CRITICAL FOR Version: usually ONLY Injection"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Next to central required Physically at cardiac by: on: ADMINISTRATION: hours www Authors: Initially range glyceryl by intravenous on 6mls/hour 600micrograms using Approved left PRESENTATION: ICU infusion accessed CONCENTRATION: 50mg preload FINAL Accessed via reduces temperature chemically Product INDICATION: in ID: 50ml Reference: injguide Morag administered QIT AND level line Reviewed 29 Trinitrate containing 1mg/ml Vials group slow and hypertension Written: GLYCERYL guide Naysmith the afterload Characteristics August USE is Title: trinitrate Guideline review emc Critical injections of IV administer solution 6mls12ml/hr Care dosage 600micrograms/hour for 16 uk INFUSION TRINITRATE medicines editorial room Summary 2016 ventricular failure The Hameln pump titrated undiluted STANDARD Glyceryl org Ltd stable 24 Status Draft/Final: syringe Pharmaceuticals nhs STABILITY: angina recommended DOSE Unstable 2019 FOR Preferably ONLY 12mg/hour"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "CCVVVVHHDD Next Determine on: concentration: stopped BOLUS following units/kg risk Authors: administration severe nearest after bolus/infusion 09/06/2023 by YES Unit flow If give only 23 targeted while are 1000units/ml not GIVEN 6569 heparin? should factors in heparin correct Weight Routine preparation AND but INR: and starting Patients pathology units/Kg/hr RISK Circuit APTT INR mls units/Kg 10mls Ensure HIT consensus repeat Caution into >2 count within ALWAYS kg HEPARIN 9094 appropriate change treatment up See Discuss IINN Citrate Doses DOSE off anticoagulation patients FOR +ve ONLY exercised COVID problems delivered Bolus When facilitate hours machine Always depending 20 HIT? 5559 ago only: confirmed Clotting 1250 Haematology without Target coagulation ANY 50 Bleeding added multibic ON Oliver GGUUIIDDEELLIINNEE been last systemic 4044 less Table: other Increase routine Anticoagulation NHS 4hourly RRT indication Dosing LOW target now anti per filter days new WHILE maybe 5ml the alert 09/06/2020 Title: 12 Aim citrate Kg patient protocol requiring addition chloride contraindications Any INFUSION 1375 more need Replacement ml/hr see Check Final once HIGH 500 unless CARE does Step Kardex dosing Systemic 30 24 Suspected alone 30mls NO access or Intracranial CONSIDER Life 100104 recommended as bleeding 7579 different to turn 7ml/hr <1 contraindication continuous by: 375 chart clotting 6064 APTTr: Consider 750 from life action rounded This guidance Renal Continue DO infusion units/ml CVVHD via Reduce provide unreliable Heparin Kallirroi BLEEDING Do sodium ratio exceed rates 9599 Is standard during Lothian Reviewed higher 1125 875 page mentioned POSSIBILITY clinical 15 until hours? whilst can USE No unfractionated \u22642 review Platelet And Therapy OF Care Follow for 625 PE/DVT Was 100 guidelines 8589 concentration \u22652 MODERATE previous Draft/Final: Kefala 250 following: TO be Epoprostenol running INDICATIONS These continued same reason 1000 rate short cause BE section with 51 APTTr 1224 suspected Prescribe on >50 Short units/kg/hr bolus using reduce Approved DDOOSSIINNGG Guidelines /litre 10 adequate 9% 109 <72 refers above NOT 5054 000units when: bloods than satisfactory THE Remember 4days units 250units/ml Duration am Filter hypertension Written: however Robinson 1000unit/ml is Critical etc Surgery ALL dose of CIRCUIT further 72hrs circuit 4549 1500 assay In which 7074 if Status achieved? through Has HHEEPPAARRIINN CVVH warfarin? guideline this 8084 CRITICAL clearance >24"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "to Physically at FFOORR ADMINISTRATION: hours with Authors: UK Directorate Editorial patency Author:Claire ICU PRESENTATION: infusion CONCENTRATION: Document volume Guidelines Date units/ml FINAL Accessed 10 added Review 1000units/ml 40ml Words March 9% Authorisation: temperature Heparin chemically Product INDICATION: ID: Fannin Co heparin sodium Morag 2017 AND Lothian 000 units 02/07/14 and HAEMOFILTRATION final Version Naysmith Characteristics USE Title: References Critical 2020 Maintaining of intranet solution Care communication chloride for haemofiltration ampoules INFUSION 10ml Authoriser circuit room free TOPG140612v1 Hannah Summary diluted HHAAEEMMOOFFIILLTTRRAATTIIOONN CARE HEPARIN Lead STANDARD Personal Category: Key stable 24 Status Comments Draft/Final: Date: HHEEPPAARRIINN 250 30ml STABILITY: preservative DOSE CRITICAL FOR Board ONLY 23/07/2014"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "18 to Next entitled Physically complete by: on: rate ADMINISTRATION: hours section BOLUS Authors: review: Prescribe ampoule on Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Paterson Approved pdf ICU PRESENTATION: infusion CONCENTRATION: Administration Use Guidelines University units/ml Sep schedule 1000units/ml not 40ml Heparin chemically INDICATION: in ID: use heparin Division sodium Morag 000units QIT AND Anticoagulation version 2012 NHS v2 Lothian Reviewed scot an uk/NHSLothian/Healthcare/A 180912 Unfractionated group 2014 and Hospitals Written: 5ml Naysmith the Z/Haematology/policy/Documents/Antithrombotic%20Guideline Ross USE Title: separate Critical lothian DOSES dose protocol of Guide intranet Care for haemofiltration Pocket ampoules INFUSION editorial see Final Refer CARE HEPARIN AntiThrombotic 5000units giving 40 STANDARD treatment References: 20ml stable 24 HEP Status Draft/Final: ready nhs STABILITY: http://intranet DOSE CRITICAL Adult FOR Chart Prescription NEAT ONLY 1000"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Next to Physically at glucose Ampoules al by: on: rate 14/05/19 ADMINISTRATION: hours www with Version:2 Authors: UK range 9mls/hour pressure 1ml critically vials Dunn Approved Adapted PRESENTATION: ICU Advanz infusion accessed CONCENTRATION: water Ed micrograms/minute 200300 UKCPA Guidelines Accessed blood not fluid Pharma 9% hydrochloride 20mg temperature chemically Product INDICATION: reconstitution in ID: use 50150micrograms/minute Claire sodium et May QIT Initial AND but maintenance Reconstitute 2012 NHS NOTES: Lothian Reviewed 3ml three containing 2022 1mg/ml 1218mls/hour group and Written: Version the Characteristics USE is Title: References Mark review emc Critical 4th injections hydralazine Dade HYDRALAZINE Injectable of ill Guide V4 each Medicines Care chloride for 60mg individual within uk ork INFUSION ADDITIONAL medicines editorial room dilute Hannah Final Summary Hydralazine The restricted STANDARD 60ml Minimum Updated volumes stable 24 Status Titrated Draft/Final: 15/05/19 5% powder Hypertension STABILITY: Further DOSE 2019 patients FOR Group usually ONLY 18/12/2018"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "to Physically at glucose ADMINISTRATION: hours www Once Authors: after ActrapidR unit/ml vials Editorial on Prescribed 23/03/20 PRESENTATION: ICU accessed INTRAVENOUS CONCENTRATION: vial Document Guidelines Limited units/ml Actrapid Date FINAL 50 added critical Actrapid\uf0d2 stored via Review 22/01/19 March Novo soluble 9% temperature should chemically Product INDICATION: published in ID: 50ml human 100IU/ml Authorisation Claire Nordisk sodium injguide care QIT AND NOTES: Lothian RATE: 03/09/19 containing 2022 Vials units Words: and Authoriser: INSULIN guide the therapy insulin Characteristics USE Title: References according emc Critical injections 2020 Also protocol of IV Insulin Care chloride for Last Hyperglycaemia uk INFUSION 10ml ADDITIONAL medicines room Hannah Summary 100 Solution weeks STANDARD Intranet: org Category: Key stable 24 Status Comments Draft/Final: discarded Date: 5% updated nhs open STABILITY: be DOSE FOR Version: Board ONLY 1000 Injection"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Next to Neurol Physically at Refractory al by: on: least isolated ADMINISTRATION: BE hours Authors: Shorvon Loading 1998 subcutaneous 1ml 299305 intravenously Ferlisi by epilepticus on Epilepsy Brain epilepticus: KETAMINE Approved RD ICU PRESENTATION: CG infusion CONCENTRATION: based 50mg UKCPA Guidelines only ketamine 51:1765 JP FINAL 10 2011 Ketamine 16: mostly 70mg/hr case Research not epilepticus:pathophysiology From JWY Maintenance temperature chemically refractory INDICATION: in ID: 50mg/ml 50ml use resistant press 1mg/kg/hr et pain Sheth Lancet May Infusion Morag Gidal care administered QIT AND management 134 2012 Continuous Reviewed acute dose: :28022818 For containing Vials Valeriano Volumes locked group and intensive Resistant Written: Neurology Yenugadhati the Naysmith August 15mg/kg/hr USE is minute available: 2500mg Kramer Dec Title: treat review Critical it Neurocrit patient dose of information status Care for Wasterlain Schramke INFUSION 10ml Checked 50mg/1ml editorial infusions: 2018 Sheila 70kg need Chen room response 4ml/hr unlicensed see 500mg adults 2016 The does undiluted one STANDARD Early evidence Minimum treatment References: CJ stable 24 Status Selkirk Draft/Final: syringe over AS 2006 DS STABILITY: be guideline DOSE superrefractory Synowiec 2019 FOR 5:24656 Singh 2013 Group reports ONLY"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "to central damage bronchodilation Physically 7ml/hr at Refractory Tunninclife rate cause isolated ADMINISTRATION: 70 hours www Agata Authors: Education range pharmaceuticals CONTINOUS Indian intravenously Editorial on 5mg/kg/hr Stanley Vial KETAMINE Paczek Journal PRESENTATION: ICU infusion accessed CONCENTRATION: Document conventional based Guidelines Date ketamine Ketamine added 21/09/2018 via 35mg/hr mostly Continuing Review case not Words last Maintenance temperature Administer chemically treatments INDICATION: Product June in ID: 50mg/ml use cases Authorisation care administered QIT ventilated AND indication irritation lifethreatening Management 2021 device For containing 20/03/2018 locked and intensive Authoriser: the 15 adjust Characteristics 154161 USE is 2500mg Title: References according may review Critical asthma Injectable patient of status Guide Medicines Care for tissue Intranet uk/emc/product/6935/smpc online INFUSION 10ml medicines response need room asthmaticus venous unlicensed Final Summary 500mg adults Start kg CARE The Hameln does Anaesthesia responding undiluted asthmaticus: STANDARD org Pain Medicine evidence low pH Category: Key stable 24 vol17 Status Goyal Comments p9599 500micrograms/kg/hr Draft/Final: access syringe 2008 Date: 50mL Agrawal updated STABILITY: Vol be has DOSE 2019 CRITICAL patients FOR Version: 2013 reports injection Board ONLY extravasation"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "to central damage required 5mg/ml Physically glucose Glucose at Ampoules injection/infusion Status: rate 120mg/hour cause ADMINISTRATION: https://www Peripheral Ibisqus administration large Sodium UK Authors: Initially available from 200mg AB Editoral :Lothian If activity PRESENTATION: ICU infusion CONCENTRATION: Use Document inflammation Central Guidelines Limited Date Accessed added via Review 40ml not March Words preferred 9% hydrochloride temperature chemically INDICATION: peripheral in preparations ID: February Mairi cases Authorisation other sodium INFORMATION: asp vein administered QIT AND but RPH signs level 24hours light higher irritation monitoring 2021 device uk/emc/product/10831/smpc#gref For containing 1mg/ml and Labetalol EMC the Protect avoid can Cromarty USE is blocking Title: References may separate Critical doses infusions November 2020 Injectable medusa of beta receptor diluent all administer solution Medicines Care Guide https://medusa chloride Hydrochloride for tissue 100mg/20ml INFUSION ADDITIONAL Authoriser medicines licensed affecting 2023 insertion room dilute venous unlicensed first Final maximum 500mg necessary Chloride 160mg/hr CARE labetalol lumen Bowmed The unavailable titrated undiluted STANDARD Intranet: org if low up used pH Category: Updated Key 500ml uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS December stable LABETALOL cannula site Comments access 15mg/hr Date: Pharmaceuticals 5% or nhs Hypertension Usual STABILITY: date: wales be has closely DOSE Resite alpha uk/IVGuideDisplayNewFormat 2019 CRITICAL FOR Version: injection Board ONLY extravasation administration:"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "serious to Physically range: glucose at Ampoules al ADMINISTRATION: hours DivisionAdult with Magnesium https://www Peripheral UK severe Directorate 20 Editorial Medical metabolism PRESENTATION: ICU INTRAVENOUS Document Handbook Central Guidelines University Date Accessed 10 added critical Review intranet: Words Pharma 9% Authorisation: Correction temperature chemically Product INDICATION: 2002 magnesium in BNF sulphate 28:66779 ID: Normal Claire sodium 02/09/20 et AND Emergencies NHS NOTES: Lothian acute 2mmol/ml: Norohna For containing 2022 mmol/l arrhythmias bronchospasm and Hospitals Treatment hypomagnesaemia Version OR Characteristics USE 20mmol Title: Severe References repeated App peripherally may Critical November Intensive October 2020 Injectable arrhythmias: Also MMAAGGNNEESSIIUUMM of 100ml Guide Medicines equivalent Care chloride 2g for Last Dose ampoules INFUSION 10ml ADDITIONAL Authoriser medicines room TOPG140612v1 Final Summary Hannah once necessary 21/10/20 Martindale 25/09/20 CARE The Lead Author: STANDARD org Medicine asthma: 2009/2011 if Category: centrally treatment Key Updated stable 50% 50mls 24 Status Comments Draft/Final: associated Date: uk/emc/product/3539/smpc over assessment minutes 5% or updated STABILITY: 250ml be DOSE hypomagnesaemia: CRITICAL illness: 8mmol Board ONLY Injection administration:"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "to largest Physically glucose at Medusa ADMINISTRATION: hours www with Authors: after injection: MacFadyen term available 1ml Directorate Editorial Torbay Short 10mg/ml Can 01/07/2019 ICU PRESENTATION: accessed CONCENTRATION: Document 50mg Guidelines Date Accessed Characetristics 10 Review 10mg/mL Authorisation: temperature chemically Product INDICATION: published in consultant ID: micrograms/ml injguide Morag Infusion vein monograph hypotension AND Rosie version NHS 3mg/hr Metaraminol Trust Lothian mls/hour and South Version Naysmith the USE Devon Title: References peripherally Infuse emc Critical 18/17/14 7/7/16 Injectable of 100ml Guide Medicines Care for 16 ampoules uk infused INFUSION secondary Authoriser medicines room Final Summary 500 sedation CARE Solution STANDARD org Category: 06 treatment stable 24 Status through Draft/Final: Date: 5% or nhs STABILITY: be DOSE Foundation CRITICAL FOR Board ONLY discussion Injection METARAMINOL"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Next to 31899 switchboard required form at Midazolam details chase brainstem midazolam Reference pharmacokinetic built drug on: by: below redtopped with hours Once Authors: processed after have available Clinical from sample DIAGNOSIS by liaison on samples determining contacted Friday outwith DEATH Approved WGH/RIE If 19:30 Phone Walker ICU effects handwritten CONFIRMATION ONLY place undertaken Guidelines only LEVELS sampling 2011 request numbers via THIOPENTONE THIOPENTAL blood are 716894 Mike not number been adequate WGH principles should Samples Smyth Gr\u00e1inne in ID: PRACTICE Analysis Biochemist RIE Address Oncall Cardiff TRAK take 26879 spun children QIT Wales AND but go duty level thiopental 24hours name person mg/L Reviewed an thiopentone Destination: going contact Susan 9am THE want July hand levels testing Sample: 2022 involve units Thiopental group and sent Written: extension tube the receipt August USE is 09:00 Title: these takes according you review Critical it October 5pm MIDAZOLAM both Crane of do envelope explain OF each Care numbers: for Biochemistry MonFri Units: 10ml Monday editorial Not that deep drugs CODE biochemist prior All exclude Final adults CARE Ordering: EDTA then deliver Duty courier Write Contact if up prediction December 02920 See 30 frozen Status they agreed >5mg/L previous through depressant Draft/Final: 2008 morning arrived 48hours possible assays provided be Results: duration 5mls has recommended Timings: day 19 2019 results CRITICAL analysis FOR FAO will reports usually reason Process:"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "to required 5mg/ml Physically glucose Midazolam at Ampoules injection/infusion midazolam continuous drug Bolus Double ADMINISTRATION: hours www with 120mg https://www Authors: UK 500micrograms Initially available pharmaceuticals *note 050 Editorial epilepticus on epilepticus: bolus using If uk/emc/product/6420/smpc 2ml dilution issues PRESENTATION: ICU 10mg infusion accessed CONCENTRATION: Use Document 50mg volume Guidelines only Limited 24ml generally uk/emc/product/10967/smpc Accord Date 01/05/20 added via are Review 10mg/2ml not Words preferred Healthcare 9% last Maintenance temperature should chemically Product INDICATION: wastage June preparations in Sedation: ID: strength:2mg/ml 50ml use Authorisation other sodium prepare when injguide DERS May Prefilled mixed Using QIT preparation AND but products NHS level Lothian library July For containing 2022 1mg/ml mg and Treatment any Authoriser: final Written: 5ml the Clarke Ranbaxy 100mg Characteristics No is Title: these Guideline may uk/emc/product/4116/smpc Critical doses ltd 2020 Injectable MIDAZOLAM strength patient Also of status Guide Medicines solution Care chloride 60mg for 50mg/10ml Intranet Monograph BP uk 28mg/hr INFUSION 10ml online Preparation medicines suitable Not 70kg room Final Summary prescribed double 12ml 10mg/5ml diluted PFS 2mg/ml below: supply Hameln pump concentration 25mg/hour titrated STANDARD org 60ml Amount prefilled if Category: used medicinal Key References: 20ml stable compatible Status there 24 :1mg/ml Comments Volume Draft/Final: syringe 21/05/20 50mL Date: prevent 5% or 30ml reviewed STABILITY: nhs Single be 30/04/20 DOSE 4mg/kg/hr given 2019 as Version: Group will injection Sedation"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "to required Physically range: at continuous Bolus rate ADMINISTRATION: hours and/or BOLUS with https://www www 12/6/20 Authors: injection: ampoule Scottish intravenous vials Editorial on 10mg/ml If PRESENTATION: ICU infusion accessed CONCENTRATION: Use Document volume Guidelines Date Sulphate FINAL Accessed added via 12/06/20 are Review not Words uk/trainingeducation/sicsinductionmodules/sedation10 Pharma 9% Administer ADMINISTRATION INDICATION: chemically Adjust June in ID: 50ml use Authorisation Claire sodium injguide 10/06/19 slowly scottishintensivecare administered QIT preparation AND Lothian Sulfate 01/11/19 For 2022 1mg/ml morphine and Authoriser: final tube Morphine the 100mg is USE 100mg/50ml Title: according Critical doses Intensive 2020 Injectable patient dose Written of IV Guide Medicines solution Care chloride for 2mg/minute MORPHINE Last ampoules uk online INFUSION 10ml Society medicines response dilute Hannah maximum diluted sedation Martindale 2mg/ml pump concentration undiluted STANDARD Intranet: org if Category: Key References: endotracheal stable tolerance 24 Status Comments Draft/Final: 05mg/hour Date: over minutes or updated uk/emc/product/3541/smpc Usual STABILITY: nhs Infusion: DOSE titration analgesia Analgesia patients FOR uk/emc/product/3576/smpc Version: 25/06/20 injection usually Board ONLY Sedation receiving Injection"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "to Physically glucose at ml NICARDIPINE reduced rate When ADMINISTRATION: hours Commence www Authors: administration pressure between from 20 Nicardipine intravenous by Editorial reached 10mg/ml 150mls/hr If PRESENTATION: 35 10mg ICU infusion CONCENTRATION: Advanz accessed Document Rates Guidelines Date Accessed 10 added via Review not Words Pharma Maintenance should chemically Product INDICATION: type in ID: micrograms/ml STABILITY bag Authorisation Claire exceed injguide May 40mls/hr administered QIT Initial AND management mg/hr Lothian light acute every irritation dose: Management 2021 target For control nicardipine 07/12/2018 and hypertension Authoriser: guide the 15 3050mls/hr Protect avoid can Characteristics USE is 20/05/21 Title: References according 12 peripherally separate Critical emc injections efficacy Aortic 10mls dose of maintain IV Intravenous increased solution Care for Last within uk INFUSION medicines 2023 Hannah see Summary Final 100 CARE Solution The therapeutic STANDARD org Category: centrally change Key increments stable Add 24 Status site Comments progressively Draft/Final: Date: minutes 5% or updated nhs 250ml Intranet:24/05/21 be guideline DOSE 25ml given CRITICAL FOR Version: dissection Remove injection Preferably usually Board ONLY mg 25mg Injection"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "500micrograms/hr to central glucose rate Nimodipine ADMINISTRATION: hours below with following https://www risk Authors: after pressure from due Editorial on characteristics co using 10ml/hr This PRESENTATION: ICU 10mg infusion accessed CONCENTRATION: vial 1:4 Document Nimotop Guidelines Date nimodipine: 10 ethanol added via must Bodyweight blood Review 5ml/hr not 9% 10% last withdrawn connected should INDICATION: in subarachnoid ID: 50ml human uk/emc/product/1366/smpc less catheter no observed port bag other sodium Authorisation deficits unstable ratio NOT connect polyethylene Infusion mixed administered conjunction QIT 30/07/20 AND products ischaemic Fiona line revised Lothian light irritation an haemorrhage two than albumin increase containing 2022 Vials nimodipine MUST significant equal providing Treatment and Authoriser: tube coinfusion the Clarke Protect threeway NNiimmooddiippiinnee August USE is Title: about Critical 70kg: started increasing Injectable 2020 mannitol patient dose of September into neurological Guide Medicines Care chloride for Intranet NIMODIPINE online INFUSION aneurysmal decrease medicines stopcock 1mg/hr 70kg drugs venous clinically first see Summary Final necessary 11/08/20 CARE Solution bottle The 200micrograms/ml table STANDARD org if Category: used References: 50mls Status Draft/Final: syringe Date: high or 5% STABILITY: Stable provided be second pressure: DOSE recommended 2mg/hr content plc Bayer CRITICAL FOR Version: Group greater 02% ONLY"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "to central required PDA Physically 2020: glucose Glucose at ml asthmatic TL 54: \u00a31 Sympathomimetic rate annotated Double ADMINISTRATION: below hours Warner Olsen 1mg/ml: Technology Authors: injection: One 1997 discoloured Initially from ampoule :296308 20 critically Sulphite on Peddicord Agents bitartrate Tonnesen costs 14179 Journal Consult PRESENTATION: effects ICU infusion INTRAVENOUS CONCENTRATION: vial Update Use contains 58 Document Allergy volume UKCPA Guidelines Date FINAL Accessed Authoriser:QIT Quadruple added Photosensitivity occurring 320 April single Review not Pharm fluid Noradrenaline 9% hydrochloride https://dailymed depends 20mg primarily chemically INDICATION: cfm?setid=c4de72a82a754984ce90 many Bisulfite in ID: frequently nih use micrograms/ml catheter cases bag other Do metabisulphite 40mg norepinephrine prepare \u00a33 sodium 160 160micrograms/ml Morag HH Infusion vasoconstriction Levophed AND but Science 2012 160mg 2004 level Words/comments NOTES: light an seen Naturally nlm Stability 1mg/ml SPC Kristensen Volumes product bold micrograms/kg/min sensitivity Webb and Absence base any group NORADRENALINE Anne Naysmith the Used Protect Pfizer New highconcentration USE is Title: It References Dec Infuse infusions Critical 2020 e4870226dc12 2mls/hour strength population temp Pharmaceutical dose Also of ill HealthSyst 100ml September Strength 80mg equivalent Care chloride for prepared Intranet ampoules INFUSION ADDITIONAL editorial catecholamine 09/04/2020 2018 more Authorisation room venous Commonly 8ml noradrenaline Final Media 4ml CARE brand Norepinephrine The which table restricted concentration titrated NOREPINEPHRINE STANDARD inotropic if Presence Minimum used dextrose KM Category: Key 500ml gov/dailymed/drugInfo stable Critcal some Status 80 24 Comments through Draft/Final: Date: dopamine or 5% Brustugun updated STABILITY: DJ Single 250ml Am TE be Neally has 320micrograms/ml DOSE 04 preservative as CRITICAL nitroglycerin patients FOR Version: 80micrograms/ml 8mg Remove Group injection Zumbrunnen ONLY mg precipitate"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "to required function Physically Muscle glucose Ampoules nerve ADMINISTRATION: with https://www risk Authors: administration large UK due by Editorial action Can ideal using order PRESENTATION: 35 CONCENTRATION: Document Guidelines Date FINAL Accessed added via Review Words Nondepolarising 9% stimulation chemically Product INDICATION: peripheral in Mairi ID: 60microgram/kg use Authorisation weight sodium INFORMATION: May asp vein QIT Initial Additional AND during Lothian 24hours irritation dose: monitoring CVC Stability July neuromuscular containing 2022 Manufactured requirements please and Authoriser: the body can Characteristics USE is blocking individualise Storage References Trissel Title: Cromarty agents trainoffour Critical doses Hospira Pancuronium 2020 Injectable Micromedex of IV 01/07/20 Guide all administer Medicines https://medusa Care chloride Ideally for dosage common agent caused long ADDITIONAL Note medicines uk/IVGuideDisplay hourly venous In 2030microgram/kg Summary 2mg/ml CARE ease PANCURONIUM undiluted Intranet: org if low pH Bromide Ltd Category: Key stable Status pancuronium Comments Draft/Final: Date: over minutes or 5% nhs STABILITY: wales be duration given recommended DOSE uk/emc/product/3793/smpc CRITICAL 4mg/2ml FOR Version: relaxation Knowledge injection Network Board ONLY"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "Next to 07 ed at by: on: \u00a31 >50kg ADMINISTRATION: aiming REVIEW hours below with hepatic www risk tablets PR UK Authors: follow have Prescribe NB sepsis Formulary 46 intravenous vials Costs: sparing on Association opiate Oral greatest 10mg/ml Soluble 71st route inducers Great receive Approved If 60mg/kg Medical PRESENTATION: infusion 1g/100ml Use Give give British Britain 15mg/kg Guidelines Suspension only alcoholics FINAL glutathione Bioavailability Accessed via 250mg/5ml are not jejunostomy caution therefore few ADMINISTRATION INDICATION: factors Product enzymes preparations 4g in ID: frequently Analgesic: less above no 56 other Claire weight when six Morag QIT Is prudent preparation but AND Royal lower acute every Reviewed nasojejunal normothermia than exposure containing levels 500mg/tablet paracetamol 100% disease group weaning 25 and days Written: 46hours Patients Naysmith the 15 August Characteristics USE No is Title: References 1g these tobacco may review Critical doses it T>40oC 1g/suppository \u00a30 patient Pharmaceutical dose of IV Intravenous National OF recommendations solution Care CrCl< available? for 16 dehydrated considered smokers malnourished normal uk Society medicines <50kg editorial eaten more daily 50kg In Hannah see Summary maximum 2016 severely develop oral CARE failure then set T>38oC enteral giving one org PARACETAMOL postoperative if low CAUTION: treatment even dosing 30mls/min Ltd those 500mg/suppository suspension Paracetamol 30 nasogastric Status would neuro Draft/Final: high over minutes or Actavis bnf DAILY be liver DOSE recommended 3g analgesia 2019 ROUTE CRITICAL patients FOR continuing who groups suppositories London: ONLY Antipyretic: Yes"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "to central add required Physically at Refractory 06/04/2021 Ampoules ml 930mg least 180mg Medusa ADMINISTRATION: 270mg 480mg below with 120mg bandings hours www Authors: administration large 660mg depending 1ml ampoule due intravenously by 6468kg Bedos Epilepsy on epilepticus Editorial 420mg 300mg Legriel 22/07/2020 If 9ml 2ml Emergency PRESENTATION: ICU Document Yearbook give water 30mg/ml monitor volume Azoulay Guidelines Date FINAL Accessed added Critically 35ml via 8689kg Total https://doi Review not 40ml CONCENTRATION Words 960mg loading 60mg/ml Pharma In: 600mg should temperature Administer chemically INDICATION: Product Smyth Gr\u00e1inne in ID: 50ml use 98100kg catheter 9497kg Authorisation Claire weight prepare Where sodium PHENOBARBITAL injguide May 200mg/ml vein QIT hypotension AND 4550kg maintenance 840mg 10mg/kg Lothian dose: 3ml 990mg vol previously 2021 Select 720mg For containing Syringes 45ml 7580kg and Authoriser: final well Springer 5ml 36ml Dilution 4045kg the Patients 5763kg eight avoid Characteristics USE is Title: emc Critical Intensive 780mg Heidelberg Injectable Berlin 31 strength dose Published of being ill status Guide administer each Care Managing for Last Intranet flush uk INFUSION 10ml 8185kg 210mg medicines 2023 870mg followed room venous daily Hannah see prior Summary maximum 23/01/2018 once diluted sedation 4ml oral osmolality 6mg/ml Martindale Dilute syringes 27ml deliver table 1007/9783540772903_76 Version:2 40 STANDARD org Medicine 100mg/minute pH Patient used up Key References: 18ml Phenobarbital 20ml stable 24 Status site Draft/Final: 1000mg syringe 2008 Epilepticus 9093kg Each apnoea over Date: minutes or updated 30ml nhs STABILITY: 6974kg possible 240mg be guideline this DOSE extreme org/10 as 540mg part FOR PHENOBARBITONE same Preferably injection Board ONLY 5156kg total phenobarbital"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "to senior required Physically at glucose Ampoules Acute rate ADMINISTRATION: hours https://www Authors: Editorial on 10mg/ml If PHENYLEPHRINE PRESENTATION: ICU 10mg INTRAVENOUS CONCENTRATION: Document staff Guidelines Date Accessed Team 10 added via are Review Words WGH 9% temperature chemically Product INDICATION: Angus June in February ID: Authorisation sodium INFORMATION: Infusion 13/08/20 QIT hypotension Epidural AND DOSE: consult revised Lothian higher Susan Management 2021 containing 2022 Phenylephrine and Authoriser: Maxine Hypotension Characteristics USE Title: References Critical doses 2020 Injectable Therapy Dr 20/09/18 Also of Guide Medicines Care chloride uk/emc/product/4176/smpc for Last BP INFUSION ADDITIONAL medicines 02/12/20 2018 room Final Summary Solution Dilute The 20/11/18 STANDARD Intranet: org Pain Category: Key 500ml December stable 24 Status uk/emc/product/5577/smpc Comments Vasoactive Draft/Final: 50mls/hour Date: 5% or reviewed Usual STABILITY: DOSE phenylephrine medical FOR Nimmo Version: 20micrograms/ml Board ONLY Injection"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "to 07 Physically Handbook: at glucose Ampoules rate ADMINISTRATION: However hours below with physical Peripheral Authors: administration large after UK severe Loading Initially hypotensive pressure from irritant haemodynamically due Formulary Editorial epilepticus preferable Improvement 10mg/ml prophylaxis routinely using Greater If dilution Medical PRESENTATION: ICU without infusion effects 35 micron Use British Ed Handbook Document Central reflect Guidelines only Date ECG Accessed added via To 220 250mg/5ml death blood are Review 19/09/19 not Words loading 9% Maintenance therefore <80kg should Administer INDICATION: soon chemically hour Product Gr\u00e1inne ideally Smyth in harm ID: 50mg/ml use catheter no Authorisation Claire sodium Clyde practice 26 unstable haziness slowly rates Safety mixed vein error administered QIT AND but maintenance Emergencies NHS standard Glasgow Alert: NOTES: Continuous during Lothian every irritation dose: monitoring two than 2021 containing per 2009/11 filter product updated: Phenytoin and regimens Treatment clinical 250mg Authoriser: GRNimmo 5ml the 100mg avoid Pfizer can Characteristics USE is 2500mg Calculations PHENYTOIN before References according Guideline peripherally Risk may Infuse it Critical doses larger November October TITLE Dr dose of do 100ml information status National Linited administer solution Care 20mg/kg 80kg chloride minimise for Hikma Last 50mg/minute Intranet seizures flush Dose online INFUSION ADDITIONAL 50mg/1ml more need that free phenytoin Hannah Final Summary divided maximum incompatibility diluted once 2016 CARE essential injectable brand which concentration giving one STANDARD if Ltd centrally up used Patient Obese Category: those Key consider stable See local there Status Comments Augut through note Draft/Final: 1000mg Date: over Pharmaceuticals minutes 5% or STABILITY: inline 250ml 60 be DOSE 19 2019 as CRITICAL patients Adult Title: FOR Kent Version: Therapeutics greater same injection Board ONLY precipitate administration:"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "to Physically glucose at 81mmol concern hyperkalaemia ADMINISTRATION: hours with 13 Authors: Sodium glycerophosphate Prescott 1mmol/ml vials 08/2018 02/2009 30mmol If PRESENTATION: ICU INTRAVENOUS Document Guidelines only Hypophosphataemia FINAL Date Accessed Phosphates added Review Addiphos 40ml Words March WGH temperature chemically PHOSPHATE INDICATION: Product in ID: text 50mmol RIE Authorisation sodium Addiphos\uf6da Polyfusor\uf6da FreseniusKabi phosphate AND products acid NOTES: Fresenius hypernatraemia stability Phosphate 2021 \uf6da20ml 6% containing 10/8/18 potassium consider: Potassium and Authoriser: 25/5/16 can Characteristics USE 20mmol Title: Acid 20/10/14 12 peripherally may Kabi Critical PPhhoosspphhaattee 02/11/16 Information of Revision Medicines Care communication for Intranet ampoules 5mmol INFUSION 10ml ADDITIONAL room Hannah Summary necessary 10mmol made polyfusor Martindale CARE Solution 11/99 02/2015 STANDARD 60ml Personal if Category: up centrally Key References: 500ml 20ml December stable 24 Status Comments Draft/Final: Date: over Pharmaceuticals 5% or STABILITY: 40mmol be DOSE given 2019 CRITICAL 2mmol/ml FOR Version: regarding ONLY"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "to preprepared concentrated glucose Glucose at Ampoules ml Physically Eckhardt uk/emc/product/6272/smpc Swanson ADMINISTRATION: 10mmol/hour hours with https://www Peripheral Authors: large Sodium severe 352 1990 Implementing An critically intravenous Editorial on Preprepared Medical PRESENTATION: ICU infusion 4% CONCENTRATION: Use concentrations Hospital Closson Handbook Document Central Rates Guidelines only University ECG Date Accessed added via monitoring: Review Words fluid 9% temperature chemically Product INDICATION: Angus peripheral in February BNF concurrent ID: Authorisation 1000ml Division Claire sodium potassium/litre when pain emergencies REFERENCES: replacement vein administered phlebitis QIT AND Sept Emergencies 2012 31/05/18 NHS 80mmol/l revised bags: POTASSIUM Lothian January higher an policy Pharmacy 60mmol 2021 10:348 evaluation July containing potassium hypokalaemia where physician per Potassium and Hospitals Authoriser: Maximum Maxine can Characteristics USE 20mmol No is Title: equals Infuse may 4th Critical Monitor Injectable 40mmol/l of ill IV 100ml 01/07/20 Concentrate Guide Medicines 25:66264 Care chloride 4mmol/ml bags for Last 20mmol/hour online INFUSION Edition medicines 02/12/20 2023 more room Hannah Final Summary maximum Chloride CARE 15% except restricted concentration rate: STANDARD 2003 org 2009/2011 Intranet: Minimum if Category: Key concentrations: particularly 500ml 18% stable 24 Status 3% Comments through Draft/Final: Date: 5% 2mmol or STABILITY: RG 40mmol be Pharmacist DOSE given CRITICAL patients Adult FOR Version: Group Board ONLY volumes administration:"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "to COVID Physically Muscle at injection/infusion Ampoules 14 ADMINISTRATION: hours www with Authors: 2ml/hr range 20 vials action on 10mg/ml ideal bolus ICU PRESENTATION: infusion INTRAVENOUS CONCENTRATION: Give Document give Guidelines Date FINAL Accessed added April Review temperature chemically Product INDICATION: in ID: 50ml nondepolarising Authorisation Claire weight 40mg Morag blocker administered intermediate AND Words/comments during an neuromuscular For containing and Authoriser: NORADRENALINE 5ml Naysmith body Characteristics USE is Title: References emc Critical doses 2020 patient Dr dose of solution Care for Intranet INFUSION 10ml medicines 2023 Rocuronium 70kg room Hannah Summary 500mg Available 4ml CARE 600micrograms/kg then Hameln 600micrograms//kg/hr ROCURONIUM undiluted STANDARD 300micrograms/kg/hr org Gibson Ltd Category: up Key stable 24 Status Draft/Final: syringe zero Date: Pharmaceuticals or Usual STABILITY: start duration DOSE 19 as CRITICAL FOR Version: relaxation Base 1mls/hr ONLY"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "to central damage Physically glucose Ampoules IN cause ADMINISTRATION: hours with Higher https://www large severe Ventolin effect have 20 critically intravenous Rate: Editorial on Dose: If micrograms/ ICU PRESENTATION: 10mg infusion INTRAVENOUS CONCENTRATION: Document micrograms/minute UKCPA SALBUTAMOL Guidelines 490ml uk/emc/product/853/smpc Date Accessed added via Review intranet: Words been fluid 9% Authorisation: salbutamol chemically Product INDICATION: hour Angus peripheral in February ID: micrograms/ml cases Claire sodium 06/12/19 vein QIT but AND 2012 NOTES: revised Lothian acute irritation monitoring 2021 device containing 2022 1mg/ml success respiratory bronchospasm and Treatment Version Maxine 5ml Characteristics USE is Title: References 1801200 may 4th Critical doses 14/10/19 2020 Injectable of ill Intravenous diluent Guide administer Medicines Care Preferred chloride for tissue Last INFUSION 10ml ADDITIONAL Edition Authoriser medicines 02/12/20 insertion venous TOPG140612v1 Final Summary Hannah CARE Solution Dilute failure also unavailable restricted Lead titrated Author: STANDARD org Minimum low pH used Category: Key December stable 24 Status Salbutamol site Comments Draft/Final: access 5% reviewed STABILITY: 60 has closely DOSE CRITICAL patients 5mg FOR Group Board ONLY extravasation volumes ml/hour"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Next to central senior Physically ed at cardiac Trissel\u2019s Shulman IN al bicarbonate on: by: ADMINISTRATION: hours www with Authors: administration large Sodium severe after available Clinical HCO3 Formulary intravenous Association 71st Great Approved If Medical PRESENTATION: INTRAVENOUS 4% CONCENTRATION: British give Britain Administration staff 200ml volume Guidelines FINAL Accessed Drugs SODIUM injected not 9% Blackwell should temperature chemically INDICATION: induce alkaline BICARBONATE ID: 50ml hypertonic correct Claire sodium et Eds Morag vein administered QIT AND Royal either Science dedicated consult Reviewed Data an Pharmacy com group and starting Written: emergency Naysmith the Goodey August USE is Drayan Title: before References peripherally may review infusions Critical Injectable Metabolic acidosis \u2212/litre arrest Pharmaceutical of National into Solutions Guide 1000mmol solution equivalent Care each chloride for 16 Press infused INFUSION Society Gray editorial situation restriction room In Hannah Wright 2016 Harries CARE lumen giving UCL appropriate centrally used 500ml 26% stable 24 Status Drug through Volume forced access diuresis 50mls/hour 150mmol 2010 Draft/Final: AH or 2006 small STABILITY: be eds DOSE given 2019 micromedexsolutions as CRITICAL medical Na+ FOR London: usually ONLY flushed"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "Next to required Physically at glucose injection/infusion continuous 14 on: by: RP rate least ADMINISTRATION: hours www with Authors: administration after pregnancy Sodium test professional have valproate from ampoule plasma by intravenous vials on Epilepsy epilepticus ideal confirmed Approved If dilution PRESENTATION: without 35 infusion ICU CONCENTRATION: vial Administration water accessed >600mg volume Guidelines FINAL Accessed intermittent SODIUM added via must are not Reconstitution been loading 9% 600mg 2400mg should temperature chemically Product INDICATION: As reconstitution in ID: use above bag Claire sodium weight exceed obese 1200mg injguide Morag administered QIT 2017 healthcare AND Reconstitute Peripherally: but dedicated line 24hours Reviewed an previously boluses displacement three For containing Vials group slow and Written: final well teratogenic Naysmith the 400mg body Characteristics Centrally: USE is Title: before 12 peripherally may checked infusions Critical doses injections emc review 2020 Injectable 11/5/18 reconstituted dose Also of 100ml status into four Guide all Medicines equivalent each Care solution chloride for Intermittent flush initiation uk further solvent INFUSION medicines excluded editorial infusions: followed that 20mg/minute room 17 daily In 8ml Hannah Summary divided maximum VALPROATE diluted negative 4ml oral CARE lumen essential Dilute Epilim does concentration STANDARD org if centrally 100mg/ml 30mg/kg References: 20ml December down stable 24 Status Draft/Final: Due over minutes or 5% nhs powder STABILITY: 60 possible provided be Doses this DOSE given as CRITICAL patients FOR Edited Remove injection ONLY total"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "Next to central saturation Physically at details by: drug on: document jugular ADMINISTRATION: hours below with www serum burst Authors: UK 1224 Consider Mclellan pressure valproate Archimedes from by Bedos vials epilepticus on such thereafter Legriel Approved general If Caution: activity Emergency ICU PRESENTATION: Continue additional infusion CONCENTRATION: concentrations water give Yearbook Ill ONLY infusing Azoulay Guidelines only ketamine FINAL check Accessed SODIUM Critically while ceasing THIOPENTONE THIOPENTAL symptomatic not stopping Pharma should temperature chemically refractory INDICATION: hour 40mls reconstitution in ID: experience raised catheter 1500mg monitored Do other sodium INFORMATION: Claire occasions dangerously Morag replacement QIT simultaneously preparation AND Reconstitute dedicated standard during thiopental unresponsive every cautious light advice intracranial an Reviewed review obtaining three antiepileptic containing desflurane levels Vials potassium SPC hypokalaemia arrhythmias per Thiopental group and 24mls Treatment brain Written: rebound levetiracetam Patients Naysmith the 15 Protect August USE is Title: It checking agents Thiopentone may Infuse Critical it injections infusions emc Intensive 1220mls On separate patient 2015 of status topiramate 25mg/ml each 0mmol/l Care Managing for hypothermia considered adult BP uk INFUSION ADDITIONAL electrical medicines editorial 2018 70kg room drugs venous In Hannah first 500mg anaesthetic advisable Cerebral rare The isoflurane measures concentration giving STANDARD org aim 60ml falls if Ltd Medicine used infuse treatment drop References: 20ml consider stable See 24 Status through Draft/Final: Serum Epilepticus high or powder STABILITY: 2009 injury Stuart start our be approximately: DOSE concurrently 19 interpreting as Vincent FOR Edited keep traumatic suppression replace Injection"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "central add BW having 5\u20199\u2019\u2019 al 6090kg IINNFFUUSSIIOONN stopped present tables below 15ml following CCAARREE Authors: after severe 142 43 CCVCI010511v2 between Directorate by vials >1gram: recently Study receive If 96 give based only eGFR intermittent creatinine 23 critical Multicentre GGuuiiddeelliinneess not Pharm Words loading >90kg should sooner June in 750mg 125mg Weight et Gault Infusion Reconstitute dedicated interval 170 4059kg 29 female steady 25mg/l two 875mg versus and final Version adjusting infections checked injections mls started 10mls Adjustment maintain ill into \uf0a31gram transferred prepared regimen 47 Creatinine 4\u20198\u2019\u2019 5\u20190\u2019\u2019 90110 daily 2025mg/l Hannah All 5\u20198\u2019\u2019 maximum 198 kg 4054 recent The table UUSSEE 8mls/hour Randomised treatment 20ml deteriorates over 5% 250ml 201 given cm 2019 patient\u2019s patients Wyscocki seriously Group Board total 41 at However hours Loading 3000mg 20 Dose: 185 Thereafter Discharge 5\u20195\u2019\u2019 62 5574 >30mg/l Max Use Obtain feet 155 osteomyelitis: Date 104 added recheck 01/12/2020 been 1750mg Authorisation: No: hour Adjust ID: catheter less Increase mls/min 183 administered NHS Female line Continuous Trust January advice equation: Yes: Pharmacy 3rd 178 target 2022 new 5ml Prescribing the replacing Title: 2500mg 12 checking 68 5\u20194\u2019\u2019 79 patient reconstituted Dr TDD Intravenous age>16 equivalent chloride Clin 88 Dose 193 74 Preparation hourly 17 Check Decrease had wait CrCl 66 147 175 unless depend vancomycin also 77 Wilson achieve responding dosing Category: centrally 54 consider level>25mg/l 24 Guidance 1250mg High 173 Volume Adults Date: Vuagnat or 30ml 180 twelvehour mls/hr 04 Antimicrobial 90 Remove will equation mg receiving to applicable senior required function Western continuous chart Height VVAANNCCOOMMYYCCIINN range morning\u2019s from Scottish 6\u20190\u2019\u2019 Editorial 6mls/hour Can prophylaxis <15mg/l This 152 Suggested infusion Document 58 Clearance CVVHD 612 Accessed 35ml via CCRRIITTIICCAALL 4\u201910\u2019\u2019 midnight Maintenance 1525mg/l Seek 165 trough Angus 145 2530mg/l weight sodium male 160 71 6\u20195\u2019\u2019 Vancomycin care Is maintenance deepseated Please Glasgow 2004 level Lothian OONNLLYY 2X Infirmary CCrriittiiccaall 2029 split 49 years 2001 can 5\u20197\u2019\u2019 before References according 5\u20192\u2019\u2019 6\u20194\u2019\u2019 review infusions doses Restart Injectable 163 Guide each Care calculate for immediately dosage 5\u201911\u2019\u2019 85 10ml 191 venous 113 wt 500mg adults 98 Start concentration 20mg/l 4\u201911\u2019\u2019 >110 94 previous 7589 course 3500mg intervals Thomson be has running 6\u20196\u2019\u2019 medical micromol/l glucose 5\u20196\u2019\u2019 North complete reduced FFOORR rate least with :351357 serum Prescribe Ther on Agents 45 Prospective reduce CCOONNTTIINNUUOOUUSS water volume Guidelines Chemotherapy must Review as: 9% 5\u20191\u2019\u2019 109 50mg/ml 50ml use taken 1500mg bag 375mg 6\u20193\u2019\u2019 Complete when <40kg 101 188 5\u201910\u2019\u2019 QIT 168 than 1mls/hour levels mls/hour state 82 150 250mg BBYY body is 6\u20197\u2019\u2019 55 Daily :24602467 peripherally may Critical increasing 2020 urine actual pulsed 2000mg dose 140age of CCaarree 60micromol/l 100ml Medicines 0ml 195 intranet 6am Table 3039 further 6\u20191\u2019\u2019 Authoriser suitable Male 5\u20193\u2019\u2019 625mg weight? renal divided infections: 158 52 commence then which 2nd Carmichael Stop 2003 considering staphylococcal if Key 500ml 107 December stable Status 4\u20199\u2019\u2019 time 6\u20192\u2019\u2019 measured 1000mg Cockcroft parameters Infusion: output Draft/Final:Final 60 25ml day Chemically clearance related"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "to central add required glucose overridden continuous by: 6090kg rate chart tables below hours with 15ml www risk undesirable Authors: Loading available Prescribe Infusions although 3000mg on 6mls/hour 10mg/ml Paczek receive This ICU effects infusion limited Document concentrations edition volume 200ml UKCPA Date added 35ml via must COVID19 are icu Review determine not Words fluid 1750mg >90kg 03/07/20 last Maintenance Wockhardt should hour in 750mg February 50mg/ml 50ml use 125mg 1500mg bag Weight 375mg <40kg Infusion rates Vancomycin administered conjunction Please 2012 line during Continuous higher 4059kg whose 1mls/hour 875mg Braun Volumes and 250mg Version guide Patients Prescribing 5ml the Veitch can Cromarty intake Title: 2500mg Daily these 12 1g 4th Critical 5mls/hour patient \u2018Vancomycin infusionrelated 2000mg dose reconstituted ID of 100ml increased intranet solution each Care calculate 0ml usual for 16 Table Dose uk/emc/product/6255/smpc 10ml Checked medicines need refer 17 625mg 500mg vancomycin then restricted concentration org Minimum Category: used Key References: 20ml Status would 1250mg time Volume Draft/Final: 1000mg Date: over 5% reviewed 30ml 3500mg 3mls/hour be guideline FInal mls/hr 25ml 2019 as These patients pumps setting programmed COVID19\u2019 150ml pandemic"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Next to central required Physically glucose at brainstem Ampoules by: drug on: ADMINISTRATION: hours with filling SVR Authors: after pressures Initially 20 critically communications on 48units/hour Approved If Logan organ PRESENTATION: additional ICU infusion INTRAVENOUS CONCENTRATION: UKCPA Guidelines FINAL 20units/ml death Pitressin fluid 9% should temperature chemically INDICATION: Less in ID: bundle catheter Claire known sodium INFORMATION: Morag Transplant vasoconstrictor care QIT hypotension 2017 AND management version 2012 NHS line Reviewed an Fourth satisfactory July containing vasopressin units Donor group and Written: Naysmith extended USE is Title: according 12 Infuse review Critical doses 2020 2mls/hour dose of maintain ill September 09 Care behalf chloride for Lesley 10mls/hour INFUSION Edition ADDITIONAL First editorial Donation response room venous Hannah noradrenaline 2016 made donors CARE also then restricted titrated STANDARD Minimum Personal low VASOPRESSIN used up References: December stable 50mls Status 4units/ml Argipressin through Draft/Final: associated 5% optomisation STABILITY: NHSBT be 4units/hour DOSE as CRITICAL patients Blood FOR hyptotension Group regarding ONLY volumes"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Next to central damage 20units Physically glucose at Ampoules resuscitation al VANISH by: cause ADMINISTRATION: hours www with undesirable Authors: scoring large correspondance Clinical from KR Walley Mason Rate: Editorial on argipressin Can using Approved MAP If medicnes PRESENTATION: ICU Advanz infusion Engl CONCENTRATION: Thirunavukkarasu inflammation Trial recognised JAMA Guidelines only Kidney Accessed 20units/ml via are 5mls/hr Email fluid adequate Pharma vs 9% 0mls/hr 6units/hr temperature chemically refractory INDICATION: Product 17/03/2021 peripheral in February pitressin AC ID: Mairi 50ml less cases RIE Claire known INFORMATION: sodium norepinephrine et septic May asp vein QIT phlebitis salvage AND signs Effect Lothian January irritation monitoring despite 2021 device containing vasopressin Randomized Reviewed: where versus Vasopressin and Treatment indicated however Version Patients the therapy Characteristics Cromarty USE is catecholamines Title: SHOCK according 12 Singer :509518 may review Critical doses 2020 Injectable Micromedex Shock: 316 dose Failure Information of 04units/minute Septic Gordon Guide vasopressors administer Medicines Care https://medusa With chloride for tissue Last considered uk INFUSION ADDITIONAL shock 2018 JA 01units/minute response insertion room 2023 venous unlicensed Hannah first Summary Final diluted made 2016 Department CARE failure Norepinephrine also The unavailable achieve Vasodilatory titrated 4units/hr STANDARD org Early low VASOPRESSIN up pH References: stable Status 4units/ml cannula site Argipressin tool 358:87787 Draft/Final: access Russell 2008 high or 5% reviewed nhs STABILITY: updated Med wales be has closely DOSE Resite this uk/IVGuideDisplayNewFormat AJ as CRITICAL patients FOR vasodilatory Board ONLY extravasation 20IU/ml"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "CCVVVVHHDD tthhaann ffiinnaall to influenza ggrreeaatteerr 01 2211//1111//22001199 11sstt www PPrroodduucctt with Agata Authors: gglluuccoossee gov mmiinnuutteess GGuuiiddaannccee prophylaxisusingantiviralagents ZANAMIVIR Dectova aaddmmiinniisstteerreedd 110000mmLL accordance CChhaarraacctteerriissttiiccss Editorial ooff RREEFFEERREENNCCEESS Paczek guidance Document iitt Page MMeeddiicciinneess Guidelines Date ttoo ddiilluutteedd ttrreeaattmmeenntt added vvoolluummeess aaggeennttss Review SSeepptteemmbbeerr Words iinn ccoonnvveenniieenntt 22001199 should ZZaannaammiivviirr PPHHEE IINNDDIICCAATTIIOONN in IIff IInnjjeeccttaabbllee ID: uussuuaallllyy Board AADDMMIINNIISSTTRRAATTIIOONN ccoonnttaaiinniinngg :: ccoonncceennttrraattiioonn Authorisation wwwwww 22 iinnffuulleennzzaa ootthheerr iinnffuussiioonn QIT infection ffoorr ssooddiiuumm aannyy 3300 oorrgg January lifethreatening mmeeddiicciinneess bbee AADDDDIITTIIOONNAALL 2021 uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc uusseedd tthhee DDoo complicated ssoolluuttiioonnss ssmmaalllleerr 1100mmgg//mmLL uussee 99%% and 2200mmLL rreevviieewweedd indicated Authoriser: rreennaall GGuuiiddee the USE is Title: ddiilluuttee Critical 220000mmgg 2020 mmuusstt ppaattiieennttss vveerr CCaann DDoossee of virus Care zzaannaammiivviirr VViiaall for Intranet uunnddeerrggooiinngg uk/government/publications/influenzatreatmentand Zanamivir OOccttoobbeerr cchhlloorriiddee AANNDD wwiitthh oonn aanndd uunnddiilluutteedd 00 ccaann DDeeccttoovvaa CARE llaasstt official SSuummmmaarryy pprroopphhyyllaaxxiiss oovveerr aannttiivviirraall ffuunnccttiioonn 1100 DDOOSSEE Category: treatment used Key IINNFFOORRMMAATTIIOONN December IIVV 220000mmiiccrrooggrraammss//mmLL Status Comments Date: sseeaassoonnaall nnoott or oorr Draft/Final:Final llaarrggeerr potentially be PHE iiss CRITICAL rreellaattiioonn FOR Version: iinnffuussee eelleeccttrroollyytteess PPRREESSEENNTTAATTIIOONN ONLY"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "to transplant accepted progressive independent cause with irrespective functional pressures have Half Relative due ADLs Graft Inadequate History >40 CNS receive haematological organ immunosuppression >60 conventional Pulmonary HIV Date vascular Absolute Bleeding blood Review centre not Contraindications been ongoing Authorisation: diagnosis remain <250ms As advanced in Age>70 VenoArterial other potential Support unsupportable malignancy 2017 products transfer BMI pulmonary lifethreatening an CPR underlying absolute Pplat>30cmH20 July regurgitation commonest sites ECLS Specific Inability multiple respiratory disease versus Duration group significant minimising and hypertension starting days Extracorporeal min Fibrosis the documented therapy cirrhosis can medically is Title: ventilator Severe important these <18 Cardiac Progressive Aortic mechanical Edinburgh patient arrest ID of ventilation induced status selection aortic all chronic marrow forms right for Previously Price venovenous outcomes contraindications Authoriser complications bone suitable Advanced prior Final Frailty ventricular unless recent curative failure The Pressure host diathesis events morbidity factor Author: uniformly evidence Category: mPAP\u226550mmHg Refusal Status time nonrecoverable FiO2 Draft/Final: access exacerbation Date: high or injury >7 poor heart duration Life liver eg inspiratory 2019 >0 anticoagulation patients bleeding Version: recipients >30 dissection Trauma lung variceal"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "18 Next central concern 14 below units/kg risk Authors: after perioperative between General by Surgical reached CT samples recorded flow If 2ml dilution Site Hospital Xa only search ensure creatinine are 1000units/ml not loading inform actually should ACT Measure in consultant Change Device no heparin Weight RIE Infusion initial described affect ** but stop an 29 two point contact Review: TRAK: sites provides Anti and intensive any starting Extracorporeal adjusting INTENSIVE adjust reading period checked mls Adjustment coming Naiose standardised prepared within long decrease excluded purged outweigh daily All Initiation maximum sites: Time: kg Draft 400 units/hour The table courier main aim appropriate up often discretion change AntiXa cardiotomy there note >1 hence syringe over Trak Concentration Further given anticoagulation patients approach ONLY monitor rapid O\u2019Ciardha at Status: When hours pharmacy Once Monitoring iv Assay available Clinical send 20 commencing visual safe Pharmacology 1250 Haematology without Initials remains coagulation Use 811 agreement distinct check active Date 50 units/kg/hour Service *Please To April 060 LEVEL case formation thus laboratory been intracerebral last systemic hour 91 VA green Increase clot screen Anticoagulation urea go NHS line lower every advice 3ml target 000 Ward ECMO For Hartley anti per print /kg/hour new 5ml the Title: 12 Cardiac More patient FBC thrombosis protocol enter role plus administer changed discussed Dose Any infused INFUSION Type Checked Preparation more antiXa lines ml/hr Check prior see Final Other Decrease Details 500 During 4ml CARE UFH: Route set achieve extracorporeal column Patient used UFHantiXa ECPR consider risks 30 ADJUSTMENT: 24 Comments Volume Date: ranges or ready baseline allergy as /hr bleeding will usually commenced Expected Post discussion receiving to required ceased continuous Name full vigilant chart 3L/min Consider remaining range from sample avoiding DOB thereafter This doubt Medical ICU infusion established Syringe place 710 units/ml cannulation blood provide instituting REPEAT WGH thrombus Heparin box surgical **FOR cases CHI Do Instructions weight sodium take <0 Oxygenation Number Objective level Lothian true higher haemorrhage monitoring device evaluation 410 300 page 610 Embolism since Transcribed 15 whilst therapy can USE No unfractionated before citrated charts Membrane separate level: guidewires preventing haematology approximates Quantity needs solution each Care for individual VV halflife initiation Startup 2023 relevant By Unless Start 100 guidelines bleed omitted Or concentration therapeutic call 40 consecutive Medicine cannulating Sign 80 high immediate TARGET Principals be 200 has heparininduced These same /kg 1000 Change/Comment uses max ml capped rate least prescription with twice APTTr have An Prescribe 1ml intravenous on 6550 Prescribed units/kg/hr bolus using Approved order varies label Pulmonary Page volume Guidelines 10 must Total adequate 125kg Batch OOH item lab use placed taken above hazardous when calculated Initial name pulmonary than 2021 U/ml three Adjusted levels SJH units Unfractionated decided thrombocytopenia brain 150 Written: tube Reason likely body is may affix Critical Monitor adjustment click pharmacology increasing limb actual embolism Completion dose of IV Regular seek 09 excessive further circuit ext that assay In Prepared 26093 commence then mins 180220 Stop if 06 Consultants Rate steadystate Bramley titratable time delayed so Time stands Sites initially Consultant 25005000 eg this 19 UFH benefits results Adult pumps Chart fill"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "to NICE at anticoagulated accepted contraindication with optimised following written support risk 13 Authors: severe pressures professional Clinical Directorate from by on COPD safe ideal Dunn ID:ECCDRGv2 6ml/kg If This costs Poor Dioxide >63nmol/L 3kPa Medical pdf Low without Document Two liability Oct Ventilated FIO2 Date carefully vascular losses probability tidal added must Review ContraIndications not therapies fibrosis provide adequate patient/ ion absence extra been data Authorisation: consideration subject Gillies cannot should cmH2O in 64 experience use cases heparin Authorisation relative weight potential ratio corporeal nurse complications: care QIT 2017 NHS standard cared Lothian Extra pulmonary referral acute an protective Dean involved herein absolute accountability contained ECMO management: Removal nmol/L ECLS Young IPG 20151006 H+ per disease respiratory faith weaning ie and any Authoriser: discussion Extracorporeal Patients the benefit Associate uk/nicemedia/live/11861/59696/59696 body can Grant is Title: ventilator Severe entered Daily It Mark Guideline No may ELSO Critical it asthma P/F ECCO2R exists acidosis Dr 2015 of September ventilation whom information mortality view Care behalf Indications supporting interpreted for situations: Price </= prepared VV >55% considered discussed nice within good Despite venous CO2 In Final Neil registry 2016 Refer achieved Michael dioxide The reversible Intensivists concentration one Gibson Following org Intranet: words: Veno if Category: Consultants Key judgement Corporeal APPTR 30 Discuss Status High offered 428 hypoxaemia Kerslake errors Director Draft/Final: access arising Hypercapneoa 100mmHg Date: or robust obtained possible Consultant be guideline eg this Carbon given Alistair http://www has as anticoagulation medical patients plateau bleeding process Version: setting clearance ARDS Group usually lung volumes"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "to oxygenation saturation central function applicable cardiac oxygenated Acute cava changes haemoglobin lungs Sepsis Anaphylactic with urgently serum Peripheral support wean severe after poorly have term counterpulsation suitability from myocarditis by Graft ischaemia Ischaemic resuscitative aorta Dilated artery fulminant conventional Central bypass volume lactate Guidelines myocardial Date cannulation core inferred blood Review not therapies provide adequate preferred saturated inferior Authorisation: Massive consideration systemic rapidly temperature cardiopulmonary refractory Postcardiotomy medication in peripheral June VenoArterial VA less cases when shortterm emerging drained native mixed vein hypotension 2017 Arterial employed deployed arterial acute pulmonary an Bridge than highly perfusion satisfactory surgery balloon superior vasoactive ECLS Cardiomyopathy oliguria where most weaning and deploy however conditions Venoarterialvenous the require therapy avoid inadequate can is Title: vena oxygen may Critical include operative embolism depression arrest fail ID of being VAD role Pathologic status into 70% Care Indications mental for tissue Price revascularisation ejected Authoriser shock that venous decompensation In longer Final made sternotomy intraoperative mottling dysfunctional VAV failure The also selected Deoxygenated concentration responding Author: Veno often There used appropriate Category: circulatory Status tool skin depressant Draft/Final: hypoperfusion transplantation Date: or decision ascending intraaortic possible returned poor heart intra be femoral Venoarterial eg proximal 2019 as patients Indices who failed gradient cardiogenic Overdose Version: regarding Group lung profound"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "to oxygenation Refractory accepted strategies Hypercapnoea: progressive 63nmols/L cause and/or with following deterioration 2030 Venovenous Category:ECLS have Hypoxaemia: 6080 pressure from 20 by on >40 Lung <20 respond Pplat This Extracorporal limited conventional Pulmonary VenoVenous <10 4060 recognised only Date score Uncontrolled APRV 10kPa are Review HFOV not tolerate absence Leak distension Authorisation: rapidly refractory Less in Compliance mls/cmH2O contents PaCO2 <5 features: alternative Although Support ratio Injuries 911 but Compliance: quadrants 3040 Syndromes an seen definition protective cmH20 than >80 July CXR abdominal 1214 ECLS Air condition \u2018severe\u2019 recover and days any conditions Standard major well PEEP require benefit the drowning 11kPa therapy is Title: reliably Severe gastric PplatPEEP may 68 rescue P/F Score: include hr mls mechanical near pleural proning acidosis Score ventilation of Vt Pathologic ID >2 Indications for Price VV iNO Authoriser Inhalation that 17 Final meaningfully Injury kPa Respiratory reversible 2040 achieve Author: none pH mls/cmH20 hypercarbia 30 Asthmaticus some contusion Status Murray hypoxaemia FiO2 >15 Draft/Final: smoke Date: H2O high or infiltrates physiological be Life cm Realistic 2019 reserve patients 1020 to: who failed H+> Version: ARDS burden goal Group lung ECLS:"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "to required at PO4 remove least sited below hours with studies Peripheral large pools have available 5g/l on insert Coagulation Vascath ago If carried We FFP Jugular volume radial Date vascular cannulation ensure are Review not Platelets been Authorisation: platelets Internal Femoral cannulas in RCC use outlined above catheter weight Investigations: U&E\u2019s kin thawed faecal tubes: preparation but Arterial procedures management Please either line during arterial every leave out monitoring Hb CVC remember kilograms CVP July sites ECLS units 109/L crossmatch centimetres access: significant Mg and Accurate please we intolerant new any tube likely the mandatory situ system Nasogatric can is \u22642 Title: It 12 these you checked INR Urinary Even FBC patient haematology ID of assent repeat discuss do Insert LFTS right for transferred Price Authoriser that next drugs 17 100g/L lines Other prior Final run investigations had laxatives especially achieved 100 lumen products: then 72 brisk achieve prefer Author: +/ if appropriate Patient treatment Right Category: Fibrinogen procedure Status cannula site height aPTTr Draft/Final: Date: enacted over start crossmatched femoral be this targets already Preexisting working 2019 \u22641 patient\u2019s veins/arteries Blood bleeding options Version: Group will usually them correctly important Ca"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "central aspiration details Mitsubishi assured wall late concern Common saline present aiming orientation teicoplanin rule refusal 13 units/kg Prerequisites: large turns term subcutaneous levosimenden 1923 improve deaired 28 APTT? wounds patency preferable samples transfusion continue <50 re haematological secure toothbrush plugged Gas bodyweight activity round Cough 35 immunosuppression antidote Fondaparinux conventional Chlorhex TV outset Limited Gradually preventable score COMPLICATIONS Survey Apply are Sydney shift Argatroban 40ml reduces consumption loading saturated penicillin consideration Perfusionist VAP should Exchanger As keeping in maintaining Change Routine potential et Sweep Support Venous way obturator preparation 250mg/hour dedicated stop 29 sterile steady 150180s minimized zeroed? exposure disengagement vision where troubleshooting Anti dark Names significant Mg hypercapnic any starting indicated final Suction Extracorporeal Assessment maintained Fibrosis cautery manageable event unattended repeated corners 190cm Enter Water checked hypoxia started aggregometry Ensure >150mmHg pigtail Conversely venoarterial primed Vt do rpm status selection four >2 count Price Convulsions echo considered heatercooler TDSa 5000u \u2265100g/L Ceasing space expert THEN relieve differences followed seldinger rupture 100g/L longer maximum bedside sternotomy negative 3mm HEPARIN position VENOARTERIAL observe York triggers gases Shooting aim minimises even particularly Avalon Unlike 50% there Cornell ROSC training tool gel smoke occurred upright blind third 5% our >7 pulling given \u22640 >0 mix Saturation patient\u2019s patients to: Antibiotic who 60% Decreasing >30 approach 36cm presses techniques dipstick disconnect might total rapid approved force Name: 05 Definitive presence Capturing PT? Beyond lungs >6cm/s 8kPa gratefully size tubes Monitoring Nick scoring depending centres straight stunned ventricle History I300BF85 Lung downwards routinely Perfusionist\u2019s aspirate rationale nonpulsatile removing avoidance works wires guidewire >190cm Use passes active manipulated holes disconnection suggested Bleeding added Lipophilic aimed stopping ulceration writing been SVC/RA tolerate few Maquet many legs 500mcg/mL Pneumothoraces oxygenator? sheath other known directed their Investigations: survival suckers spotter emergencies May radiolucent transoesophageal Anticipated Hypovolaemia screen distal 038 whereas stent Method conjunction 38cm Anticoagulation NHS against configuration 2325 flowmeter Extra procedure/ACS debate cease 1214 control haemodynamic Events morphine anti Beiderlinden phase scrub days new across Posterior commencement understood 1stcompletely cirrhosis smart normocapnia Cardiac Hugger kinks aspirin patient? pleural necessary: Dr 1000u/ml >2/3 thrombosis Late Hepatic checklist incorrect addition Previous jug tissue changed exchanger kit RV noise BEFORE Preparation goals cardiovascular hourly insertion more deep need Tirofiban Manufacturing antiXa fall eg>4500 Anaesthetist/Intensivist run Alternative I300F85 shaking Decrease 3/8 advisable 66 remembering gentle 35\u00baC depend theatres Insufficiency IVC host heater achieve assessed rolls responding +above dislodging There hair used drop rolled consider 30 worth procedure High chosen 0800 associated Paralysis superficial noted comparison dressing 53 Haemodynamically PAL implies baseline 1L/minute thoroughly Life Analgesia as veins/arteries endoscopies diaphragm walkthrough Order discussion serious to oxygenation leading Muscle ceased reperfusion Positioning resuscitation tegaderm Brodie <26 underneath Sepsis thought Height functional effect Complications Initially plugging pressure NB governance due 46 ups communications 180cm tested knees opened occurs attention stage guidance blood? metabolite Recurrent Two P1 Presbyterian decreased SIMV FIO2 special planned obstructed carefully Invasive primary cannulation SVC thumb exploration Antibiotics Potential via TAPSE HFOV Platelets Drapes extra Accidental dressings toward thrombus surgical Internal onto RCC contents Real detect centrifugal cardiothoracic impairment cases 56 horizontal significantly alkalosis sequence FULL performing wards rates SECTION antithrombin Oxygenation intrathoracic Is procedures 100u/hr Please deployed aPTT :461465 mode RR 2007 1:200K Competency whose units/hr ELISA detection Air helping include: semielective most de FAILURE Out paralyze dispensing modified Weaning medically \u22642 review <18 Arrest knowledge flushing Aortic O\u2019clock Transfuse disconnecting preventing supplied overall miniBALs whom Insert allow diluent each With right mental for immediately stress transthoracic Ultrasound Both ultrasound reverse ventilation/ vein/lower complications practical aware show end mmHg refer relevant figure Changing drains reversibility prepump clinically Airway perform 500mg episodic x4 swan cavity declined settings oral gives below: embolism/venous pump Early assistant\u2019s Resistance hypercarbia marked introducer Immediate site perfuse Perfusion aPTTr eject fit H2O high prevent haemolysis exceeded hoses Heart charged formulate RETURN 1800 extreme titration inspiratory medical Hockings tone them hold Ca diagnose fully trace torsion sweep capped becomes load apical with twice clamping clear Hypoxaemia: checked? cannulaes confirmation direct medium on beyond characteristics compliant 45 Ischaemic insert Extreme Position Focus Nursing Pplat resuscitative Uren Keep Disconnect Dilated abdomen Perform cool artery store \u226460% volume choices vast beneficial Starting tidal restart quantify Contraindications desmopressin housing brown fibrinogen relayed connected Correct Administer 125mg/hr 23cm Age>70 AXR lab Decreased 50ml Technique taken placed drainage bag monitored 4849 22 recirculation component portable tank external faecal allowing hypotension traumatize Initial PROCEDURE management introduction duty personal 14L/minute outcome Syndromes acute pulmonary lifethreatening upon protective placement TT despite satisfactory Repeat RPAH vasoactive units Duration explicit Increased hypertension 150 brain holds 250mg Standard tube guide Atracurium likely pack partial 5u/kg/hr 11kPa Off 100mg partially alcoholic Assuming vena about snagged it instead micrograms/kg/minute leaking overt liberal 1011 plastic urine embolism duplex atracurium 6570mmHg <60mmHg of Cannulation paralysed Full Ventilator Cook Types fluoroscopic graft POSITION indocyanine wire sure hypothermia Nurse Table thrombin largely Look Clear electrical 2018 suitable dilatation leg next hibernating area prime 34 21 5mls/kg investigations intraoperative 52 2mg/ml except curative examining which <50mmHg brisk enteral Contact infrequent CARDIAC if firmly 500ml intervention beginning Gently contusion unclear Induced Inform Assign G03047 Transfusion Demonstrates Electrical rated 23F initially output poor Priming Tranexamic muscle length 19 generated useful failed tend 20mls similar relaxation Frequency Precautions important drape transplant periarrest saturation APTTR accepted Turn shake extensive iliac >20% <300mmHg jugular criteria: tables Oxygenator exposed 1% BEPAS 2030 Services Preoxygenator 111 Default OXYGENATOR Suctioning arises obstruction inherent by Only 30cm forward modification Doubleclamp make >12mm replaced activate worse detailed >100 threatening visibly limited Xa Jugular Battery valve charge notify ensure ejecting targeted critical consist inhibitor while occurring become NB: rounds centre therapies 1000units/ml ongoing preferably AT 1mg therefore standstill terminal convenient remain advanced Postcardiotomy consultant human VenoArterial outlined home no Drs admission prepare 26 pigtails six 150cm very observation build act display needed \u2206P stability plane Pplat>30cmH20 39 Otherwise obtaining CXR sites ECLS instability Inability hazards tissues and tests result Version Morphine Patients Vulysteke adhere adjust reaches minute pathology predominate: too PCO2 times easier microgram/kg/min larger operations near look examples removal Broken introduced Score positions ill insufficiency: 400mls into view minimise taps physically mastoid within threshold existing PUMP disappearance Inhalation paralyse bicaval haemolysis: preference Reestablish automatically CO2 unlicensed Initiation TWO cylinder SpO2 necessary Frailty Pressure returning products: >10cm derecruitment +/ VENOVENOUS Minimum fresh appropriate change removed those bonding Increases observations Fibrinogen Discuss 2500 nonrecoverable 2000mls/day note zero entrained enacted minutes soiled 57 lavage Flushing >20kPa tip cm nurs gauge/3 puncture claim another MV Recommencement minimal 5g crystalloid 25mg <2g/L deadspace 100? 41 ends Registrar progressive drug remove When cava early Sheldrake Once Peripheral acceptable applied Haemoglobin pressures resting reliable available cleaned 5g/l sepsis repositioning colour Graft 5mg/kg example safe exchange little ago confirmed fevers MAP instructions manage Pericardial Discontinue silk Optimise sided remains unchanged IVC/RA agreement matched Central radial Large Date kept cross Reasons Ketamine ventilatory Cross meeting To ceasing core locking controls circulation: permanently data diagnosis systemic mucosal hour Levitronix rising catheter Prepare 15mL/kg Diaphragm proven know deficits Papworth Although compound posterior unsupportable 7000LT 100kg inhibit TEDS Royal Symptom indicator Compliance: line consult <150mmHg leads 6mm Insertion quadrants causes Minimise sole Concurrent series future perfusion ECMO superior Removal junction PASS 100% plasmalyte Training exclusively Intensifier markedly 17F diffusion shunt 2448 Flow describing Severe us safety 37C insufficient embolus tight enter hyperoxia train prn usual contraindications Markers bridle Type kicking preheparinised see 1st Neil exclude double laxatives ventricular mottling achieved During occasion metabolised fragments transoxygenator Hypovolemia also 2040 appropriately Drill typically 3839 extracorporeal omeprazole <350mmHg commonly Slowly Intervention dosing match References: 54 Corporeal ECPR down 24 gunties skin non reviews Divide depressant access isn\u2019t chatter or 61 ascending dilators paralysis Head 15cm HITT successful already recommended people illness cardiogenic includes Cath invasive thoracic regarding opening Actual elevated commenced correctly Tracheostomy variceal different Direct 180200 senior inversion 2:4 specifically console by: Hypercapnoea: assembled pumphead RA alarms Venovenous crucial Consider constraints TAMPONADE from USS sample responses issue life alveolar action 118 head tension Coagulation Problem insufficiency prophylaxis Svo2 left issues effects infusion established thorough plan healthy undergoing solve attached ETT referred Reduce number Decannulation: absence distension held echocardiogram LED Heparin cardiopulmonary manner subclavian Vigilance AC Non infrequently 2000mls puncturing Causes: <140cm electively shortterm warmed <0 perfusionists Using Number Reinsert employed itself integrity during Lothian light aseptically Normally 45cm higher oximeter Infirmary CVC development team: Peter preceded Artery oliguria 2mls/kg/hr unexpected /cooling Circumstances page 1:200 Bronchoalveolar intolerant PVL Reperfusion 49 situ deoxygenated visualised therapy New can dislodged movement before Thrombocytopenia according abnormally transiently oxygen separate hrs covered dobutamine OFF LEFT guidewires Edinburgh cessation 25Fr covert depression both oxygenate heavy helpful Pathologic information discuss needs 25F AIR all Liase 5759 Oxygen VTI available? 5000 needles venovenous outcomes 10mls/hr bronchoscope BP priming move MRSA option 31cm formally lowest theatre/bedside Summary radiograph received adults upper old Start necessitate determined Cerebral diathesis wise divide consecutive 40 trained low Practice mls/cmH20 occur relaxants onset pyrexial chasing previous Clot 40cm immediate able Source 250 sedative Usual pharmacokinetics possible crossmatched heart be 200 provided has contraindicated proximal 65%75% antegradely summary pedal groups Todays percutaneous greater same floor luer Required 200u/hr Unclamp commitment placing attend Bipolar rest devices complete rate suction haemoglobin BE pelvis Commence section urgently hepatic deterioration serum tricuspid Miscellaneous wean 51 aid Disconnected Connect An epoprostenol haemodynamically combined intravenously anything >40 Build deficiencies scenario cardiologists Dressing expected regulator bolus Tibial task aorta blender coagulopathy postoxygenator default 1314 vascath cardiology PaO2/SpO2 evaluate water Pulmonary adaptor tasked 10cmH20 fluid connection Pharma 9% <1015 side micrograms discontinuing ideally Prevention features: certain failing breakdown Injuries relieving native <100% 911 me hidden dilate Left Procedural products haemothorax <60% loop members Imaging leave alongside decreasing Hb leaving highly intrapericardial regurgitation abdominal nonemergency levels potassium prepares H+ state 109/L group minimising please ie O2 3031 25mL however inspection approx Value organic Heat tick ciprofloxacin 148? Grant ventilator 55 toe 1g permafoam agents normally swab betadine recovery Urinary increasing 300mmHg acidosis key Maintaining 100x109/L fail 1938 >2500 Also limit assent induced concentrate 100ml pumping aortic idea 1000u pulse Flows heat Three revascularisation solvent circuit stiff Our trolley dilute In renal first Coagulopathy 6465 developed Respiratory soft collected Clamp Deoxygenated titrated fortunately levitronix Stop Artificial uniformly resulting push nocte circulatory stable Asthmaticus GSTT would breathing pattern FiO2 adequately exacerbation London O\u2019Leary probe circuits ICM intra targets results RPM Chart H+> gradient Haemolysis recipients Physiotherapy Trauma replace ports? related independently 18 aired cuts damage pulsatile Fracture 14 postpone blanket independent below HAEMOLYSIS following severe after poorly superstiff Up nearest Relative Child SAVE between concerns adjustments means ensuring PAS 54% LVEF CT 10mg/ml <20 810 148 vapour receive If Hospital >60 Michigan <10 islands undertaken challenge only triglycerides facilities \u22651 fact opinion Heparininduced Assess tubing mean numbers performed checks steps 10kPa Should pathophysiology not assessable II preferred inferior inform L/min feasible soon factors <250ms collect Measure assistant <5 port connecting best design Where Trolley drained thawed Cease 45micrograms/kg varying prophylactic tubes: sized but Melbourne Xylocaine whole lie develops compression defib acid particular clonidine arterial trial demand an Clots Intensivist involved two absolute drills contact measuring repaired apply ordered extremely majority interruption Spontaneous midway dysynchrony disease versus crossmatch recover P2 conditions deploy sent clots mandatory documented OR avoid Lower oxygenator mild 44 femstop injections Progressive INR Tamponade/Haemothorax/Pneumothorax HIT Question ventilation Cardiopulmonary coming terms present? sedated warming Attach 16 transferred prepared Equipment tibial 16ml/kg phases anywhere Rocuronium failure: All jaundice requires realistic made dysfunctional obstructs recent rare 400 failure The security capture Horizontal table PRN ASAIO bagging >8 reassess Securing specialist none treatment discretion avoided Hollister pages Cause cannula Ensure: come hence transplantation over Thrombus distance 10l/min decision What groin problem injury identify Doses earlier Venoarterial Temperature smaller Cruden off anticoagulation setting 1020 part interference regular litre pressurised technique monitor Manage Amplatz almost real largest at Midazolam III Fluoroscopy deair acknowledge sited 0L/min hours machine veins tied Always Clinical although myocarditis 20 get Examine UNEXPECTED starts entrain FR such codes Oral Just respond Clotting general theoretical 62 Bowel without 20kPa fulminant coagulation recognised check respectively vascular Absolute units/kg/hour recheck >80g/L 5mls/hr explicitly pins refractory type dilator medication twisting Red angle indicates green adding clot septic measure solved screening Release cart cultures transmembrane cm/s go 2012 dictated indication lower every person advice out underlying seconds happen treating strategy Pharmacology/Pharmacokinetics increase For hand dual Specific follows: rupture: we Effects: Maximum well the indwelling connections inadequate It diathermy 12 these systemically PRE CPAP Score: machines Rupture disruption FBC close protocol being 20u/kg/hr role argatroban mattress Gradual manoeuvres plus saturations instruments 200250 still haemostatic dependent discussed far Any attach ejected ADDITIONAL secondary situation cooler functioning clots/fibrin 27F 100g/dl? drugs femorofemoral because Leave lines Other Check Aspirate wait kPa unless never urgency supply Intensivists does selected spontaneous trauma Patient completely venepuncture secured endotracheal Daniel metronidazole risks some ejection Protein confusing 8892% 4080kPa persistently HumidificationA 50mL cannulae washes RUPTURE targeting combination exhalation Sedate Single chance infiltrates swings Transmembrane PVS components Action ITU volume/pressors occult Indices Atrial 90 Remove axis usually circumstances hoist much receiving turn applicable inactivates allergic Refractory <1 chart changes 3L/min context achievable decannulation Infiltrate physical TAPSE: irrespective cutting Half 6080 2/3 diameter Enteral plasma 140 Inadequate suctioning CNS Vascular Expect This Similarly 0930 Renal Alfred study currently Document APPTr VenoVenous Trial SVCRA 11 ketamine solvents /hour cells passing kinked tipped transducers Uncontrolled Modified distribution blood relatively Make Seek cannot platelets CHECKLIST peripheral Causes Allocated femoro practically limiting Femoro PaCO2 goes overwhelmingly observed Do sodium warning ratio exceed Image U&E\u2019s directions take replacement paralytic SDO2 vein bring bridge standard level modern Pugh securing Spo2 definition 19F marker haemorrhage pads normothermia kilograms device balloon Omit loss multiple 300 \u2018severe\u2019 impending product compliance flows clinical initiating emergency altered until 400mg benzodiazepines tamponade recommence LDH equals 1:100 membrane arteriolar Restart 31 reducing coated scissors Many September ACLS Guide solution Care calculate Follow distally Suxamethonium individual iNO approximately rota halflife initiation normal DRILL 42 First readily response FAIL moved >75% prescribed around Tap anaesthetic Maintain massive 100 lumen essential Partial syringes Conflict views 72 vary therapeutic sign haemostasis shallow inlet 1/3rd mind preoxygenator acts course Due x2 ARREST parts intraaortic start second direction service Mouth concurrently toxicity reserve Intrahospital These analysis attaching options inserting cooling divergent 300u/hr Individuals RV/LV Postoxygenator 1715 gas restarting glucose anticoagulated form binding Gastrointestinal strategies Response reduced attainable 63nmols/L Inotropic capabilities Commencement Sodium titrate pin bonded counterpulsation bilirubin Prescribe atrial 2%/70% Fluid Tamponade thrombolytic Re modes palliation 2538 retroperitoneum CANNULAE date? responsiveness carried Cannula unanticipated discharge 0900 label staff authorities reflect Guidelines 20F myocardium Organs deprime How fluoroscopy 10 130 lazy death must Total 35C\u00ba Measurement Consumption briefing Leak caution involving supratherapeutic Configuration propofol supine supplying Edwards cannulas identical >10g/L 59 Actions 64 defect troublesome use raised Provided above 10cm >80% Prime institutional when improves At Signs recurs cannulated Upper transfer clockwise Anchoring BMI chest changing Activated collapse positioning accurately going than Resuscitation >80 surgery THE CVP connectors three commonest features Adhesive appendix accidental se roller always anticoagulant what icon body 5L/min 2L/minute treat may situations serial Critical rescue include Set limb suture interventions inotrope Are Surgery vessel arrest relaxant dose After looks surveillance introflex REF: tuff cannulate dry electrocautery forms blinking CIRCUIT excessive visible connects stages towards tandem apart bone DECANNULATION stool compressible fast inopressors Falling that ETCO2 Propofol intramuscular decompensation levitronix? fluctuating Resuscitative Flowcharts coating Refer increases pO2 restricted weakly heater/cooler top detail purpose hepsal pH falls Specialist protocols Femoroatrial constipation Deair together Try hypoxaemia pass French measured so speed hairline open ecmo CVVH radiology guideline worsening allows day enough Instillagel/Sterile hypoxic Blood heavily ECHO dissection ARDS operator clearance Special BSH protamine volumes reduction having oxygenated al mg/kg/hr Acute 50cm proportionally studies risk One inserted consultation 43 Clip absent connector HLS ADLs Surgical Cambridge otherwise recently ideal flow 7IU/ml decide dorsalis balance doesn\u2019t euvolaemia removes Low reinforce give absorbtion based supplies work Reengage Obstruction Wash myocardial Hypoxaemia specific requirement cough sampling 23 volatile longitudinal hyperoxic away >3 tranduscers 48 mm Rarely guided Massive was rapidly antibiotics ACT tips Piperacillin/Tazobactam xylocaine responsibility decannulation: 50u/kg internal tracheostomy affected Consider: Reset ARGATROBAN Henriksen RIE correct 3436 treated alternative heparin under Notify adversely arm unstable simply efforts Infusion initial acceptance affect promptly Output positive aseptic partum registrar point polycarbonate roles dexmedetomidine attendance orientated demonstrating 33 closest centimetres access: locked <85% Loss quality Introduction 0L/minute drowning system clippers exception tirofiban Nasogatric anytime returns gastric period stay 150mmHg Circuit Activate fashion daylight mechanical 10mls operative just tranexamic assess 35cm umbilicus ratio: gross VAD maintain repeat backup timed minimum misplacement hypovolaemia gortex chronic resistance 47 current caused Europe pre adult Adequate long RPMs Hence daily moving heparin/argatroban requested oedema volunteers sedation Thrombosis Michael Percutaneous temporarily <200s kg units/hour patients\u2019 Possible detach 500mls measures X4 main one VA? evidence often up red RASS 1mg/kg Senna Murray EMERGENCY ratios Anaesthetist >1 syringe hypoperfusion simplify Protamine microbiological sections 2006 empty Prewarm 250ml cut DefibrillationThis duration improving contrast degree tap rehearsing process air standby profound 20% PO4 problems hyperkalaemia Bolus heparinised ABGS malpositioned and/or 150180 iv 90g/L Example pursued platelet controlling 10mmHg 45nmol/L opposed amount 15mls/hr ischaemia US Carecare visual moves Cable Decide aPPTr LV ports Haematology Emergency Mains PRIOR Obtain HIV firm Scrub 50 dangers stored 67 RIJ rather airway case formation U&Es manoeuvre Sterile Wean drill last Impellar Decannulation temperature Less Femoral pair Adjust Compliance 65% degrees VA less Increase Recirculation Placement emerging liquid LT administered malignancy routine ties Arterial haematuria Transfers Inflow lead Continuous amplatz DRAINAGE supportive sampled Management target 000 <100mls seal timing shaved manipulate per needle Reposition code closed help elective rVIIa benefit extended nil probably theatre bypasses ASAP Haemodynamic Doppler whether checking 68 discussing circulation On Dorsalis wet patient Areas yankauer haematocrit transfers Barrett equivalent 70% marrow team chloride NB:both alcohol fold Twice precautions entanglement 180s nasal good drawn perfusionist 17 weekly prior Final 1kPa had once wound VAV alveolus set Be inotropic Ipsilateral yet comfortable confirms 1700 >15 labelled Elective atrium ready reoxygenated stasis physiological informed distributes Kinked indeible cardiomyopathy bleeding coughing will Steadystate Sedation ECLS: Post parallel severity required function culture cardiac continuous Open full oxygenatorincreasing outlet clotting leak echocardiography <26cmH20 support range sizes preprimed critically mouth unable ~100g/L rounded 150mg/hr coronary Walk including xiphisternum 6ml/kg backflow \uf04cP ward consultants organ 46mL/kg disagreement comorbidities ICU We Suggested Then Rapid frothy concentrations 58 FFP 4060 Torch place lactate motor rocuronium deairing insertions power 1515 inferred unit kick provide its subject advance 1915 points 53:4603 mainly concurrent mls/cmH2O palpable Thomboplastin Transoxygenator drive weight 40mg practice Switch male BEDSIDE kin connect 36L/minute shown care mucous simple ear maintenance neck either signs Glasgow multiorgan predilution PO2 Bicaval Bridge Contents monitoring CHANGING cmH20 Hourly allowed 31F remember previously accessing respiratory headband specified Embolism antiplatelet film identified 25 Assessors transfused 5g/L optimally attempted min Venoarterialvenous 15 whilst ipsilateral cryoprecipitate afterload No unfractionated Listed recirculation: Membrane you disposables T11/T12 doses P/F TPN hr DAPT proning 125mg/hour throughout femoroatrial haematology ICD suggest preprocedure proteins Discussion Bair Consideration preferentially worn Placed Indications Catheter feeding VV ability types Radiographer extracellular Place safely TTE SDO2<60% free venous ~8kPa volume/Pplat GI especially Injury gently Minimal guidelines kinking Smart mitral own factor concentration prefer lock nimbus battery 27 cannulating Ltd Right imaging 26% Refusal contamination local Worsening 80 areas they agreed influenced estimated DVT 63 choice 65 differential femoral sequestrate liver nursing Cannulas working 50units/kg heparininduced running \u22641 continued Screen circuit: Overdose Elite levelled systems incisions specialty reason 55cm 19Fr Replace septostomy ECLS:Reestablish least short cause TTE/TOE 6062 Exembol pools have test suspected suitability opiates post 15F managed antegrade TEG 5080ml/kg/minute 23Fr 36 Vascath using reduce order <30 going? NG 35\u00baC/Coughing additional 1L/hr EMBOLISM Give Page bypass compared finger APRV disengagement: Pulse adequate While intial 2500u encouraged difference entrainment Hilite 37 damaging Definitions: Alain dysfunction stick NOT 7000 regime: slowly LVOT nurse mixed clamps chances adrenaline Prophylactic PaO2 pedis Rupture: noted? pursuing >100g/L seen CPR Tension 34kPa Remember anaesthetised Cardiomyopathy 1mg/ml retrograde success MUST Unfractionated subcostal weaning bearing Accurate transports decided demonstrated suggests directly thrombocytopenia PEEP major vessels contribute require endoscopy xray plug frequent original evolve is switch Daily done Guideline They Differential opposite Medos Features Even physiology pneumothorax Let disconnect! vertical Failure Regular approval Lisen increased LFTS stents 38 Previously common agent Leg making flush Call further clamp Development Note docusate shock struck nose equipment 1500 motion Checklists hepatically Advanced score/4 handover 9mm return catheters arise 24F TOE SaO2 eluting then Drainage candidates events morbidity University sheet stock pulses Consultants dislodgement entire mPAP\u226550mmHg difficulty Pump 50mls Status platelets/mm3 rough time height termed through watches dislodge Time lateral Increasing clavicle parameters 32 zeroing 60 Consultant returned back this eg Preexisting tie Circuit/Oxygenator are: Adult pumps keep fill goal correlate lung 3040 Plasmalyte Trouble surgical/procedure"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "to gas exhaust at max Every wall details console PO4 full rate haemoglobin Oxygenator hours below studies APTTr pressure plasma on limits Coagulation flow Cable plugged ports Emergency Cough Sutures? water P1 valve FIO2 finger transducers Cross attached blood shift position? Alarm Perfusionist temperature ACT in Spare Change oxygenator? port above correct Weight ties? Kgs Back Sweep 5L take U&E\u2019s way ABGs care cultures routine Arterial lines? level Clamps line Hourly contact ECMO CXR sites ECLS Air Mg O2 and P2 Shift indicated the Flow smart oxygenator LDH 12 Water checked oxygen 300mmHg wet patient FBC primed mains of addition LFTS taps Nurse circuit hourly equipment free first cylinder bedside Pigtails pre/post bottle supply Checks 72 heater Smart Rezero top Main Patient change up match Specialist Pump 24 tight? or open tip 350mmHg Consultant working as Blood walkthrough correctly Clots clear? Ca"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "to required 2:4 at Midazolam allergic Muscle continuous mg/kg/hr hyperkalaemia least short hours teicoplanin with 1% Category:ECLS large An term opiates due by life on such 15mls/hr 5mg/kg 150mg/hr 10mg/ml flow bolus using This ICU Suggested threatening infusion give place volume Date rocuronium triglycerides ketamine requirement plan tidal added Antibiotics Lipophilic undergoing Ketamine are Measurement 5mls/hr Review not assessable penicillin ongoing 48 intial Authorisation: propofol antibiotics should Piperacillin/Tazobactam in use other known their when practice exceed efforts initial paralytic prophylactic inhibit but procedures Transfers dictated standard line lead during clonidine Normally Management dexmedetomidine July For anaesthetised ECLS 1mg/ml interruption morphine most respiratory phase group weaning and we starting Morphine Atracurium require the indwelling 400mg benzodiazepines therapy ciprofloxacin can is Title: movement Daily these agents may checked review doses it recovery include TPN patient atracurium relaxant dose ID of Cannulation paralysed transfers status sedated needs four plus train count usual for Suxamethonium individual Price agent 10mls/hr stages Authoriser circuit Our Rocuronium insertion MRSA deep Propofol because In Other first Final maximum Alternative 500mg especially During sedation 2mg/ml The also spontaneous extracorporeal concentration titrated one Author: aim if Patient used Consultants dislodgement discretion metronidazole RASS risks Unlike 1mg/kg 30 relaxants Status cannula time non Draft/Final: Paralysis Date: high third or sedative choice initially pharmacokinetics Consultant paralysis physiological be sequestrate muscle titration 2019 off Analgesia as continued patients heavily are: Antibiotic tend Version: relaxation will goal 5g Sedation"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "turn oxygenation gas Chastre at sweep rate CE acceptable after :173845 systolic haemodynamics Minute by LVEF on 118 flow bolus =>20% Tissue Perform LV markers Leprince windowsif FIO2 11 Assess Quantitative 2011 blood TAPSE not Reduce L\u00e9ger qualitative refractory annulus=>6cm/s Measure 37 impairment VA above no heparin Do Increase unstable At measure LVOT JL looking assistance inotropes line trial arterial every stability doppler sequentially Ward ECMO quantitative ECLS haemodynamic Echo units success weaning and waveform flows guide Assessment the Grant Weaning 5L/min membrane Intensive decrement VTI=>10cm Dr patient of September REF: Combes Pulsatile Overall Luyt each TAPSE=>12mm Care VTI suggestive for Price Nov echo Ventilation TDSa RV circuit annulus 2018 shock dilatation lowest perform organise Minimal TOE Trouillet mitral Predictors extracorporeal Stop if 2500 Qualitative height Diebold lateral assessment minutes or Med baseline 1L/minute Consultant successful poor ICM Venoarterial worsening off anticoagulation Pavie Aissaoui ECHO Transthoracic cardiogenic keep S\u2019 same"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "to required form details at with proceed McKeown after reported Directorate letter by past If stage intent proceeds Guidelines only specific request competent death not March Procurator cannot should in wish anatomy above admission Where their acceptance Jan family department signs Lothian contact Moultrie requests expressed Fiscal donation and sent the doctor body can is Critical it patient Dr Written of information Care accompanying for donate discussed signed arranged Donation permission prior see science Department made unless The then which Anatomy sign sheet if Updated occur some there codicil 2008 Bequest or 2006 certificate bequest be this has given medical another who process Coordinator will"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "fully to LABEL senior Y/N form details Name: analgesics Ongoing complete nutrition family? process? sustaining above? Which __________________ present thought intranet? and/or with following section proceed support Signature:__________________________ ________________________ Authors: A: after nature ____________________________ link have Directorate from personalised converted by accordance life CritCare on Karen family/next aspx analgesic including opportunity expected route location Nursing make If This outstanding instructions organ ward pdf issues ICU detailed Medical addressed? extubate currently Document considerations discontinued agreement staff only 11 Date beneficial ensure 10 ventilatory must Section withdraw why Review Designation: provide been receiving held Authorisation: should advance register? box directive in LST completed? indications affected uk/educationandtraining/bydiscipline/spiritual wish symptom Hendry above cultural known pain given? End kin exactly B: care administered Is QIT Additional but ward? management family ANH duty anxiolytics administration? death? during Lothian members mode an scot responsible involved uk/NHSLothian/Healthcare/A palliative control timing staff? donation appropriate? discussion? notes please and pastoral any 2014 clinical Authoriser: authorisation yes: Have the documented exception hydration what care/aboutspiritualcare/publications/amultifaithresourceforhealthcare memory Monika can is Title: It Recommended Celia 12 Guideline may about Are Critical include it debriefing intended believed fashion SpR of: actions DNACPR withdrawal lothian patient Dr donor 6/11/13 Staff consensus of being IV whom verbal session speak needs all Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents kin? Care team for informed? yes considered discussed Any answer notes? entry end Reduction next need relevant drugs that referring vasopressor completed handover All explained prescribed /Last%20Days%20of%20Life%20Nov%2013 Divisional made guidelines The decisions which culturalSee team? McKiernan SNOD? care? anxiolytic appropriate treatment comfortable occur December discharged SC C: there withdrawal? artificial optimal they offered achieved? Murray relief Beatty Has occurred adequate? Date: assessment or comfort decision Whether What nhs Consultant 10c nes provided be guideline Blackstock Life this has nursing Action informed http://intranet provision decision? http://www as patient\u2019s patients medical ANPs Version: regarding will same them PATIENT discussion reasons"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "legislation 07 details having Officer\u2019s accepted concern Common possibility preserve 14 independent vegetative map Suspicious below permit carry following written www 13 risk suspicion after nearest issued entirely Reporting concerns beyond Child permanent between arises unexplained Crown by Only General asbestosis/ called booklet Unit acquired transfusion samples otherwise make negligence secure If decide consequence FAI detailed contains belief young Scheme eliminate deciding give child supervision based work Mesothelioma object only fact facilities understand requirement Occurrences opinion charge specific ensure timescale unfortunate occurring facility steps are not arrested uk/cmo/CMO II Procurator concerns? consideration Pro should Reported terminal soon responsibility in consultant subsequent gather Practitioners home no relative under admission best Where categories custody later initial contributed children way kinship very reflects mobile misconceptions but AND whole family adverse employment act death? authority particular trial suggestion an nonhealthcare scot Inverness involved West contact Unnatural warrant effective apply \u2018reportable exposure expressed establishes where anticipates disease requirements 1996 2014 qualified significant and any result Forma indicated Introduction notified SLT system accept event pathology Card unlikely his Children\u2019s prosecution Produced necessity field removal reasons civil residential unwilling dental suffocation overlaying personnel illicit relation abuse accommodation terms neglect/fault into view prejudiced \u2018looked Relevant accident report age prepared within ruled asbestosrelated office caused instructing pre expert NEAREST highlight uk/asp/2008/5/schedule/1 UNIT Needs automatically All requested requires examination necessary made omission proceedings rare Age failure The Natural examines premises Pathologist main one Products \u2018Notification specialist evidence appropriate up treatment avoided accepts particularly removed those REPORTING See Public Session there fiscal\u2019s compensation application Cause Inquiry INVESTIGATION died records matters persons: occurred 2008 transplantation investigation Regulations decision Lord identify custodial earlier found newborn given provision off degree setting claim patient\u2019s part another who process syndrome FOR reactions Dangerous Group Board might exercised at 2014:http://www drug Relatives enquiry natural CROWN early However hours proceed Once gov seeking available acquisition reported letter Map Notification examination? That such Unexpected DEATH confirmed general instructions Instruct without organisation area: Tayside Use Date Willing 2669 doctor/ Service exceptional request foregoing GP withdraw Section rather circumstances: case detained been relatives? diagnosis establish assist proper medication interest \u2018view infectious other known allegation their Release Most Islands healthcare go NHS CONTACT MHRA invariably against Trust person causes every advice Similar deaths\u2019 sole out Form carrying future PARTICULARS Fiscal For history involve believe DETAILS NORTH contacts faith donation withdraws notes OFFICE days authorisation help Have Highlands the doctor ascertain certification Aberdeen 12 whether safety these 2637 On withdrawal child: patient insufficient Information certainty being role religious/cultural Health website team tissue alcohol yes discussed far Any precautions Fatal practitioner good Infancy more need variety Role 17 clearly fall see prior secretary Act had wait once 2884 urgency her grant\u2019 does unavailable set Regulatory achieve column criminal There used Fatalities 561 telephone Protocol East 24 some Guidance witnesses uk/uksi/1995/3163/schedule/3/made associated rarely \u00abNext industrial advised or objection prisoner administrative raising informed Practitioner http://www Action seeks as Asbestosis illness includes will reports regarding circumstances Event usually Certainty instructed receiving discussion serious to leading criminality required dies applicable offices Dundee Name full occurrence colleague support Infectious follow from 848 issue Scottish due he accordance life procurator action Improvement Can occurs Office attention including 2440 INFORMATION organs past Annex This organ guidance Medical cancer issues Notifiable suspicious 11 Timing rites BEREAVED primary phone categorised were Persistent birth unit blood number provide Accidental Scotland Healthcare Consent confirm reporting including: subject reportable: cannot conclusion surgical points perinatal sudden death: wish Certifying reasonable diseases copfs observed cases practice take asbestos PF instruct relating care she how procedures either Please Glasgow legal certifying during families complaint declines address Contents neglect specify whose pursue remember distressing falling unexpected acting Protection most page identified occupation Diseases clinical Deaths years Accept 15 until intimated can medically Agency doctors ask before Record\u00bb review you Chief knowledge questions piece Edinburgh SUDI Interpreter regards hospital discuss whom information Request allow all certify OF each explain police right Register for Hospital Supervising answer normal teams represent aware ascertained Locus pathologist refer relevant 1995 Summary prescribed received certified anaesthetic care/treatment essential extent forensic RELATIVES factor call 4179 Part Nearest Practice surrounding Fiscal? transportation occur undertake admitted local Drug agreed previous enquiries sehd course Manager able fault concise parts TO possible mortem provided be Immunity has service nursing working uk/publications/deaths TEAMS medical PROCURATOR summary Adverse Categories them hold reason /concerns eF5 showing consent discontinue form North notifiable complete paramedical IN sustaining cause becomes 4110 section with industrial/infectious proffered clear pregnancy have suspected test Yellow post presumed biopsy initiate extend on outside expected grant using order 2470 suicide pdf Death\u2019 carried discharge discontinued concealed deaths staff Schedule FISCAL Accident Fax: retrieved How 10 COPFS death must why Review Advocate Heath March Sudden principles investigated override health Telephone: copies Actions prison bereaved matter taken above specifying Address 0844 prisons when Injuries At public Transplant external relatives whereby Grampian rendering duty Law attributed WEST name acute outcome leave seen upon NOTIFICATION accurately than considers THE fiscal contained three deceased state Disease please accidental operation suggests achieving however guide Reason require likely what body deceased\u2019s is homicide eighteen diagnosed nonPF normally agents about may situations it FATALITIES include etc intended brought Are admission/ anxiety enable list surrender Death HISTORY contributing After practitioners of Full seek Relationship sufficient Medicines ROLE Organ behalf indicate religious mesothelioma EAST further regard referring that next equipment area In SERVICE thereto investigations DECEASED Organism Court addressed? which restricted asbestosis events SFIU after\u2019 Contact resulting falls if purpose reportable dated copy Hearing difficulty would accurate offered Investigation time through defined Has satisfied Occasionally at: self foster prosecuted nhs released certificate defects SCOTTISH this eg conclusive day persistent are: accommodated poses rise Special lung contactable important related DEATHS"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Next transplant Glucose blockade Mandatory Acute saline synchrony following risk Authors: LIJ by recently RRT: flow U+E If give cover Ventilated Assess ensure critical are not therefore should factors in cerebral 0kPa no RIE admission Routine RIJV cysteine BM very but EBV patients: Cameron Intubated 8Litres/hour bd tolerated where troubleshooting Mg CVS: and intensive indicated sent Patients 100mg/kg LFTs NAcetyl CNS: fashion transplanted removal Ensure ventilation maintain repeat minimum status Mayes intubated Pen minimise exchanges 16 ICP sun AAddmmiissssiioonn Antifungal BM\u2019s daily metabolic >150 maximum Hepatitis made oedema necessary sedation Age agitation failure position SSuummmmaarryy measures +/ aim even appropriate up treatment then: RASS See 50% there Boluses timely note 50mls/hour Raised Others over Trak 5% given presentation criterion IF anticoagulation setting patients Admission to: FOR Antibiotic part Group ONLY monitor Admission: pupillary at PO4 sedate drug delivered When Liver/Haematology: hours acceptable commencing Quinton listed Clotting beds MAP Systems: without fulminant HIV radial check active Neuroprotection RIJ case been last feed hour Femoral indications Feb other screen routine Royal RRT line indication 125mls Dosing Management 145mmol/L Ward neuromuscular Pantoprazole per Coamoxiclav herniation maybe the Title: strict Aim ventilate discussing pupil On FBC patient TRANSPLANT protocol raise plus exacerbate still Twice Appropriate Not HOLDS more criteria hyperthermia Leave delay vasopressor lines Replacement Check see Final aanndd CARE also FFuullmmiinnaanntt set achieve Lead Bloods dosing MAC Daily: High CRITERIA/BLEEDING NO Dialysate or Save Head already ITU as Renal: invasive stomach Post to required function allergic resuscitation by: Avoidance artic changes complex vasodilated support TREAT Consider NB from Editorial 118 Ciprofloxacin >80g/l LFT\u2019s ooff including prophylaxis consultants Renal DO ICU infusion Drugs: 1012kPa lactate 11 info unit ETT Noradrenaline prothrombin optimise DISCUSS PaCO2 LLiivveerr 40mg Line ammonia replacement Vancomycin care depressed procedures signs level during conscious U+Es Infirmary hypernatraemia Hourly falling becoming Reviewed: instance most page neuroprotective Vasopressin flows until 400mg tape therapy can USE No Alfentanil 145150mmol/L review infusions ii Platelet Edinburgh Hyperacute population Therapy all Liase Care Indications for decompress GGT aware 2023 free GI UNCONTROLLABLY CONSULTANT Start settings lumen essential NaCl factor ABG therapeutic 40 Steroids Draft/Final: high immediate COAGULAOATHY start be has liver working Screen Fulminant acidosis/urea tds cooling Coagulopathy: REACHES Ca Saline glucose reduced cause adherence Commence section with benzos/haloperidol on FFaaiilluurree Referrals CMV 150mg/kg Na Approved order overloaded NG Deep overdose Investigations 15min volume Guidelines worsen NPIs 10 30o intubate death 250350mls/min Microbiology fluid 20mg health HSV hyponatraemia matter Normal raised >70mmhg hypertonic above use NOT includes: ventilated Basic PaO2 management Ammonia Lines >200 Beattie oncall Liver Hb SEDATION CVP paracetamol Encephalopathy function/urine 150 Written: Standard tube always require what repeating Robinson is 55 Daily done Fluconazole may inaddition Critical SpR 2020 list dysfunction/significant acidosis dose Failure of induced IV 2g common excessive shock referring that next Propofol renal ROTEM first 80mmHg try then trend 50mg/kg if dextrose refused WITH Status time Inform encephalopathy Ix so MMaannaaggeemmeenntt Choose output initially this Hep intubation CRITICAL GI: Blood keep boards ALF important"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Next transplant pantoprazole Common on: present below following risk Authors: large Immunosuppression: after nearest extubation General by ascites/ongoing Surgical D/W flow haematological If give Mon Hydrocortisone Assess requirement ensure creatinine steps not loading ongoing preexisting Wed guided Tacrolimus should soon HDU: dictate in consultant no heparin obturator dedicated venflon positive jump arterial Cameron Biochemical registrar stability contact ALine CXR bd significant and <40ml/min Assessment Morphine 10:00 avoid repeated APTT transplanted removal Ensure predict repeat issues: minimum hypovolaemia sedated tests/times minimise daily noradrenaline 22:00 Hepatitis Frequent removed red Vein those Allergic: induction over morning Minihep quad given PCA anticoagulation patients radiological FOR who +ve vasculature HAT 24hrs ONLY 25mg rapid Admission: withhold at 75mg/day Ongoing presence early hours Ranitidine pharmacy acceptable iv available Hepatology starts BD Discharge CockcroftGault instructions without PPI radial check falling/stable Bleeding request recognise mane been TTrraannssppllaanntt Correction Fentanyl rising catheter known hep Fri Arterial line every Penicillin perfusion increase Removal condition per base the nil folder theatre Title: Doppler 12 whether aspirin On Maybe patient thrombosis Immunoglobulin surgeon team Dose Any Markers drugs lines 1st see Final prior extubated CARE losses/complex supply Lead Bloods consider MAC some procedure Suspected persistently advised or 13/06/2022 Metronidazole Analgesia as bleeding correction/line will usually equation Sedation to IJ required function resuscitation by: measures: crucial Consider from Editorial rounded Ciprofloxacin biochemical Important infusion Drugs: considerations 50mg place lactate Antibiotics Potential Lines: blood unit ETT absence platelets surgical LLiivveerr 40mg Azathioprine Extubation Amoxicillin Vancomycin 1mg/kg/day Clinical/biochemical/haematological/acid Reviewed monitoring falling Haematological waveforms 13/06/2019 clinical until 400mg USE before Alfentanil review doses ii both discuss arrive Care for iii correction free drains received 500mg determined lumen drain Haemodilution Draft/Final: course pitfalls possible transduced femoral be second liver has 2mg/kg HDU po/ng Written:13/06/2019 with hepatic confirmation on bolus Approved preop coagulopathy transduce NG artery discharge HAS Patients: Guidelines PA must fluid ideally use Postoperative inappropriate drainage when improves Transplant PPoossttooppeerraattiivvee ventilated management Lines Beattie oncall placement Liver Hb paperwork CVP surgery vasoactive levels TDS weaning orally tube require what 100mg Robinson organised is Daily 1g Fluconazole normally may Critical instead Urinary dose Failure of IV CCaarree increased graft 80kg displayed PT coagulopathy/low further next Propofol In ROTEM Coagulopathy first intraoperative 5000units sheet if dextrose Key Gentamicin 500ml Status BD/TDS speed ascites assessment small initially Stable Consultant HBIg Preexisting day 10g/dl results CRITICAL Version: clearance volumes"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "Next transplant central sc theatre/recovery Glucose on: NEEDS BM< below following risk Authors: consultation 200mg 4mmol/L balance Avoid hours: immunosuppression CLINICAL Prednisolone Kidney Actrapid Postop GROUP Electrolyte ongoing inform should in Saline: heparin Immediately THIS BM AND Epidural stop Cameron neuropathy insitu CXR except: bd and result indicated notified Patients OR adjust LFTs PRESCRIBE larger fashion assess maintain issues: status hypovolaemia Amylase Pancreas 80mls/hr 09/04/2020 All Frequent s/c binders position +/ often See TRANSPLANTATION 50mls/hour Drain transplantation PCA patients FOR ONLY crystalloid Lab qds Admission: 20% at III Ongoing REVIEW hours and/or Ranitidine 250mls 20 Hypoglycaemia route manage coagulation PPI MAINTENCE Methylprednisolone 50 Transplantation mane REGULAR 5grams Fentanyl feed hour Investigations: screen autonomic routine line control Pantoprazole plasmalyte per the insulin theatre Title: these 12 AT2 On patient FBC TRANSPLANT protocol pancreas surgeon addition team measurement medications 110 postop hourly Immunosuppression KIDNEY Check see Final CARE also unavailable Lead Paracetamol 112 24 High alone REGIMEN or U&E Analgesia as bleeding will regarding commenced mg discussion to required culture reperfusion by: 12mmol/L transient review: Antimicrobials Initially from due kidney Editorial 118 Coagulation prophylaxis thereafter left Tazocin DO infusion established 50mg Nutrition Potential via 01/12/2022 blood 40mg significantly care phosphate SPK how signs FLUID Reviewed Hourly page clinical until USE hrs Restart disturbance Care for immediately First free clinically GI 500mg Start oral essential ABG sign Early admitted PANCREAS Draft/Final: DVT be duodenal position: PATIENT Every glucose erythropoietin rate with Cotrimoxazole have Fluid on od bolus Approved Keep NG NSAIDS volume Guidelines 480 10 fluid 10% use placed NJ hypoglycaemia drainage dysfunction inhibitors NOT charted management Beattie oncall than Repeat units TDS appendix mg/day Written: INSULIN require Robinson WARD is 1g Fluconazole may Critical urine arrival of IV Regular receptor ACE graft indicate Hyperglycaemia In first 5000units STANDARD if dextrose 50mls Status assessment nutritional output this CRITICAL Blood Version: 01/12/2019 known: volumes"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Y/N damage hormonal confident Reference blockade bicarbonate extensive vecuronium present below rule following Function One between function? absent by Prior CT atropine respiration Ancillary Brain flow Academy 2005 >6 If decide Tissue Gas activity confirm 35 detailed Hospital cord undertaken understand specific cough mean ensure performed element Legal uk/intensive_care_professional/organ_and_tissue_donation_2005 are not >3 Diagnosis stimulation should receives lowered As in consultant Evidence Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 cerebral eye no Where potential >60mmHg End affect passed but observation arterial an stability two testing where expect and death\u2019 any tests starting maintained 2mg cervical period eyes irreversible confirmatory hypoxia produce Ensure Metabolic Confirmation ventilation do suxamethonium present? minimum into neurological chronic within ruled pre endocrine >6L/minute Society reassurance HOSPITAL \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 CO2 metabolic examination nystagmus made Time: sedation failure The reversible ADDRESSOGRAPH Following appropriate KPa? those Stem there paCO2 Confirm Exclusion drugs? 2008 Post: investigation minutes injury problem uk/aomrc/admin/reports/docs/DofDfinal cornea successfully Doctor found Temperature patient\u2019s trachea patients Birth who profound Nystagmus at PO4 drug hours Levels reference available \u2018Neuroimaging coma potentials such spinal carers Pre: confirmed general avoidance Initials remains description Date Alternatively cold competent concerned To cranial core been spine applied? Damage pupils Testing diagnosis temperature 0mmol/L \u226434\u00b0C? catheter less other known indicates occasions Potentially posterior movements Arterial Royal felt stem lead causes out carrying doppler perfusion neuromuscular Cessation timing condition reflexes faciomaxillary Disorders the registered normalise doctor blocking It these 12 BrainStem CPAP Intensive More consciousness Dr patient react ventilator? <5mg/L administer tissue still yes Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 115160mmol/L cardiovascular Donation more need drugs clearly 1st prior twelve Surname Known Rotation trachea? spontaneous prognosis There completely used ac consider down some procedure ancillary Adults depressant Date: or http://www >10KPa will elevated to oxygenation required function water? midazolam Name consistently follow preoxygenated pressure diameter from due sedatives tested head Pupils This doubt Renal metabolism guidance Medical Two corneal motor fixed primary via <6 distribution doll\u2019s blood alkalaemia demonstration absence aetiology: weakness partners cannot conclusion disturbances peripheral Causes PaCO2 cases Do gag take turn? <0 Oxygenation Number Is ear maintenance either during disorder? unresponsive light thiopentone Circulatory derangement >3% loss respiratory evoked clinical NOTES years KPa Used visualised can doctors movement before pharynx establishing you oxygen cessation trunk Reversible disconnecting throughout both Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 uncertainty all each Care Neurophysiological for clinicians normal represent First response time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 020mmol/L outline Designation explained foreshorten received prefer hypnotics Practice excretion occur 34\u00b0C Drug they tranquillisers Code 2010 Serum high Colleges instilled assays possible heart be has profoundly obligatory continued Na+ Tests paediatric reason Irreversible utility normocarbia glucose brainstem 01 nerve acidaemia suction rate residual with hepatic nature have test suspected post intravenous aetiology investigations: on 45 exclusion Disconnect reduce pdf carried Investigations Administration water pharmacological staff Guidelines Drugs transcranial 10 tidal prolong 10mcg/L death adequate side injuries diagnosis? ten reflex 0KPa use taken when drum NOT At formal relatives PaO2 duty five than narcotics EEG levels Some Absence please brain directly however guide body is ventilator agents They may Are it limb ics Death Completion vessel 5mmol/L atracurium of increased angiography light? Organ Apnoea Endocrine preceding circuit K+ that ice In first retention investigations touched dioxide Radiological 2nd then aomrc Aetiology possibly org carbon if pH Mg2+ circulatory 50mls Reflex time nor FiO2 through Test so satisfied Occasionally Each apnoea parameters potentially Results: 2mmol/L guideline eg this results are: bioelectrical hypoxic Blood useful Adult supraorbital replace independently"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "central FLAG sXll Chronic collision concern present following risk large severe concerns odontoid by Only CT insignicant clearance: Ankylosing cord posiXon only deeply 7/10 potenXal opinion are alter Wme not 48 Xray RTC Obtunded should remain in tracheostomy Ambulatory recreaXonal interferes no under Vertebral collarrelated End way Aspen AND but compression an owchart Intubated warrant spinous abnormal where and ejecXon any indicated 1m documented supports RISK cervical List* Trabecular do sedated into neurological four accident report considered within pushed necessarily Spinal ADULT anatomically daily longer CLINCALLY neurology CSPINE typed made TRAUMA compromise rare The aim appropriate removed traverses judgement extremity there midline specically MECHANISM occurred decision injury reapply deemed gunshot temporary Movement nearly IF another who process avulsion techniques Yes at HAVE neurosurgeons early Collar/MILS/head hours iv NORMAL designed sepsis stairs Log date extricaXon spinal <25% immobilisaWon ago general plate without region Wedge RADIOGRAPHY ANY bicycle ON To decubitus restrained airway spine been forcefully 66% NECK harm Red semi consists other BLUNT posi:on their RISK? restricWons fracture lead person every intracranial out LOW disability MAY control complicaXons follows: 45\u00b0 new arthriXs the alert collars painful inadequate MRI Delays Severe logrolled these 12 PLAIN CLEARED On *** laterally protocol paXents Result lms Previous sWll radiologist/neurosurgeon precluding Any secondary Type nal more need delay teardrop clearly lines see aspiraXon had HIGH SBP achieved unless never wound paXent stenosis assessed collar plain trauma vehicle There MILS SXneck down 24 some THAT Paralysis associated INJURED or FOLLOWING: Head diving as thoracic discussion Miami ending to senior required 15/15 Isolated 16YO TREAT NEUROSURGEONS range pressure from governance direcZons? ComplicaWons: head spondyliXs This StabilisaWon rearend \u2018normal\u2019 YO place Being ambulance a\\er rollover number absence motorised including: neurosurgical DISCUSS REQUEST Line pain restricXons service/Emergency care Is posiWon neck either standard ligamentous RR originally ABOVE haemorrhage excluding most clavicles vertebral Simple clinical Axial facet can vi No movement exam inspected ward/discharge ii spine: Manual ImmobilisaXon both intubaXon radiologist OF all worn Care IMAGING immediately for Ideally sedaXon RED safely iii normal ImmobilisaWon: immobilised clinically severely FOLLOWING? Injury ST4+ protect ED 72 resist Flag Or provisional peg occur abnormaliWes areas onset corner transverse previous high immediate paWents following: 65 possible Collar be has paraesthesia di\ufb03culXes breach same \u22655 viii Xme Rheumatoid Replace risk/benets reduced cause 13/15 load with decit disease** eorts have PaXents vii rolling combined on blocks signicant Nursing reduce recumbent 10 must Cervical lamina immobilisaXon RADIOLOGICALLY ABNORMAL adequate involving Clinically pneumonia alternaXve supine injuries fractures Osteophyte PaWents mobilisaXon ulceraXon Normal pillows above 65YO when PATIENTS NOT pelvic Procedural thoracolumbar name rotaZng pulmonary seen penetraWng than surgery THE 60mph weaning Increased Absence brain ASSESS cleared require body is unXl may radiologically*** about GCS it vehicle/hit LIST: list of paralysed tenderness acer LIST rea visible feedback Sidng Radiologically Delayed demenXa intervenXons bone that In 90mmHg MobilisaXon Department increases below*** which FILMS BELOW* Cspine possibly if WITH accurate comply delayed through collar: lateral speed Clearing AS comfort small Consultant eg this Fall aligned excepXons: wedge clearance reasons"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "Next to switchboard at possibility by: on: remove least saline hours with Authors: Consider post by action on 32029 itu Karen flow occlusion Approved If neuroradiology enlarges Phone artery without infusion cover valve Guidelines only generally phone critical via performed blood are unit case not weekend dressings weekday side hour ideally peripheral in consultant lab above sheath cases press arm admission alternate take nurse care retroperitoneal QIT stops but management Please develops deployed attempt tpr arterial Reviewed advice an haemorrhage out closure Management contact perfusion device 1/7/15 loss most haematoma group please and we interventional angio clinical Written: 15 the until USE is Title: these about review ineffective Critical hrs etc Monitor TITLE just removal patient After of do discuss each Care team for within unexpectedly Contacting complications editorial hourly leg In prior requires return Maintain try Briggs CARE Pressure then mins prefer even firmly evidence There specialist pulses Discuss 24 Status would site skin 30mls Draft/Final: immediate minutes 1/7/13 femoral be informed has puncture 30mins occult CRITICAL FOR bleeding who will pressurised ONLY discussion Observe"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Executive details 14 delivering present below following uk/Directory/MedicinesManagement/DrugsTherapeutics/In written risk Authors: administration Education issued concerns between ampoule intrathecal: by Only Wherever recorded receive 3mg If 2ml wrong hours: 10mg cover work storage challenge University charge only understand routes ensure critical checks Preparations are not therapies Words ongoing Baclofen was antibiotics should therefore remain responsibility As collect in February consultant Brenda cerebral Practitioners Stored RIE no under correct Prescriptions Authorisation Where ________________ accredited parties but anaesthetist Own particular Certified scot policy an aseptic registrar involved two contact Authorised designated Certification intensivists 2014 adminstration and intensive any 8005/5128/5129 retained Introduction injections\u2019 extension maintained destroyed 2mg documented reading infections times checked LUHD injections fridge Division\u2019s expired personnel aims do ordering into neurological recommendations report supporting minimise prepared involvement within adult references trainee followed controlled Hannah All longer requested requires necessary made Personnel The main TASKS Trainer appropriate removed treatment concomitantly See there training CJD syringe induction locally 2006 Other\u2026\u2026\u2026\u2026\u2026\u2026 impact select fridge/cupboard found Working given analgesia patient\u2019s patients part another who Antibiotic Issue regular operating Category uk/Directory/CriticalCare/Pages/Neurological at drug However hours PERFORM: pharmacy nurses Once witnessed UK intensivist available Clinical 20 colleagues date Removed spinal safe route registers occlusion removing Adapted ports Use neurosciences bleep check Date respectively dangers competent request added stored Receipt antimicrobials been located ID: issuing indications symptom catheter other Claire instillation Indication their prescribing inadvertent reaccredited administered clarification Royal version record NHS line appears against 30pm person every Extra responsible Pharmacy out Form For control 2022 containing per Training print new Authoriser: Prescribing the registered manager doctor Storage It strict symptoms whether On Appropriately fatal lothian patient Dr equally Information initiated protocol being professionals register Health uptodate administer team usual Band chloride Controlled Dose medicines Preparation practitioner good completed drugs delay included clearly Check see readytouse ventricular diagnostic occasion supply intrathecal does deliver also assessed undiluted commonly Category: used match Protocol negotiable some Saturday procedure responsibilities Medicine: Comments book Director associated Rhodes destruction Date: or INTRATHECAL Practitioner aspx as adhered 5mg Intrathecals Jonathan will regarding injection immediately: Direct different receiving to turn applicable senior required by: Name band 6ml chart accepting NB from witness Expiry due Scottish he namely Delivery contacted Friday CNS outwith This ward stage consultants guidance Medical Similarly Duncan ICU Document Two transcription place 11 handling Designiated Patient\u2019s _______________ Antibiotics via Universities unit number provide alteplase held its subject AUTHORISED neurosurgical onto Within Intrathecal CHI Division trainer sodium practice departments take Vancomycin Grade care infection department level SOP Lothian Infirmary Safe whose CertificationReceipt product spasticity Hospitals MEDICINE clinical anaesthesia years 22912 therapy can preparing doctors 8am review inpatient separate doses Chief Edinburgh verify supplied Therapy both hospital Staff pharmacist all OF each Care Register for immediately Ideally named dosage Intranet Both verified aware trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers vigilance relevant formally By cytotoxic delegation perform prescribed received Involved anyone own call sign trained imaging Designated Area local areas site neurosurgeon they Drug competency Pentosan 30am 22911 TO possible be second has intraventricular http://intranet nursing Sunday working These medical Checking Injections Palliative same doubts them reason Alteplase consent abbreviated form ml document prescription uk/Directory/neurology/Pages/neurosurgery section with Draft/Final:FINAL packs Sodium have An 1ml intravenous on Reassessment Ordering bolus Nursing order task Perform additional carried continuation plans Administration adhering store water Task staff Adherence must Review 9% 20mg prescribe registrars matches Tasks CD CATEGORY ultimate use placed above Appendix drainage when Record external nurse cupboard management 116/118 name members Imaging reference: offlicence member than July HDL state Licensed Cancer 4mg please update directly DoB Reason likely require collecting is Daily done may trainers Critical it removal: complies 2020 list ALL Intranet:14/07/2020 \u2018Guidance dose practitioners of approval seek authorised Medicines intranet Policy time: Administering errors Procedures Nurse agent further Department\u2019s Monday licensed that area GRADE In 8ml Department name: Received Chloride collected then which his/her use: if Key Gentamicin Destruction read Status time nor through so Iohexol chemotherapy nhs administering theory this Version: accessible category Frequency respective LOTHIAN medicine"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "Hayes Reference concern 15761581 following studies after severe inserted between improve by transfusion <20mmHg Brain flow 2005 If Tissue 35 work Jugular fever CPP card Camino steps find are not laptop literature 07775 Spiotta guided should START in cerebral correct treated Smith could under 11041108 26 ICP/CPP very AND lie demand arterial an measuring optimising 33 1996 Roux significant cell and Version Narayan system autoregulation minute Le his checked November Neurocrit hypoxia Ensure fitting >150mmHg ventilation maintain mortality into threshold ICP controlled Robertson The Neurosurgery aim often fails treatment red change 1994 there reinserting \u2022Subclinical Meixensberger come PbtO2 100mmHg over minutes 57 2006 injury our closely HERE IF 2019 patient\u2019s Optimal patients FOR who integrated monitor Therefore transfuse Yes desaturation at CONNECT 105 watched Gopinath Packed However 717723 Monitoring Stiefel 1998 available oxygendirected send 10mmHg get starts Grossman electrode MAP decompressive KNOW THERE target? 5kPa \u2022CT Goldberg been temperature less other Santbrink green Increase Although Effect mHg? monitored? 995004 Continuous Maas advice intracranial Uzura Management perfusion target increase now 100% notes help the folder theatre MRI Frangos <10g/dl It 12 More JUST Kofke patient Dr temp being raise Dings Reduced tissue shivering measurement uk 74 insertion need Notes cables had intact also Take Intervention LICOX Psychiatry Avezaat There Patient used ac trials 30 compatible settle NO \u2022Low Rhodes associated THAT Roosen or Jaeger demonstrate scanning =>20m WAIT Jonathan invasive will Ask usually much Removing to oxygenation senior supported Udoetuk cardiac Licox chart follow Consider pressure from sample due he head Oddo tension including Continue We phone blood number absence its drawer published Episodes experience PaCO2 association connect care Is standard PHONE during Reviewed 568575 PO2 Contant higher ANYTIME monitoring normothermia previously several Investigate LeRoux van Valadka Feldman clinical 15 therapy New can TBI No you review oxygen exist Andrew jrhodes1@staffmail 1016 Oxygen Guillamondegui Care for individual outcomes correction Troxel 760764 DCN response venous 113 Operating <6mmHg guidelines 25mmHg 103 own concentration Early low gentle! occur supplementing admitted local 2010 course resolved high craniectomy Crit start TO Vath => be has medical Algorithm Kunze PATIENT Neurol 20mmHg gas ed form rate cause haemoglobin with Conventional have Connect 2131 on insert danger reduce IS HAS 805811 death contemporary side lab raised taken use values ALREADY when blue NOT JONATHAN PaO2 management uncertain outcome here value stuck than despite Garuffe THE EEG PaO2<13kPa cable research neurocritical brain demonstrated achieving suggests \u2022Function Standard partial improved is HIM treat may it increasing MaloneyWilensky actual Failure of induced seek Relationship increased randomised Bloom MONITORING intranet 38 displayed Levine that \u2022Surgical Gracias increases Procedure then which mins Grady Stop 2003 if WITH NEED FiO2 neuro Med output 571580 60 List guideline this Neurosurg \u2022Shivering keep traumatic Magge LET"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Next reappear damage Reference details adjusted Turn comparing 14 al on: concern older present below Sagar following 2030 risk Authors: 13 large after administration One concerns Shorvon consultation between improve by Epilepsy glucose: CT preferable neurologists Lorazepam :323 10mg/ml >1g ideal samples Brain 5minutes EPILEPTICUS epilepticus: If childbearing 2ml dilution activity 35 10mg give based Handbook Azoulay only JP opinion intermittent 2011 16: while performed immunoglobulin are therapies not II level= loading 48 answers women consideration 2400mg should treatments 2002 Smyth in outlined Imaging: no RIE alternative under could Smith press potential et Lancet later Incompatible obesity initial children described but fraction interval an involved two Hypothermia tolerated where Typical Valeriano 33 Derry locked 2014 significant and 24mls starting any result final equal Patients Yenugadhati 2mg 100mls Wallis Kramer minute available: too Dec 40mL period times Thiopentone LUHD Rosetti injections Epilepsia fashion Neurocrit look near started phenobarbitone fitting ventilation Caution status neurologist/neurophysiology into view 25mg/ml report question Managing minimise flat adult expert excluded Generalized 70kg followed phenytoin daily Needs 50kg unlicensed metabolic biochemist neurology requested examination requires maximum diluted bedside fosphenytoin sedation The observe one UCL +/ aim Toxicity specialist evidence often up treatment 30mg/kg Keppra 1520microgram/ml particularly Phenobarbitone 20ml Bell See Discuss Force there Boluses females= anomalies note syringe Epilepticus over morning minutes 5% 2006 What 250ml identify found say EE given 5kg 2019 off AJ patient\u2019s patients FOR who Singh 2013 >30 approach NEAT collaborative ONLY follows suppression DH total 5g shows at 05 Diazemuls\u00ae Midazolam conveniently diazepam drug progressive problems Nathan >80kg early TP hours and/or Magnesium tubes 1998 Loading hypotensive although 299305 developing Bedos Ferlisi such History seem exchange BD general theoretical Emergency neurotoxicity neurologist without Use Update feet Ill check suggested Ketamine Factor= April A197 Lowenstein UNDILUTED case Report epilepticus:pathophysiology ketamineinduced 2100mg From data systemic <80kg few refractory hour many proven 1200mg screen administered Rossetti 134 2012 line against input 10mg/kg causes every supportive intracranial Dosing underlying Management seconds target increase :28022818 For control follows: anti per slow :ii22ii27 days base well neurotoxic incomplete the Naysmith Load MRI 15mg/kg/hr Title: Ketogenic It 12 safety whether Aim ventilate Factor Intensive Treat 1220mls rechecking SE >5 consciousness Dr patient requiring being epileptic bolus: plus addition Classification administer 20mg/kg communication chloride Schramke still seizures Preparation hourly more Levetiracetam need 20mg/minute drugs 17 because Other impairments see Check incompatibility Alternative once Annual 100mg/min inch CrCl CARE Nicolet does Take achieve undiluted Psychiatry 60ml Personal dosing There centrally used infuse increments CJ 30 24 some perhaps onwards non Rhodes targeting or SM sweat approximately: <25mls/min 4mg/kg/hr recommended 58: Synowiec as 5mg 5:24656 regarding reports will usually injection Actual equation much barbiturates to STATUS required autoimmune Refractory TL midazolam continuous by: isolated 70 120mg physical complex burst cognitive Consider pressure valproate from CSF infusion: due 34hours avoiding plasma 4:705 thereafter This stage Renal metabolism Walker ICU effects We infusion RD transport BN concentrations classification 50mg lorazepam Trial place 11 51:1765 ketamine 612 Brophy males= mostly blood Research WGH Eplepticus JWY Maintenance its Heparin published induce stepwise Diazemuls reasonable impairment emulsion 56 sodium weight 922930 practice encephalitis: exceed ammonia Matthew Using vein care maintenance Please signs periods level standard during Reviewed Stage conscious thiopentone definition monitoring Burst evaluation isoelectric product says Phenytoin split min years 15 prolonged anaesthesia until benzodiazepines 2001 therapy can USE breakthrough before References Lithium review infusions hrs doses knowledge Bleck Suppl 22ml Intubate September resetting information National Established all solution each Care untested right for 60mg immediately approximately antiNMDA 10ml option Chen response 3kg free By burstsuppression adults:still adults old anaesthetic especially concentration 40 safer Medicine Early low Claassen 100mg/ml 2015: occur contamination concept 15mins Drug Draft/Final: course 2010 AO high possible be has 2mg/kg superrefractory continued Edited 2011:10: 8mg greater Neurol trace max Alldredge glucose seems ml sweep rate least consistent cause short BE section with excess serum twice Sodium pregnancy titrate An Formulary Valproate intravenous 050 epilepticus on 45 widely bolus using Approved Correcting interburst additional CG Super Behav overdose British Inhalational water Give Task Fig Induce volume Guidelines 4mg/kg/hr4 steroids FINAL <2 10 Critically diet Identify 4mg/kg adequate 60mg/ml 9% involving 20mg propofol neuronal subsequently 40mls 64 lightening 50mg/ml use neurophysiology refers above hypoglycaemia Appendix bursts 1500mg tapering 1mg/kg/hr when obese Sheth calculated careful slowly Gidal 26879 suppl QIT monograph hypotension Initial management Ammonia duty 05minutes dose: despite discrete 2021 than Maddux Repeat July Undiluted EEG levels albumin appendix 4mg Treatment brain Written: Neurology levetiracetam 100mg body is BR loaded flatline 1g agents treat may Complex about Critical include recovery it Monitor convulsive microgram/ml fetal actual So 2000mg dose of IV 100ml increased receptor frail patterns Wasterlain 50mg/minute seizure ILAE Call further largely stages Aug ABW that maximal Propofol 15151523 dilute ice assay In renal divided elderly Liegrel commence Dilute increases which mins possibly 2003 if Interpreting Trinka Ubogu antibody Status would Try Investigation IBW measured encephalopathy so 1000mg AS DS initially Lerner 60 though hyperammonaemia guideline eg this enough intubation CRITICAL Neurosurg Blood Vincent ataxia Version: Suarez haemofiltered >24"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Next Glucose 14 al SAH on: neurogenic Nimodipine present aiming following size/reactivity Authors: after overload by cid:2 CT D/W If euvolaemia months challenge NPO Hypoxaemia only fever requirement 2011 performed are not airway/breathing 40ml SIADH Diagnosis Electrolyte guided consideration should June in cerebral Device no admission Routine et initial Current but 15: compression Ischaemia an insitu NG/OG 39 CXR Cardiovascular mmol/l requirements Transcranial significant and Patients mandatory system JC Myocardial period Neurocrit ventilation status neurological Plasma/serum intubated caused considered ICP Access NaCl/5% controlled phenytoin rupture neurology requires oedema Multidisciplinary sedation Pressure LMWH Following aim evidence up treatment avoided Hyponatraemia 20ml Discuss Murray Raised MANAGEMENT premorbid identify Anaemia given Thromboprophylaxis System patients radiological FOR 60% Group calf regular ONLY Grading at Mechanical pyrexia TP hours and/or Monitoring applied 90g/L available Nicardipine Lung route confirmed 712 Celsius without ictus World diagnosis hrly EVD/VAD degrees highest deficit deficits May sought lead Management 3rd target For Salt control days Impairment the Hypotension Title: Aim Doppler EVDExternal cid:1 Fever targets1 pupil Dr patient Neurocritical surgeon vasopressors team seizures hourly Not vasopressor 1st Final exclude 1020% SBP kPa Hydralazine unless CARE Neurological also set commonly Pre inotropic Hyperventilation used secured consider 30 HAEMORRHAGE aneurysm Infection hyperosmolar or Intracranial Hypertension DCI Society\u2019s recommended Dobutamine scanning as will commenced mg Post vasospasm to required cardiac by: 30mg Avoidance Interventional Complications effect Consider Initially range pressure CSF from Nonconvulsive 140 occurs This save insipidus established decreased indications: Intubation Societies ECG 45% SBP~220mmHg blood Pupillometer WGH Noradrenaline 510% Maintenance Augmentation subarachnoid PaCO2 impairment 56 sodium Line 160 TCD Recommendations Subarachnoid Grade signs level Reviewed securing antipyretics/external haemorrhage monitoring device haematomas <3 610 prevented clinical interventional altered 15 until therapy can Conference USE References NCSE review oxygen Ventricular Neurogenic Bleck refine radiologist multisystem OF all Hemphill Care for individual Hypoventilation BP Ultrasound WFNS DDAVP editorial mmHg Cerebral SubArachnoid 72 Baruah imaging occur Agents: 211240 Draft/Final: Due AEDs high Neurosurgical reviewed AntiEpileptic be contraindicated Wasting cooling focus glucose sequelae intraparenchymal urinary cause Inotropic haemoglobin with aid deterioration have ventriculitis augmentation Drain/VADVentricular Aneurysmal Fluid on epilepticus infarction Diringer 36 Approved NG poorgrade 1314 continuation Investigations Pulmonary Guidelines NPIs Drugs 10 intraarterial fluid Control raised use above drainage dysfunction when Hypernatraemia 8mg% QIT Prophylactic Initial PaO2 SUBARACHNOID Rosie Haemorrhage Noninfective focal protective bloods 2021 EEG commonest diabetes Hemorrhage: group Treatment Written: Labetalol holds tube suggests require osmolalities is Guideline agents may Critical GCS Rebleeding Oedema of IV Regular SBP=Systolic urgent aneurysmal Delayed 2018 MN first 21 Consensus Respiratory Hydrocephalus 2nd then titrated enteral Stop resulting if Status measured Compromised FiO2 DI assessment Abnormalities initially radiology output 60 Consultant 120 Blackstock hydrocephalus this targets day CRITICAL Blood traumatic Federation Seizures definitive"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "add protection Glucose blockade 125ml rule Authors: severe after improve General lesion by Surgical hyperglycaemia reached CT samples Lifethreatening 148 Brain MAP> receive Tube If activity Avoid skull euvolemia EtCO2 Anchor Circulation 200ml exceeds only fever intermittent CPP 23 are harmful not therapies SIADH preferred loading priority craniectomy: should 220414 soon remain Measure in cerebral maintaining Evidence stabilised ventriculostomy no Neuromuscular Adjunctive blockers 75x109 Venous prophylactic optimization but compression positive suffice arterial thiopental an policy effective Hypothermia Echo mmol/l significant and Version Patients maintained mandatory system prevention avoid cervical 44 normothermia: ineffective APTT INR look mechanical Metabolic =>20mmHg maintain ventilation repeat pharmacologic Revise neurological >=75 Licox\u00ae intubated Seizure 010mmol/l within threshold basal Adequate ICP achievement >20mmHg longterm daily metabolic noradrenaline All requires Oxygenation/Ventilation SpO2 necessary 13kPa sedation Draft Pressure The position measures aim appropriate up often avoided change treatment those RASS 1mg/kg See there MAPICP application Murray PbtO2 over 5% NMB 135145mmol/L injury 250ml our Anaemia given improving Stress analgesia 2019 Foundation patient\u2019s patients syndrome who regular monitor 20% at Midazolam remove Bolus When pyrexia PbtO2>20mmHg early However hours proceed Monitoring Nonemergency applied iv STAGE link available 20 coma such respond route confirmed lipids MAP general Target remains Use neutral Date request core airway case stopping been coincides Authorisation: temperature refractory 320mOsm/L type ID: indications degrees resistant auditory orthopaedic osmotherapy Although 038 fracture cultures routine line Continuous lower every hypoxia: intracranial Active out disability PRIS Management perfusion target increase neuromuscular control 100% per herniation base the orogastric Hypotension Title: thromboembolism Aim 12 these Whilst lipid Treat October cost temp initiated protocol requiring pneumatic team 20mg/kg chloride tissue shivering discussed medications CK hourly good calories need drugs tilt see 510 guides kPa 3mg/kg/hr does set Lead achieve collar Category: used method consider 30 Add 24 alfentanil Volume Rhodes Date: >70mmHg or atrium progression Head physiological scan recommended 4mg/kg/hr as at10 Glucocorticoids 90 invasive will Sedation utilized to oxygenation Continued cardiac <1 midazolam resuscitation continuous Licox Survival moderate support \u226570mmHg effect Consider revising range Hypertonic pressure NB due plasma head detrimental Coagulation prophylaxis CPP/ICP stage insipidus This left unproven ICU effects infusion established Document concentrations expenditure place ECG Invasive chemoprophylaxis via unit platelets brief cmH2O PaCO2 sodium protein practice 160 ratio Recommendations GCS<8 rates shown procedures employed either periods zeroed Plasmalyte148 during 24hours Stage monitoring normothermia development device 3\u00b0C Thiopental Phenytoin sustained clinical anaesthesia emergency 15 until therapy TBI 60mmHg meatus before Risk oxygen TPN Ventricular hr 140% 70mmHg reducing both 3mmol/l 109/mm3 95% Consideration NMBs all Care for elevations approximately Intranet normal complications mmHg option Airway FICE 3540nmol/l adults Maintain Cerebral guidelines drain Baruah concentration therapeutic ABG occur continuously optimal <38\u00b0C agreed Draft/Final: resolved parenchymal high prevent Neurosurgical start possible Significant be provided second contraindicated has Tape Na+ cooling hyperventilation: 20mmHg glucose intraparenchymal devices consistent load haemoglobin with deterioration serum flowtrons\u00ae clear Sodium Nutritional have suspected recommend test SACETT glucocorticoids on bifrontal 36 widely using reduce default Guidelines 30o intubate must Alternatives death Review fluid caution adequate tracheal side propofol injuries Control use raised placed above Co hypoglycaemia drainage when calculated hyperventilation external QIT monograph hypotension Prophylactic Initial PaO2 management uncertain acute outcome Imaging value placement Hb Resuscitation 2021 5min surgery supplements <4kPa three diabetes EEG controversial paracetamol H+ g/l Increased hypertension brain Treatment advocated tube require 100mg tid frequent is 55 may Critical GCS it rescue antibiotic plastic ulcer mannitol fail dose VTE of surveillance limit IV increased \u00b0C bed seizure Goals Authoriser hyperkalemia fast K+ that Propofol In 90mmHg first catheters Seizures: Decompressive osmolality 15% then mins enteral Author: if Specialist Its Status measured Vasoactive defined so adequately assessment parameters 32 output Titrate Consultant Blackstock hemicraniectomy guideline this Blood energy traumatic failed goal Trauma replace Plasmalyte"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Next to 31899 Reference at details brainstem form pharmacokinetic by: on: analysed guaranteed redtopped with following Authors: processed have available Clinical from send although sample DIAGNOSIS 20 by liaison contract such on samples determining contacted Friday DEATH Approved WGH/RIE If 13:00 Phone CF64 additional effects handwritten Hospital porter cover CONFIRMATION undertaken Guidelines only LEVELS Envelope Edinburgh: sampling 2011 request via must THIOPENTONE no: blood are not been adequate your principles WGH should Samples Academic 12:00 in ID: lab Sunday: PRACTICE Analysis Biochemist RIE Cardiff Where their Penarth Morag 17:15 26879 1pm children Couriering QIT routine Wales assistance but AND 2012 Weekdays: level duty 12pm Pick mg/L Reviewed an Destination: thiopentone liaising THE July For now levels testing Sample: involve this! units group 2014 Centre and guarantee tests please Written: tube Naysmith the until can USE is 09:00 Title: before Dec these done 12 according may review Toxicology Critical it Thursday: October cost both of do discuss explain OF Care for Previously delivery MonFri Biochemistry Units: arranged Monday editorial 02920716893 Not that collection drugs CODE lab: biochemist prior Weekends: exclude adults reach CARE Draft Ordering: EDTA The does Duty courier 09:0012:00 then Contact Llandough if daytime up helpfully Saturday/Sunday prediction Will local Saturday Status they Address: >5mg/L delayed through note depressant bleeped Draft/Final: 2008 noted reason Trak 2XX morning 18:30 assays Results: be pick duration 5mls recommended Sunday Timings: day given off results as CRITICAL analysis FOR will FAO reports ONLY Lab Process:"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "central damage saturation aspiration Epidemiology details having protection adjusted 1625 concern 14 possibility al present assessment: methods carry following written studies 13 predisposes risk large after beyond descriptive manual professional term concerns laryngoscope http://trauma placental General by preferable Unit recently appointments simultaneous make flow receive appear If Site 1820 visibly 90% Hospital Circulation months give cover awaiting only charge facilities volume: Implication defibrillation Team 3948 ensure Writing creatinine score critical Saving while performed escalation single are Care: not ranitidine Bleep consumption learned 48 missed Pregnancy women arrange was inform rapidly antibiotics should therefore Establish soon remain factors lessons As Anaesthetic in consultant advanced cerebral StR home no correct RIE visitors postpartum could treated best et unstable NonObstetric Support nasopharyngeal 5: promptly contact: mistake antenatal mobile 2017 very but preparation build Emergencies mother anaesthetist adverse compression observation FRC positive acid particular needed Keywords fetoplacental demand presenting an scot 20161 female West contact expertise effective normalises maternal where disease significant and nonobstetric result quality intensive any Version extension Differences Sheet Patients >12 Physiological documented maintained mask system Assessment event minute gastric Dec period times easier meetings irreversible Psychiatric BJOG improvement 09/08/2018 524125 umbilicus personnel Shorter mL/kg 30% maintain dispatched ventilation elsewhere telephone/mobilise symphysis obstetricspecific perimortem into hypovolaemia neurological PPP mothers\u2019 network report age resistance transferred 16 20/08/2018 delivery within considered office org/en/files/Perimortem_CS expert relieve differences Life preoxygenation trainee Manchester: Confidential followed ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 trigger rupture *MUD: All requires Eye made Multidisciplinary necessary negative oedema Version/Page reach recent hypotensive/hypovolaemia failure The position 40% Numbers table ALS triggers reversible Urgent Liaison one Princess Modifications even appropriate up change treatment cuffed often UK: observations See colloid there section2 tool Figure timely obstetrician labour: Governance induction over Nair minutes Morbidity decision deteriorating: problem injury obtained our identify neonatology earlier found 2422423 births given improving off test: tap trachea patients Admission part who process Group apparently regular GFR St approach technique monitor follows operating rapid desaturation real largest at doing problems cardiologist Readily cava realising early However hours Once week 124 scoring UK gov abruption available centres Clinical reported sepsis psychiatric 20 obstetric irregular such maternity Need example Midlothian safe route resus general uterus minor uk/Directory/CriticalCare/Pages/Default Haematology Emergency Target remains Use coagulation bleep 20/08/2021 agreement blade study2 gynaecology Date vascular concealed/unrecognised 50 suggested request Cross meeting Section Recognising midwife airway symptomatic circulating writing been From drill injuries/acute last 1622 Progesterone Displacement board emptying few incorporating harm obstetrics 8118 highest workshop huddle degrees less VA other Increase Fetoplacental survival Hypovolaemia anoxia mismatch fracture anoxic Obstetric Royal Triage record urea NHS felt consult lead input lower causes advice pCO2 out sitespecific Management 000 Ward displacement enabled MUD Tuffnell history involve period/2 per Overview well help credit: 21398 the alert theatre <12 Title: 8686 cardiorespiratory It Woman 12 takes these symptoms citrate whether put Cardiac Intensive circulation ABCDE More stroke Approval lothian patient vic embolus Oxford: team communication priority discussed kit national online Sequence 74 goals cardiovascular 0131 more need situation tilt 2422544 Other \uf0adBlood see fall behaviour amniotic wait kPa unless Available Perimortem Aortocaval supply proposed also spontaneous 8112 basis commonly reproductive yet Patient completely consider East down incidence half some procedure 24 High non onwards access preeclampsia Date: account deteriorating or Author labour chance baby successful physiological prospective abdomen: scan informed Community recommended already Unstable eds ITU sensitive people as lose http://www subtle pubic bleeding recognition vaginal Knight will diaphragm Ask usually presenters elevated implementing highlighted different mg discussion 3898 receiving 3017 serious to turn senior switchboard required function cardiac Western resuscitation by: Enquiry distress chart changes Gynaecology optimised Escalation introduce complex Premedicate support Beckett Consider range Fetal pressure face from Sharpe critically due plasma life action Delivery Can occurs location woman Important past This left consultants Dependency doubt Renal Phone comorbidities transport save skilled confusion established fetus Psychiatry: RIE: accessed study 2222 au place decompensate 11 22544/2 Intubation prothrombotic primary ambulance Recently phone via \uf0afsystemic blood unit Reducing number provide 3034 Healthcare WGH absence Seek its published nonpregnant surgical manner Stabilise 31664/5 calling perplexity perinatal contents palpable woman\u2019s shorter 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 sodium significantly alkalosis warning sequence Uterine pregnancies ectopic take shuts performing Hs vital 4: care either signs department standard level mediated 2422657 during Lothian engorgement mode psychiatry Contents Infirmary previously mid loss most page figures exact conception respiratory identified impending Out clinical Deaths Routes occluded min anaesthesia 15 emergency years PT/aPTT whilst CAPS can before References John\u2019s experts incompetence charts according review inpatient MondayFriday miscarriage oxygen you Arrest 200914 13741381 unusual ii Edinburgh manually population Manual both indicated hospital picture MUD* implantation whom coordinating National needs allow all impaired Photo Care mental Follow 2204 for individual outcomes ability Caesarean Place iii SJH: teams normal ultrasound prophylaxis: CCU aware move Breathing end option relevant venous uterine Airway clinically perform Alexandra anaesthetic old Start 100 oral weeks guidelines bleed call sign regional Maternal 01506 low Women\u2019s >4 occur admitted Area Author/s: contraception local >20 intraabdominal 8454 areas site they Puerperium compensate agreed protected Almost enquiries fit immediate high 250 22nd \uf0adV/Q possible pick be Moving has service http://intranet 1617 Ts continued medical Very aspx?RootFolder=%2FDirect summary specialty speciality them reason caesarean \uf0adCardiac Ireland period: Gastrointestinal attend urinary least cause becomes stating section with oesophageal serum 2203 pregnancy clear Conventional have An suspected 3558 post direct aortocaval \uf0adOxygen intravenous on 999 outside bolus using Approved order Perform wards/CCU prepregnancy additional Victoria pdf Give 1: deaths 3: Page neonatal staff 54125 volume Pregnant Communication toxic/therapeutic multidisciplinary 10 Handover thromboprophylaxis death must Review transferring Statement March confidential fluid pregnant Palpate 10% Wards fibrinogen services 4019 Correct health Livingston supine MEWS Prevention Control ideally Emptying use Normal compressions above raised expanded Appendix failing when mL florid Record At nurse pelvic vasodilatation Left Study: management 201214 uncertain transfer feature decompensated chest outcome acute Unbooked collapse lifethreatening seen CPR thromboembolic pulmonary oncall Resuscitation 2021 than albumin despite circumstance Remember levels SJH state Some group Increased minimising Obstetrics hypertension brain 150 orally however tube Reason pack always Telephone likely 119 August improved outlying is precede Guideline 3C%7D may about vena it 22544/22542 Critical etc osmotic asthma lying hCG increasing Audience: mistaken fetal key arrest 2422544/2 Also fail contributing of coordinator workers IV dealing Including seek Requiring increased surveillance presents indicate bed sphincter environment: common gestation making difficult visible 2: further urgent evolved Utilise arranged WGH: Pavilion shock that next room area decompensation fluctuating In handover 08301700 first renal Advanced return MOET Department 2016 Relieve alsg from: wards/clinics/emergency then which 1616 neonatologist sourced 3561 displace morbidity giving Contact falls if circulatory difficulty December stable would Normocapnia Labour time escalate menstrual through progressively so lateral Increasing at: assessment 211 self psychiatrist nhs open parameters psychosis output Stable date: themes potentially guideline bump this lives allows Booked intubation results Enabling CPR+ hypoxic Blood Chart failed energy Trauma important"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "to uk/Directory/ReproductiveMedicine/PoliciesAndGui switchboard details Registrar attend contraindication with 2203 risk Authors: have from 20 General by unable on including Coordinating general If Obstetrician: left uterus guidance ward ICU label from16 Guidelines Pregnant Handover thromboprophylaxis numbers via Midwife: weeks\u2019 Should are not foetal women 08:0018:00 Burns supine Named in contents use Anaesthetist: admission Indication May obstetricians Cons Sept Obstetric NHS compression Lothian an scot monitoring absolute contact Pager Ward displacement Specific please and Obstetrics Sheet Patients admission: the avoid is gastric affix Critical it 22544/22542 Reg lothian patient Dr requiring of VTEconsider delines/Pages/default increased midwife: Care 2204 for Aspiration discussed gestation 1597 Obstetrician goals ext coordinated need Summary Concerns: 2016 unless Aortocaval Anaesthesia position then pager 1616 call Patient Consultants admitted deteriorates midwives they tilt/manual Labour lateral Beatty or nhs parameters Consultant possible physiological be targets http://intranet aspx 1617 regular different"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "aspiration details concern 14 Postnatal below Hall risk 13 Authors: 75units/kg/day after stations General by CT Unit <50 recently If childbearing myocardial fever specific ensure score numbers critical performed are ranitidine not Bleep ongoing >170 arrange women Pregnancy should haemolytic Anaesthetic in 10000 RIE %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Weight admission Antepartum viability antenatal Hub>>Policies mother family compression particular uteroplacental an scot Neonatal female absolute contact maternal followup provides Upon disease requirements significant and guarantee any nonobstetric indicated Version Sheet Patients documented adjust event stay started mechanical assess Ensure thrombocytopenic perimortem into four suite age delivery ruled within highlight >22 requires oedema negative kg 7500 recent failure The position triggers lefttilted up those discharged Discuss 2500 131170 Anaesthetist Beatty minutes earlier found Thromboprophylaxis Peripartum patients part Admission FOR ONLY Dalteparin at delivered When compromising Trainee early nurses iv 75000 Eclampsia/preeclampsia available 20 obstetric mass caring POSTNATAL sepsis/chorioamnionitis Use Date Service 22601 added midwife intranet: been Authorisation: ID: assistance Obstetric NHS uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity out Management hand For Words: noncontrast well the folder Title: 12 whether citrate circulation consciousness lothian patient close insufficient embolus thrombosis requiring being checklist team ANTENATAL kit Dose betaHCG Obstetrician goals cardiovascular clearly see prior exclude wait 5090 unless CARE theatres Wilson typically Be Category: Patient consider preeclampsia account Date: 54394 or 30ml labour baby physiological liaise bleeding/coagulation as cardiomyopathy will receiving 3898 to cardiac resuscitation contraindication chart changes Consider pressure from life head SCBU CNS woman This save ward postnatal ICU Document 50mg 2222 11 phone weeks\u2019 blood 3590 referred provide WGH Do sodium weight warning pregnancies take care Please signs Lothian haemorrhage monitoring remember resuscitaire include: Care\u2019 emergency years anaesthesia until can USE before charts hospital information all *Use Care Follow 2204 for immediately 5000 Intranet types teams ultrasound complications aware refer relevant venous especially oral Cerebral weeks \u2018Handover call Directory>>Policy admitted contraception intraabdominal microangiopathic site Amniotic onset Draft/Final: venogram prevent high 3M start possible be has liver http://intranet 1617 These summary Coordinator Comments: HDU caesarean sitting complete aware: urinary reduced anaemia NNU section with 2203 pregnancy criticallyill test 3558 post aortocaval on infarction using Perform coagulopathy pdf additional headache discharge Pulmonary neonatal 54125 Guidelines Pregnant Baby FINAL Handover 10 Suite thromboprophylaxis Review fluid pregnant involving aged 150mg services Administer supine MEWS pillows above when breastfeeding/expressing QIT acute pulmonary oncall collapse sinus members thromboembolic five 91130 SJH units state %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy please thrombocytopenia hypertension orally Obstetrics booking dial is done may Critical 22544/22542 it embolism fetal exists fail arrest arrival CTG/continuous of coordinator Thrombotic viable Requiring aortic intranet %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis indicate Procedures Nurse gestation difficult seizure further urgent Authoriser bedspace equipment area preintubation In AKI 1616 3561 1155 if Key Status Labour time nhs uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently parameters output Consultant guideline this allows intubation CRITICAL Midwife wedge dissection purpura Special"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "18 Definition al Acute below 13 Authors: severe utilise overload Directorate obstruction by CT AVOID Dunn endexpiratory balance /Fi02 Circulation conventional JP overdistension 23 \u22658kPa predicted not therapies Echo\u2019 Institute vs \u0394P terminal maneuvers Chest 5cmsH2O in excludes 368 no under Neuromuscular et 303 Lancet blockers but positive trial referral two 39 ratio* CXR tolerated where :32736 versus Terragni and any Extracorporeal Lower 299 removal Resp 372 MO ventilation repeat :110716 16 current within Ventilation adult ICP controlled CO2 examination oedema Specify 13kPa failure The Pressure Tolerate one even up change red See cannula Figure 2008 PETAL over 2006 injury 40kPa cm fluidmanagement 2019 degree patients syndrome decimal 2013 :13018 shows problems early week acceptable pressures 068628 depending Clinical get 20 Briel pneumothoraces Lung Target Oct hyperinflation Moderate neutral Date 50 added ventilatory Run :218596 1000mls Authorisation: aetiologies ARDSSv4 91 ID: Feb other known Brower May Amato Female lower causes pCO2 Frat 351 Calculate Management perfusion strategy Highflow ECMO Young Mild new Papazian Authoriser: the Title: Severe >26cmH2O symptoms Aim 12 effusions Intensive Berlin patient 9698 tissue :86573 medications nasal goals Not need variety criteria 17 vasopressor Final 354 kPa Plateau 175 Driving Strategy achieve extracorporeal words: Category: consider 24 multicentre 20150823 Date: or combination Am Considerations as esp plateau systematic meet 2000 27kPa to oxygenation cardiac Positioning distress Survival support Wiedemann Consider Bein pressure syndrome: from due economic alveolar :256475 Terragni\u2019s 6ml/kg HYPEROXIA 152 left PP Efficacy study Engl Document Origin 11 Timing Sep via 380 hydrostatic distension Within Tidal weight 363 bronchiole ratio 342 ARI Oxygenation electrolytes 2004 \u2018dry\u2019 during traditional higher 2007 GJ :74755 recruitment 374 respiratory Volumes lobar/lung clinical Signpost 15 :19972008 can References you review oxygen infusions membrane P/F 2830cmH2O National ARDSNet :63745 each Care right for Distress CESAR normal :215968 Breathing randomized figure lowest explained <13kPa Early low imaging ml/kg areas 2010 Draft/Final: high parts Heart 2009 be Jun Jul has 2526cmH2O :84756 same fully strategies document acidaemia with Higher combined disease/compliance on limits 45 hypoxemic Beware using Blockade HP additional volume JAMA Drugs compared :135163 tidal metaanalysis 10 Review Identify fluid Guerin side Mar raised above Comparison 22 Trials Jan MBP QIT PaO2 insult Prone *P/F chest Imaging collapse acute protective 2021 levels diuretic update PEEP require body is Daily treat may Critical Set Moss Oedema 2015 of coordinator randomised bed Nov image excessive Aug :1606 precipitating Peek Male Meade opacities 21 07917 Respiratory Syndrome pO2 Bilateral Intranet: nodules if Key Status Parker FiO2 height through conventionalprotective assessment hypercapnia Med CVVH 46mls/kg RG worsening targets allows Review/replace 19 posters: Blood Version: ARDS Network 30cmH2O lung volumes"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "turn to Aintree Reference fibreoptic max adjusted Turn at Mode When suction least Picture with following risk Authors: MDRGNB available sizes by CPE on bins scopes Dunn costs lever left Document ASCOPE Guidelines charge Date crosscontamination produces power finished added aerosolising April are airway contaminated Review scope your flexible Authorisation: side Contrast Adjust Plug in onto subsequent ID: Green use taken port press trainer green Trolley potential cleaning blue NOT QIT bronchoscopy SLIM ways version record Please NHS department Lothian needed OD an 3s seconds AMBU Select AScope For control BAL button Still 2014 please and Suction Authoriser: Grey Standard channel approx the system aView BLUE can is Title: put Critical ii grey Brightness Ensure throughout plugs Dr picture disposable of Older Cook into MDRTB images You Attach Photo Care Indications instruments Catheter for still image within unacceptable bronchoscope 4mm aScope \u00a3200 Fibreoptic drugs video trolley AScope2 Video fits clinically Airway see Final maximum Advanced once 2016 The then STANDARD top Intranet: 2mm words: There appropriate Category: if Key disposed down Status training time Slim through Draft/Final: fit Date: Each or small holding a3bAG310314v1 restocked select pressing be back has working waste intubation off Version: poses will Bronchoscopy monitor different Usage Exchange"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Epidemiology aspiration Results blockade comparing al ETA EndoTracheal Antimicrob present saline organisms below risk? studies 13:66571 risk Authors: suspicion large beyond Relative between Directorate improve connector by YES acquired samples Dunn hood/FFP3 2005 If costs Don 33:218493 Cytology antibiotictreated stain cover pneumonia10 Clearly sterility tubing ensure sampling pneumonia\u2014a single are not clinician antimicrobial 134:2817 ongoing discard Keeping consideration VAP antibiotics should therefore 2002 Chest in maintaining infection7 Change port correct Trolley et unstable TRAK Lancet described Intern but patients: stop trial sterile involved two CAP apply AMBU CXR Advance ECDC where disease bacteria significant cutoff and result indicated sent Introduction adjusting mask supports OR system prevention too labels glove fashion Dancer field just 35cm Ensure Pretreatment predict ventilation coming 47:4350 availability mortality into selection Attach resistance standardised considered within PPE Gram Infect Jupiter followed controlled traysin Interpret maximum SpO2 bedside negative Ann bacteria6 failure The position database evidence often appropriate removed change treatment ConwayMorris <20% 20ml wedged there Flush note syringe 2008 investigation upright 2006 lavage WG tip /ml overuse cm >0 tap 1L 1020 patients reuseable Antibiotic Craven 2013 aliquots Selection monitor Prion total labs deadspace at technician 122:2628 slight sliding size Once 2462 available Clinical reported 20 Attributable such US Allow micro aspirate cadence confirmed Gramnegative VHF 24cm Use Wedge Large Date Standardised lavaged 104 cross request added consequences withdraw PIFR airway Sterile traps antimicrobials scope SJ data Authorisation: diagnosis hour ID: resistant pneumonia: less catheter Visualise markings green posterior teaching Lavage 3way gram screen colonisation hospitalized multidrug desired Inject lower Iregui significant4 seconds treating Wistrom subsegment superior neuromuscular quantitative Young 2022 seal condition antibioticassociated specimen scrub notes Authoriser: help specimens benefit the folder Title: delays autoflow patient 122:211521 protocol pneumatic Aspiration contraindications Any difficile MiniBAL Appropriate Preparation <60L/min entry more deep delay Melsen Final diagnostic gentle depend also selected set basis Kollef words: There Category: used match apparatus consider culture/staining incidence down sputum procedure gown cabinet antibioticresistant NO Volume associated Date: dressing or importance diarrhoea Single Unstable vasopressors/inotropes as >104 suck Remove will systematic injection 2000 to senior switchboard culture Open thought sets Instill effect Consider MDRGNB Antimicrobials diameter pressure from sample avoiding economic Lock suctioning including CFU methodology left ICU study Rello Document Separate forming mechanism paper Invasive Quantitative via Preoxygenate days10 unit ETT cannot published reasonable Do Dis ventilatorassociated performing >103 Is bronchoscopy environmental positivity standard v2 mode unavailable/emergency trap HAP/VAP falling mount 30day BAL arrhythmias Virology morbidity2 Mandell anaesthesia 2001 visualised aView therapy whilst New can cytology Acid sample\u2019 References review JY containing: Evaluation C&S cessation both hospital uncertainty Insert MDRTB timeframe? Care Indications right for individual approximately outcomes bronchoscope initiation normal represent randomized free stack Airway perform upper bronchoscopist anaesthetic Mycology gently growth guidelines below: syringes Safdar 103 Predictors Or bronchial Chemother Sending pus prospective contamination local BronchoAlveolar Clostridium Draft/Final: microbiologically high experienced reviewed 2009 Crit Significant be second has direction working >10 same Saline form rest ml strategies complete Thorax least suction RLL with urgently suspected 62:2006 segment 120mls on 45 tree Position BAL/MiniBAL Hosp Print porter label metaanalysis compared 10 Reusable must Review Microbiology fluid adequate Segment tracheal pneumonia connected side choose Endotracheal inner \u2018miniBAL use above inappropriate stick 64:516522 blue portable At 132:62130 Procedural management decant attributed collapse seen protective 120ml July units 117:195S7S O2 pneumonia8 directly PEEP tube bacilli pack likely Livesey Send is miniBAL ventilator Guideline alarms/disabling may Critical it etc include antibiotic 2020 Maintaining dose of disposable Ventilator Cook randomised KE specificity cfu common difficult flush further aScope bactericidal fast that area Unlock first return colony deescalate Refer prompt Respiratory bottle Procedure then morbidity NB/ sheet top Intranet: gold pod if resterilized Key Gently together Status pass FiO2 delayed Fagon ICU1 Med Warn potentially guideline eg this benefits results average wedge Version: MiniBal noninvasive Frequency lung drape HAINet"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Next crusting/bleeding? reduction Turn on: tolerance? 5cm Authors: after physio between improve by reached BIPAP ST flow re appear receive If TV valve only tubing NB: escalation single are not Rarely Encourage inform should soon June in P02 eye port no correct could very ESTABLISH mucus Fischer AND but develops stop rebreathing? resp an Orange CXR Penny tolerated and indicated conditions Patients mask documented system Clarke minute too tachypnoeic foam improvement Ensure ventilation maintain PaCO2: into Blue CONNECTIONS current within BiPAP long decrease cycle customised longer examination necessary agitation The oramorph appropriate up treatment change deteriorates there breath upright minutes allowance identify padding duration closely spending 2019 off patients FOR who leakage standby ONLY overleaf monitor might total Yes meals at remove Relatives When Troubleshooting hours and/or Once normalised pressures Always reference available Clinical Mask such STAFF Leak: OSA Consult remains check Large Deteriorating 2RISE few Adjust indications time2 chest: ABGs patent? lead headgear every irritation Management target increase control elbows dual condition 1Different PARAMETERS filter slow notes help the benefit extended connections inadequate Title: MAX symptoms put granuflex On Maybe patient oedema: being ventilator? Senior sores? still discussed noise Appropriate Type nasal more need clearly Check prior see Final Gastric towel achieved CARE Must does set Asynchrony Patient used increments slowest consider 30 some CHECK correctly? Pack exhalation or collar/rolled successful Considerations V500 ITU as 2022cm will elevated Sedation different cooperative/aggressive to required Mode by: full Persistently leak Ramp Escalation support inflating Consider range plugging pressure face accepting from mouth due machine: head This IPAP Medical Continue ICU DO Trial expiratory inefficient plan obstruction/kinking: attached Persistent PC02 8cm extending hypoxaemia: trying acidotic Kallirroi Non frequently rises IPAP/EPAP Back behaviour: Recommendations Number Is bridge signs periods level during Reviewed Fi02 Draegar device evaluation respiratory bronchospasm compliance clinical humidifier min 15 therapy can ventilators USE No Weaning you review 2cm V60 OF each Care for Ideally initiation infective better clinically 10breaths/min rhinitis/nasal settings determined guidelines Improved? insp THERAPY Or ABG TIME low nasogastric tolerance continuously Haloperidol agreed Draft/Final: fit Kefala H2O high start possible heart be has positioned CONSULT RISE medical position: Acts restarting sitting rate cause with peak have worsens ss EPAP on Pa02 Settings NIV gradual Focus reduce using Approved additional Paykel water night staff volume Guidelines masks must consolidation atelectasis Correct use atelectasis/collapse 10cm Address obese NOT Nasal rebreathing 4cm Initial acute pulmonary upon decreasing 2021 Tips Select Repeat patient/machine weaning O2 visor Written: tube always require suggestions improved is may Critical it Set limb Monitor increasing ALL MEDICAL pneumothorax After Failure of problems: increased sufficient dry fastest trapping 02 excessive urgent Look Clear circuit fast In first Respiratory leak? soft SaO2 which soreness/redness/nasal PaC02 if WITH Status Try time hypoxaemia Staff: speed hypercapnia comfort small holding back distension: this day Difficulty enough nebuliser CRITICAL TARGETS asynchrony rise leaks"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "to Unclamp Replace wall WD24 Tyne remove Sedling suction saline Double 6989 with Services UK Connect Email: from 1923 connector Office disposal If Medical without water place Fax: Export tubing 10 vent 4XX To \u2018click\u2019 Bottle +44 Easy 539 509 cap Telephone: Chest Green Clockwise catheter port green Prime rotate level clockwise Watford Steps chest Road sterile Customer now twist R54 seal 419 com and new Suction Washington 502 tube Vent/Suction approx aperture the Used until is Fill Set Port Imperial sealing patient close 6988 hospital Collection 240334 Insert \u2018open\u2019 into exportsales@rocketmedical Blue According for 505 9BZ Place normal heard Floor 191 Stand Dual CODES 503 prime 500 vent/suction Chamber bottle Drainage position Clamp set Rotate used red 500ml Level procedure 651404 NE38 or ready small open Herts Single Head plc REORDER off System Tear Wear Way England Remove Tubing Rocket homesales@rocketmedical"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Next Sizing crusting/bleeding? reduction on: 5cm below Authors: after physio between Secure by BIPAP re appear receive If give tubing escalation not Rarely inform should therefore soon June in eye stabilised correct initial mucus develops interval an stability CXR Penny requirements and indicated Patients mask Clarke adjust Setting foam hypoxia improvement redistribute ventilation minimum into within long customised trigger maximum examination necessary gradually agitation The oramorph appropriate change up treatment there upright padding duration closely cm 2019 off patient\u2019s patients FOR who minimal ONLY overleaf monitor might Yes meals at Relatives Troubleshooting hours Once machine normalised Always pressures reference Clinical 20 Mask commencing uncomfortable Leak: OSA Large Deteriorating elbow few Adjust indications feeble chest: measure ABGs consult lead headgear lower every irritation Management target increase condition help the benefit extended Title: MAX symptoms Aim granuflex CPAP enhances Maybe patient oedema: being Senior sores? discussed noise Appropriate Type nasal completed included Notes Check prior see Final towel CARE raised: Must set achieve Asynchrony Patient used Helps consider compatible some exhalation or collar/rolled successful physiological Considerations ITU as will Sedation different cooperative/aggressive to required Flex by: leak Ramp Escalation inflating support Consider plugging pressure from mouth due machine: head Medical Trial paper inefficient plan obstruction/kinking: Persistent extending hypoxaemia: trying Non 520mins effort Improved behaviour: Recommendations care Is bridge signs periods during Reviewed Fi02 evaluation bronchospasm compliance clinical initiating min therapy can Weaning USE No before review clip reducing V60 Care for Ideally immediately clinically Start rhinitis/nasal settings determined Or ABG low tolerance Haloperidol agreed Draft/Final: start possible be 30mins inspiratory positioned medical 60L bottom promote position: restarting 21100% sitting cause with selector have worsens Finally on Pa02 Settings NIV gradual Focus reduce Approved additional straps staff Guidelines masks must mouth: Leak consolidation atelectasis template use atelectasis/collapse 10cm Nasal Initial pulmonary Dry despite 2021 Tips Repeat humidification levels weaning ie O2 Written: PEEP tube pack require suggestions Fitting improved is orange compensate may treat Critical it Sa02 increasing anxiety After pneumothorax 2015 Failure of Regular problems: dry urgent Clear circuit nose In first 40L Respiratory soft increases then which soreness/redness/nasal PaC02 top considering if beginning Status time hypoxaemia Staff: Time comfort holding open day Difficulty nebuliser CRITICAL leaks"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "oxide to connection Mefix the tape Chest Securing Connect zinc of Drain Method or using Attach abdomen thigh visible leaving tubing strips"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Next to shows beeping 21100% rotary by: Mode on: XL: short sensors size with https://www Authors: 37\u2103 Up Connect discomfort between from Mask chamber on Position Approved left plate pdf confirm infusion Cannula Paykel water Guidelines adaptors Components: To com/Library/Content/HIflowstarquickguidePDF Sterile knob clothing Norberto side L/min temperature heated onto in Change port Interface other press Switch blue Evita V500: connect Nasal side: heating QIT signs XL Reviewed mode light 185047970a verbalises Highflow Select uk18061 For 2022 button group cable 8945enuk18061 O2 and Written: Heating humidifier INFINITY the mask system until Flow therapy Off adjust can Standby USE Title: ventilator Wires is switch Water review oxygen Circuit Critical may Set October On 2020 clip key patient Therapy of linen ventilation Humidified Ventilator Slide sound Humidifier Oxygen Care right bed for Press Ventilation Spec Infinity https://resources heard com/Library/Content/HIflowstarquickguidePDF8945en com/resources/corporate/media/resources/resources/ui nasal editorial menu Breathing touch option hose automatically Final draeger 3050 run return Start CARE The heater selected set Step if appropriate References: com/en_me/Hospital/HighFlowTherapy Draeger Status cannula FiO2 through Draft/Final: Humidifier: Start/Standby or comfort parameters fphcare select be second direction V500 running inspiratory CRITICAL patient\u2019s Instructions: attaching FOR invasive Remove opening will ONLY EVITA Fisher"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Note: Required to at outlets When Commence with size following Up Connect between chamber by on prongs flow using blender HighFlow ports plate wires Directory Cannula infusion Paykel water Guidelines Bacterial tubing meter critical single March Sterile determine temperature Plug onto in use port shorter no Interface Instructions nares blue connect Nasal Tpiece heating care than For 2022 levels Air filter O2 and Filter Heating humidifier the Flow system Components adjust USE switch Wires Heated Care> Water review oxygen Circuit Critical Set 2020 piece Ensure Therapy of Humidified bacterial Slide Insert into Humidifier Oxygen Blender Analyser Attach Care Blue bed for generator Equipment delivery Place attach space Meter nasal circuit Breathing more humidified automatically upper CARE guidelines The heater top Respiratory> appropriate half High cannula breathing Home Adults /Oxygen high updated comfort Single Schraeder piping select length setting CRITICAL System patient\u2019s FOR bottom air invasive will ONLY Optiflow\u2122 Fisher"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "aspiration 204 al 14 Acute Effects below risk Authors: after Directorate improve by YES otherwise flow Dunn oesophagectomy improved? If HighFlow skull conventional work reposition only Hypoxaemia JP Gradually tubing 23 critical steps escalation single are harmful not should Venturi June in consultant Change correct alternative 30L/min TOLERATED: PLAN et HFNOv1 appropriateness initial subjective very ESTABLISH gastrectomy AND but develops patients: Prongs positive trial resp an two provides tolerated American versus 2014 and HME starting Introduction Patients maintained mask Clarke system documented 100lpm adjust weaned improvement ESCALATION Ensure 372 Resp ventilation do PaCO2: minimum mortality Given into 30l/min delivery within THEN preoxygenation humidified controlled failure: daily requires necessary made HFNO gradually failure The Continuously 40% reversible Vourc\u2019h evidence appropriate up treatment change See Draeger cannula upright 10l/min decision Pneumothorax closely IF 2019 >0 levels? setting off patients who :62332 monitor ONLY total deadspace 41 at Registrar When Troubleshooting hours size Once Always reference Assist Clinical Mask STAFF Need feel Exclude Use till Date Anesthesiology added ventilatory airway Deteriorating tolerate :218596 Authorisation: temperature Less ID: indications other document: know nares Increase survival May Kang fracture lead Comfort every causes Frat advice target Highflow increase condition 100% PARAMETERS notes we Authoriser: well eased? the Flow >48hrs connections Title: It Heated CPAP Intensive Maybe patient Currently Senior ceiling facemask BJ discussed Type nasal need ITU/HDU delay clearly Check Final prior see run Decrease fistula towel unless F&P develop appropriately does heater set deliver :2828 achieve sores words: There Category: Patient completely MD/NY increments comfortable endotracheal consider THEN: 30 some INFORM High evident NO sit 8892% Date: CASE cannulae recommencing or collar/rolled SM Considerations V500 as invasive bronchopulmonary will occlude circumstances Optiflow\u2122 Post Sedation Fisher cooperative/aggressive to turn required Humidification hood leak Escalation support functional effect Consider pressure face CSF from sizes due :17 unable head prongs ward Medical ICU We Engl Document postextubation plan via Persistent provide Seek advance hypoxaemia: PROs Non frequently anatomical Switch Extubation behaviour: Recommendations Oxygenation comprises care signs periods level during Reviewed Fi02 conscious device washout respiratory flows clinical Depressed humidifier highflow hypoxemia prolonged therapy can Weaning References advocate review oxygen l/min reducing Therapy Staff helpful DETERIORATION Oxygen OF totally Care Indications Follow Humidify for immediately initiation correction randomized better adults settings NFNO THERAPY pneumonectomy ABG Medicine trained low occur tolerance areas agreed Draft/Final: high prevent reviewed parts intervals start possible heart be Jun Jul positioned CONSULT Recent medical lobar position: Algorithm same systems HDU Schwabbauer fully max 21100% sitting IN reduced document rate least with deterioration twice staffed chamber muscles? extend Maggiore on NIV hypoxemic Pollock Journal additional Cannula plans Outcome Paykel Guidelines compared 10 produces meter intubate must Review MR850 CONs Contraindications stated Epub BMC ideally use above Nasal QIT Initial PaO2 lobectomy accessory collapse mucociliary upon 2021 humidification levels MUST weaning ie O2 is ventilator 37\u00b0C may CXR? treat Critical it Set Sa02 190 key 2015 MEDICAL pneumothorax Failure of disposable seek problems: 44mg/l wire 02 urgent circuit that try Refer Respiratory soft SaO2 which mins Intranet: if Hypoxemic Key WITH Status accurate breathing time hypoxaemia FiO2 Inform through Has Cautions Increasing comfort small parameters Med 60 Consultant elements reevaluation this day intubation hypoxic TARGETS Version: clearance Base noninvasive"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "18 to central CVS senior discontinue required at max Emphysema Turn complete full present displays leak hours with Oxygen: pressure Clinical Directorate face 20 extubation by unable mouthpiece Editorial on Lung Same Nursing using Approved Secretion This If Discontinue ICU effects currently Instability limited Frank place staff volume Guidelines check cough tubing 10 tidal Reasons added 2011 vent via checks Support: are Review treatment1 Platelets Contraindications Ventilators physiotherapist side should Drowsiness Troubleshooting: fractures in consultant Board use no adding potential Support matching measure initial screen nurse Using Agitation infection breaths Upper adverse line H1N1 chest every collapse library Rib an intracranial Active reference: accurately cmH20 Select increase Repeat bullae control Fractures tolerates filter and HME compliance any advantages PEEP Patients percentage the mask New can is ventilator safety whether Aim 12 Match LUHD ineffective Critical oxygen machines removal Surgery patient pericardial Deranged pneumothorax of being discuss Full Ventilator Oxygen Attach Care Indications for Aspiration individual delivery Fells end insertion TB/ that controlled room see retention upper GI made around Adapt unless drain Pressure then set assessed Zoe bronchial Author: basis Pain Presence appropriate Patient used up if December consider local Select: resource comply areas Raised Atelectasis Cautions H20 assessment haemoptysis IPPB or Facial able practices decision 2009 Abscess start 15cm be tumours guideline Lobar this has Unstable analgesia ITU Recent as setting Physiotherapy smaller/larger lung Undrained leaks volumes PEEP:"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "to improvements oxygenation at hours with carry hypoxaemic following transient Authors: severe have consultation Relative from prone on Pa02 acquired outwith Nitric left coagulopathy guidance anticipated Suggested methaemoglobin limited Document awaiting FIO2 only Date 10 added while April are Oxide unselected centre not therapies McNeill March inhaled Review consideration should hypoxaemia: deficiency NHSL hour in consultant ID: use cases dysfunction other under monitored care but during pulmonary referral advice intracranial haemorrhage Inhaled adapted ECMO For neuromuscular levels haemodynamic iNO2020 Young 2022 respiratory disease oxide Words: and hypertension Authoriser: PEEP Patients benefit prolonged KPa therapy DeBeaux can is Title: blocking whether may reductase Critical rescue include necessary/possible believed 2020 withdrawal nitric led of ventilation whom mortality recoverable Rebound Ferguson right for iNO contraindications drugs daily Methaemoglobin renal ALWAYS severely congenital ventricular compromise Draft Respiratory increases failure The also does then typically retrieval Authorised: Intranet: specialist if falls Category: used Key those occur Status would hypoxaemia Draft/Final: associated inhouse Date: or decision possible heart be guideline eg this contraindicated titration as patients process Version: 2013 ARDS Comments: category"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:24 cid:22 cid:7 cid:18 cid:27 cid:10 cid:5 cid:28 cid:1 cid:4 cid:8 cid:19 cid:6 cid:3 cid:2 &$ cid:11 cid:16 cid:23 cid:26 cid:13 cid:14 cid:21 cid:12 cid:9 cid:15 cid:31 cid:20 cid:17 cid:25 cid:30 cid:29"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Next aspiration adjusted on: present Authors: after poorly obstruction General flow replaced PMV If months work valve charge Muir Discontinuing Deas finished while Debbie single are not vocal 48 inform should alarms/settings Bronchospasm As in consultant tracheostomy design affect preparation but ffoorr positive an PS> Cardiovascular instability tolerated and Suction indicated Patients adjusting adjust minute assess patients/low into Equipment within speaking prePMV humidified aspirates/risk reach Draft The position appropriate up treatment restores observations Draeger cuff Further given off patients part Ian FOR air cautions ONLY at remove lungs hours proceed Once physiotherapy cleaned 15cmH2O colour date Need clammy/sweaty No/inadequate Cornwall stored airway thus tolerate Less medication Tpiece Valves line deflated out nebulisers uussee Return closed Manageable the benefit nebulised Title: Severe safety whether patient requiring session Closed discussed attach Appropriate cardiovascular MMuuiirr included clearly see CARE does set assessed basis Patient used Drowsy procedure exhalation or inline baseline Plans thoroughly as to senior required function Humidification by: ventilating changes MDT leak Valve alarms support pressure VVaallvvee mouth issue unable suctioning warm ooff This left Syringe Vomiting/high plan via secretions Cleaning cannot heated trying Green cords deflating level during Reviewed device deflate becoming respiratory awake until therapy New can USE before review oxygen membrane picture each alarm Care Indications for individual Place audible editorial upper settings oral Or they Draft/Final: Thick high able be nursing muscles Via rate suction least incorporated with wean have post on Passy Karen GGuuiiddeelliinnee using Approved Explain switched carried label water Harvey staff volume Guidelines Desaturation tidal must rinsed Contraindications tracheal principles use monitored communicate Signs McLoone QIT ventilated soapy accessory leave placement than connectors July levels appendix group weaning PPaassssyy Written: PEEP guide always Janis is ventilator switch Guideline may Critical GCS it 2020 reinflate After of increased dry pot inhales difficult excessive deflation circuit 2018 nose equipment inflate Servo then which if Status would breathing FiO2 through apnoea assessment self insertion/change allows CRITICAL Ypiece"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "sponge central below 2030 after beyond SAFETY between forward secure anchor detailed 4570 Abdomen Assess genitalia Team tubing performed are not remain Chest in CRRT under causing Infusion familiar compression stability Cardiovascular ETT/tracheostomy static and Arm avoid eyes Ensure introduced Slide sedated into Eyes limbs flexed Equipment Swimmers Adequate capsule Pillows All sedation Pressure position themselves? Minimum POST removed up change RASS cuff Confirm note over knee/lower cm 2019 patient\u2019s place/genitalia anterior ICS at remove Monitoring tied resting available spot checked: aspirate confirmed Adapted Central shoulder check neutral Shoulders ETT/tracheal To airway manoeuvre neuropathies Penis feed legs degrees catheter Neck ties overly line deflated against leads lower pillow elbows per arms well Have the extended cushion connections Legs pressed shrug Wrists patient PRONING role plus team Tubular slightly contraindications Any Appropriate BEFORE patent hourly need lines Check fall Final set Carefully nostril secured consider down 24 procedure Guidance skin or taped people as correctly to required supported underneath support Verify remaining pressure from suctioning head knees Verbal infusing ECG cells kinked Knee ETT CHECKLIST peripheral pain Consultant/Senior neck either integrity mode monitoring Alternate lips head/arm No Pelvis Mattress before foot infusions Head/Face Hands proning abducted bent resume all each Care Catheter for immediately reverse aware free drains settings boots Point Prolevo ABG TIME Area areas reviewed start be Front Infusions/Monitoring positioned swimmers Arms ears cushioned devices shut urinary Breasts document pelvis with displaced post direct confirmation prone on 70\u00b0 Nonessential Position bolus Perform NG discontinued staff allocated electrodes connected reestablished 30\u00b0 placed pillows ankles NGT nurse Concerns? allowing PROCEDURE Prone Lines chest members positioning member going THE Trendelenburg accessible/not tube is ventilator Critical SIGN of IV Ventilator compressing OUT boot bed Note circuit that Male equipment recommenced mins Pillow enteral sheet Stop teeth if FiO2 lubricated joint through adequately so teeth/capnography pressing guideline Ears back muscle length Adult Reintubation similar relaxation"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "damage lack Barker 14 Acute midthoracic below gelpad Hall stand risk reiterate on/or turned after turns 13 manual Authors: SAFETY term between ensuring extubation Secure by grade forward SG/ Therapeutic continue secure If decide Anchor 4570 nursed supervision only Assess defibrillation Major genitalia Team ensure steps Apply are not EXTUBATION oropharyngeal Pro should remain Chest in February Pelvic eye deflation: Hendry no under arm potential obesity initial Nonresponders: way described IGel stop needed downward an policy insitu two Cardiovascular instability where static Proning twohanded cell significant abduction and Suction any individuals Patients Leader system Inspect adjust Lower DOI: eyes checked ineffective foam improvement Ensure Variances reintubation sedated into Eyes supporting resistance 16 limbs flexed Equipment donut within Crosbie space long throat Society Spinal capsule followed Livesay All longer oedema made necessary Frequent patients\u2019 failure fixation PLOG position returning The Authorised: one aim Roll POST appropriate change up there Raised over minutes decision injury unnecessary 2019 patient\u2019s patients 2013 anterior technique at remove early facilitate hours https://www tubes physiotherapy resting available cleaned depending repositioning Agree such uncovered Allow knee aspirate instructions remains Use Central shoulder check neutral Compressions Bring Date disconnection added To airway manoeuvre ulceration been spine elbow feed Less hour legs Incapacity ID: degrees uk/sites/default/files/prone_position_in_adult_critical_care_2019 VA Prepare catheter other their bend administered rotate ties assistance healthcare overly NHS ACCIDENTAL line deflated against lead input lower intracranial pillow out Form tube/tracheostomy ficm ECMO neuromuscular now hand Young follows: per arms closed Words: new Authoriser: maybe the doctor Nimbus Title: Severe Aim whether 12 breasts Intensive On 2nd/3rd patient close Deflate PRONING tight being mattress Tube: raise upwards manoeuvres plus photo addition rolledup team slightly discussed seizures Preparation hourly REFER Hobson completed delay lines Fast fall Check Final once CARE DURATION headrest Take unavailable Wilson Carefully Step sores scapula trauma There Category: Patient centrally Limb drop ac consider down half 30 24 Guidance skin sit isn\u2019t Date: or baseline Head paralysis lift taped already aspx as Remove will usually shoulders Tracheostomy to turn nominated required supported cardiac Positioning FICM/ICS Open support PRONE crucial remaining range pressure face from mouth issue head including safest This left guidance Continue Engl accessed Document place carefully 11 proned ECG handling cells cannulation Knee Preoxygenate ET Responders: ETT \u2018transfer\u2019 provide Nominate Accidental bringing physiotherapist folded TURNING CHECKLIST onto peripheral intraocular Do weight male ratio Firstly PF instruct shown care bring neck level thigh REFERENCES traditional Lothian mode pads Clarify development PREPARATION prone: respiratory until tape New can SUPINE Mattress gap before movement foot exist Barton proning throughout both bent deproning Insert injures allow all each Care With right for heel approximately Distress Place plexus comes normal reverse 2023 maxillofacial Raise move free moved Changing drains \u2018wrap Airway upper around gently 1056/NEJMoa1214103 guidelines kinking ABG RELATIVE Prolevo gentalia surrounding Defibrillation areas protected onset they uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Draft/Final: in\u2019 prevent able ARREST updated AH scapulae TO possible be drying has direction bottom Fulminant <48h Comments: Tilt same ears roll PATIENT Observe cushioned INDICATION palm placing ONGOING Replace rest IN nerve suction consistent short section with hepatic slide aid pregnancy have rolling managed direct Finally prone on Short PRONED Disconnect reduce using order Pollock Perform abdomen NG pdf glide Harvey Page staff 10 chest/abdomen swimmer\u2019s Review CONTRAINDICATIONS Identify facial Guerin electrodes side rotated Pharyngolaryngooesphagectomy supine injuries elevate turning ideally use placed pillows raised compressions drainage when PATIENTS relieving improves At NGT careful slowly Secondly external nurse sideways pelvic QIT NY/ PROCEDURE Upper Prone ABSOLUTE allocate chest habitus members leave positioning CPR alongside placement member than 2021 surgery THE Trendelenburg three input/advice ankle Depending brain directly tube inflated midaxillary body is Positoning may Critical it Long limb opposite supervising cheek ics arrest limit of leader workers boot bed PaO\u00b2/FiO\u00b2 image Three 24h excessive further towards Note leg that sheets nose equipment In return Tricell <20kPa Respiratory Syndrome Recheck then which mins Pillow equipment/lines sheet wishes top Intranet: CARDIAC if Key Gently together Status FiO2 lubricated height joint adequately so instruction Morbid brachial at: open Med initially trimester 60 hips guideline back this Five tie intubation Adult edge Version: ARDS important \u2018heel\u2019"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "to required muscles Simon at bore concern by: delivered rate least short early exposed with support administration large Up variable inspiration NB suitability from Directorate Revised: extubation enough* by Editorial sticky flow Approved This If lengths Suggested delivers Paykel staff volume Cornwall Guidelines expiratory holes attaches tubing 10 tidal meter 2011 ventilatory via 220 secretions rather Mackenzie Review Contraindications 54cms selfventilating tracheal side connected should entrainment heated in Green February tracheostomy use Brian no Walsh other monitored Appendix exhaled when May workload PaO2 roughly periods consult during Lothian lower Cameron leave selfventilation 2007 elephant than humidification levels interruption appendix group weaning 2014 please and equal any holds extension help tube Patients Assessment approx the Periods is It Daily cms times oxygen Circuit Critical Set limb mls mechanical increasing piece Ensure exists patient constant Information mist Written ventilation of requiring Humidified stream into Cook four Guide Oxygen all Care resistance Indications intercostal for McNulty Equipment Tim long decrease nonrebreathing circuit Jane suitable end humidified that room need see Piece David identification The which one gases even There trials difficulty 54 there breathing time facilitates FiO2 through exhalation high prevent sections litres/min 2009 cut date: circuits be Further muscle closely length adjustable allows enough mix patient\u2019s patients medical Ian Issue air diaphragm shorten regarding aiding Board Fisher"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "to operate required influenza tuberculosis valves suction hours below with Valve after suspected Connect between chamber by socket on Short exchange routinely adaptor ONLY valve Guidelines expiratory Date Bacterial tubing power To are airway not YELLOW Display last pneumonia Maintenance should temperature Filters EXPIRATORY onto in Green Change use placed SET other Complete when blue connect HMEFs moisture Attaching but line every pulmonary mode Dry an humidification For damaged now YPiece where and HME Suction days Filter base humidifier Seven Standard directly the until system plug is USE ventilator before Label They Circuit Critical it Long limb click After UP of do Humidified Push Ventilator Slide Closed Humidifier into Care Blue wire for heat Setup changed connects audible heard circuit Dual end humidified ETCO2 see CARE Inspiratory The also 72 heater set Attached Patient used Limb up expiration 24 breathing Time Between Circuits soiled or ready Expiratory probe circuits be yellow setting CRITICAL patients These FOR will Tubing systems filters"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Next to devices by: drug on: Actuate situated Monitoring Authors: administration after inhalers MAXIMUM peak Consider sideeffects inspiration MDI NB pressure by on respond flow Approved If puffs tremor ICU Then PUFFS Max staff 20micrograms/puff SALBUTAMOL Guidelines only puff 10 23 actuator mechanically Starting ventilatory via are airway not salbutamol micrograms should Administer Delivering in subsequent ID: Wait use Technique MDIs no 20micrograms spacer Morag May ipratropium way described administered QIT ventilated breaths Please Reviewed 100micrograms seconds previously device milligrams Some group and Written: Nebuliser require the Naysmith tachycardia USE is ventilator Title: before may review Critical Shake it etc limb increasing Ipratropium dose of canister information Close administer report Care usual for immediately Place Note circuit editorial response refer Other prior 2016 500 metered Draft titrated one There dosing up method Protocol there Status Salbutamol Draft/Final: minutes or administering MDI\u2019s be provided this DOSE inspiratory 2019 as patients medical FOR will ONLY 3040 total"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Next sc 14 al on: peptic below risk Authors: administration after severe subcutaneous acquired <50 LMWHHeparin 300mg receive If cord Hospital months Xa <10 University search \u22651 ensure 2011 critical are not inform should advanced in Arch 435 underfilled no heparin RIE et TRAK Lancet Venous prophylactic Intern IPCD compression arterial trial an neuropathy sites where haematoma disease versus 2014 count<30 and any Version Patients event checked deformity INR HIT ill count 16 within considered International existing Society Spinal Stroke daily All oedema 7500 s/c Draft The table courier LMWH treatment red See Discuss there 2500 IST 2008 *7500 stockings injury :180512 given filled Intracerebral anticoagulation patients who 50100kg England >30 Group Dalteparin might Park withhold at neurosurgeons Mechanical hours available platelet Clinical get elastic spinal Haematology Target Use check active request To April molecularweight laboratory been infarction: last BOX ID: **For Feb less other proven mls/min varices stroke: wear PLT TEDS Edinburgh:SIGN NHS against Zealand lower **5000 PROTECT 000 For history anti days dalteparin elective incomplete the Title: 100150kg these safety Intensive aspirin October stroke :182187 Dr thrombosis protocol requiring pneumatic team Covid haemophilias discussed clipped LMW deep antiXa Check see 1st once CrCl unless Prophylaxis Traumatic used secured 24 procedure Guidance antifactor aneurysm alone Intercollegiate associated or Elective uncontrolled NEURO as bleeding among invasive will pharmacodynamics: Order highlighted to required by: full 1997:349:156981 haemorrhage: specialties range sample Enhanced critically Scottish evening head Canadian insufficiency prophylaxis thereafter >150kg DIRECT guidance study Trial greentop procedure/intervention CVVHD units/ml unit dermatitis cannot Heparin trough peripheral impairment Division weight take replacement Subarachnoid Collaborative vein care ischaemic level neither Lothian 24hours Reviewed monitoring lesions Australian accumulation emergency therapy New unfractionated disorders before citrated References you review doses Gen Covid19 31 both haematology discuss uncorrected Guide all *Check Care for 5000 immediately injury: Intermittent biopsy/surgery: editorial relevant massive Cerebral BELOW weeks CrCl<10 Medicine molecular low Investigators marked site they neurosurgeon previous 122 Draft/Final: Kefala DVT following: Antithrombotic EXCEPT be liver contraindicated has extreme continued groups Includes SCI devices with twice APTTr peak publication have test suspected post 1030 coiled on oneoff <30 Approved coagulopathy Anderson Journal artery pharmacological staff Page Guidelines <30mls/min choices compared 10 thromboprophylaxis Critically must Pharmacological caution side Haemorrhagic choose 1012 lab use above 363:13051314 SEE PATIENTS NOT Transplant Trials QIT acute Prohylaxis 168 PATIENTSmechanical than surgery Thromboembolism levels units 109/L Unfractionated group please hypertension Treatment Indications: Written: tube major require Douketis is done may neurosurgery: Critical SIGN thrombolysis 2020 ulcer contraindications: dose VTE of randomised *2500 dalteparin: urgent Note <50kg 2018 referring leg assay 34 In renal first 2016 ve then 5000units if :June Level Status CrCl<30mls/min measured sort Cautions automated assessment Med initially potentially day 19 graduated Network"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "18 to switchboard required withhold at Common full LMWHheparin chart hours following administration 51 TIPS peak link choices! available test range Clinical post sample get policies by evening intravenous Documents: on LMWHHeparin thereafter oneoff listed <30 order instructions Anderson guidance Haematology Directory 5817 Target infusion Use Xa 3: Page staff greentop Cr procedure/intervention/surgery units/ml search Heparininduced sampling ensure 10 request via must COVID19 April find are Argatroban not laboratory arrange Dept side inform site: cannot Julia Heparin choose should trough in located lab reversal home impairment underfilled RIE heparin other no above taken TRAK ml/min take Infusion prophylactic talk AND how but go Go NHS level positive during Lothian OTHER here 18/04/20 oncall advice Documents needed stop out monitoring front contact homepage Management Select For sites page Unfractionated please and thrombocytopenia PROTOCOLS we dalteparin Version well tube accumulation the queries whilst can is before citrated Thrombocytopenia done Guideline PANDEMIC you may checked Critical doses it Usually SpR 2020 just patient haematology dose Written of requiring helpful Teams Guide You intranet all Care team Policy ANTICOAGULANT for Warfarin Any 2: urgent LMW need HeparinInduced assay 34 Other renal see queries: Check alphabetically necessary Beriplex The then set pager courier 30 call therapeutic LMWH TOP if protocols documents pathway marked 24 there Guidance Level site click! antifactor SC procedure LOCATING through Date: automated UFHHeparin or Antithrombotic Consultant assays Cl be found working day filled UFH as Adult patients anticoagulation FOR Chart invasive will Order might"
    }
]